{
 "cells": [
  {
   "attachments": {
    "fa2690c6-6d2c-48c5-9560-3ef7e4fe87e5.png": {
     "image/png": "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"
    }
   },
   "cell_type": "markdown",
   "id": "79499a96-e985-468f-82dd-c1bd050258c2",
   "metadata": {},
   "source": [
    "![images.png](attachment:fa2690c6-6d2c-48c5-9560-3ef7e4fe87e5.png)\n",
    "\n",
    "# mHealth Industry Exploratory Analysis\n",
    "DataSource: Crunchbase \n",
    "\n",
    "Last Edited Date : Aug 15, 2024\n",
    "\n",
    "For full interpretation of the analysis, please visit Medium (LINK)\n",
    "\n",
    "Author: Celine Liu"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "8f6845df-1514-4ce9-b2b6-673c37e9d769",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import datetime"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0d55ee62-55c4-4b3e-9aa0-d0a1e622c83b",
   "metadata": {},
   "source": [
    "# Load Datasets\n",
    "\n",
    "#### Dataset #1 \n",
    "#### Filter Criteria: MHealth Company; Founded after 2020; ordered by total funding descending; limit top 50\n",
    "#### Datasource: Crunchbase\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "e75f55b4-ab6a-4735-81b6-ae34122902b5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industries</th>\n",
       "      <th>Headquarters Location</th>\n",
       "      <th>Description</th>\n",
       "      <th>CB Rank (Company)</th>\n",
       "      <th>Estimated Revenue Range</th>\n",
       "      <th>Website</th>\n",
       "      <th>Company Type</th>\n",
       "      <th>Founded Date</th>\n",
       "      <th>Operating Status</th>\n",
       "      <th>Full Description</th>\n",
       "      <th>...</th>\n",
       "      <th>Funding Status</th>\n",
       "      <th>Last Funding Date</th>\n",
       "      <th>Last Funding Amount</th>\n",
       "      <th>Total Funding Amount</th>\n",
       "      <th>Last Funding Type</th>\n",
       "      <th>Last Equity Funding Amount</th>\n",
       "      <th>Last Equity Funding Type</th>\n",
       "      <th>Total Equity Funding Amount</th>\n",
       "      <th>Top 5 Investors</th>\n",
       "      <th>IPO Status</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Organization Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Cerebral</th>\n",
       "      <td>Health Care, Medical, Mental Health, mHealth, ...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Cerebral is a mental health telemedicine compa...</td>\n",
       "      <td>24,597</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>cerebral.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cerebral is a mental health telemedicine compa...</td>\n",
       "      <td>...</td>\n",
       "      <td>Late Stage Venture</td>\n",
       "      <td>08-Dec-21</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...</td>\n",
       "      <td>Private</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Harbor Health</th>\n",
       "      <td>Health Care, Medical, mHealth, Personal Health...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Harbor Health is a multi-specialty clinic grou...</td>\n",
       "      <td>5,140</td>\n",
       "      <td>—</td>\n",
       "      <td>harborhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Harbor Health is a multi-specialty clinic grou...</td>\n",
       "      <td>...</td>\n",
       "      <td>Early Stage Venture</td>\n",
       "      <td>11-Jan-24</td>\n",
       "      <td>$95,500,000</td>\n",
       "      <td>$125,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$95,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$125,500,000</td>\n",
       "      <td>General Catalyst, 8VC, Alta Partners, Martin V...</td>\n",
       "      <td>Private</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Avi Medical</th>\n",
       "      <td>Health Care, Medical, mHealth, Personal Health</td>\n",
       "      <td>Munich, Bayern, Germany</td>\n",
       "      <td>Avi Medical is a digital health care company t...</td>\n",
       "      <td>7,992</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>avimedical.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Avi Medical is a digital health care company t...</td>\n",
       "      <td>...</td>\n",
       "      <td>Early Stage Venture</td>\n",
       "      <td>06-Apr-22</td>\n",
       "      <td>€ 50,000,000</td>\n",
       "      <td>€ 88,500,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>€ 50,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>€ 88,500,000</td>\n",
       "      <td>Eurazeo, Picus Capital, 3VC, Operator Partners...</td>\n",
       "      <td>Private</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                          Industries  \\\n",
       "Organization Name                                                      \n",
       "Cerebral           Health Care, Medical, Mental Health, mHealth, ...   \n",
       "Harbor Health      Health Care, Medical, mHealth, Personal Health...   \n",
       "Avi Medical           Health Care, Medical, mHealth, Personal Health   \n",
       "\n",
       "                                      Headquarters Location  \\\n",
       "Organization Name                                             \n",
       "Cerebral           San Francisco, California, United States   \n",
       "Harbor Health                  Austin, Texas, United States   \n",
       "Avi Medical                         Munich, Bayern, Germany   \n",
       "\n",
       "                                                         Description  \\\n",
       "Organization Name                                                      \n",
       "Cerebral           Cerebral is a mental health telemedicine compa...   \n",
       "Harbor Health      Harbor Health is a multi-specialty clinic grou...   \n",
       "Avi Medical        Avi Medical is a digital health care company t...   \n",
       "\n",
       "                  CB Rank (Company) Estimated Revenue Range           Website  \\\n",
       "Organization Name                                                               \n",
       "Cerebral                     24,597          $100M to $500M      cerebral.com   \n",
       "Harbor Health                 5,140                       —  harborhealth.com   \n",
       "Avi Medical                   7,992           Less than $1M    avimedical.com   \n",
       "\n",
       "                  Company Type Founded Date Operating Status  \\\n",
       "Organization Name                                              \n",
       "Cerebral            For Profit         2020           Active   \n",
       "Harbor Health       For Profit         2022           Active   \n",
       "Avi Medical         For Profit         2020           Active   \n",
       "\n",
       "                                                    Full Description  ...  \\\n",
       "Organization Name                                                     ...   \n",
       "Cerebral           Cerebral is a mental health telemedicine compa...  ...   \n",
       "Harbor Health      Harbor Health is a multi-specialty clinic grou...  ...   \n",
       "Avi Medical        Avi Medical is a digital health care company t...  ...   \n",
       "\n",
       "                        Funding Status Last Funding Date Last Funding Amount  \\\n",
       "Organization Name                                                              \n",
       "Cerebral            Late Stage Venture         08-Dec-21       $300,000,000    \n",
       "Harbor Health      Early Stage Venture         11-Jan-24        $95,500,000    \n",
       "Avi Medical        Early Stage Venture         06-Apr-22        € 50,000,000   \n",
       "\n",
       "                  Total Funding Amount Last Funding Type  \\\n",
       "Organization Name                                          \n",
       "Cerebral                 $462,000,000           Series C   \n",
       "Harbor Health            $125,500,000           Series A   \n",
       "Avi Medical               € 88,500,000          Series B   \n",
       "\n",
       "                   Last Equity Funding Amount Last Equity Funding Type  \\\n",
       "Organization Name                                                        \n",
       "Cerebral                        $300,000,000                  Series C   \n",
       "Harbor Health                    $95,500,000                  Series A   \n",
       "Avi Medical                      € 50,000,000                 Series B   \n",
       "\n",
       "                  Total Equity Funding Amount  \\\n",
       "Organization Name                               \n",
       "Cerebral                        $462,000,000    \n",
       "Harbor Health                   $125,500,000    \n",
       "Avi Medical                      € 88,500,000   \n",
       "\n",
       "                                                     Top 5 Investors  \\\n",
       "Organization Name                                                      \n",
       "Cerebral           Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...   \n",
       "Harbor Health      General Catalyst, 8VC, Alta Partners, Martin V...   \n",
       "Avi Medical        Eurazeo, Picus Capital, 3VC, Operator Partners...   \n",
       "\n",
       "                  IPO Status  \n",
       "Organization Name             \n",
       "Cerebral             Private  \n",
       "Harbor Health        Private  \n",
       "Avi Medical          Private  \n",
       "\n",
       "[3 rows x 26 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Load excel file \n",
    "df_1 = pd.read_csv('MHealth Dataset.csv',index_col=\"Organization Name\")\n",
    "df_1.head(3)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "77e43072-4472-4f1f-87ee-b3e36d3928f1",
   "metadata": {},
   "source": [
    "#### Dataset #2\n",
    "#### Filter Criteria: Healthcare Company (includes Mhealth Companies); Founded after 2020; ordered by total funding descending; limit top 50\n",
    "#### Datasource: Crunchbase\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "fc005535-6097-4d8e-8bf8-7d3a432c5649",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industries</th>\n",
       "      <th>Headquarters Location</th>\n",
       "      <th>Description</th>\n",
       "      <th>CB Rank (Company)</th>\n",
       "      <th>Estimated Revenue Range</th>\n",
       "      <th>Website</th>\n",
       "      <th>Company Type</th>\n",
       "      <th>Founded Date</th>\n",
       "      <th>Operating Status</th>\n",
       "      <th>Full Description</th>\n",
       "      <th>...</th>\n",
       "      <th>Funding Status</th>\n",
       "      <th>Last Funding Date</th>\n",
       "      <th>Last Funding Amount</th>\n",
       "      <th>Total Funding Amount</th>\n",
       "      <th>Last Funding Type</th>\n",
       "      <th>Last Equity Funding Amount</th>\n",
       "      <th>Last Equity Funding Type</th>\n",
       "      <th>Total Equity Funding Amount</th>\n",
       "      <th>Top 5 Investors</th>\n",
       "      <th>IPO Status</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Organization Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Kenvue</th>\n",
       "      <td>Lifestyle, Personal Health, Wellness</td>\n",
       "      <td>Skillman, New Jersey, United States</td>\n",
       "      <td>Kenvue is a consumer health company that deliv...</td>\n",
       "      <td>3,970</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>kenvue.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2023</td>\n",
       "      <td>Active</td>\n",
       "      <td>Kenvue is a consumer health company that deliv...</td>\n",
       "      <td>...</td>\n",
       "      <td>IPO</td>\n",
       "      <td>14-May-24</td>\n",
       "      <td>$3,646,591,000</td>\n",
       "      <td>$3,646,591,000</td>\n",
       "      <td>Post-IPO Secondary</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Goldman Sachs, J.P. Morgan Securities Inc.</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cencora</th>\n",
       "      <td>Emergency Medicine, Enterprise Software, Healt...</td>\n",
       "      <td>Conshohocken, Pennsylvania, United States</td>\n",
       "      <td>Cencora is a global healthcare company that ad...</td>\n",
       "      <td>1,466</td>\n",
       "      <td>$10B+</td>\n",
       "      <td>cencora.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2023</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cencora, building on the legacy of Amerisource...</td>\n",
       "      <td>...</td>\n",
       "      <td>IPO</td>\n",
       "      <td>05-Feb-24</td>\n",
       "      <td>$500,000,000</td>\n",
       "      <td>$3,025,000,000</td>\n",
       "      <td>Post-IPO Debt</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Altos Labs</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care, Health ...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Altos Labs focuses on cellular rejuvenation pr...</td>\n",
       "      <td>2,590</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>altoslabs.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Altos Labs is a biotechnology company focused ...</td>\n",
       "      <td>...</td>\n",
       "      <td>Early Stage Venture</td>\n",
       "      <td>01-Jan-21</td>\n",
       "      <td>$3,000,000,000</td>\n",
       "      <td>$3,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$3,000,000,000</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>ARCH Venture Partners</td>\n",
       "      <td>Private</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                          Industries  \\\n",
       "Organization Name                                                      \n",
       "Kenvue                          Lifestyle, Personal Health, Wellness   \n",
       "Cencora            Emergency Medicine, Enterprise Software, Healt...   \n",
       "Altos Labs         Biopharma, Biotechnology, Health Care, Health ...   \n",
       "\n",
       "                                       Headquarters Location  \\\n",
       "Organization Name                                              \n",
       "Kenvue                   Skillman, New Jersey, United States   \n",
       "Cencora            Conshohocken, Pennsylvania, United States   \n",
       "Altos Labs          San Francisco, California, United States   \n",
       "\n",
       "                                                         Description  \\\n",
       "Organization Name                                                      \n",
       "Kenvue             Kenvue is a consumer health company that deliv...   \n",
       "Cencora            Cencora is a global healthcare company that ad...   \n",
       "Altos Labs         Altos Labs focuses on cellular rejuvenation pr...   \n",
       "\n",
       "                  CB Rank (Company) Estimated Revenue Range        Website  \\\n",
       "Organization Name                                                            \n",
       "Kenvue                        3,970             $1B to $10B     kenvue.com   \n",
       "Cencora                       1,466                   $10B+    cencora.com   \n",
       "Altos Labs                    2,590            $10M to $50M  altoslabs.com   \n",
       "\n",
       "                  Company Type Founded Date Operating Status  \\\n",
       "Organization Name                                              \n",
       "Kenvue              For Profit         2023           Active   \n",
       "Cencora             For Profit         2023           Active   \n",
       "Altos Labs          For Profit    15-Apr-21           Active   \n",
       "\n",
       "                                                    Full Description  ...  \\\n",
       "Organization Name                                                     ...   \n",
       "Kenvue             Kenvue is a consumer health company that deliv...  ...   \n",
       "Cencora            Cencora, building on the legacy of Amerisource...  ...   \n",
       "Altos Labs         Altos Labs is a biotechnology company focused ...  ...   \n",
       "\n",
       "                        Funding Status Last Funding Date Last Funding Amount  \\\n",
       "Organization Name                                                              \n",
       "Kenvue                             IPO         14-May-24     $3,646,591,000    \n",
       "Cencora                            IPO         05-Feb-24       $500,000,000    \n",
       "Altos Labs         Early Stage Venture         01-Jan-21     $3,000,000,000    \n",
       "\n",
       "                  Total Funding Amount   Last Funding Type  \\\n",
       "Organization Name                                            \n",
       "Kenvue                 $3,646,591,000   Post-IPO Secondary   \n",
       "Cencora                $3,025,000,000        Post-IPO Debt   \n",
       "Altos Labs             $3,000,000,000             Series A   \n",
       "\n",
       "                   Last Equity Funding Amount Last Equity Funding Type  \\\n",
       "Organization Name                                                        \n",
       "Kenvue                                      —                        —   \n",
       "Cencora                                     —                        —   \n",
       "Altos Labs                    $3,000,000,000                         —   \n",
       "\n",
       "                  Total Equity Funding Amount  \\\n",
       "Organization Name                               \n",
       "Kenvue                                      —   \n",
       "Cencora                                     —   \n",
       "Altos Labs                                  —   \n",
       "\n",
       "                                              Top 5 Investors IPO Status  \n",
       "Organization Name                                                         \n",
       "Kenvue             Goldman Sachs, J.P. Morgan Securities Inc.     Public  \n",
       "Cencora                                                     —     Public  \n",
       "Altos Labs                              ARCH Venture Partners    Private  \n",
       "\n",
       "[3 rows x 26 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_2 = pd.read_csv ('HealthCare Dataset.csv',index_col = \"Organization Name\")\n",
    "df_2.head(3)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "44b0ce23-44f4-4b66-a466-7c26b161a3a2",
   "metadata": {},
   "source": [
    "# Data Cleaning and Preparation\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "85934410-9590-4f8d-8f50-ec8b43e51bdf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Industries                     0\n",
       "Total Equity Funding Amount    0\n",
       "Last Equity Funding Type       0\n",
       "Last Equity Funding Amount     0\n",
       "Last Funding Type              0\n",
       "Total Funding Amount           0\n",
       "Last Funding Amount            0\n",
       "Last Funding Date              0\n",
       "Funding Status                 0\n",
       "Number of Funding Rounds       0\n",
       "Number of Employees            0\n",
       "Founders                       0\n",
       "Industry Groups                0\n",
       "Investment Stage               0\n",
       "Investor Type                  0\n",
       "Full Description               0\n",
       "Operating Status               0\n",
       "Founded Date                   0\n",
       "Company Type                   0\n",
       "Website                        0\n",
       "Estimated Revenue Range        0\n",
       "CB Rank (Company)              0\n",
       "Description                    0\n",
       "Headquarters Location          0\n",
       "Top 5 Investors                0\n",
       "IPO Status                     1\n",
       "dtype: int64"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#check null value \n",
    "df_1.isnull().sum().sort_values()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "4f9e7de5-e78b-4d31-bc24-4fc874065f6f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Industries                     0\n",
       "Total Equity Funding Amount    0\n",
       "Last Equity Funding Type       0\n",
       "Last Equity Funding Amount     0\n",
       "Last Funding Type              0\n",
       "Total Funding Amount           0\n",
       "Last Funding Amount            0\n",
       "Last Funding Date              0\n",
       "Funding Status                 0\n",
       "Number of Funding Rounds       0\n",
       "Number of Employees            0\n",
       "Founders                       0\n",
       "Industry Groups                0\n",
       "Investment Stage               0\n",
       "Investor Type                  0\n",
       "Full Description               0\n",
       "Operating Status               0\n",
       "Founded Date                   0\n",
       "Company Type                   0\n",
       "Website                        0\n",
       "Estimated Revenue Range        0\n",
       "CB Rank (Company)              0\n",
       "Description                    0\n",
       "Headquarters Location          0\n",
       "Top 5 Investors                0\n",
       "IPO Status                     0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_2.isnull().sum().sort_values()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "39316f95-a5fb-429e-834c-8eda2f02bbc0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False])"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#check duplicative company \n",
    "df_1.index.duplicated()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "02acf547-ad29-4465-9ad2-0c1ff6031c06",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False, False, False, False, False,\n",
       "       False, False, False, False, False])"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_2.index.duplicated()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "b46a4a23-d894-4ce4-b63f-9810a9fde0bf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industries</th>\n",
       "      <th>Headquarters Location</th>\n",
       "      <th>Description</th>\n",
       "      <th>CB Rank (Company)</th>\n",
       "      <th>Estimated Revenue Range</th>\n",
       "      <th>Website</th>\n",
       "      <th>Company Type</th>\n",
       "      <th>Founded Date</th>\n",
       "      <th>Operating Status</th>\n",
       "      <th>Full Description</th>\n",
       "      <th>...</th>\n",
       "      <th>Last Funding Date</th>\n",
       "      <th>Last Funding Amount</th>\n",
       "      <th>Total Funding Amount</th>\n",
       "      <th>Last Funding Type</th>\n",
       "      <th>Last Equity Funding Amount</th>\n",
       "      <th>Last Equity Funding Type</th>\n",
       "      <th>Total Equity Funding Amount</th>\n",
       "      <th>Top 5 Investors</th>\n",
       "      <th>IPO Status</th>\n",
       "      <th>Country</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Organization Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Cerebral</th>\n",
       "      <td>Health Care, Medical, Mental Health, mHealth, ...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Cerebral is a mental health telemedicine compa...</td>\n",
       "      <td>24,597</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>cerebral.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cerebral is a mental health telemedicine compa...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Dec-21</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Harbor Health</th>\n",
       "      <td>Health Care, Medical, mHealth, Personal Health...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Harbor Health is a multi-specialty clinic grou...</td>\n",
       "      <td>5,140</td>\n",
       "      <td>—</td>\n",
       "      <td>harborhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Harbor Health is a multi-specialty clinic grou...</td>\n",
       "      <td>...</td>\n",
       "      <td>11-Jan-24</td>\n",
       "      <td>$95,500,000</td>\n",
       "      <td>$125,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$95,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$125,500,000</td>\n",
       "      <td>General Catalyst, 8VC, Alta Partners, Martin V...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Avi Medical</th>\n",
       "      <td>Health Care, Medical, mHealth, Personal Health</td>\n",
       "      <td>Munich, Bayern, Germany</td>\n",
       "      <td>Avi Medical is a digital health care company t...</td>\n",
       "      <td>7,992</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>avimedical.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Avi Medical is a digital health care company t...</td>\n",
       "      <td>...</td>\n",
       "      <td>06-Apr-22</td>\n",
       "      <td>€ 50,000,000</td>\n",
       "      <td>€ 88,500,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>€ 50,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>€ 88,500,000</td>\n",
       "      <td>Eurazeo, Picus Capital, 3VC, Operator Partners...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>BetterVet</th>\n",
       "      <td>Health Care, mHealth, Veterinary</td>\n",
       "      <td>Boston, Massachusetts, United States</td>\n",
       "      <td>BetterVet is a veterinary startup that provide...</td>\n",
       "      <td>12,253</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>bettervet.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>01-Jul-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>BetterVet is a veterinary startup that provide...</td>\n",
       "      <td>...</td>\n",
       "      <td>28-Mar-24</td>\n",
       "      <td>$17,928,818</td>\n",
       "      <td>$57,928,818</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$17,928,818</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$57,928,818</td>\n",
       "      <td>Alta Partners, Daniel J Adams, Bruce Herzfelder</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Antidote Health</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, mHe...</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Antidote Health offers an AI-based health plat...</td>\n",
       "      <td>8,740</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>antidotehealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>15-Mar-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Antidote Health offers an AI-based health plat...</td>\n",
       "      <td>...</td>\n",
       "      <td>30-Nov-23</td>\n",
       "      <td>$13,000,000</td>\n",
       "      <td>$56,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$13,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$56,000,000</td>\n",
       "      <td>iAngels, Google for Startups, Flint Capital, G...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Pace</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Social, W...</td>\n",
       "      <td>California City, California, United States</td>\n",
       "      <td>Pace provides online peer support groups to gi...</td>\n",
       "      <td>12,690</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>pace.group</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Inactive</td>\n",
       "      <td>Pace is a mental fitness and social wellness p...</td>\n",
       "      <td>...</td>\n",
       "      <td>16-Dec-21</td>\n",
       "      <td>$13,000,000</td>\n",
       "      <td>$50,900,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$13,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$50,900,000</td>\n",
       "      <td>Sequoia Capital, BoxGroup, SV Angel, Pace Capi...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>DeepCardio</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, mHe...</td>\n",
       "      <td>Seoul, Seoul-t'ukpyolsi, South Korea</td>\n",
       "      <td>DeepCardio develops artificial intelligence te...</td>\n",
       "      <td>78,967</td>\n",
       "      <td>—</td>\n",
       "      <td>deepcardio.net</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>—</td>\n",
       "      <td>...</td>\n",
       "      <td>17-Feb-22</td>\n",
       "      <td>₩40,000,000,000</td>\n",
       "      <td>₩40,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>₩40,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>₩40,000,000,000</td>\n",
       "      <td>SoftBank, Dayli Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>South Korea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Brisk Health</th>\n",
       "      <td>Health Care, Home Health Care, Medical, mHealt...</td>\n",
       "      <td>Denver, Colorado, United States</td>\n",
       "      <td>All-Inclusive Healthcare</td>\n",
       "      <td>31,918</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>briskhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Oct</td>\n",
       "      <td>Active</td>\n",
       "      <td>Brisk Health developed the most advanced mobil...</td>\n",
       "      <td>...</td>\n",
       "      <td>26-Dec-23</td>\n",
       "      <td>$1,000,000</td>\n",
       "      <td>$27,080,000</td>\n",
       "      <td>Series D</td>\n",
       "      <td>$1,000,000</td>\n",
       "      <td>Series D</td>\n",
       "      <td>$27,080,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Courier Health</th>\n",
       "      <td>Health Care, Medical, mHealth</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Courier Health develops a patient engagement p...</td>\n",
       "      <td>720</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>courierhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Courier Health develops a patient engagement p...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Jul-24</td>\n",
       "      <td>$16,500,000</td>\n",
       "      <td>$20,450,002</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$16,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$20,450,002</td>\n",
       "      <td>Norwest Venture Partners, Work-Bench</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cartwheel</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Therapeut...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Cartwheel offers mental health support to stud...</td>\n",
       "      <td>10,286</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.cartwheelcare.org</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cartwheel offers mental health support to stud...</td>\n",
       "      <td>...</td>\n",
       "      <td>26-Sep-23</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Reach Capital, Menlo Ventures, General Catalys...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Clearing</th>\n",
       "      <td>Consumer, Health Care, mHealth, Wellness</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Clearing is a healthcare platform focused on p...</td>\n",
       "      <td>19,828</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.clearing.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Jul</td>\n",
       "      <td>Active</td>\n",
       "      <td>Clearing is a digital healthcare platform buil...</td>\n",
       "      <td>...</td>\n",
       "      <td>25-May-21</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Hims &amp; Hers, Grubhub, Founders Fund, Bessemer ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cardo Health</th>\n",
       "      <td>Health Care, mHealth</td>\n",
       "      <td>Stockholm, Stockholms Lan, Sweden</td>\n",
       "      <td>Cardo Health is a digital health company with ...</td>\n",
       "      <td>40,403</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>cardohealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cardo Health is a digital health company with ...</td>\n",
       "      <td>...</td>\n",
       "      <td>11-Jan-22</td>\n",
       "      <td>$17,500,000</td>\n",
       "      <td>$17,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$17,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$17,500,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>Sweden</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Anima</th>\n",
       "      <td>Health Care, Medical, mHealth, Mobile Apps</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>The next generation care enablement platform</td>\n",
       "      <td>8,353</td>\n",
       "      <td>—</td>\n",
       "      <td>www.animahealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Anima is a next generation clinical operating ...</td>\n",
       "      <td>...</td>\n",
       "      <td>19-Mar-24</td>\n",
       "      <td>$12,000,000</td>\n",
       "      <td>$14,625,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$12,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$14,625,000</td>\n",
       "      <td>Y Combinator, Molten Ventures, Hummingbird Ven...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oliva Health</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Personal ...</td>\n",
       "      <td>Barcelona, Catalonia, Spain</td>\n",
       "      <td>Employee Mental Well-Being Platform</td>\n",
       "      <td>13,133</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.oliva.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Oliva Therapy is an online therapy for busy pe...</td>\n",
       "      <td>...</td>\n",
       "      <td>22-Jun-23</td>\n",
       "      <td>£4,260,000</td>\n",
       "      <td>£10,720,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£4,260,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£10,720,000</td>\n",
       "      <td>Alumni Ventures, Molten Ventures, Moonfire Ven...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Spain</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Inflow</th>\n",
       "      <td>Health Care, mHealth, Wellness</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>Inflow develops a science-based digital progra...</td>\n",
       "      <td>88,841</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.getinflow.io</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Inflow develops a science-based digital progra...</td>\n",
       "      <td>...</td>\n",
       "      <td>11-Jan-23</td>\n",
       "      <td>$11,000,000</td>\n",
       "      <td>$13,980,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$11,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$13,980,000</td>\n",
       "      <td>Y Combinator, Octopus Ventures, Route 66 Ventu...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Likeminded</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Wellness</td>\n",
       "      <td>Berlin, Berlin, Germany</td>\n",
       "      <td>Likeminded operates a digital platform for men...</td>\n",
       "      <td>11,739</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>www.likeminded.care</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Likeminded operates a digital platform for men...</td>\n",
       "      <td>...</td>\n",
       "      <td>26-Oct-23</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>€ 10,900,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 10,900,000</td>\n",
       "      <td>Heartcore Capital, IBB Ventures, Holtzbrinck D...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Heading Health</th>\n",
       "      <td>Health Care, Medical, Mental Health, mHealth, ...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Heading Health is a technology-enabled mental ...</td>\n",
       "      <td>14,148</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>headinghealth.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Heading Health is a technology-enabled mental ...</td>\n",
       "      <td>...</td>\n",
       "      <td>21-Dec-23</td>\n",
       "      <td>—</td>\n",
       "      <td>$9,978,120</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>—</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$9,878,120</td>\n",
       "      <td>Alumni Ventures, Global Brain Corporation, Gai...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Violet</th>\n",
       "      <td>Health Care, Medical, mHealth</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Violet is a platform that helps the healthcare...</td>\n",
       "      <td>26,457</td>\n",
       "      <td>—</td>\n",
       "      <td>www.joinviolet.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Feb</td>\n",
       "      <td>Active</td>\n",
       "      <td>Violet is a platform that helps the healthcare...</td>\n",
       "      <td>...</td>\n",
       "      <td>15-Aug-22</td>\n",
       "      <td>$5,300,000</td>\n",
       "      <td>$6,800,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,300,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$6,800,000</td>\n",
       "      <td>The Venture Collective, SemperVirens Venture C...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Anebulo Pharmaceuticals</th>\n",
       "      <td>Biotechnology, Life Science, mHealth</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Anebulo is a biotech company developing novel ...</td>\n",
       "      <td>11,250</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.anebulo.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Anebulo is a clinical-stage biotechnology comp...</td>\n",
       "      <td>...</td>\n",
       "      <td>22-Jul-24</td>\n",
       "      <td>$900,000</td>\n",
       "      <td>$7,500,000</td>\n",
       "      <td>Grant</td>\n",
       "      <td>$6,600,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$6,600,000</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA), Merid...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alyve Health</th>\n",
       "      <td>Health Care, mHealth, Wellness</td>\n",
       "      <td>Mumbai, Maharashtra, India</td>\n",
       "      <td>Alyve Health is a tech platform providing pers...</td>\n",
       "      <td>425</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.alyve.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>18-May-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Imagine a healthcare ecosystem where care meet...</td>\n",
       "      <td>...</td>\n",
       "      <td>18-Jun-24</td>\n",
       "      <td>₹450,000,000</td>\n",
       "      <td>$6,288,066</td>\n",
       "      <td>Series A</td>\n",
       "      <td>₹450,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$6,288,066</td>\n",
       "      <td>1Crowd, Axilor Ventures, Trifecta Capital Advi...</td>\n",
       "      <td>Private</td>\n",
       "      <td>India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Radicle Science</th>\n",
       "      <td>Dietary Supplements, Health Care, mHealth, Wel...</td>\n",
       "      <td>San Diego, California, United States</td>\n",
       "      <td>Radicle Science is a health tech company that ...</td>\n",
       "      <td>26,451</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>radiclescience.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>AI-driven healthtech B-Corp providing history'...</td>\n",
       "      <td>...</td>\n",
       "      <td>30-Mar-22</td>\n",
       "      <td>—</td>\n",
       "      <td>$5,999,716</td>\n",
       "      <td>Seed</td>\n",
       "      <td>—</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,999,716</td>\n",
       "      <td>Everywhere Ventures (The Fund), Wayne Chang, S...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Behavidence</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Mobile Apps</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Behavidence develops tools to monitor and mana...</td>\n",
       "      <td>29,177</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.behavidence.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Jun</td>\n",
       "      <td>Active</td>\n",
       "      <td>Behavidence utilizes AI to detect and monitor ...</td>\n",
       "      <td>...</td>\n",
       "      <td>10-Mar-22</td>\n",
       "      <td>$4,300,000</td>\n",
       "      <td>$5,625,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,300,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,625,000</td>\n",
       "      <td>Fusion, GoAhead Ventures, Kicker Ventures, Lon...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>MYNDUP</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Personal ...</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>Live 1-1 virtual mental health sessions to sto...</td>\n",
       "      <td>47,661</td>\n",
       "      <td>—</td>\n",
       "      <td>www.myndup.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Feb</td>\n",
       "      <td>Active</td>\n",
       "      <td>MYNDUP is stopping the “one size fits all” app...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Nov-22</td>\n",
       "      <td>£4,400,000</td>\n",
       "      <td>£4,700,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>£4,400,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>£4,700,000</td>\n",
       "      <td>Arpit Gupta</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Persimmon</th>\n",
       "      <td>Beauty, Cosmetic Surgery, Medical, mHealth, Te...</td>\n",
       "      <td>Larkspur, California, United States</td>\n",
       "      <td>Persimmon provides aesthetic treatments in the...</td>\n",
       "      <td>23,433</td>\n",
       "      <td>—</td>\n",
       "      <td>www.persimmon.life/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Persimmon is an in-home aesthetics teleHealth ...</td>\n",
       "      <td>...</td>\n",
       "      <td>18-Apr-23</td>\n",
       "      <td>$5,323,629</td>\n",
       "      <td>$5,323,629</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,323,629</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,323,629</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Elfie</th>\n",
       "      <td>Health Care, Home Health Care, Medical, mHealt...</td>\n",
       "      <td>Singapore, Central Region, Singapore</td>\n",
       "      <td>Elfie is a product that reduces the burden of ...</td>\n",
       "      <td>16,903</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.elfie.co</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>25-Oct-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Elfie is a product that reduces the burden of ...</td>\n",
       "      <td>...</td>\n",
       "      <td>15-May-23</td>\n",
       "      <td>$4,000,000</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>Google for Startups, Hustle Fund, FEBE Venture...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Singapore</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Comedi Health Technology Limited</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, Ima...</td>\n",
       "      <td>Hong Kong, Hong Kong Island, Hong Kong</td>\n",
       "      <td>Comedi Health is a platform that provides tele...</td>\n",
       "      <td>89,470</td>\n",
       "      <td>—</td>\n",
       "      <td>www.comedi.com.hk</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>31-May-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>COMEDI Health is a one-stop technology platfor...</td>\n",
       "      <td>...</td>\n",
       "      <td>01-Nov-21</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>Hong Kong</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tapouts</th>\n",
       "      <td>Apps, Health Care, Mental Health, mHealth, Mob...</td>\n",
       "      <td>Venice, California, United States</td>\n",
       "      <td>Mobile Mental Health Care</td>\n",
       "      <td>26,340</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.tapouts.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>12-Jan-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>tapouts is a mental health edutainment platfor...</td>\n",
       "      <td>...</td>\n",
       "      <td>16-Mar-24</td>\n",
       "      <td>$3,200,000</td>\n",
       "      <td>$4,800,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$3,200,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,800,000</td>\n",
       "      <td>M Venture Partners (MVP), Sidespin Ventures, R...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>TOM Medications</th>\n",
       "      <td>Health Care, mHealth, Mobile Apps, Personal He...</td>\n",
       "      <td>Uster, Zurich, Switzerland</td>\n",
       "      <td>TOM - Medications - Making therapies easier to...</td>\n",
       "      <td>72,709</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.tommedications.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Jan</td>\n",
       "      <td>Active</td>\n",
       "      <td>TOM Medications is a digital solution for pati...</td>\n",
       "      <td>...</td>\n",
       "      <td>25-Jan-23</td>\n",
       "      <td>CHF1,300,000</td>\n",
       "      <td>$4,762,184</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>CHF1,300,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$4,762,184</td>\n",
       "      <td>Galenica, Sanitas Disruptive</td>\n",
       "      <td>Private</td>\n",
       "      <td>Switzerland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Realize Me</th>\n",
       "      <td>Dietary Supplements, Fitness, Health Care, mHe...</td>\n",
       "      <td>Los Angeles, California, United States</td>\n",
       "      <td>The premium platform for health and performanc...</td>\n",
       "      <td>72,273</td>\n",
       "      <td>—</td>\n",
       "      <td>www.realize.me</td>\n",
       "      <td>—</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>—</td>\n",
       "      <td>...</td>\n",
       "      <td>27-Sep-21</td>\n",
       "      <td>$4,025,000</td>\n",
       "      <td>$4,025,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,025,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,025,000</td>\n",
       "      <td>Moonshots Capital</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Axenya</th>\n",
       "      <td>Health Care, Medical, mHealth</td>\n",
       "      <td>Montevideo, NA - Uruguay, Uruguay</td>\n",
       "      <td>Axenya is a digital health platform.</td>\n",
       "      <td>52,530</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.axenya.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Apr</td>\n",
       "      <td>Active</td>\n",
       "      <td>Axenya leverages the power of data to deliver ...</td>\n",
       "      <td>...</td>\n",
       "      <td>01-Aug-22</td>\n",
       "      <td>—</td>\n",
       "      <td>$4,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>—</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$4,000,000</td>\n",
       "      <td>NXTP Ventures, Igah Ventures, big_bets, Alexia...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Uruguay</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Phenomune</th>\n",
       "      <td>Health Care, mHealth, Wellness</td>\n",
       "      <td>Houston, Texas, United States</td>\n",
       "      <td>Phenomune engages in bringing general wellness...</td>\n",
       "      <td>98,808</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>phenomune.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Phenomune engages in bringing general wellness...</td>\n",
       "      <td>...</td>\n",
       "      <td>11-Aug-21</td>\n",
       "      <td>$3,300,000</td>\n",
       "      <td>$3,300,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$3,300,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$3,300,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Shen.AI @ MX Labs</th>\n",
       "      <td>Artificial Intelligence (AI), Health Diagnosti...</td>\n",
       "      <td>Tallinn, Harjumaa, Estonia</td>\n",
       "      <td>Shen.AI offers app &amp; tele-health integration f...</td>\n",
       "      <td>32,136</td>\n",
       "      <td>—</td>\n",
       "      <td>shen.ai</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Oct</td>\n",
       "      <td>Active</td>\n",
       "      <td>Shen.AI is clinically proven software technolo...</td>\n",
       "      <td>...</td>\n",
       "      <td>17-Mar-23</td>\n",
       "      <td>€ 100,000</td>\n",
       "      <td>$3,107,521</td>\n",
       "      <td>Grant</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$3,000,000</td>\n",
       "      <td>SMOK Ventures, Superhero Capital, Verge Health...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Estonia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Fleming</th>\n",
       "      <td>Apps, Health Care, Information Technology, mHe...</td>\n",
       "      <td>Vilnius, Vilniaus Apskritis, Lithuania</td>\n",
       "      <td>Fleming is a smart healthcare app that allows ...</td>\n",
       "      <td>68,562</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>fleming.app</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Fleming app is a smart way to take care of you...</td>\n",
       "      <td>...</td>\n",
       "      <td>01-Aug-21</td>\n",
       "      <td>€ 1,200,000</td>\n",
       "      <td>€ 2,510,030</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,200,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 2,510,030</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>Lithuania</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oska Health</th>\n",
       "      <td>Health Care, mHealth</td>\n",
       "      <td>Frankfurt, Hessen, Germany</td>\n",
       "      <td>A German-UK health-tech company delivering dig...</td>\n",
       "      <td>56,935</td>\n",
       "      <td>—</td>\n",
       "      <td>oska-health.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>25-Jul-22</td>\n",
       "      <td>Active</td>\n",
       "      <td>Oska Health delivers digital-enabled care solu...</td>\n",
       "      <td>...</td>\n",
       "      <td>06-Mar-23</td>\n",
       "      <td>€ 2,500,000</td>\n",
       "      <td>€ 2,500,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>€ 2,500,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>€ 2,500,000</td>\n",
       "      <td>Calm/Storm Ventures, LBBW VC, Hessen Kapital I...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PERSOWN</th>\n",
       "      <td>Health Care, Health Diagnostics, mHealth</td>\n",
       "      <td>Jacksonville, Florida, United States</td>\n",
       "      <td>PERSOWN provides a family health diagnostic so...</td>\n",
       "      <td>39,782</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>persown.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>PERSOWN provides a family health diagnostic so...</td>\n",
       "      <td>...</td>\n",
       "      <td>11-Mar-24</td>\n",
       "      <td>$110,000</td>\n",
       "      <td>$2,618,250</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$110,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,618,250</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Una Health</th>\n",
       "      <td>Artificial Intelligence (AI), Diabetes, Health...</td>\n",
       "      <td>Berlin, Berlin, Germany</td>\n",
       "      <td>The most effective Digital Therapy to reverse ...</td>\n",
       "      <td>57,957</td>\n",
       "      <td>—</td>\n",
       "      <td>unahealth.io</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Una Health uses mobile technology, biosensors,...</td>\n",
       "      <td>...</td>\n",
       "      <td>15-Feb-24</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>Plug and Play, PeakBridge, FoodLabs, Frank Wes...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Lifetime Health</th>\n",
       "      <td>Health Care, Health Diagnostics, Home Health C...</td>\n",
       "      <td>Bengaluru, Karnataka, India</td>\n",
       "      <td>Delivering healthcare to your doorstep with a ...</td>\n",
       "      <td>13,414</td>\n",
       "      <td>—</td>\n",
       "      <td>lifetimehealth.in/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>22-Mar-23</td>\n",
       "      <td>Active</td>\n",
       "      <td>We are a digital platform, transforming the he...</td>\n",
       "      <td>...</td>\n",
       "      <td>24-May-24</td>\n",
       "      <td>₹124,000,000</td>\n",
       "      <td>$2,392,919</td>\n",
       "      <td>Seed</td>\n",
       "      <td>₹124,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,392,919</td>\n",
       "      <td>SharesPro, The Garage Syndicate</td>\n",
       "      <td>Private</td>\n",
       "      <td>India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Legion Health</th>\n",
       "      <td>Elder Care, Health Care, Home Health Care, Men...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Legion Health is reimagining mental health.</td>\n",
       "      <td>35,432</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>legion.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Legion Health is backed by Y Combinator and th...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Mar-22</td>\n",
       "      <td>$2,000,000</td>\n",
       "      <td>$2,125,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,125,000</td>\n",
       "      <td>Y Combinator, Soma Capital, UpHonest Capital, ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ONVY HealthTech</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, Mac...</td>\n",
       "      <td>Munich, Bayern, Germany</td>\n",
       "      <td>AI-as-a-Service for the Health and Wellness In...</td>\n",
       "      <td>33,467</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.onvy.health/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>16-Jan-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Predictive health - powered by AI. The world's...</td>\n",
       "      <td>...</td>\n",
       "      <td>09-Aug-23</td>\n",
       "      <td>—</td>\n",
       "      <td>€ 2,650,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>—</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,400,000</td>\n",
       "      <td>New Forge, Isartal Ventures, Wort &amp; Bild Verla...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Ailin</th>\n",
       "      <td>Health Care, Medical Device, mHealth, Telehealth</td>\n",
       "      <td>Madrid, Madrid, Spain</td>\n",
       "      <td>Ailin offers digital health monitoring solutio...</td>\n",
       "      <td>57,002</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>ailin.es</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Ailin specializes in providing health and well...</td>\n",
       "      <td>...</td>\n",
       "      <td>19-Feb-24</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>Decelera, Centre for the Development of Indust...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Spain</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Malaica</th>\n",
       "      <td>Health Care, mHealth, Women's</td>\n",
       "      <td>Nairobi, Nairobi Area, Kenya</td>\n",
       "      <td>Malaica is a digital healthcare firm that offe...</td>\n",
       "      <td>52,863</td>\n",
       "      <td>—</td>\n",
       "      <td>malaica.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>22-Jan</td>\n",
       "      <td>Active</td>\n",
       "      <td>Malaica is on a mission to make the pregnancy ...</td>\n",
       "      <td>...</td>\n",
       "      <td>10-Jul-24</td>\n",
       "      <td>$1,000,000</td>\n",
       "      <td>$1,600,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>$1,000,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>$1,600,000</td>\n",
       "      <td>Markus Gemuend, Kapor Capital</td>\n",
       "      <td>Private</td>\n",
       "      <td>Kenya</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Small Joys</th>\n",
       "      <td>Health Care, mHealth, Personal Health, Wellness</td>\n",
       "      <td>Fort Lee, New Jersey, United States</td>\n",
       "      <td>Small Joys is a pediatric behavioral health co...</td>\n",
       "      <td>83,107</td>\n",
       "      <td>—</td>\n",
       "      <td>www.smalljoys.life/home</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Jul</td>\n",
       "      <td>Active</td>\n",
       "      <td>Small Joys is a pediatric behavioral health co...</td>\n",
       "      <td>...</td>\n",
       "      <td>01-May-22</td>\n",
       "      <td>$1,200,000</td>\n",
       "      <td>$1,540,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,200,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,540,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SupportRoom</th>\n",
       "      <td>Employee Benefits, Health Care, Mental Health,...</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>SupportRoom is a digital behavioural technolog...</td>\n",
       "      <td>62,619</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>supportroom.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>01-Apr-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Workplace wellness people transformation platf...</td>\n",
       "      <td>...</td>\n",
       "      <td>15-Dec-21</td>\n",
       "      <td>£874,000</td>\n",
       "      <td>$1,529,565</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£874,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,529,565</td>\n",
       "      <td>8X Ventures, Deepak Bhavsar</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Total Life</th>\n",
       "      <td>Elder Care, Electronic Health Record (EHR), He...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Total Life is rethinking aging making it easy ...</td>\n",
       "      <td>48,254</td>\n",
       "      <td>—</td>\n",
       "      <td>totallife.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Total Life is a medicare platform that special...</td>\n",
       "      <td>...</td>\n",
       "      <td>31-Jan-22</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Primetime Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Frankie Health</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Wellness</td>\n",
       "      <td>Dublin, Dublin, Ireland</td>\n",
       "      <td>Frankie is a B2B mental health platform that d...</td>\n",
       "      <td>59,081</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.frankie.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>01-Aug-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Frankie gets high-quality support to employees...</td>\n",
       "      <td>...</td>\n",
       "      <td>11-Jan-21</td>\n",
       "      <td>$1,250,000</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,250,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>E15 VC</td>\n",
       "      <td>Private</td>\n",
       "      <td>Ireland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Docty Inc.</th>\n",
       "      <td>Health Care, Medical, mHealth, SaaS</td>\n",
       "      <td>Norwalk, Connecticut, United States</td>\n",
       "      <td>A SaaS Data-Driven, Human-Centric Digital heal...</td>\n",
       "      <td>75,552</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>docty.ai</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>17-Mar-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Our interactive ecosystem connects patients an...</td>\n",
       "      <td>...</td>\n",
       "      <td>06-Jan-21</td>\n",
       "      <td>$500,000</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>HECCO Technologies Inc (Prescribe)</th>\n",
       "      <td>Health Care, Hospital, Information Technology,...</td>\n",
       "      <td>Malappuram, Kerala, India</td>\n",
       "      <td>IIT-Madras based HealthTech Start-Up providing...</td>\n",
       "      <td>96,209</td>\n",
       "      <td>—</td>\n",
       "      <td>www.heyprescribe.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>26-Feb-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Prescribe is an IIT-M and IIM-C backed HealthT...</td>\n",
       "      <td>...</td>\n",
       "      <td>01-Jan-22</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Y Combinator, Acequia Capital (AceCap), Vignes...</td>\n",
       "      <td>Private</td>\n",
       "      <td>India</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ApoWiser</th>\n",
       "      <td>B2B, Digital Marketing, E-Commerce, Health Car...</td>\n",
       "      <td>Ra'anana, HaMerkaz, Israel</td>\n",
       "      <td>ApoWiser: The Digital Bedrock of the OTC Self-...</td>\n",
       "      <td>122,028</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.apowiser.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>17-Jan-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Empowering the self-care revolution, ApoWiser ...</td>\n",
       "      <td>...</td>\n",
       "      <td>30-Jan-23</td>\n",
       "      <td>—</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Grant</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>MATTER, Longliv Ventures</td>\n",
       "      <td>Private</td>\n",
       "      <td>Israel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Holly Health</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, mHe...</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>Digital coach, providing compassionate, popula...</td>\n",
       "      <td>44,308</td>\n",
       "      <td>—</td>\n",
       "      <td>www.hollyhealth.io</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>01-Apr-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Holly Health helps individuals to change their...</td>\n",
       "      <td>...</td>\n",
       "      <td>07-Dec-23</td>\n",
       "      <td>£327,000</td>\n",
       "      <td>£2,060,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£327,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£1,197,000</td>\n",
       "      <td>Innovate UK, Plug and Play, Kima Ventures, Mod...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Aide Health</th>\n",
       "      <td>Health Care, mHealth, Software</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>A new digital health service that helps patien...</td>\n",
       "      <td>57,266</td>\n",
       "      <td>—</td>\n",
       "      <td>www.aide.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>11-Jan-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Aide is a health technology company with a mis...</td>\n",
       "      <td>...</td>\n",
       "      <td>03-Jul-23</td>\n",
       "      <td>—</td>\n",
       "      <td>$1,320,000</td>\n",
       "      <td>Non-equity Assistance</td>\n",
       "      <td>$1,200,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>$1,320,000</td>\n",
       "      <td>Fuel Ventures, Salica, APX, 1818 Venture Capit...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>United Kingdom</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>50 rows × 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                           Industries  \\\n",
       "Organization Name                                                                       \n",
       "Cerebral                            Health Care, Medical, Mental Health, mHealth, ...   \n",
       "Harbor Health                       Health Care, Medical, mHealth, Personal Health...   \n",
       "Avi Medical                            Health Care, Medical, mHealth, Personal Health   \n",
       "BetterVet                                            Health Care, mHealth, Veterinary   \n",
       "Antidote Health                     Artificial Intelligence (AI), Health Care, mHe...   \n",
       "Pace                                Health Care, Mental Health, mHealth, Social, W...   \n",
       "DeepCardio                          Artificial Intelligence (AI), Health Care, mHe...   \n",
       "Brisk Health                        Health Care, Home Health Care, Medical, mHealt...   \n",
       "Courier Health                                          Health Care, Medical, mHealth   \n",
       "Cartwheel                           Health Care, Mental Health, mHealth, Therapeut...   \n",
       "Clearing                                     Consumer, Health Care, mHealth, Wellness   \n",
       "Cardo Health                                                     Health Care, mHealth   \n",
       "Anima                                      Health Care, Medical, mHealth, Mobile Apps   \n",
       "Oliva Health                        Health Care, Mental Health, mHealth, Personal ...   \n",
       "Inflow                                                 Health Care, mHealth, Wellness   \n",
       "Likeminded                              Health Care, Mental Health, mHealth, Wellness   \n",
       "Heading Health                      Health Care, Medical, Mental Health, mHealth, ...   \n",
       "Violet                                                  Health Care, Medical, mHealth   \n",
       "Anebulo Pharmaceuticals                          Biotechnology, Life Science, mHealth   \n",
       "Alyve Health                                           Health Care, mHealth, Wellness   \n",
       "Radicle Science                     Dietary Supplements, Health Care, mHealth, Wel...   \n",
       "Behavidence                          Health Care, Mental Health, mHealth, Mobile Apps   \n",
       "MYNDUP                              Health Care, Mental Health, mHealth, Personal ...   \n",
       "Persimmon                           Beauty, Cosmetic Surgery, Medical, mHealth, Te...   \n",
       "Elfie                               Health Care, Home Health Care, Medical, mHealt...   \n",
       "Comedi Health Technology Limited    Artificial Intelligence (AI), Health Care, Ima...   \n",
       "tapouts                             Apps, Health Care, Mental Health, mHealth, Mob...   \n",
       "TOM Medications                     Health Care, mHealth, Mobile Apps, Personal He...   \n",
       "Realize Me                          Dietary Supplements, Fitness, Health Care, mHe...   \n",
       "Axenya                                                  Health Care, Medical, mHealth   \n",
       "Phenomune                                              Health Care, mHealth, Wellness   \n",
       "Shen.AI @ MX Labs                   Artificial Intelligence (AI), Health Diagnosti...   \n",
       "Fleming                             Apps, Health Care, Information Technology, mHe...   \n",
       "Oska Health                                                      Health Care, mHealth   \n",
       "PERSOWN                                      Health Care, Health Diagnostics, mHealth   \n",
       "Una Health                          Artificial Intelligence (AI), Diabetes, Health...   \n",
       "Lifetime Health                     Health Care, Health Diagnostics, Home Health C...   \n",
       "Legion Health                       Elder Care, Health Care, Home Health Care, Men...   \n",
       "ONVY HealthTech                     Artificial Intelligence (AI), Health Care, Mac...   \n",
       "Ailin                                Health Care, Medical Device, mHealth, Telehealth   \n",
       "Malaica                                                 Health Care, mHealth, Women's   \n",
       "Small Joys                            Health Care, mHealth, Personal Health, Wellness   \n",
       "SupportRoom                         Employee Benefits, Health Care, Mental Health,...   \n",
       "Total Life                          Elder Care, Electronic Health Record (EHR), He...   \n",
       "Frankie Health                          Health Care, Mental Health, mHealth, Wellness   \n",
       "Docty Inc.                                        Health Care, Medical, mHealth, SaaS   \n",
       "HECCO Technologies Inc (Prescribe)  Health Care, Hospital, Information Technology,...   \n",
       "ApoWiser                            B2B, Digital Marketing, E-Commerce, Health Car...   \n",
       "Holly Health                        Artificial Intelligence (AI), Health Care, mHe...   \n",
       "Aide Health                                            Health Care, mHealth, Software   \n",
       "\n",
       "                                                         Headquarters Location  \\\n",
       "Organization Name                                                                \n",
       "Cerebral                              San Francisco, California, United States   \n",
       "Harbor Health                                     Austin, Texas, United States   \n",
       "Avi Medical                                            Munich, Bayern, Germany   \n",
       "BetterVet                                 Boston, Massachusetts, United States   \n",
       "Antidote Health                              New York, New York, United States   \n",
       "Pace                                California City, California, United States   \n",
       "DeepCardio                                Seoul, Seoul-t'ukpyolsi, South Korea   \n",
       "Brisk Health                                   Denver, Colorado, United States   \n",
       "Courier Health                               New York, New York, United States   \n",
       "Cartwheel                              Cambridge, Massachusetts, United States   \n",
       "Clearing                                     New York, New York, United States   \n",
       "Cardo Health                                 Stockholm, Stockholms Lan, Sweden   \n",
       "Anima                                 San Francisco, California, United States   \n",
       "Oliva Health                                       Barcelona, Catalonia, Spain   \n",
       "Inflow                                         London, England, United Kingdom   \n",
       "Likeminded                                             Berlin, Berlin, Germany   \n",
       "Heading Health                                    Austin, Texas, United States   \n",
       "Violet                                       New York, New York, United States   \n",
       "Anebulo Pharmaceuticals                           Austin, Texas, United States   \n",
       "Alyve Health                                        Mumbai, Maharashtra, India   \n",
       "Radicle Science                           San Diego, California, United States   \n",
       "Behavidence                                  New York, New York, United States   \n",
       "MYNDUP                                         London, England, United Kingdom   \n",
       "Persimmon                                  Larkspur, California, United States   \n",
       "Elfie                                     Singapore, Central Region, Singapore   \n",
       "Comedi Health Technology Limited        Hong Kong, Hong Kong Island, Hong Kong   \n",
       "tapouts                                      Venice, California, United States   \n",
       "TOM Medications                                     Uster, Zurich, Switzerland   \n",
       "Realize Me                              Los Angeles, California, United States   \n",
       "Axenya                                       Montevideo, NA - Uruguay, Uruguay   \n",
       "Phenomune                                        Houston, Texas, United States   \n",
       "Shen.AI @ MX Labs                                   Tallinn, Harjumaa, Estonia   \n",
       "Fleming                                 Vilnius, Vilniaus Apskritis, Lithuania   \n",
       "Oska Health                                         Frankfurt, Hessen, Germany   \n",
       "PERSOWN                                   Jacksonville, Florida, United States   \n",
       "Una Health                                             Berlin, Berlin, Germany   \n",
       "Lifetime Health                                    Bengaluru, Karnataka, India   \n",
       "Legion Health                                     Austin, Texas, United States   \n",
       "ONVY HealthTech                                        Munich, Bayern, Germany   \n",
       "Ailin                                                    Madrid, Madrid, Spain   \n",
       "Malaica                                           Nairobi, Nairobi Area, Kenya   \n",
       "Small Joys                                 Fort Lee, New Jersey, United States   \n",
       "SupportRoom                                    London, England, United Kingdom   \n",
       "Total Life                            San Francisco, California, United States   \n",
       "Frankie Health                                         Dublin, Dublin, Ireland   \n",
       "Docty Inc.                                 Norwalk, Connecticut, United States   \n",
       "HECCO Technologies Inc (Prescribe)                   Malappuram, Kerala, India   \n",
       "ApoWiser                                            Ra'anana, HaMerkaz, Israel   \n",
       "Holly Health                                   London, England, United Kingdom   \n",
       "Aide Health                                    London, England, United Kingdom   \n",
       "\n",
       "                                                                          Description  \\\n",
       "Organization Name                                                                       \n",
       "Cerebral                            Cerebral is a mental health telemedicine compa...   \n",
       "Harbor Health                       Harbor Health is a multi-specialty clinic grou...   \n",
       "Avi Medical                         Avi Medical is a digital health care company t...   \n",
       "BetterVet                           BetterVet is a veterinary startup that provide...   \n",
       "Antidote Health                     Antidote Health offers an AI-based health plat...   \n",
       "Pace                                Pace provides online peer support groups to gi...   \n",
       "DeepCardio                          DeepCardio develops artificial intelligence te...   \n",
       "Brisk Health                                                 All-Inclusive Healthcare   \n",
       "Courier Health                      Courier Health develops a patient engagement p...   \n",
       "Cartwheel                           Cartwheel offers mental health support to stud...   \n",
       "Clearing                            Clearing is a healthcare platform focused on p...   \n",
       "Cardo Health                        Cardo Health is a digital health company with ...   \n",
       "Anima                                    The next generation care enablement platform   \n",
       "Oliva Health                                      Employee Mental Well-Being Platform   \n",
       "Inflow                              Inflow develops a science-based digital progra...   \n",
       "Likeminded                          Likeminded operates a digital platform for men...   \n",
       "Heading Health                      Heading Health is a technology-enabled mental ...   \n",
       "Violet                              Violet is a platform that helps the healthcare...   \n",
       "Anebulo Pharmaceuticals             Anebulo is a biotech company developing novel ...   \n",
       "Alyve Health                        Alyve Health is a tech platform providing pers...   \n",
       "Radicle Science                     Radicle Science is a health tech company that ...   \n",
       "Behavidence                         Behavidence develops tools to monitor and mana...   \n",
       "MYNDUP                              Live 1-1 virtual mental health sessions to sto...   \n",
       "Persimmon                           Persimmon provides aesthetic treatments in the...   \n",
       "Elfie                               Elfie is a product that reduces the burden of ...   \n",
       "Comedi Health Technology Limited    Comedi Health is a platform that provides tele...   \n",
       "tapouts                                                     Mobile Mental Health Care   \n",
       "TOM Medications                     TOM - Medications - Making therapies easier to...   \n",
       "Realize Me                          The premium platform for health and performanc...   \n",
       "Axenya                                           Axenya is a digital health platform.   \n",
       "Phenomune                           Phenomune engages in bringing general wellness...   \n",
       "Shen.AI @ MX Labs                   Shen.AI offers app & tele-health integration f...   \n",
       "Fleming                             Fleming is a smart healthcare app that allows ...   \n",
       "Oska Health                         A German-UK health-tech company delivering dig...   \n",
       "PERSOWN                             PERSOWN provides a family health diagnostic so...   \n",
       "Una Health                          The most effective Digital Therapy to reverse ...   \n",
       "Lifetime Health                     Delivering healthcare to your doorstep with a ...   \n",
       "Legion Health                             Legion Health is reimagining mental health.   \n",
       "ONVY HealthTech                     AI-as-a-Service for the Health and Wellness In...   \n",
       "Ailin                               Ailin offers digital health monitoring solutio...   \n",
       "Malaica                             Malaica is a digital healthcare firm that offe...   \n",
       "Small Joys                          Small Joys is a pediatric behavioral health co...   \n",
       "SupportRoom                         SupportRoom is a digital behavioural technolog...   \n",
       "Total Life                          Total Life is rethinking aging making it easy ...   \n",
       "Frankie Health                      Frankie is a B2B mental health platform that d...   \n",
       "Docty Inc.                          A SaaS Data-Driven, Human-Centric Digital heal...   \n",
       "HECCO Technologies Inc (Prescribe)  IIT-Madras based HealthTech Start-Up providing...   \n",
       "ApoWiser                            ApoWiser: The Digital Bedrock of the OTC Self-...   \n",
       "Holly Health                        Digital coach, providing compassionate, popula...   \n",
       "Aide Health                         A new digital health service that helps patien...   \n",
       "\n",
       "                                   CB Rank (Company) Estimated Revenue Range  \\\n",
       "Organization Name                                                              \n",
       "Cerebral                                      24,597          $100M to $500M   \n",
       "Harbor Health                                  5,140                       —   \n",
       "Avi Medical                                    7,992           Less than $1M   \n",
       "BetterVet                                     12,253            $10M to $50M   \n",
       "Antidote Health                                8,740           Less than $1M   \n",
       "Pace                                          12,690           Less than $1M   \n",
       "DeepCardio                                    78,967                       —   \n",
       "Brisk Health                                  31,918             $1M to $10M   \n",
       "Courier Health                                   720             $1M to $10M   \n",
       "Cartwheel                                     10,286             $1M to $10M   \n",
       "Clearing                                      19,828             $1M to $10M   \n",
       "Cardo Health                                  40,403             $1M to $10M   \n",
       "Anima                                          8,353                       —   \n",
       "Oliva Health                                  13,133             $1M to $10M   \n",
       "Inflow                                        88,841             $1M to $10M   \n",
       "Likeminded                                    11,739           Less than $1M   \n",
       "Heading Health                                14,148             $1M to $10M   \n",
       "Violet                                        26,457                       —   \n",
       "Anebulo Pharmaceuticals                       11,250             $1M to $10M   \n",
       "Alyve Health                                     425             $1M to $10M   \n",
       "Radicle Science                               26,451             $1M to $10M   \n",
       "Behavidence                                   29,177             $1M to $10M   \n",
       "MYNDUP                                        47,661                       —   \n",
       "Persimmon                                     23,433                       —   \n",
       "Elfie                                         16,903             $1M to $10M   \n",
       "Comedi Health Technology Limited              89,470                       —   \n",
       "tapouts                                       26,340             $1M to $10M   \n",
       "TOM Medications                               72,709             $1M to $10M   \n",
       "Realize Me                                    72,273                       —   \n",
       "Axenya                                        52,530             $1M to $10M   \n",
       "Phenomune                                     98,808             $1M to $10M   \n",
       "Shen.AI @ MX Labs                             32,136                       —   \n",
       "Fleming                                       68,562             $1M to $10M   \n",
       "Oska Health                                   56,935                       —   \n",
       "PERSOWN                                       39,782             $1M to $10M   \n",
       "Una Health                                    57,957                       —   \n",
       "Lifetime Health                               13,414                       —   \n",
       "Legion Health                                 35,432             $1M to $10M   \n",
       "ONVY HealthTech                               33,467             $1M to $10M   \n",
       "Ailin                                         57,002             $1M to $10M   \n",
       "Malaica                                       52,863                       —   \n",
       "Small Joys                                    83,107                       —   \n",
       "SupportRoom                                   62,619             $1M to $10M   \n",
       "Total Life                                    48,254                       —   \n",
       "Frankie Health                                59,081             $1M to $10M   \n",
       "Docty Inc.                                    75,552             $1M to $10M   \n",
       "HECCO Technologies Inc (Prescribe)            96,209                       —   \n",
       "ApoWiser                                     122,028             $1M to $10M   \n",
       "Holly Health                                  44,308                       —   \n",
       "Aide Health                                   57,266                       —   \n",
       "\n",
       "                                                    Website Company Type  \\\n",
       "Organization Name                                                          \n",
       "Cerebral                                       cerebral.com   For Profit   \n",
       "Harbor Health                              harborhealth.com   For Profit   \n",
       "Avi Medical                                  avimedical.com   For Profit   \n",
       "BetterVet                                     bettervet.com   For Profit   \n",
       "Antidote Health                          antidotehealth.com   For Profit   \n",
       "Pace                                             pace.group   For Profit   \n",
       "DeepCardio                                   deepcardio.net   For Profit   \n",
       "Brisk Health                                briskhealth.com   For Profit   \n",
       "Courier Health                            courierhealth.com   For Profit   \n",
       "Cartwheel                             www.cartwheelcare.org   For Profit   \n",
       "Clearing                                   www.clearing.com   For Profit   \n",
       "Cardo Health                                cardohealth.com   For Profit   \n",
       "Anima                                   www.animahealth.com   For Profit   \n",
       "Oliva Health                               www.oliva.health   For Profit   \n",
       "Inflow                                     www.getinflow.io   For Profit   \n",
       "Likeminded                              www.likeminded.care   For Profit   \n",
       "Heading Health                           headinghealth.com/   For Profit   \n",
       "Violet                                   www.joinviolet.com   For Profit   \n",
       "Anebulo Pharmaceuticals                     www.anebulo.com   For Profit   \n",
       "Alyve Health                               www.alyve.health   For Profit   \n",
       "Radicle Science                          radiclescience.com   For Profit   \n",
       "Behavidence                             www.behavidence.com   For Profit   \n",
       "MYNDUP                                       www.myndup.com   For Profit   \n",
       "Persimmon                               www.persimmon.life/   For Profit   \n",
       "Elfie                                          www.elfie.co   For Profit   \n",
       "Comedi Health Technology Limited          www.comedi.com.hk   For Profit   \n",
       "tapouts                                     www.tapouts.com   For Profit   \n",
       "TOM Medications                     www.tommedications.com/   For Profit   \n",
       "Realize Me                                   www.realize.me            —   \n",
       "Axenya                                      www.axenya.com/   For Profit   \n",
       "Phenomune                                    phenomune.com/   For Profit   \n",
       "Shen.AI @ MX Labs                                   shen.ai   For Profit   \n",
       "Fleming                                         fleming.app   For Profit   \n",
       "Oska Health                                oska-health.com/   For Profit   \n",
       "PERSOWN                                         persown.com   For Profit   \n",
       "Una Health                                     unahealth.io   For Profit   \n",
       "Lifetime Health                          lifetimehealth.in/   For Profit   \n",
       "Legion Health                                 legion.health   For Profit   \n",
       "ONVY HealthTech                            www.onvy.health/   For Profit   \n",
       "Ailin                                              ailin.es   For Profit   \n",
       "Malaica                                        malaica.com/   For Profit   \n",
       "Small Joys                          www.smalljoys.life/home   For Profit   \n",
       "SupportRoom                                supportroom.com/   For Profit   \n",
       "Total Life                                   totallife.com/   For Profit   \n",
       "Frankie Health                           www.frankie.health   For Profit   \n",
       "Docty Inc.                                         docty.ai   For Profit   \n",
       "HECCO Technologies Inc (Prescribe)     www.heyprescribe.com   For Profit   \n",
       "ApoWiser                                   www.apowiser.com   For Profit   \n",
       "Holly Health                             www.hollyhealth.io   For Profit   \n",
       "Aide Health                                 www.aide.health   For Profit   \n",
       "\n",
       "                                   Founded Date Operating Status  \\\n",
       "Organization Name                                                  \n",
       "Cerebral                                   2020           Active   \n",
       "Harbor Health                              2022           Active   \n",
       "Avi Medical                                2020           Active   \n",
       "BetterVet                             01-Jul-20           Active   \n",
       "Antidote Health                       15-Mar-20           Active   \n",
       "Pace                                       2020         Inactive   \n",
       "DeepCardio                                 2020           Active   \n",
       "Brisk Health                             20-Oct           Active   \n",
       "Courier Health                             2020           Active   \n",
       "Cartwheel                                  2022           Active   \n",
       "Clearing                                 20-Jul           Active   \n",
       "Cardo Health                               2021           Active   \n",
       "Anima                                      2021           Active   \n",
       "Oliva Health                               2020           Active   \n",
       "Inflow                                     2020           Active   \n",
       "Likeminded                                 2020           Active   \n",
       "Heading Health                             2020           Active   \n",
       "Violet                                   20-Feb           Active   \n",
       "Anebulo Pharmaceuticals                    2020           Active   \n",
       "Alyve Health                          18-May-20           Active   \n",
       "Radicle Science                            2020           Active   \n",
       "Behavidence                              20-Jun           Active   \n",
       "MYNDUP                                   20-Feb           Active   \n",
       "Persimmon                                  2021           Active   \n",
       "Elfie                                 25-Oct-20           Active   \n",
       "Comedi Health Technology Limited      31-May-21           Active   \n",
       "tapouts                               12-Jan-21           Active   \n",
       "TOM Medications                          20-Jan           Active   \n",
       "Realize Me                                 2021           Active   \n",
       "Axenya                                   20-Apr           Active   \n",
       "Phenomune                                  2021           Active   \n",
       "Shen.AI @ MX Labs                        20-Oct           Active   \n",
       "Fleming                                    2020           Active   \n",
       "Oska Health                           25-Jul-22           Active   \n",
       "PERSOWN                                    2020           Active   \n",
       "Una Health                                 2021           Active   \n",
       "Lifetime Health                       22-Mar-23           Active   \n",
       "Legion Health                              2021           Active   \n",
       "ONVY HealthTech                       16-Jan-20           Active   \n",
       "Ailin                                      2021           Active   \n",
       "Malaica                                  22-Jan           Active   \n",
       "Small Joys                               20-Jul           Active   \n",
       "SupportRoom                           01-Apr-20           Active   \n",
       "Total Life                                 2021           Active   \n",
       "Frankie Health                        01-Aug-20           Active   \n",
       "Docty Inc.                            17-Mar-20           Active   \n",
       "HECCO Technologies Inc (Prescribe)    26-Feb-21           Active   \n",
       "ApoWiser                              17-Jan-21           Active   \n",
       "Holly Health                          01-Apr-20           Active   \n",
       "Aide Health                           11-Jan-21           Active   \n",
       "\n",
       "                                                                     Full Description  \\\n",
       "Organization Name                                                                       \n",
       "Cerebral                            Cerebral is a mental health telemedicine compa...   \n",
       "Harbor Health                       Harbor Health is a multi-specialty clinic grou...   \n",
       "Avi Medical                         Avi Medical is a digital health care company t...   \n",
       "BetterVet                           BetterVet is a veterinary startup that provide...   \n",
       "Antidote Health                     Antidote Health offers an AI-based health plat...   \n",
       "Pace                                Pace is a mental fitness and social wellness p...   \n",
       "DeepCardio                                                                          —   \n",
       "Brisk Health                        Brisk Health developed the most advanced mobil...   \n",
       "Courier Health                      Courier Health develops a patient engagement p...   \n",
       "Cartwheel                           Cartwheel offers mental health support to stud...   \n",
       "Clearing                            Clearing is a digital healthcare platform buil...   \n",
       "Cardo Health                        Cardo Health is a digital health company with ...   \n",
       "Anima                               Anima is a next generation clinical operating ...   \n",
       "Oliva Health                        Oliva Therapy is an online therapy for busy pe...   \n",
       "Inflow                              Inflow develops a science-based digital progra...   \n",
       "Likeminded                          Likeminded operates a digital platform for men...   \n",
       "Heading Health                      Heading Health is a technology-enabled mental ...   \n",
       "Violet                              Violet is a platform that helps the healthcare...   \n",
       "Anebulo Pharmaceuticals             Anebulo is a clinical-stage biotechnology comp...   \n",
       "Alyve Health                        Imagine a healthcare ecosystem where care meet...   \n",
       "Radicle Science                     AI-driven healthtech B-Corp providing history'...   \n",
       "Behavidence                         Behavidence utilizes AI to detect and monitor ...   \n",
       "MYNDUP                              MYNDUP is stopping the “one size fits all” app...   \n",
       "Persimmon                           Persimmon is an in-home aesthetics teleHealth ...   \n",
       "Elfie                               Elfie is a product that reduces the burden of ...   \n",
       "Comedi Health Technology Limited    COMEDI Health is a one-stop technology platfor...   \n",
       "tapouts                             tapouts is a mental health edutainment platfor...   \n",
       "TOM Medications                     TOM Medications is a digital solution for pati...   \n",
       "Realize Me                                                                          —   \n",
       "Axenya                              Axenya leverages the power of data to deliver ...   \n",
       "Phenomune                           Phenomune engages in bringing general wellness...   \n",
       "Shen.AI @ MX Labs                   Shen.AI is clinically proven software technolo...   \n",
       "Fleming                             Fleming app is a smart way to take care of you...   \n",
       "Oska Health                         Oska Health delivers digital-enabled care solu...   \n",
       "PERSOWN                             PERSOWN provides a family health diagnostic so...   \n",
       "Una Health                          Una Health uses mobile technology, biosensors,...   \n",
       "Lifetime Health                     We are a digital platform, transforming the he...   \n",
       "Legion Health                       Legion Health is backed by Y Combinator and th...   \n",
       "ONVY HealthTech                     Predictive health - powered by AI. The world's...   \n",
       "Ailin                               Ailin specializes in providing health and well...   \n",
       "Malaica                             Malaica is on a mission to make the pregnancy ...   \n",
       "Small Joys                          Small Joys is a pediatric behavioral health co...   \n",
       "SupportRoom                         Workplace wellness people transformation platf...   \n",
       "Total Life                          Total Life is a medicare platform that special...   \n",
       "Frankie Health                      Frankie gets high-quality support to employees...   \n",
       "Docty Inc.                          Our interactive ecosystem connects patients an...   \n",
       "HECCO Technologies Inc (Prescribe)  Prescribe is an IIT-M and IIM-C backed HealthT...   \n",
       "ApoWiser                            Empowering the self-care revolution, ApoWiser ...   \n",
       "Holly Health                        Holly Health helps individuals to change their...   \n",
       "Aide Health                         Aide is a health technology company with a mis...   \n",
       "\n",
       "                                    ... Last Funding Date Last Funding Amount  \\\n",
       "Organization Name                   ...                                         \n",
       "Cerebral                            ...         08-Dec-21       $300,000,000    \n",
       "Harbor Health                       ...         11-Jan-24        $95,500,000    \n",
       "Avi Medical                         ...         06-Apr-22        € 50,000,000   \n",
       "BetterVet                           ...         28-Mar-24        $17,928,818    \n",
       "Antidote Health                     ...         30-Nov-23        $13,000,000    \n",
       "Pace                                ...         16-Dec-21        $13,000,000    \n",
       "DeepCardio                          ...         17-Feb-22     ₩40,000,000,000   \n",
       "Brisk Health                        ...         26-Dec-23         $1,000,000    \n",
       "Courier Health                      ...         08-Jul-24        $16,500,000    \n",
       "Cartwheel                           ...         26-Sep-23        $20,000,000    \n",
       "Clearing                            ...         25-May-21        $20,000,000    \n",
       "Cardo Health                        ...         11-Jan-22        $17,500,000    \n",
       "Anima                               ...         19-Mar-24        $12,000,000    \n",
       "Oliva Health                        ...         22-Jun-23          £4,260,000   \n",
       "Inflow                              ...         11-Jan-23        $11,000,000    \n",
       "Likeminded                          ...         26-Oct-23         € 1,500,000   \n",
       "Heading Health                      ...         21-Dec-23                   —   \n",
       "Violet                              ...         15-Aug-22         $5,300,000    \n",
       "Anebulo Pharmaceuticals             ...         22-Jul-24           $900,000    \n",
       "Alyve Health                        ...         18-Jun-24        ₹450,000,000   \n",
       "Radicle Science                     ...         30-Mar-22                   —   \n",
       "Behavidence                         ...         10-Mar-22         $4,300,000    \n",
       "MYNDUP                              ...         08-Nov-22          £4,400,000   \n",
       "Persimmon                           ...         18-Apr-23         $5,323,629    \n",
       "Elfie                               ...         15-May-23         $4,000,000    \n",
       "Comedi Health Technology Limited    ...         01-Nov-21         $5,000,000    \n",
       "tapouts                             ...         16-Mar-24         $3,200,000    \n",
       "TOM Medications                     ...         25-Jan-23        CHF1,300,000   \n",
       "Realize Me                          ...         27-Sep-21         $4,025,000    \n",
       "Axenya                              ...         01-Aug-22                   —   \n",
       "Phenomune                           ...         11-Aug-21         $3,300,000    \n",
       "Shen.AI @ MX Labs                   ...         17-Mar-23           € 100,000   \n",
       "Fleming                             ...         01-Aug-21         € 1,200,000   \n",
       "Oska Health                         ...         06-Mar-23         € 2,500,000   \n",
       "PERSOWN                             ...         11-Mar-24           $110,000    \n",
       "Una Health                          ...         15-Feb-24         $2,500,000    \n",
       "Lifetime Health                     ...         24-May-24        ₹124,000,000   \n",
       "Legion Health                       ...         08-Mar-22         $2,000,000    \n",
       "ONVY HealthTech                     ...         09-Aug-23                   —   \n",
       "Ailin                               ...         19-Feb-24         € 1,500,000   \n",
       "Malaica                             ...         10-Jul-24         $1,000,000    \n",
       "Small Joys                          ...         01-May-22         $1,200,000    \n",
       "SupportRoom                         ...         15-Dec-21            £874,000   \n",
       "Total Life                          ...         31-Jan-22         $1,500,000    \n",
       "Frankie Health                      ...         11-Jan-21         $1,250,000    \n",
       "Docty Inc.                          ...         06-Jan-21           $500,000    \n",
       "HECCO Technologies Inc (Prescribe)  ...         01-Jan-22         $1,500,000    \n",
       "ApoWiser                            ...         30-Jan-23                   —   \n",
       "Holly Health                        ...         07-Dec-23            £327,000   \n",
       "Aide Health                         ...         03-Jul-23                   —   \n",
       "\n",
       "                                   Total Funding Amount  \\\n",
       "Organization Name                                         \n",
       "Cerebral                                  $462,000,000    \n",
       "Harbor Health                             $125,500,000    \n",
       "Avi Medical                                € 88,500,000   \n",
       "BetterVet                                  $57,928,818    \n",
       "Antidote Health                            $56,000,000    \n",
       "Pace                                       $50,900,000    \n",
       "DeepCardio                              ₩40,000,000,000   \n",
       "Brisk Health                               $27,080,000    \n",
       "Courier Health                             $20,450,002    \n",
       "Cartwheel                                  $20,000,000    \n",
       "Clearing                                   $20,000,000    \n",
       "Cardo Health                               $17,500,000    \n",
       "Anima                                      $14,625,000    \n",
       "Oliva Health                                £10,720,000   \n",
       "Inflow                                     $13,980,000    \n",
       "Likeminded                                 € 10,900,000   \n",
       "Heading Health                              $9,978,120    \n",
       "Violet                                      $6,800,000    \n",
       "Anebulo Pharmaceuticals                     $7,500,000    \n",
       "Alyve Health                                $6,288,066    \n",
       "Radicle Science                             $5,999,716    \n",
       "Behavidence                                 $5,625,000    \n",
       "MYNDUP                                       £4,700,000   \n",
       "Persimmon                                   $5,323,629    \n",
       "Elfie                                       $5,000,000    \n",
       "Comedi Health Technology Limited            $5,000,000    \n",
       "tapouts                                     $4,800,000    \n",
       "TOM Medications                             $4,762,184    \n",
       "Realize Me                                  $4,025,000    \n",
       "Axenya                                      $4,000,000    \n",
       "Phenomune                                   $3,300,000    \n",
       "Shen.AI @ MX Labs                           $3,107,521    \n",
       "Fleming                                     € 2,510,030   \n",
       "Oska Health                                 € 2,500,000   \n",
       "PERSOWN                                     $2,618,250    \n",
       "Una Health                                  $2,500,000    \n",
       "Lifetime Health                             $2,392,919    \n",
       "Legion Health                               $2,125,000    \n",
       "ONVY HealthTech                             € 2,650,000   \n",
       "Ailin                                       € 1,500,000   \n",
       "Malaica                                     $1,600,000    \n",
       "Small Joys                                  $1,540,000    \n",
       "SupportRoom                                 $1,529,565    \n",
       "Total Life                                  $1,500,000    \n",
       "Frankie Health                              $1,500,000    \n",
       "Docty Inc.                                  $1,500,000    \n",
       "HECCO Technologies Inc (Prescribe)          $1,500,000    \n",
       "ApoWiser                                    $1,500,000    \n",
       "Holly Health                                 £2,060,000   \n",
       "Aide Health                                 $1,320,000    \n",
       "\n",
       "                                           Last Funding Type  \\\n",
       "Organization Name                                              \n",
       "Cerebral                                            Series C   \n",
       "Harbor Health                                       Series A   \n",
       "Avi Medical                                         Series B   \n",
       "BetterVet                           Venture - Series Unknown   \n",
       "Antidote Health                                     Series A   \n",
       "Pace                                                Series A   \n",
       "DeepCardio                                          Series A   \n",
       "Brisk Health                                        Series D   \n",
       "Courier Health                                      Series A   \n",
       "Cartwheel                                           Series A   \n",
       "Clearing                                                Seed   \n",
       "Cardo Health                                        Series A   \n",
       "Anima                                               Series A   \n",
       "Oliva Health                                            Seed   \n",
       "Inflow                                              Series A   \n",
       "Likeminded                                              Seed   \n",
       "Heading Health                      Venture - Series Unknown   \n",
       "Violet                                                  Seed   \n",
       "Anebulo Pharmaceuticals                                Grant   \n",
       "Alyve Health                                        Series A   \n",
       "Radicle Science                                         Seed   \n",
       "Behavidence                                             Seed   \n",
       "MYNDUP                                              Series A   \n",
       "Persimmon                                               Seed   \n",
       "Elfie                                                   Seed   \n",
       "Comedi Health Technology Limited                        Seed   \n",
       "tapouts                                                 Seed   \n",
       "TOM Medications                              Corporate Round   \n",
       "Realize Me                                              Seed   \n",
       "Axenya                              Venture - Series Unknown   \n",
       "Phenomune                           Venture - Series Unknown   \n",
       "Shen.AI @ MX Labs                                      Grant   \n",
       "Fleming                                                 Seed   \n",
       "Oska Health                                         Pre-Seed   \n",
       "PERSOWN                                                 Seed   \n",
       "Una Health                                              Seed   \n",
       "Lifetime Health                                         Seed   \n",
       "Legion Health                                           Seed   \n",
       "ONVY HealthTech                                         Seed   \n",
       "Ailin                                                   Seed   \n",
       "Malaica                                             Pre-Seed   \n",
       "Small Joys                                              Seed   \n",
       "SupportRoom                                             Seed   \n",
       "Total Life                                              Seed   \n",
       "Frankie Health                                          Seed   \n",
       "Docty Inc.                                              Seed   \n",
       "HECCO Technologies Inc (Prescribe)                      Seed   \n",
       "ApoWiser                                               Grant   \n",
       "Holly Health                                            Seed   \n",
       "Aide Health                            Non-equity Assistance   \n",
       "\n",
       "                                   Last Equity Funding Amount  \\\n",
       "Organization Name                                               \n",
       "Cerebral                                        $300,000,000    \n",
       "Harbor Health                                    $95,500,000    \n",
       "Avi Medical                                      € 50,000,000   \n",
       "BetterVet                                        $17,928,818    \n",
       "Antidote Health                                  $13,000,000    \n",
       "Pace                                             $13,000,000    \n",
       "DeepCardio                                    ₩40,000,000,000   \n",
       "Brisk Health                                      $1,000,000    \n",
       "Courier Health                                   $16,500,000    \n",
       "Cartwheel                                        $20,000,000    \n",
       "Clearing                                         $20,000,000    \n",
       "Cardo Health                                     $17,500,000    \n",
       "Anima                                            $12,000,000    \n",
       "Oliva Health                                       £4,260,000   \n",
       "Inflow                                           $11,000,000    \n",
       "Likeminded                                        € 1,500,000   \n",
       "Heading Health                                              —   \n",
       "Violet                                            $5,300,000    \n",
       "Anebulo Pharmaceuticals                           $6,600,000    \n",
       "Alyve Health                                     ₹450,000,000   \n",
       "Radicle Science                                             —   \n",
       "Behavidence                                       $4,300,000    \n",
       "MYNDUP                                             £4,400,000   \n",
       "Persimmon                                         $5,323,629    \n",
       "Elfie                                             $4,000,000    \n",
       "Comedi Health Technology Limited                  $5,000,000    \n",
       "tapouts                                           $3,200,000    \n",
       "TOM Medications                                  CHF1,300,000   \n",
       "Realize Me                                        $4,025,000    \n",
       "Axenya                                                      —   \n",
       "Phenomune                                         $3,300,000    \n",
       "Shen.AI @ MX Labs                                 $2,500,000    \n",
       "Fleming                                           € 1,200,000   \n",
       "Oska Health                                       € 2,500,000   \n",
       "PERSOWN                                             $110,000    \n",
       "Una Health                                        $2,500,000    \n",
       "Lifetime Health                                  ₹124,000,000   \n",
       "Legion Health                                     $2,000,000    \n",
       "ONVY HealthTech                                             —   \n",
       "Ailin                                             € 1,500,000   \n",
       "Malaica                                           $1,000,000    \n",
       "Small Joys                                        $1,200,000    \n",
       "SupportRoom                                          £874,000   \n",
       "Total Life                                        $1,500,000    \n",
       "Frankie Health                                    $1,250,000    \n",
       "Docty Inc.                                          $500,000    \n",
       "HECCO Technologies Inc (Prescribe)                $1,500,000    \n",
       "ApoWiser                                          $1,500,000    \n",
       "Holly Health                                         £327,000   \n",
       "Aide Health                                       $1,200,000    \n",
       "\n",
       "                                    Last Equity Funding Type  \\\n",
       "Organization Name                                              \n",
       "Cerebral                                            Series C   \n",
       "Harbor Health                                       Series A   \n",
       "Avi Medical                                         Series B   \n",
       "BetterVet                           Venture - Series Unknown   \n",
       "Antidote Health                                     Series A   \n",
       "Pace                                                Series A   \n",
       "DeepCardio                                          Series A   \n",
       "Brisk Health                                        Series D   \n",
       "Courier Health                                      Series A   \n",
       "Cartwheel                                           Series A   \n",
       "Clearing                                                Seed   \n",
       "Cardo Health                                        Series A   \n",
       "Anima                                               Series A   \n",
       "Oliva Health                                            Seed   \n",
       "Inflow                                              Series A   \n",
       "Likeminded                                              Seed   \n",
       "Heading Health                      Venture - Series Unknown   \n",
       "Violet                                                  Seed   \n",
       "Anebulo Pharmaceuticals                      Post-IPO Equity   \n",
       "Alyve Health                                        Series A   \n",
       "Radicle Science                                         Seed   \n",
       "Behavidence                                             Seed   \n",
       "MYNDUP                                              Series A   \n",
       "Persimmon                                               Seed   \n",
       "Elfie                                                   Seed   \n",
       "Comedi Health Technology Limited                        Seed   \n",
       "tapouts                                                 Seed   \n",
       "TOM Medications                              Corporate Round   \n",
       "Realize Me                                              Seed   \n",
       "Axenya                              Venture - Series Unknown   \n",
       "Phenomune                           Venture - Series Unknown   \n",
       "Shen.AI @ MX Labs                                       Seed   \n",
       "Fleming                                                 Seed   \n",
       "Oska Health                                         Pre-Seed   \n",
       "PERSOWN                                                 Seed   \n",
       "Una Health                                              Seed   \n",
       "Lifetime Health                                         Seed   \n",
       "Legion Health                                           Seed   \n",
       "ONVY HealthTech                                         Seed   \n",
       "Ailin                                                   Seed   \n",
       "Malaica                                             Pre-Seed   \n",
       "Small Joys                                              Seed   \n",
       "SupportRoom                                             Seed   \n",
       "Total Life                                              Seed   \n",
       "Frankie Health                                          Seed   \n",
       "Docty Inc.                                              Seed   \n",
       "HECCO Technologies Inc (Prescribe)                      Seed   \n",
       "ApoWiser                                                Seed   \n",
       "Holly Health                                            Seed   \n",
       "Aide Health                                         Pre-Seed   \n",
       "\n",
       "                                   Total Equity Funding Amount  \\\n",
       "Organization Name                                                \n",
       "Cerebral                                         $462,000,000    \n",
       "Harbor Health                                    $125,500,000    \n",
       "Avi Medical                                       € 88,500,000   \n",
       "BetterVet                                         $57,928,818    \n",
       "Antidote Health                                   $56,000,000    \n",
       "Pace                                              $50,900,000    \n",
       "DeepCardio                                     ₩40,000,000,000   \n",
       "Brisk Health                                      $27,080,000    \n",
       "Courier Health                                    $20,450,002    \n",
       "Cartwheel                                         $20,000,000    \n",
       "Clearing                                          $20,000,000    \n",
       "Cardo Health                                      $17,500,000    \n",
       "Anima                                             $14,625,000    \n",
       "Oliva Health                                       £10,720,000   \n",
       "Inflow                                            $13,980,000    \n",
       "Likeminded                                        € 10,900,000   \n",
       "Heading Health                                     $9,878,120    \n",
       "Violet                                             $6,800,000    \n",
       "Anebulo Pharmaceuticals                            $6,600,000    \n",
       "Alyve Health                                       $6,288,066    \n",
       "Radicle Science                                    $5,999,716    \n",
       "Behavidence                                        $5,625,000    \n",
       "MYNDUP                                              £4,700,000   \n",
       "Persimmon                                          $5,323,629    \n",
       "Elfie                                              $5,000,000    \n",
       "Comedi Health Technology Limited                   $5,000,000    \n",
       "tapouts                                            $4,800,000    \n",
       "TOM Medications                                    $4,762,184    \n",
       "Realize Me                                         $4,025,000    \n",
       "Axenya                                             $4,000,000    \n",
       "Phenomune                                          $3,300,000    \n",
       "Shen.AI @ MX Labs                                  $3,000,000    \n",
       "Fleming                                            € 2,510,030   \n",
       "Oska Health                                        € 2,500,000   \n",
       "PERSOWN                                            $2,618,250    \n",
       "Una Health                                         $2,500,000    \n",
       "Lifetime Health                                    $2,392,919    \n",
       "Legion Health                                      $2,125,000    \n",
       "ONVY HealthTech                                    € 1,400,000   \n",
       "Ailin                                              € 1,500,000   \n",
       "Malaica                                            $1,600,000    \n",
       "Small Joys                                         $1,540,000    \n",
       "SupportRoom                                        $1,529,565    \n",
       "Total Life                                         $1,500,000    \n",
       "Frankie Health                                     $1,500,000    \n",
       "Docty Inc.                                         $1,500,000    \n",
       "HECCO Technologies Inc (Prescribe)                 $1,500,000    \n",
       "ApoWiser                                           $1,500,000    \n",
       "Holly Health                                        £1,197,000   \n",
       "Aide Health                                        $1,320,000    \n",
       "\n",
       "                                                                      Top 5 Investors  \\\n",
       "Organization Name                                                                       \n",
       "Cerebral                            Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...   \n",
       "Harbor Health                       General Catalyst, 8VC, Alta Partners, Martin V...   \n",
       "Avi Medical                         Eurazeo, Picus Capital, 3VC, Operator Partners...   \n",
       "BetterVet                             Alta Partners, Daniel J Adams, Bruce Herzfelder   \n",
       "Antidote Health                     iAngels, Google for Startups, Flint Capital, G...   \n",
       "Pace                                Sequoia Capital, BoxGroup, SV Angel, Pace Capi...   \n",
       "DeepCardio                                                   SoftBank, Dayli Partners   \n",
       "Brisk Health                                                                        —   \n",
       "Courier Health                                   Norwest Venture Partners, Work-Bench   \n",
       "Cartwheel                           Reach Capital, Menlo Ventures, General Catalys...   \n",
       "Clearing                            Hims & Hers, Grubhub, Founders Fund, Bessemer ...   \n",
       "Cardo Health                                                                        —   \n",
       "Anima                               Y Combinator, Molten Ventures, Hummingbird Ven...   \n",
       "Oliva Health                        Alumni Ventures, Molten Ventures, Moonfire Ven...   \n",
       "Inflow                              Y Combinator, Octopus Ventures, Route 66 Ventu...   \n",
       "Likeminded                          Heartcore Capital, IBB Ventures, Holtzbrinck D...   \n",
       "Heading Health                      Alumni Ventures, Global Brain Corporation, Gai...   \n",
       "Violet                              The Venture Collective, SemperVirens Venture C...   \n",
       "Anebulo Pharmaceuticals             National Institute on Drug Abuse (NIDA), Merid...   \n",
       "Alyve Health                        1Crowd, Axilor Ventures, Trifecta Capital Advi...   \n",
       "Radicle Science                     Everywhere Ventures (The Fund), Wayne Chang, S...   \n",
       "Behavidence                         Fusion, GoAhead Ventures, Kicker Ventures, Lon...   \n",
       "MYNDUP                                                                    Arpit Gupta   \n",
       "Persimmon                                                                           —   \n",
       "Elfie                               Google for Startups, Hustle Fund, FEBE Venture...   \n",
       "Comedi Health Technology Limited                                                    —   \n",
       "tapouts                             M Venture Partners (MVP), Sidespin Ventures, R...   \n",
       "TOM Medications                                          Galenica, Sanitas Disruptive   \n",
       "Realize Me                                                          Moonshots Capital   \n",
       "Axenya                              NXTP Ventures, Igah Ventures, big_bets, Alexia...   \n",
       "Phenomune                                                                           —   \n",
       "Shen.AI @ MX Labs                   SMOK Ventures, Superhero Capital, Verge Health...   \n",
       "Fleming                                                                             —   \n",
       "Oska Health                         Calm/Storm Ventures, LBBW VC, Hessen Kapital I...   \n",
       "PERSOWN                                                                             —   \n",
       "Una Health                          Plug and Play, PeakBridge, FoodLabs, Frank Wes...   \n",
       "Lifetime Health                                       SharesPro, The Garage Syndicate   \n",
       "Legion Health                       Y Combinator, Soma Capital, UpHonest Capital, ...   \n",
       "ONVY HealthTech                     New Forge, Isartal Ventures, Wort & Bild Verla...   \n",
       "Ailin                               Decelera, Centre for the Development of Indust...   \n",
       "Malaica                                                 Markus Gemuend, Kapor Capital   \n",
       "Small Joys                                                                          —   \n",
       "SupportRoom                                               8X Ventures, Deepak Bhavsar   \n",
       "Total Life                                                         Primetime Partners   \n",
       "Frankie Health                                                                 E15 VC   \n",
       "Docty Inc.                                                                          —   \n",
       "HECCO Technologies Inc (Prescribe)  Y Combinator, Acequia Capital (AceCap), Vignes...   \n",
       "ApoWiser                                                     MATTER, Longliv Ventures   \n",
       "Holly Health                        Innovate UK, Plug and Play, Kima Ventures, Mod...   \n",
       "Aide Health                         Fuel Ventures, Salica, APX, 1818 Venture Capit...   \n",
       "\n",
       "                                   IPO Status         Country  \n",
       "Organization Name                                              \n",
       "Cerebral                              Private   United States  \n",
       "Harbor Health                         Private   United States  \n",
       "Avi Medical                           Private         Germany  \n",
       "BetterVet                             Private   United States  \n",
       "Antidote Health                       Private   United States  \n",
       "Pace                                  Private   United States  \n",
       "DeepCardio                            Private     South Korea  \n",
       "Brisk Health                          Private   United States  \n",
       "Courier Health                        Private   United States  \n",
       "Cartwheel                             Private   United States  \n",
       "Clearing                              Private   United States  \n",
       "Cardo Health                          Private          Sweden  \n",
       "Anima                                 Private   United States  \n",
       "Oliva Health                          Private           Spain  \n",
       "Inflow                                Private  United Kingdom  \n",
       "Likeminded                            Private         Germany  \n",
       "Heading Health                        Private   United States  \n",
       "Violet                                Private   United States  \n",
       "Anebulo Pharmaceuticals                Public   United States  \n",
       "Alyve Health                          Private           India  \n",
       "Radicle Science                       Private   United States  \n",
       "Behavidence                           Private   United States  \n",
       "MYNDUP                                Private  United Kingdom  \n",
       "Persimmon                             Private   United States  \n",
       "Elfie                                 Private       Singapore  \n",
       "Comedi Health Technology Limited      Private       Hong Kong  \n",
       "tapouts                               Private   United States  \n",
       "TOM Medications                       Private     Switzerland  \n",
       "Realize Me                            Private   United States  \n",
       "Axenya                                Private         Uruguay  \n",
       "Phenomune                             Private   United States  \n",
       "Shen.AI @ MX Labs                     Private         Estonia  \n",
       "Fleming                               Private       Lithuania  \n",
       "Oska Health                           Private         Germany  \n",
       "PERSOWN                               Private   United States  \n",
       "Una Health                            Private         Germany  \n",
       "Lifetime Health                       Private           India  \n",
       "Legion Health                         Private   United States  \n",
       "ONVY HealthTech                       Private         Germany  \n",
       "Ailin                                 Private           Spain  \n",
       "Malaica                               Private           Kenya  \n",
       "Small Joys                            Private   United States  \n",
       "SupportRoom                           Private  United Kingdom  \n",
       "Total Life                            Private   United States  \n",
       "Frankie Health                        Private         Ireland  \n",
       "Docty Inc.                            Private   United States  \n",
       "HECCO Technologies Inc (Prescribe)    Private           India  \n",
       "ApoWiser                              Private          Israel  \n",
       "Holly Health                          Private  United Kingdom  \n",
       "Aide Health                               NaN  United Kingdom  \n",
       "\n",
       "[50 rows x 27 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#create \"country\" column \n",
    "\n",
    "df_1['Country']= df_1 ['Headquarters Location'].str.extract(r',\\s*([^,]+)$')\n",
    "df_1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "e33e5e40-f8dc-4e58-a3e5-5692f50d26d5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industries</th>\n",
       "      <th>Headquarters Location</th>\n",
       "      <th>Description</th>\n",
       "      <th>CB Rank (Company)</th>\n",
       "      <th>Estimated Revenue Range</th>\n",
       "      <th>Website</th>\n",
       "      <th>Company Type</th>\n",
       "      <th>Founded Date</th>\n",
       "      <th>Operating Status</th>\n",
       "      <th>Full Description</th>\n",
       "      <th>...</th>\n",
       "      <th>Last Funding Date</th>\n",
       "      <th>Last Funding Amount</th>\n",
       "      <th>Total Funding Amount</th>\n",
       "      <th>Last Funding Type</th>\n",
       "      <th>Last Equity Funding Amount</th>\n",
       "      <th>Last Equity Funding Type</th>\n",
       "      <th>Total Equity Funding Amount</th>\n",
       "      <th>Top 5 Investors</th>\n",
       "      <th>IPO Status</th>\n",
       "      <th>Country</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Organization Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Kenvue</th>\n",
       "      <td>Lifestyle, Personal Health, Wellness</td>\n",
       "      <td>Skillman, New Jersey, United States</td>\n",
       "      <td>Kenvue is a consumer health company that deliv...</td>\n",
       "      <td>3,970</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>kenvue.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2023</td>\n",
       "      <td>Active</td>\n",
       "      <td>Kenvue is a consumer health company that deliv...</td>\n",
       "      <td>...</td>\n",
       "      <td>14-May-24</td>\n",
       "      <td>$3,646,591,000</td>\n",
       "      <td>$3,646,591,000</td>\n",
       "      <td>Post-IPO Secondary</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Goldman Sachs, J.P. Morgan Securities Inc.</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cencora</th>\n",
       "      <td>Emergency Medicine, Enterprise Software, Healt...</td>\n",
       "      <td>Conshohocken, Pennsylvania, United States</td>\n",
       "      <td>Cencora is a global healthcare company that ad...</td>\n",
       "      <td>1,466</td>\n",
       "      <td>$10B+</td>\n",
       "      <td>cencora.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2023</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cencora, building on the legacy of Amerisource...</td>\n",
       "      <td>...</td>\n",
       "      <td>05-Feb-24</td>\n",
       "      <td>$500,000,000</td>\n",
       "      <td>$3,025,000,000</td>\n",
       "      <td>Post-IPO Debt</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Altos Labs</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care, Health ...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Altos Labs focuses on cellular rejuvenation pr...</td>\n",
       "      <td>2,590</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>altoslabs.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Altos Labs is a biotechnology company focused ...</td>\n",
       "      <td>...</td>\n",
       "      <td>01-Jan-21</td>\n",
       "      <td>$3,000,000,000</td>\n",
       "      <td>$3,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$3,000,000,000</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>ARCH Venture Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Resilience</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care, Life Sc...</td>\n",
       "      <td>La Jolla, California, United States</td>\n",
       "      <td>Resilience provides end-to-end biopharmaceutic...</td>\n",
       "      <td>2,627</td>\n",
       "      <td>$500M to $1B</td>\n",
       "      <td>resilience.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Resilience provides end-to-end biopharmaceutic...</td>\n",
       "      <td>...</td>\n",
       "      <td>24-Mar-23</td>\n",
       "      <td>$410,000,000</td>\n",
       "      <td>$2,515,000,000</td>\n",
       "      <td>Debt Financing</td>\n",
       "      <td>—</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>$2,105,000,000</td>\n",
       "      <td>Google Ventures, 8VC, Mubadala, New Enterprise...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>GoTo Group</th>\n",
       "      <td>Delivery Service, Health Care, Information Tec...</td>\n",
       "      <td>Jakarta, Jakarta Raya, Indonesia</td>\n",
       "      <td>GoTo Group offers a digital ecosystem for on-d...</td>\n",
       "      <td>4,999</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>gotocompany.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>GoTo Group is an application used for ride-hai...</td>\n",
       "      <td>...</td>\n",
       "      <td>03-Oct-23</td>\n",
       "      <td>$150,000,000</td>\n",
       "      <td>$1,450,000,000</td>\n",
       "      <td>Debt Financing</td>\n",
       "      <td>$1,300,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$1,300,000,000</td>\n",
       "      <td>Google, Tencent, International Finance Corpora...</td>\n",
       "      <td>Public</td>\n",
       "      <td>Indonesia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Xaira Therapeutics</th>\n",
       "      <td>Artificial Intelligence (AI), Biotechnology, H...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Xaira Therapeutics is an integrated biotechnol...</td>\n",
       "      <td>450</td>\n",
       "      <td>—</td>\n",
       "      <td>xaira.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2024</td>\n",
       "      <td>Active</td>\n",
       "      <td>Xaira Therapeutics is an integrated biotechnol...</td>\n",
       "      <td>...</td>\n",
       "      <td>23-Apr-24</td>\n",
       "      <td>$1,000,000,000</td>\n",
       "      <td>$1,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$1,000,000,000</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Menlo Ventures, Sequoia Capital, Lightspeed Ve...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Organon</th>\n",
       "      <td>Health Care, Medical Device, Pharmaceutical, W...</td>\n",
       "      <td>Jersey City, New Jersey, United States</td>\n",
       "      <td>Organon offers medicines and other products to...</td>\n",
       "      <td>9,345</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>organon.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Organon offers medicines and other products to...</td>\n",
       "      <td>...</td>\n",
       "      <td>07-May-24</td>\n",
       "      <td>$1,000,000,000</td>\n",
       "      <td>$1,000,000,000</td>\n",
       "      <td>Post-IPO Debt</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nutrabolt</th>\n",
       "      <td>Dietary Supplements, Fitness, Health Care, Mar...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Nutrabolt is a dietary health supplement distr...</td>\n",
       "      <td>60,629</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>nutrabolt.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Nutrabolt produces and sells supplements for t...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Dec-22</td>\n",
       "      <td>$863,000,000</td>\n",
       "      <td>$863,000,000</td>\n",
       "      <td>Secondary Market</td>\n",
       "      <td>—</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>—</td>\n",
       "      <td>Keurig Dr Pepper, MidOcean Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NeoCannBio</th>\n",
       "      <td>Biopharma, Cannabis, Health Care</td>\n",
       "      <td>Seoul, Seoul-t'ukpyolsi, South Korea</td>\n",
       "      <td>NeoCannBio offers natural product processing f...</td>\n",
       "      <td>59,673</td>\n",
       "      <td>—</td>\n",
       "      <td>neocannbio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>NeoCannBio provides natural product processing...</td>\n",
       "      <td>...</td>\n",
       "      <td>26-Sep-23</td>\n",
       "      <td>₩10,000,000,000</td>\n",
       "      <td>$678,925,399</td>\n",
       "      <td>Series B</td>\n",
       "      <td>₩10,000,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$678,925,399</td>\n",
       "      <td>QUAD Investment Management, HLB Group, Donghoo...</td>\n",
       "      <td>Private</td>\n",
       "      <td>South Korea</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Apogee Therapeutics</th>\n",
       "      <td>Biotechnology, Life Science, Medical, Therapeu...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Apogee Therapeutics is a biotechnology company...</td>\n",
       "      <td>37,763</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>apogeetherapeutics.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Apogee Therapeutics is a biotechnology company...</td>\n",
       "      <td>...</td>\n",
       "      <td>07-Mar-24</td>\n",
       "      <td>$483,000,000</td>\n",
       "      <td>$652,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$483,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$652,000,000</td>\n",
       "      <td>Fidelity, OrbiMed, Wellington Management, RA C...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Centessa Pharmaceuticals</th>\n",
       "      <td>Biotechnology, Pharmaceutical</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Centessa Pharmaceuticals is a next-generation ...</td>\n",
       "      <td>9,162</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>centessa.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Centessa Pharmaceuticals is a next-generation ...</td>\n",
       "      <td>...</td>\n",
       "      <td>23-Apr-24</td>\n",
       "      <td>$100,000,000</td>\n",
       "      <td>$650,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$100,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>T. Rowe Price, IP Group, Franklin Templeton, W...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Surround Care</th>\n",
       "      <td>Health Care, Hospital, Medical</td>\n",
       "      <td>St Louis, Missouri, United States</td>\n",
       "      <td>Surround Care focuses on fixing healthcare aff...</td>\n",
       "      <td>28,699</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>surround-care.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Surround Care focuses on fixing healthcare aff...</td>\n",
       "      <td>...</td>\n",
       "      <td>15-Nov-22</td>\n",
       "      <td>$573,480,000</td>\n",
       "      <td>$573,480,000</td>\n",
       "      <td>Undisclosed</td>\n",
       "      <td>$573,480,000</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Avenzo Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Medical, Oncology,...</td>\n",
       "      <td>San Diego, California, United States</td>\n",
       "      <td>Avenzo Therapeutics specializes in the develop...</td>\n",
       "      <td>7,746</td>\n",
       "      <td>—</td>\n",
       "      <td>avenzotx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Avenzo Therapeutics specializes in the develop...</td>\n",
       "      <td>...</td>\n",
       "      <td>26-Mar-24</td>\n",
       "      <td>$150,000,000</td>\n",
       "      <td>$569,350,002</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$150,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$569,350,002</td>\n",
       "      <td>New Enterprise Associates, SR One, Lilly Asia ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ACELYRIN</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care</td>\n",
       "      <td>Los Angeles, California, United States</td>\n",
       "      <td>ACELYRIN is a biopharma company that identifie...</td>\n",
       "      <td>5,972</td>\n",
       "      <td>—</td>\n",
       "      <td>acelyrin.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>ACELYRIN is a biopharma company focused on pro...</td>\n",
       "      <td>...</td>\n",
       "      <td>13-Sep-22</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>$558,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$558,000,000</td>\n",
       "      <td>OrbiMed, Decheng Capital, RTW Investments, Sur...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Taysha Gene Therapies</th>\n",
       "      <td>Biotechnology, Genetics, Life Science</td>\n",
       "      <td>Dallas, Texas, United States</td>\n",
       "      <td>Taysha Gene Therapies develops treatments to e...</td>\n",
       "      <td>2,137</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>tayshagtx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Taysha Gene Therapies is on a mission to eradi...</td>\n",
       "      <td>...</td>\n",
       "      <td>26-Jun-24</td>\n",
       "      <td>$75,000,000</td>\n",
       "      <td>$543,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$75,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$403,000,000</td>\n",
       "      <td>Fidelity, BlackRock, Trinity Capital, Google V...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alumis</th>\n",
       "      <td>Biotechnology, Health Care, Life Science, Prec...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Alumis is a precision medicine company focused...</td>\n",
       "      <td>319</td>\n",
       "      <td>—</td>\n",
       "      <td>alumis.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Alumis develops precision medications to treat...</td>\n",
       "      <td>...</td>\n",
       "      <td>06-Mar-24</td>\n",
       "      <td>$259,000,000</td>\n",
       "      <td>$529,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$259,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$529,000,000</td>\n",
       "      <td>Foresite Capital, Cormorant Asset Management, ...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Biohaven</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care</td>\n",
       "      <td>New Haven, Connecticut, United States</td>\n",
       "      <td>Biohaven is a clinical-stage biopharmaceutical...</td>\n",
       "      <td>8,102</td>\n",
       "      <td>—</td>\n",
       "      <td>biohaven.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Biohaven is a clinical-stage biopharmaceutical...</td>\n",
       "      <td>...</td>\n",
       "      <td>18-Apr-24</td>\n",
       "      <td>$264,500,000</td>\n",
       "      <td>$523,200,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$264,500,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$523,200,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Odyssey Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Oncology, Therapeu...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Odyssey Therapeutics creates precision immunom...</td>\n",
       "      <td>44,888</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>odysseytx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Odyssey Therapeutics is pioneering the efficie...</td>\n",
       "      <td>...</td>\n",
       "      <td>05-Dec-23</td>\n",
       "      <td>$101,000,000</td>\n",
       "      <td>$487,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$101,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$487,000,000</td>\n",
       "      <td>Fidelity, T. Rowe Price, General Catalyst, Orb...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Mirador Therapeutics</th>\n",
       "      <td>Health Care, Medical, Therapeutics</td>\n",
       "      <td>San Diego, California, United States</td>\n",
       "      <td>Mirador Therapeutics envisions precision medic...</td>\n",
       "      <td>6,447</td>\n",
       "      <td>—</td>\n",
       "      <td>miradortx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2024</td>\n",
       "      <td>Active</td>\n",
       "      <td>Mirador Therapeutics envisions precision medic...</td>\n",
       "      <td>...</td>\n",
       "      <td>21-Mar-24</td>\n",
       "      <td>$400,000,000</td>\n",
       "      <td>$480,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$400,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$480,000,000</td>\n",
       "      <td>Fidelity, Sanofi, Blue Owl, OrbiMed, Point72 V...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Treeline Biosciences</th>\n",
       "      <td>Biotechnology, Health Care, Life Science, Medi...</td>\n",
       "      <td>Stamford, Connecticut, United States</td>\n",
       "      <td>Treeline Biosciences is a biotech company buil...</td>\n",
       "      <td>53,808</td>\n",
       "      <td>—</td>\n",
       "      <td>treeline.bio</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Treeline Biosciences is a biotech company buil...</td>\n",
       "      <td>...</td>\n",
       "      <td>11-Oct-22</td>\n",
       "      <td>$261,266,523</td>\n",
       "      <td>$473,266,523</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$261,266,523</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$473,266,523</td>\n",
       "      <td>Kohlberg Kravis Roberts, OrbiMed, Google Ventu...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Invivyd</th>\n",
       "      <td>Biotechnology, Pharmaceutical, Therapeutics</td>\n",
       "      <td>Waltham, Massachusetts, United States</td>\n",
       "      <td>Invivyd develops antibodies to transcend the l...</td>\n",
       "      <td>7,599</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>invivyd.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Invivyd is on a mission to rapidly and perpetu...</td>\n",
       "      <td>...</td>\n",
       "      <td>19-Apr-21</td>\n",
       "      <td>$336,000,000</td>\n",
       "      <td>$466,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$336,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$466,000,000</td>\n",
       "      <td>Fidelity, OrbiMed, Google Ventures, RA Capital...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cerebral</th>\n",
       "      <td>Health Care, Medical, Mental Health, mHealth, ...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Cerebral is a mental health telemedicine compa...</td>\n",
       "      <td>24,999</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>cerebral.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cerebral makes high-quality mental health care...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Dec-21</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Areteia Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Life Science, Ther...</td>\n",
       "      <td>Bernardsville, New Jersey, United States</td>\n",
       "      <td>Areteia Therapeutics is a biotechnology compan...</td>\n",
       "      <td>10,909</td>\n",
       "      <td>—</td>\n",
       "      <td>areteiatx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Areteia Therapeutics is committed to putting a...</td>\n",
       "      <td>...</td>\n",
       "      <td>13-Feb-24</td>\n",
       "      <td>$75,000,000</td>\n",
       "      <td>$425,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$75,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$425,000,000</td>\n",
       "      <td>Sanofi, Google Ventures, Marshall Wace, Viking...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Transcarent</th>\n",
       "      <td>Health Care, Personal Health, Software</td>\n",
       "      <td>Denver, Colorado, United States</td>\n",
       "      <td>Transcarent is a provider of a healthcare plat...</td>\n",
       "      <td>1,715</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>transcarent.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Transcarent is a consumer-directed health and ...</td>\n",
       "      <td>...</td>\n",
       "      <td>02-May-24</td>\n",
       "      <td>$126,000,000</td>\n",
       "      <td>$424,000,000</td>\n",
       "      <td>Series D</td>\n",
       "      <td>$126,000,000</td>\n",
       "      <td>Series D</td>\n",
       "      <td>$424,000,000</td>\n",
       "      <td>General Catalyst, Kleiner Perkins, GreatPoint ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Scorpion Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Life Science, Onco...</td>\n",
       "      <td>Boston, Massachusetts, United States</td>\n",
       "      <td>Scorpion Therapeutics is a clinical-stage onco...</td>\n",
       "      <td>317</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>scorpiontx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Scorpion Therapeutics develops targeted small-...</td>\n",
       "      <td>...</td>\n",
       "      <td>16-Jul-24</td>\n",
       "      <td>$150,000,000</td>\n",
       "      <td>$420,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$150,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$420,000,000</td>\n",
       "      <td>Fidelity, OrbiMed, Lightspeed Venture Partners...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Upstream Bio</th>\n",
       "      <td>Biotechnology, Health Care, Pharmaceutical, Th...</td>\n",
       "      <td>Waltham, Massachusetts, United States</td>\n",
       "      <td>Upstream Bio focuses on developing an antibody...</td>\n",
       "      <td>8,112</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>upstreambio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Upstream Bio focuses on developing an antibody...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Jun-23</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>$408,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$408,000,000</td>\n",
       "      <td>OrbiMed, Wellington Management, Omega Funds, E...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CorroHealth</th>\n",
       "      <td>Document Management, Financial Services, Healt...</td>\n",
       "      <td>Plano, Texas, United States</td>\n",
       "      <td>CorroHealth helps individuals in the reimburse...</td>\n",
       "      <td>6,000</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>corrohealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>CorroHealth helps individuals in the reimburse...</td>\n",
       "      <td>...</td>\n",
       "      <td>05-Oct-23</td>\n",
       "      <td>$50,000,000</td>\n",
       "      <td>$376,268,825</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>$50,000,000</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>$376,268,825</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sonoma BioTherapeutics</th>\n",
       "      <td>Biotechnology, Life Science, Therapeutics</td>\n",
       "      <td>South San Francisco, California, United States</td>\n",
       "      <td>Sonoma BioTherapeutics develops adoptive Treg ...</td>\n",
       "      <td>8,596</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>sonomabio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Sonoma Biotherapeutics is developing adoptive ...</td>\n",
       "      <td>...</td>\n",
       "      <td>28-Mar-23</td>\n",
       "      <td>$30,000,000</td>\n",
       "      <td>$365,000,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$30,000,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$365,000,000</td>\n",
       "      <td>Fidelity, Mirae Asset, Regeneron, Google Ventu...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tourmaline Bio</th>\n",
       "      <td>Biotechnology, Clinical Trials, Therapeutics</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Tourmaline Bio is a clinical biotechnology com...</td>\n",
       "      <td>3,834</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>tourmalinebio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Tourmaline Bio is a clinical biotechnology com...</td>\n",
       "      <td>...</td>\n",
       "      <td>25-Jan-24</td>\n",
       "      <td>$172,500,000</td>\n",
       "      <td>$359,500,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$172,500,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$359,500,000</td>\n",
       "      <td>RA Capital Management, Great Point Partners, L...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Center for Breakthrough Medicines</th>\n",
       "      <td>Biotechnology, Genetics, Manufacturing, Medical</td>\n",
       "      <td>King Of Prussia, Pennsylvania, United States</td>\n",
       "      <td>Center for Breakthrough Medicines is an innova...</td>\n",
       "      <td>23,276</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>breakthroughmedicines.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Center for Breakthrough Medicines is an innova...</td>\n",
       "      <td>...</td>\n",
       "      <td>10-Jan-22</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>SK Holdings</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Main Street Health</th>\n",
       "      <td>Health Care, Health Diagnostics, Medical</td>\n",
       "      <td>Nashville, Tennessee, United States</td>\n",
       "      <td>Main Street Health is a supplier of value-base...</td>\n",
       "      <td>6,051</td>\n",
       "      <td>—</td>\n",
       "      <td>mainstreetruralhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Main Street Health is a provider of value-base...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Oct-23</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>$342,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$342,000,000</td>\n",
       "      <td>Humana, Oak HC/FT, CVS Health, Optum Ventures,...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Capstan Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Therapeutics</td>\n",
       "      <td>San Diego, California, United States</td>\n",
       "      <td>Capstan Therapeutics is advancing cell enginee...</td>\n",
       "      <td>43,621</td>\n",
       "      <td>—</td>\n",
       "      <td>capstantx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Capstan Therapeutics is advancing precision in...</td>\n",
       "      <td>...</td>\n",
       "      <td>20-Mar-24</td>\n",
       "      <td>$175,000,000</td>\n",
       "      <td>$340,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$175,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$340,000,000</td>\n",
       "      <td>Bristol-Myers Squibb, OrbiMed, RA Capital Mana...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>METiS Pharmaceuticals</th>\n",
       "      <td>Artificial Intelligence (AI), Biopharma, Biote...</td>\n",
       "      <td>Hangzhou, Zhejiang, China</td>\n",
       "      <td>METiS Pharmaceuticals is the world's first AI-...</td>\n",
       "      <td>8,268</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>metispharmaceuticals.cn</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Jitai Medicine (METiS) is a biotechnology comp...</td>\n",
       "      <td>...</td>\n",
       "      <td>22-Jun-24</td>\n",
       "      <td>$100,000,000</td>\n",
       "      <td>$336,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$100,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$336,000,000</td>\n",
       "      <td>XtalPi, Sequoia Capital China, Source Code Cap...</td>\n",
       "      <td>Private</td>\n",
       "      <td>China</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Forge Biologics</th>\n",
       "      <td>Biotechnology, Health Care, Medical, Therapeutics</td>\n",
       "      <td>Grove City, Ohio, United States</td>\n",
       "      <td>Forge Biologics is a gene therapy development ...</td>\n",
       "      <td>68,370</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>forgebiologics.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Forge Biologics is a gene therapy development ...</td>\n",
       "      <td>...</td>\n",
       "      <td>12-Sep-22</td>\n",
       "      <td>$90,000,000</td>\n",
       "      <td>$330,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$90,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$250,000,000</td>\n",
       "      <td>Drive Capital, MidCap Financial, RA Capital Ma...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Zenas BioPharma</th>\n",
       "      <td>Biopharma, Health Care, Pharmaceutical</td>\n",
       "      <td>Waltham, Massachusetts, United States</td>\n",
       "      <td>Zenas BioPharma is a biopharmaceutical company...</td>\n",
       "      <td>3,020</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>zenasbio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Zenas BioPharma is a biopharmaceutical company...</td>\n",
       "      <td>...</td>\n",
       "      <td>07-May-24</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>$318,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$318,000,000</td>\n",
       "      <td>Wellington Management, Xencor, New Enterprise ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2seventy bio</th>\n",
       "      <td>Biotechnology, Genetics, Health Care, Oncology...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>2seventy bio is an immuno-oncology cell therap...</td>\n",
       "      <td>3,928</td>\n",
       "      <td>$50M to $100M</td>\n",
       "      <td>2seventybio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>2seventy bio is an immuno-oncology cell therap...</td>\n",
       "      <td>...</td>\n",
       "      <td>28-Feb-23</td>\n",
       "      <td>$125,000,000</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$125,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Regeneron, Casdin Capital, Janus Henderson Inv...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gen4 Dental Partners</th>\n",
       "      <td>Dental, Health Care</td>\n",
       "      <td>Tempe, Arizona, United States</td>\n",
       "      <td>Gen4 Dental Partners is a doctor-centric, part...</td>\n",
       "      <td>22,565</td>\n",
       "      <td>$50M to $100M</td>\n",
       "      <td>gen4dental.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Gen4 Dental Partners provides world-class supp...</td>\n",
       "      <td>...</td>\n",
       "      <td>21-May-24</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Debt Financing</td>\n",
       "      <td>—</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>—</td>\n",
       "      <td>Saratoga Partners, Varagon Capital Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Hasten</th>\n",
       "      <td>Health Care, Hospital, Manufacturing, Pharmace...</td>\n",
       "      <td>Hefei, Anhui, China</td>\n",
       "      <td>Hasten is a pharmaceutical manufacturing compa...</td>\n",
       "      <td>36,870</td>\n",
       "      <td>—</td>\n",
       "      <td>hastenpharma.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Hasten is a pharmaceutical manufacturing compa...</td>\n",
       "      <td>...</td>\n",
       "      <td>20-Apr-23</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Mubadala, C-Bridge Capital</td>\n",
       "      <td>Private</td>\n",
       "      <td>China</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bicara Therapeutics</th>\n",
       "      <td>Biopharma, Biotechnology, Life Science, Oncolo...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Bicara Therapeutics develops dual-action cance...</td>\n",
       "      <td>58,367</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>bicara.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Bicara Therapeutics is a clinical-stage biotec...</td>\n",
       "      <td>...</td>\n",
       "      <td>12-Dec-23</td>\n",
       "      <td>$165,000,000</td>\n",
       "      <td>$313,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$165,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$313,000,000</td>\n",
       "      <td>TPG, F-Prime Capital, RA Capital Management, B...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CARGO Therapeutics</th>\n",
       "      <td>Biotechnology, Medical, Therapeutics</td>\n",
       "      <td>San Mateo, California, United States</td>\n",
       "      <td>CARGO Therapeutics develops an adoptive cell t...</td>\n",
       "      <td>36,449</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>cargo-tx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>CARGO Therapeutics develops CAR T-cell therapy...</td>\n",
       "      <td>...</td>\n",
       "      <td>28-May-24</td>\n",
       "      <td>$110,000,000</td>\n",
       "      <td>$310,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$110,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$310,000,000</td>\n",
       "      <td>T. Rowe Price, Wellington Management, Cormoran...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ArriVent Biopharma</th>\n",
       "      <td>Biotechnology, Life Science, Pharmaceutical</td>\n",
       "      <td>Pennsylvania Furnace, Pennsylvania, United States</td>\n",
       "      <td>ArriVent develops pharmaceutical products to c...</td>\n",
       "      <td>6,744</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>arrivent.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>ArriVent is a biopharmaceutical company develo...</td>\n",
       "      <td>...</td>\n",
       "      <td>29-Dec-22</td>\n",
       "      <td>$155,000,000</td>\n",
       "      <td>$305,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$155,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$305,000,000</td>\n",
       "      <td>General Catalyst, OrbiMed, Sequoia Capital Chi...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Normax Biomed</th>\n",
       "      <td>Biotechnology, Manufacturing, Pharmaceutical</td>\n",
       "      <td>Cork, Cork, Ireland</td>\n",
       "      <td>Normax Biomed is an mRNA Vaccine research and ...</td>\n",
       "      <td>60,951</td>\n",
       "      <td>—</td>\n",
       "      <td>normaxbiomed.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Normax Biomed is an mRNA Vaccine research and ...</td>\n",
       "      <td>...</td>\n",
       "      <td>11-Jul-22</td>\n",
       "      <td>€ 300,000,000</td>\n",
       "      <td>€ 300,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>€ 300,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>€ 300,000,000</td>\n",
       "      <td>The Global Emerging Markets Group</td>\n",
       "      <td>Private</td>\n",
       "      <td>Ireland</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Uniquity Bio</th>\n",
       "      <td>Biotechnology, Medical</td>\n",
       "      <td>Malvern, Pennsylvania, United States</td>\n",
       "      <td>Uniquity Bio operates as a drug development co...</td>\n",
       "      <td>7,949</td>\n",
       "      <td>—</td>\n",
       "      <td>uniquity.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Uniquity Bio operates a drug development company.</td>\n",
       "      <td>...</td>\n",
       "      <td>15-May-24</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Blackstone Life Sciences</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>KELIX bio</th>\n",
       "      <td>Manufacturing, Pharmaceutical</td>\n",
       "      <td>Dubai, Dubai, United Arab Emirates</td>\n",
       "      <td>KELIX bio is a specialty generic business focu...</td>\n",
       "      <td>28,207</td>\n",
       "      <td>—</td>\n",
       "      <td>kelixbio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>KELIX bio is a specialty generic business focu...</td>\n",
       "      <td>...</td>\n",
       "      <td>09-Mar-22</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>British International Investment, Development ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Arab Emirates</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ReNAgade Therapeutics</th>\n",
       "      <td>Biotechnology, Medical, Therapeutics</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>ReNAgade Therapeutics focuses on the boundless...</td>\n",
       "      <td>64,077</td>\n",
       "      <td>—</td>\n",
       "      <td>renagadetx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>ReNAgade Therapeutics focuses on the boundless...</td>\n",
       "      <td>...</td>\n",
       "      <td>23-May-23</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>MPM Capital, F2 Ventures</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Beacon Therapeutics</th>\n",
       "      <td>Health Care, Therapeutics</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>Beacon Therapeutics is an ophthalmic gene ther...</td>\n",
       "      <td>1,196</td>\n",
       "      <td>—</td>\n",
       "      <td>beacontx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2023</td>\n",
       "      <td>Active</td>\n",
       "      <td>Beacon Therapeutics is an ophthalmic gene ther...</td>\n",
       "      <td>...</td>\n",
       "      <td>03-Jun-24</td>\n",
       "      <td>$170,000,000</td>\n",
       "      <td>$290,139,662</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$170,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$290,139,662</td>\n",
       "      <td>Oxford Science Enterprises, Forbion Capital Pa...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Metsera</th>\n",
       "      <td>Biopharma, Health Care, Medical</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Metsera operates as a clinical-stage biopharma...</td>\n",
       "      <td>8,384</td>\n",
       "      <td>—</td>\n",
       "      <td>metsera.com</td>\n",
       "      <td>—</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Metsera operates as a clinical-stage biopharma...</td>\n",
       "      <td>...</td>\n",
       "      <td>18-Apr-24</td>\n",
       "      <td>$290,000,000</td>\n",
       "      <td>$290,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$290,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$290,000,000</td>\n",
       "      <td>Google Ventures, F-Prime Capital, Mubadala Cap...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AmplifyBio</th>\n",
       "      <td>Biotechnology, Health Care, Life Science</td>\n",
       "      <td>West Jefferson, Ohio, United States</td>\n",
       "      <td>AmplifyBio is a biotechnology company that dev...</td>\n",
       "      <td>3,681</td>\n",
       "      <td>$50M to $100M</td>\n",
       "      <td>amplify-bio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>AmplifyBio is a biotechnology company that dev...</td>\n",
       "      <td>...</td>\n",
       "      <td>15-Nov-23</td>\n",
       "      <td>$49,750,000</td>\n",
       "      <td>$279,750,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$49,750,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$229,750,000</td>\n",
       "      <td>Hercules Capital, Battelle, Narya Capital, Vik...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Mineralys Therapeutics</th>\n",
       "      <td>Biopharma, Biotechnology, Medical, Pharmaceutical</td>\n",
       "      <td>Radnor, Pennsylvania, United States</td>\n",
       "      <td>Mineralys Therapeutics is a clinical-stage bio...</td>\n",
       "      <td>11,923</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>mineralystx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Mineralys Therapeutics is a biopharmaceutical ...</td>\n",
       "      <td>...</td>\n",
       "      <td>08-Feb-24</td>\n",
       "      <td>$120,000,000</td>\n",
       "      <td>$278,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$120,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$278,000,000</td>\n",
       "      <td>Andera Partners, OrbiMed, RA Capital Managemen...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Orbital Therapeutics</th>\n",
       "      <td>Alternative Medicine, Biotechnology, Life Scie...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Orbital Therapeutics is a biotechnology compan...</td>\n",
       "      <td>62,764</td>\n",
       "      <td>—</td>\n",
       "      <td>orbitaltx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Orbital Therapeutics aims to enhance global he...</td>\n",
       "      <td>...</td>\n",
       "      <td>26-Apr-23</td>\n",
       "      <td>$270,000,000</td>\n",
       "      <td>$270,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$270,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$270,000,000</td>\n",
       "      <td>Andreessen Horowitz, EXOR N.V., Invus, Alexand...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>50 rows × 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                          Industries  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                                          Lifestyle, Personal Health, Wellness   \n",
       "Cencora                            Emergency Medicine, Enterprise Software, Healt...   \n",
       "Altos Labs                         Biopharma, Biotechnology, Health Care, Health ...   \n",
       "Resilience                         Biopharma, Biotechnology, Health Care, Life Sc...   \n",
       "GoTo Group                         Delivery Service, Health Care, Information Tec...   \n",
       "Xaira Therapeutics                 Artificial Intelligence (AI), Biotechnology, H...   \n",
       "Organon                            Health Care, Medical Device, Pharmaceutical, W...   \n",
       "Nutrabolt                          Dietary Supplements, Fitness, Health Care, Mar...   \n",
       "NeoCannBio                                          Biopharma, Cannabis, Health Care   \n",
       "Apogee Therapeutics                Biotechnology, Life Science, Medical, Therapeu...   \n",
       "Centessa Pharmaceuticals                               Biotechnology, Pharmaceutical   \n",
       "Surround Care                                         Health Care, Hospital, Medical   \n",
       "Avenzo Therapeutics                Biotechnology, Health Care, Medical, Oncology,...   \n",
       "ACELYRIN                                       Biopharma, Biotechnology, Health Care   \n",
       "Taysha Gene Therapies                          Biotechnology, Genetics, Life Science   \n",
       "Alumis                             Biotechnology, Health Care, Life Science, Prec...   \n",
       "Biohaven                                       Biopharma, Biotechnology, Health Care   \n",
       "Odyssey Therapeutics               Biotechnology, Health Care, Oncology, Therapeu...   \n",
       "Mirador Therapeutics                              Health Care, Medical, Therapeutics   \n",
       "Treeline Biosciences               Biotechnology, Health Care, Life Science, Medi...   \n",
       "Invivyd                                  Biotechnology, Pharmaceutical, Therapeutics   \n",
       "Cerebral                           Health Care, Medical, Mental Health, mHealth, ...   \n",
       "Areteia Therapeutics               Biotechnology, Health Care, Life Science, Ther...   \n",
       "Transcarent                                   Health Care, Personal Health, Software   \n",
       "Scorpion Therapeutics              Biotechnology, Health Care, Life Science, Onco...   \n",
       "Upstream Bio                       Biotechnology, Health Care, Pharmaceutical, Th...   \n",
       "CorroHealth                        Document Management, Financial Services, Healt...   \n",
       "Sonoma BioTherapeutics                     Biotechnology, Life Science, Therapeutics   \n",
       "Tourmaline Bio                          Biotechnology, Clinical Trials, Therapeutics   \n",
       "Center for Breakthrough Medicines    Biotechnology, Genetics, Manufacturing, Medical   \n",
       "Main Street Health                          Health Care, Health Diagnostics, Medical   \n",
       "Capstan Therapeutics                        Biotechnology, Health Care, Therapeutics   \n",
       "METiS Pharmaceuticals              Artificial Intelligence (AI), Biopharma, Biote...   \n",
       "Forge Biologics                    Biotechnology, Health Care, Medical, Therapeutics   \n",
       "Zenas BioPharma                               Biopharma, Health Care, Pharmaceutical   \n",
       "2seventy bio                       Biotechnology, Genetics, Health Care, Oncology...   \n",
       "Gen4 Dental Partners                                             Dental, Health Care   \n",
       "Hasten                             Health Care, Hospital, Manufacturing, Pharmace...   \n",
       "Bicara Therapeutics                Biopharma, Biotechnology, Life Science, Oncolo...   \n",
       "CARGO Therapeutics                              Biotechnology, Medical, Therapeutics   \n",
       "ArriVent Biopharma                       Biotechnology, Life Science, Pharmaceutical   \n",
       "Normax Biomed                           Biotechnology, Manufacturing, Pharmaceutical   \n",
       "Uniquity Bio                                                  Biotechnology, Medical   \n",
       "KELIX bio                                              Manufacturing, Pharmaceutical   \n",
       "ReNAgade Therapeutics                           Biotechnology, Medical, Therapeutics   \n",
       "Beacon Therapeutics                                        Health Care, Therapeutics   \n",
       "Metsera                                              Biopharma, Health Care, Medical   \n",
       "AmplifyBio                                  Biotechnology, Health Care, Life Science   \n",
       "Mineralys Therapeutics             Biopharma, Biotechnology, Medical, Pharmaceutical   \n",
       "Orbital Therapeutics               Alternative Medicine, Biotechnology, Life Scie...   \n",
       "\n",
       "                                                               Headquarters Location  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                                           Skillman, New Jersey, United States   \n",
       "Cencora                                    Conshohocken, Pennsylvania, United States   \n",
       "Altos Labs                                  San Francisco, California, United States   \n",
       "Resilience                                       La Jolla, California, United States   \n",
       "GoTo Group                                          Jakarta, Jakarta Raya, Indonesia   \n",
       "Xaira Therapeutics                          San Francisco, California, United States   \n",
       "Organon                                       Jersey City, New Jersey, United States   \n",
       "Nutrabolt                                               Austin, Texas, United States   \n",
       "NeoCannBio                                      Seoul, Seoul-t'ukpyolsi, South Korea   \n",
       "Apogee Therapeutics                         San Francisco, California, United States   \n",
       "Centessa Pharmaceuticals                     Cambridge, Massachusetts, United States   \n",
       "Surround Care                                      St Louis, Missouri, United States   \n",
       "Avenzo Therapeutics                             San Diego, California, United States   \n",
       "ACELYRIN                                      Los Angeles, California, United States   \n",
       "Taysha Gene Therapies                                   Dallas, Texas, United States   \n",
       "Alumis                                      San Francisco, California, United States   \n",
       "Biohaven                                       New Haven, Connecticut, United States   \n",
       "Odyssey Therapeutics                         Cambridge, Massachusetts, United States   \n",
       "Mirador Therapeutics                            San Diego, California, United States   \n",
       "Treeline Biosciences                            Stamford, Connecticut, United States   \n",
       "Invivyd                                        Waltham, Massachusetts, United States   \n",
       "Cerebral                                    San Francisco, California, United States   \n",
       "Areteia Therapeutics                        Bernardsville, New Jersey, United States   \n",
       "Transcarent                                          Denver, Colorado, United States   \n",
       "Scorpion Therapeutics                           Boston, Massachusetts, United States   \n",
       "Upstream Bio                                   Waltham, Massachusetts, United States   \n",
       "CorroHealth                                              Plano, Texas, United States   \n",
       "Sonoma BioTherapeutics                South San Francisco, California, United States   \n",
       "Tourmaline Bio                                     New York, New York, United States   \n",
       "Center for Breakthrough Medicines       King Of Prussia, Pennsylvania, United States   \n",
       "Main Street Health                               Nashville, Tennessee, United States   \n",
       "Capstan Therapeutics                            San Diego, California, United States   \n",
       "METiS Pharmaceuticals                                      Hangzhou, Zhejiang, China   \n",
       "Forge Biologics                                      Grove City, Ohio, United States   \n",
       "Zenas BioPharma                                Waltham, Massachusetts, United States   \n",
       "2seventy bio                                 Cambridge, Massachusetts, United States   \n",
       "Gen4 Dental Partners                                   Tempe, Arizona, United States   \n",
       "Hasten                                                           Hefei, Anhui, China   \n",
       "Bicara Therapeutics                          Cambridge, Massachusetts, United States   \n",
       "CARGO Therapeutics                              San Mateo, California, United States   \n",
       "ArriVent Biopharma                 Pennsylvania Furnace, Pennsylvania, United States   \n",
       "Normax Biomed                                                    Cork, Cork, Ireland   \n",
       "Uniquity Bio                                    Malvern, Pennsylvania, United States   \n",
       "KELIX bio                                         Dubai, Dubai, United Arab Emirates   \n",
       "ReNAgade Therapeutics                        Cambridge, Massachusetts, United States   \n",
       "Beacon Therapeutics                                  London, England, United Kingdom   \n",
       "Metsera                                            New York, New York, United States   \n",
       "AmplifyBio                                       West Jefferson, Ohio, United States   \n",
       "Mineralys Therapeutics                           Radnor, Pennsylvania, United States   \n",
       "Orbital Therapeutics                         Cambridge, Massachusetts, United States   \n",
       "\n",
       "                                                                         Description  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                             Kenvue is a consumer health company that deliv...   \n",
       "Cencora                            Cencora is a global healthcare company that ad...   \n",
       "Altos Labs                         Altos Labs focuses on cellular rejuvenation pr...   \n",
       "Resilience                         Resilience provides end-to-end biopharmaceutic...   \n",
       "GoTo Group                         GoTo Group offers a digital ecosystem for on-d...   \n",
       "Xaira Therapeutics                 Xaira Therapeutics is an integrated biotechnol...   \n",
       "Organon                            Organon offers medicines and other products to...   \n",
       "Nutrabolt                          Nutrabolt is a dietary health supplement distr...   \n",
       "NeoCannBio                         NeoCannBio offers natural product processing f...   \n",
       "Apogee Therapeutics                Apogee Therapeutics is a biotechnology company...   \n",
       "Centessa Pharmaceuticals           Centessa Pharmaceuticals is a next-generation ...   \n",
       "Surround Care                      Surround Care focuses on fixing healthcare aff...   \n",
       "Avenzo Therapeutics                Avenzo Therapeutics specializes in the develop...   \n",
       "ACELYRIN                           ACELYRIN is a biopharma company that identifie...   \n",
       "Taysha Gene Therapies              Taysha Gene Therapies develops treatments to e...   \n",
       "Alumis                             Alumis is a precision medicine company focused...   \n",
       "Biohaven                           Biohaven is a clinical-stage biopharmaceutical...   \n",
       "Odyssey Therapeutics               Odyssey Therapeutics creates precision immunom...   \n",
       "Mirador Therapeutics               Mirador Therapeutics envisions precision medic...   \n",
       "Treeline Biosciences               Treeline Biosciences is a biotech company buil...   \n",
       "Invivyd                            Invivyd develops antibodies to transcend the l...   \n",
       "Cerebral                           Cerebral is a mental health telemedicine compa...   \n",
       "Areteia Therapeutics               Areteia Therapeutics is a biotechnology compan...   \n",
       "Transcarent                        Transcarent is a provider of a healthcare plat...   \n",
       "Scorpion Therapeutics              Scorpion Therapeutics is a clinical-stage onco...   \n",
       "Upstream Bio                       Upstream Bio focuses on developing an antibody...   \n",
       "CorroHealth                        CorroHealth helps individuals in the reimburse...   \n",
       "Sonoma BioTherapeutics             Sonoma BioTherapeutics develops adoptive Treg ...   \n",
       "Tourmaline Bio                     Tourmaline Bio is a clinical biotechnology com...   \n",
       "Center for Breakthrough Medicines  Center for Breakthrough Medicines is an innova...   \n",
       "Main Street Health                 Main Street Health is a supplier of value-base...   \n",
       "Capstan Therapeutics               Capstan Therapeutics is advancing cell enginee...   \n",
       "METiS Pharmaceuticals              METiS Pharmaceuticals is the world's first AI-...   \n",
       "Forge Biologics                    Forge Biologics is a gene therapy development ...   \n",
       "Zenas BioPharma                    Zenas BioPharma is a biopharmaceutical company...   \n",
       "2seventy bio                       2seventy bio is an immuno-oncology cell therap...   \n",
       "Gen4 Dental Partners               Gen4 Dental Partners is a doctor-centric, part...   \n",
       "Hasten                             Hasten is a pharmaceutical manufacturing compa...   \n",
       "Bicara Therapeutics                Bicara Therapeutics develops dual-action cance...   \n",
       "CARGO Therapeutics                 CARGO Therapeutics develops an adoptive cell t...   \n",
       "ArriVent Biopharma                 ArriVent develops pharmaceutical products to c...   \n",
       "Normax Biomed                      Normax Biomed is an mRNA Vaccine research and ...   \n",
       "Uniquity Bio                       Uniquity Bio operates as a drug development co...   \n",
       "KELIX bio                          KELIX bio is a specialty generic business focu...   \n",
       "ReNAgade Therapeutics              ReNAgade Therapeutics focuses on the boundless...   \n",
       "Beacon Therapeutics                Beacon Therapeutics is an ophthalmic gene ther...   \n",
       "Metsera                            Metsera operates as a clinical-stage biopharma...   \n",
       "AmplifyBio                         AmplifyBio is a biotechnology company that dev...   \n",
       "Mineralys Therapeutics             Mineralys Therapeutics is a clinical-stage bio...   \n",
       "Orbital Therapeutics               Orbital Therapeutics is a biotechnology compan...   \n",
       "\n",
       "                                  CB Rank (Company) Estimated Revenue Range  \\\n",
       "Organization Name                                                             \n",
       "Kenvue                                        3,970             $1B to $10B   \n",
       "Cencora                                       1,466                   $10B+   \n",
       "Altos Labs                                    2,590            $10M to $50M   \n",
       "Resilience                                    2,627            $500M to $1B   \n",
       "GoTo Group                                    4,999             $1M to $10M   \n",
       "Xaira Therapeutics                              450                       —   \n",
       "Organon                                       9,345             $1B to $10B   \n",
       "Nutrabolt                                    60,629          $100M to $500M   \n",
       "NeoCannBio                                   59,673                       —   \n",
       "Apogee Therapeutics                          37,763             $1B to $10B   \n",
       "Centessa Pharmaceuticals                      9,162            $10M to $50M   \n",
       "Surround Care                                28,699          $100M to $500M   \n",
       "Avenzo Therapeutics                           7,746                       —   \n",
       "ACELYRIN                                      5,972                       —   \n",
       "Taysha Gene Therapies                         2,137            $10M to $50M   \n",
       "Alumis                                          319                       —   \n",
       "Biohaven                                      8,102                       —   \n",
       "Odyssey Therapeutics                         44,888            $10M to $50M   \n",
       "Mirador Therapeutics                          6,447                       —   \n",
       "Treeline Biosciences                         53,808                       —   \n",
       "Invivyd                                       7,599             $1B to $10B   \n",
       "Cerebral                                     24,999          $100M to $500M   \n",
       "Areteia Therapeutics                         10,909                       —   \n",
       "Transcarent                                   1,715            $10M to $50M   \n",
       "Scorpion Therapeutics                           317             $1M to $10M   \n",
       "Upstream Bio                                  8,112             $1M to $10M   \n",
       "CorroHealth                                   6,000          $100M to $500M   \n",
       "Sonoma BioTherapeutics                        8,596             $1M to $10M   \n",
       "Tourmaline Bio                                3,834             $1M to $10M   \n",
       "Center for Breakthrough Medicines            23,276            $10M to $50M   \n",
       "Main Street Health                            6,051                       —   \n",
       "Capstan Therapeutics                         43,621                       —   \n",
       "METiS Pharmaceuticals                         8,268             $1M to $10M   \n",
       "Forge Biologics                              68,370             $1M to $10M   \n",
       "Zenas BioPharma                               3,020             $1M to $10M   \n",
       "2seventy bio                                  3,928           $50M to $100M   \n",
       "Gen4 Dental Partners                         22,565           $50M to $100M   \n",
       "Hasten                                       36,870                       —   \n",
       "Bicara Therapeutics                          58,367             $1M to $10M   \n",
       "CARGO Therapeutics                           36,449             $1B to $10B   \n",
       "ArriVent Biopharma                            6,744            $10M to $50M   \n",
       "Normax Biomed                                60,951                       —   \n",
       "Uniquity Bio                                  7,949                       —   \n",
       "KELIX bio                                    28,207                       —   \n",
       "ReNAgade Therapeutics                        64,077                       —   \n",
       "Beacon Therapeutics                           1,196                       —   \n",
       "Metsera                                       8,384                       —   \n",
       "AmplifyBio                                    3,681           $50M to $100M   \n",
       "Mineralys Therapeutics                       11,923             $1M to $10M   \n",
       "Orbital Therapeutics                         62,764                       —   \n",
       "\n",
       "                                                     Website Company Type  \\\n",
       "Organization Name                                                           \n",
       "Kenvue                                            kenvue.com   For Profit   \n",
       "Cencora                                          cencora.com   For Profit   \n",
       "Altos Labs                                     altoslabs.com   For Profit   \n",
       "Resilience                                    resilience.com   For Profit   \n",
       "GoTo Group                                   gotocompany.com   For Profit   \n",
       "Xaira Therapeutics                                 xaira.com   For Profit   \n",
       "Organon                                          organon.com   For Profit   \n",
       "Nutrabolt                                      nutrabolt.com   For Profit   \n",
       "NeoCannBio                                    neocannbio.com   For Profit   \n",
       "Apogee Therapeutics                   apogeetherapeutics.com   For Profit   \n",
       "Centessa Pharmaceuticals                        centessa.com   For Profit   \n",
       "Surround Care                              surround-care.com   For Profit   \n",
       "Avenzo Therapeutics                             avenzotx.com   For Profit   \n",
       "ACELYRIN                                        acelyrin.com   For Profit   \n",
       "Taysha Gene Therapies                          tayshagtx.com   For Profit   \n",
       "Alumis                                            alumis.com   For Profit   \n",
       "Biohaven                                        biohaven.com   For Profit   \n",
       "Odyssey Therapeutics                           odysseytx.com   For Profit   \n",
       "Mirador Therapeutics                           miradortx.com   For Profit   \n",
       "Treeline Biosciences                            treeline.bio   For Profit   \n",
       "Invivyd                                          invivyd.com   For Profit   \n",
       "Cerebral                                        cerebral.com   For Profit   \n",
       "Areteia Therapeutics                           areteiatx.com   For Profit   \n",
       "Transcarent                                  transcarent.com   For Profit   \n",
       "Scorpion Therapeutics                         scorpiontx.com   For Profit   \n",
       "Upstream Bio                                 upstreambio.com   For Profit   \n",
       "CorroHealth                                  corrohealth.com   For Profit   \n",
       "Sonoma BioTherapeutics                         sonomabio.com   For Profit   \n",
       "Tourmaline Bio                             tourmalinebio.com   For Profit   \n",
       "Center for Breakthrough Medicines  breakthroughmedicines.com   For Profit   \n",
       "Main Street Health                 mainstreetruralhealth.com   For Profit   \n",
       "Capstan Therapeutics                           capstantx.com   For Profit   \n",
       "METiS Pharmaceuticals                metispharmaceuticals.cn   For Profit   \n",
       "Forge Biologics                           forgebiologics.com   For Profit   \n",
       "Zenas BioPharma                                 zenasbio.com   For Profit   \n",
       "2seventy bio                                 2seventybio.com   For Profit   \n",
       "Gen4 Dental Partners                          gen4dental.com   For Profit   \n",
       "Hasten                                      hastenpharma.com   For Profit   \n",
       "Bicara Therapeutics                               bicara.com   For Profit   \n",
       "CARGO Therapeutics                              cargo-tx.com   For Profit   \n",
       "ArriVent Biopharma                              arrivent.com   For Profit   \n",
       "Normax Biomed                               normaxbiomed.com   For Profit   \n",
       "Uniquity Bio                                    uniquity.com   For Profit   \n",
       "KELIX bio                                       kelixbio.com   For Profit   \n",
       "ReNAgade Therapeutics                         renagadetx.com   For Profit   \n",
       "Beacon Therapeutics                             beacontx.com   For Profit   \n",
       "Metsera                                          metsera.com            —   \n",
       "AmplifyBio                                   amplify-bio.com   For Profit   \n",
       "Mineralys Therapeutics                       mineralystx.com   For Profit   \n",
       "Orbital Therapeutics                           orbitaltx.com   For Profit   \n",
       "\n",
       "                                  Founded Date Operating Status  \\\n",
       "Organization Name                                                 \n",
       "Kenvue                                    2023           Active   \n",
       "Cencora                                   2023           Active   \n",
       "Altos Labs                           15-Apr-21           Active   \n",
       "Resilience                                2020           Active   \n",
       "GoTo Group                                2021           Active   \n",
       "Xaira Therapeutics                        2024           Active   \n",
       "Organon                                   2020           Active   \n",
       "Nutrabolt                                 2020           Active   \n",
       "NeoCannBio                                2021           Active   \n",
       "Apogee Therapeutics                       2022           Active   \n",
       "Centessa Pharmaceuticals                  2021           Active   \n",
       "Surround Care                             2022           Active   \n",
       "Avenzo Therapeutics                       2022           Active   \n",
       "ACELYRIN                                  2020           Active   \n",
       "Taysha Gene Therapies                     2020           Active   \n",
       "Alumis                                    2021           Active   \n",
       "Biohaven                                  2022           Active   \n",
       "Odyssey Therapeutics                      2021           Active   \n",
       "Mirador Therapeutics                      2024           Active   \n",
       "Treeline Biosciences                      2021           Active   \n",
       "Invivyd                                   2020           Active   \n",
       "Cerebral                                  2020           Active   \n",
       "Areteia Therapeutics                      2022           Active   \n",
       "Transcarent                               2020           Active   \n",
       "Scorpion Therapeutics                     2020           Active   \n",
       "Upstream Bio                              2021           Active   \n",
       "CorroHealth                               2020           Active   \n",
       "Sonoma BioTherapeutics                    2020           Active   \n",
       "Tourmaline Bio                            2021           Active   \n",
       "Center for Breakthrough Medicines         2020           Active   \n",
       "Main Street Health                        2021           Active   \n",
       "Capstan Therapeutics                      2021           Active   \n",
       "METiS Pharmaceuticals                     2020           Active   \n",
       "Forge Biologics                           2020           Active   \n",
       "Zenas BioPharma                           2020           Active   \n",
       "2seventy bio                              2021           Active   \n",
       "Gen4 Dental Partners                      2021           Active   \n",
       "Hasten                                    2020           Active   \n",
       "Bicara Therapeutics                       2020           Active   \n",
       "CARGO Therapeutics                        2021           Active   \n",
       "ArriVent Biopharma                        2021           Active   \n",
       "Normax Biomed                             2020           Active   \n",
       "Uniquity Bio                              2022           Active   \n",
       "KELIX bio                                 2020           Active   \n",
       "ReNAgade Therapeutics                     2021           Active   \n",
       "Beacon Therapeutics                       2023           Active   \n",
       "Metsera                                   2022           Active   \n",
       "AmplifyBio                                2021           Active   \n",
       "Mineralys Therapeutics                    2020           Active   \n",
       "Orbital Therapeutics                      2022           Active   \n",
       "\n",
       "                                                                    Full Description  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                             Kenvue is a consumer health company that deliv...   \n",
       "Cencora                            Cencora, building on the legacy of Amerisource...   \n",
       "Altos Labs                         Altos Labs is a biotechnology company focused ...   \n",
       "Resilience                         Resilience provides end-to-end biopharmaceutic...   \n",
       "GoTo Group                         GoTo Group is an application used for ride-hai...   \n",
       "Xaira Therapeutics                 Xaira Therapeutics is an integrated biotechnol...   \n",
       "Organon                            Organon offers medicines and other products to...   \n",
       "Nutrabolt                          Nutrabolt produces and sells supplements for t...   \n",
       "NeoCannBio                         NeoCannBio provides natural product processing...   \n",
       "Apogee Therapeutics                Apogee Therapeutics is a biotechnology company...   \n",
       "Centessa Pharmaceuticals           Centessa Pharmaceuticals is a next-generation ...   \n",
       "Surround Care                      Surround Care focuses on fixing healthcare aff...   \n",
       "Avenzo Therapeutics                Avenzo Therapeutics specializes in the develop...   \n",
       "ACELYRIN                           ACELYRIN is a biopharma company focused on pro...   \n",
       "Taysha Gene Therapies              Taysha Gene Therapies is on a mission to eradi...   \n",
       "Alumis                             Alumis develops precision medications to treat...   \n",
       "Biohaven                           Biohaven is a clinical-stage biopharmaceutical...   \n",
       "Odyssey Therapeutics               Odyssey Therapeutics is pioneering the efficie...   \n",
       "Mirador Therapeutics               Mirador Therapeutics envisions precision medic...   \n",
       "Treeline Biosciences               Treeline Biosciences is a biotech company buil...   \n",
       "Invivyd                            Invivyd is on a mission to rapidly and perpetu...   \n",
       "Cerebral                           Cerebral makes high-quality mental health care...   \n",
       "Areteia Therapeutics               Areteia Therapeutics is committed to putting a...   \n",
       "Transcarent                        Transcarent is a consumer-directed health and ...   \n",
       "Scorpion Therapeutics              Scorpion Therapeutics develops targeted small-...   \n",
       "Upstream Bio                       Upstream Bio focuses on developing an antibody...   \n",
       "CorroHealth                        CorroHealth helps individuals in the reimburse...   \n",
       "Sonoma BioTherapeutics             Sonoma Biotherapeutics is developing adoptive ...   \n",
       "Tourmaline Bio                     Tourmaline Bio is a clinical biotechnology com...   \n",
       "Center for Breakthrough Medicines  Center for Breakthrough Medicines is an innova...   \n",
       "Main Street Health                 Main Street Health is a provider of value-base...   \n",
       "Capstan Therapeutics               Capstan Therapeutics is advancing precision in...   \n",
       "METiS Pharmaceuticals              Jitai Medicine (METiS) is a biotechnology comp...   \n",
       "Forge Biologics                    Forge Biologics is a gene therapy development ...   \n",
       "Zenas BioPharma                    Zenas BioPharma is a biopharmaceutical company...   \n",
       "2seventy bio                       2seventy bio is an immuno-oncology cell therap...   \n",
       "Gen4 Dental Partners               Gen4 Dental Partners provides world-class supp...   \n",
       "Hasten                             Hasten is a pharmaceutical manufacturing compa...   \n",
       "Bicara Therapeutics                Bicara Therapeutics is a clinical-stage biotec...   \n",
       "CARGO Therapeutics                 CARGO Therapeutics develops CAR T-cell therapy...   \n",
       "ArriVent Biopharma                 ArriVent is a biopharmaceutical company develo...   \n",
       "Normax Biomed                      Normax Biomed is an mRNA Vaccine research and ...   \n",
       "Uniquity Bio                       Uniquity Bio operates a drug development company.   \n",
       "KELIX bio                          KELIX bio is a specialty generic business focu...   \n",
       "ReNAgade Therapeutics              ReNAgade Therapeutics focuses on the boundless...   \n",
       "Beacon Therapeutics                Beacon Therapeutics is an ophthalmic gene ther...   \n",
       "Metsera                            Metsera operates as a clinical-stage biopharma...   \n",
       "AmplifyBio                         AmplifyBio is a biotechnology company that dev...   \n",
       "Mineralys Therapeutics             Mineralys Therapeutics is a biopharmaceutical ...   \n",
       "Orbital Therapeutics               Orbital Therapeutics aims to enhance global he...   \n",
       "\n",
       "                                   ... Last Funding Date Last Funding Amount  \\\n",
       "Organization Name                  ...                                         \n",
       "Kenvue                             ...         14-May-24     $3,646,591,000    \n",
       "Cencora                            ...         05-Feb-24       $500,000,000    \n",
       "Altos Labs                         ...         01-Jan-21     $3,000,000,000    \n",
       "Resilience                         ...         24-Mar-23       $410,000,000    \n",
       "GoTo Group                         ...         03-Oct-23       $150,000,000    \n",
       "Xaira Therapeutics                 ...         23-Apr-24     $1,000,000,000    \n",
       "Organon                            ...         07-May-24     $1,000,000,000    \n",
       "Nutrabolt                          ...         08-Dec-22       $863,000,000    \n",
       "NeoCannBio                         ...         26-Sep-23     ₩10,000,000,000   \n",
       "Apogee Therapeutics                ...         07-Mar-24       $483,000,000    \n",
       "Centessa Pharmaceuticals           ...         23-Apr-24       $100,000,000    \n",
       "Surround Care                      ...         15-Nov-22       $573,480,000    \n",
       "Avenzo Therapeutics                ...         26-Mar-24       $150,000,000    \n",
       "ACELYRIN                           ...         13-Sep-22       $300,000,000    \n",
       "Taysha Gene Therapies              ...         26-Jun-24        $75,000,000    \n",
       "Alumis                             ...         06-Mar-24       $259,000,000    \n",
       "Biohaven                           ...         18-Apr-24       $264,500,000    \n",
       "Odyssey Therapeutics               ...         05-Dec-23       $101,000,000    \n",
       "Mirador Therapeutics               ...         21-Mar-24       $400,000,000    \n",
       "Treeline Biosciences               ...         11-Oct-22       $261,266,523    \n",
       "Invivyd                            ...         19-Apr-21       $336,000,000    \n",
       "Cerebral                           ...         08-Dec-21       $300,000,000    \n",
       "Areteia Therapeutics               ...         13-Feb-24        $75,000,000    \n",
       "Transcarent                        ...         02-May-24       $126,000,000    \n",
       "Scorpion Therapeutics              ...         16-Jul-24       $150,000,000    \n",
       "Upstream Bio                       ...         08-Jun-23       $200,000,000    \n",
       "CorroHealth                        ...         05-Oct-23        $50,000,000    \n",
       "Sonoma BioTherapeutics             ...         28-Mar-23        $30,000,000    \n",
       "Tourmaline Bio                     ...         25-Jan-24       $172,500,000    \n",
       "Center for Breakthrough Medicines  ...         10-Jan-22       $350,000,000    \n",
       "Main Street Health                 ...         08-Oct-23       $315,000,000    \n",
       "Capstan Therapeutics               ...         20-Mar-24       $175,000,000    \n",
       "METiS Pharmaceuticals              ...         22-Jun-24       $100,000,000    \n",
       "Forge Biologics                    ...         12-Sep-22        $90,000,000    \n",
       "Zenas BioPharma                    ...         07-May-24       $200,000,000    \n",
       "2seventy bio                       ...         28-Feb-23       $125,000,000    \n",
       "Gen4 Dental Partners               ...         21-May-24       $315,000,000    \n",
       "Hasten                             ...         20-Apr-23       $315,000,000    \n",
       "Bicara Therapeutics                ...         12-Dec-23       $165,000,000    \n",
       "CARGO Therapeutics                 ...         28-May-24       $110,000,000    \n",
       "ArriVent Biopharma                 ...         29-Dec-22       $155,000,000    \n",
       "Normax Biomed                      ...         11-Jul-22       € 300,000,000   \n",
       "Uniquity Bio                       ...         15-May-24       $300,000,000    \n",
       "KELIX bio                          ...         09-Mar-22       $200,000,000    \n",
       "ReNAgade Therapeutics              ...         23-May-23       $300,000,000    \n",
       "Beacon Therapeutics                ...         03-Jun-24       $170,000,000    \n",
       "Metsera                            ...         18-Apr-24       $290,000,000    \n",
       "AmplifyBio                         ...         15-Nov-23        $49,750,000    \n",
       "Mineralys Therapeutics             ...         08-Feb-24       $120,000,000    \n",
       "Orbital Therapeutics               ...         26-Apr-23       $270,000,000    \n",
       "\n",
       "                                  Total Funding Amount  \\\n",
       "Organization Name                                        \n",
       "Kenvue                                 $3,646,591,000    \n",
       "Cencora                                $3,025,000,000    \n",
       "Altos Labs                             $3,000,000,000    \n",
       "Resilience                             $2,515,000,000    \n",
       "GoTo Group                             $1,450,000,000    \n",
       "Xaira Therapeutics                     $1,000,000,000    \n",
       "Organon                                $1,000,000,000    \n",
       "Nutrabolt                                $863,000,000    \n",
       "NeoCannBio                               $678,925,399    \n",
       "Apogee Therapeutics                      $652,000,000    \n",
       "Centessa Pharmaceuticals                 $650,000,000    \n",
       "Surround Care                            $573,480,000    \n",
       "Avenzo Therapeutics                      $569,350,002    \n",
       "ACELYRIN                                 $558,000,000    \n",
       "Taysha Gene Therapies                    $543,000,000    \n",
       "Alumis                                   $529,000,000    \n",
       "Biohaven                                 $523,200,000    \n",
       "Odyssey Therapeutics                     $487,000,000    \n",
       "Mirador Therapeutics                     $480,000,000    \n",
       "Treeline Biosciences                     $473,266,523    \n",
       "Invivyd                                  $466,000,000    \n",
       "Cerebral                                 $462,000,000    \n",
       "Areteia Therapeutics                     $425,000,000    \n",
       "Transcarent                              $424,000,000    \n",
       "Scorpion Therapeutics                    $420,000,000    \n",
       "Upstream Bio                             $408,000,000    \n",
       "CorroHealth                              $376,268,825    \n",
       "Sonoma BioTherapeutics                   $365,000,000    \n",
       "Tourmaline Bio                           $359,500,000    \n",
       "Center for Breakthrough Medicines        $350,000,000    \n",
       "Main Street Health                       $342,000,000    \n",
       "Capstan Therapeutics                     $340,000,000    \n",
       "METiS Pharmaceuticals                    $336,000,000    \n",
       "Forge Biologics                          $330,000,000    \n",
       "Zenas BioPharma                          $318,000,000    \n",
       "2seventy bio                             $315,000,000    \n",
       "Gen4 Dental Partners                     $315,000,000    \n",
       "Hasten                                   $315,000,000    \n",
       "Bicara Therapeutics                      $313,000,000    \n",
       "CARGO Therapeutics                       $310,000,000    \n",
       "ArriVent Biopharma                       $305,000,000    \n",
       "Normax Biomed                            € 300,000,000   \n",
       "Uniquity Bio                             $300,000,000    \n",
       "KELIX bio                                $300,000,000    \n",
       "ReNAgade Therapeutics                    $300,000,000    \n",
       "Beacon Therapeutics                      $290,139,662    \n",
       "Metsera                                  $290,000,000    \n",
       "AmplifyBio                               $279,750,000    \n",
       "Mineralys Therapeutics                   $278,000,000    \n",
       "Orbital Therapeutics                     $270,000,000    \n",
       "\n",
       "                                          Last Funding Type  \\\n",
       "Organization Name                                             \n",
       "Kenvue                                   Post-IPO Secondary   \n",
       "Cencora                                       Post-IPO Debt   \n",
       "Altos Labs                                         Series A   \n",
       "Resilience                                   Debt Financing   \n",
       "GoTo Group                                   Debt Financing   \n",
       "Xaira Therapeutics                                 Series A   \n",
       "Organon                                       Post-IPO Debt   \n",
       "Nutrabolt                                  Secondary Market   \n",
       "NeoCannBio                                         Series B   \n",
       "Apogee Therapeutics                         Post-IPO Equity   \n",
       "Centessa Pharmaceuticals                    Post-IPO Equity   \n",
       "Surround Care                                   Undisclosed   \n",
       "Avenzo Therapeutics                                Series A   \n",
       "ACELYRIN                                           Series C   \n",
       "Taysha Gene Therapies                       Post-IPO Equity   \n",
       "Alumis                                             Series C   \n",
       "Biohaven                                    Post-IPO Equity   \n",
       "Odyssey Therapeutics                               Series C   \n",
       "Mirador Therapeutics                               Series A   \n",
       "Treeline Biosciences                               Series A   \n",
       "Invivyd                                            Series C   \n",
       "Cerebral                                           Series C   \n",
       "Areteia Therapeutics                               Series A   \n",
       "Transcarent                                        Series D   \n",
       "Scorpion Therapeutics                              Series C   \n",
       "Upstream Bio                                       Series B   \n",
       "CorroHealth                                  Private Equity   \n",
       "Sonoma BioTherapeutics                      Corporate Round   \n",
       "Tourmaline Bio                              Post-IPO Equity   \n",
       "Center for Breakthrough Medicines           Corporate Round   \n",
       "Main Street Health                 Venture - Series Unknown   \n",
       "Capstan Therapeutics                               Series B   \n",
       "METiS Pharmaceuticals                              Series C   \n",
       "Forge Biologics                                    Series C   \n",
       "Zenas BioPharma                                    Series C   \n",
       "2seventy bio                                Post-IPO Equity   \n",
       "Gen4 Dental Partners                         Debt Financing   \n",
       "Hasten                             Venture - Series Unknown   \n",
       "Bicara Therapeutics                                Series C   \n",
       "CARGO Therapeutics                          Post-IPO Equity   \n",
       "ArriVent Biopharma                                 Series B   \n",
       "Normax Biomed                      Venture - Series Unknown   \n",
       "Uniquity Bio                                       Series A   \n",
       "KELIX bio                          Venture - Series Unknown   \n",
       "ReNAgade Therapeutics                              Series A   \n",
       "Beacon Therapeutics                                Series B   \n",
       "Metsera                                            Series A   \n",
       "AmplifyBio                         Venture - Series Unknown   \n",
       "Mineralys Therapeutics                      Post-IPO Equity   \n",
       "Orbital Therapeutics                               Series A   \n",
       "\n",
       "                                  Last Equity Funding Amount  \\\n",
       "Organization Name                                              \n",
       "Kenvue                                                     —   \n",
       "Cencora                                                    —   \n",
       "Altos Labs                                   $3,000,000,000    \n",
       "Resilience                                                 —   \n",
       "GoTo Group                                   $1,300,000,000    \n",
       "Xaira Therapeutics                           $1,000,000,000    \n",
       "Organon                                                    —   \n",
       "Nutrabolt                                                  —   \n",
       "NeoCannBio                                   ₩10,000,000,000   \n",
       "Apogee Therapeutics                            $483,000,000    \n",
       "Centessa Pharmaceuticals                       $100,000,000    \n",
       "Surround Care                                  $573,480,000    \n",
       "Avenzo Therapeutics                            $150,000,000    \n",
       "ACELYRIN                                       $300,000,000    \n",
       "Taysha Gene Therapies                           $75,000,000    \n",
       "Alumis                                         $259,000,000    \n",
       "Biohaven                                       $264,500,000    \n",
       "Odyssey Therapeutics                           $101,000,000    \n",
       "Mirador Therapeutics                           $400,000,000    \n",
       "Treeline Biosciences                           $261,266,523    \n",
       "Invivyd                                        $336,000,000    \n",
       "Cerebral                                       $300,000,000    \n",
       "Areteia Therapeutics                            $75,000,000    \n",
       "Transcarent                                    $126,000,000    \n",
       "Scorpion Therapeutics                          $150,000,000    \n",
       "Upstream Bio                                   $200,000,000    \n",
       "CorroHealth                                     $50,000,000    \n",
       "Sonoma BioTherapeutics                          $30,000,000    \n",
       "Tourmaline Bio                                 $172,500,000    \n",
       "Center for Breakthrough Medicines              $350,000,000    \n",
       "Main Street Health                             $315,000,000    \n",
       "Capstan Therapeutics                           $175,000,000    \n",
       "METiS Pharmaceuticals                          $100,000,000    \n",
       "Forge Biologics                                 $90,000,000    \n",
       "Zenas BioPharma                                $200,000,000    \n",
       "2seventy bio                                   $125,000,000    \n",
       "Gen4 Dental Partners                                       —   \n",
       "Hasten                                         $315,000,000    \n",
       "Bicara Therapeutics                            $165,000,000    \n",
       "CARGO Therapeutics                             $110,000,000    \n",
       "ArriVent Biopharma                             $155,000,000    \n",
       "Normax Biomed                                  € 300,000,000   \n",
       "Uniquity Bio                                   $300,000,000    \n",
       "KELIX bio                                      $200,000,000    \n",
       "ReNAgade Therapeutics                          $300,000,000    \n",
       "Beacon Therapeutics                            $170,000,000    \n",
       "Metsera                                        $290,000,000    \n",
       "AmplifyBio                                      $49,750,000    \n",
       "Mineralys Therapeutics                         $120,000,000    \n",
       "Orbital Therapeutics                           $270,000,000    \n",
       "\n",
       "                                   Last Equity Funding Type  \\\n",
       "Organization Name                                             \n",
       "Kenvue                                                    —   \n",
       "Cencora                                                   —   \n",
       "Altos Labs                                                —   \n",
       "Resilience                                   Private Equity   \n",
       "GoTo Group                         Venture - Series Unknown   \n",
       "Xaira Therapeutics                                        —   \n",
       "Organon                                                   —   \n",
       "Nutrabolt                                    Private Equity   \n",
       "NeoCannBio                                         Series B   \n",
       "Apogee Therapeutics                         Post-IPO Equity   \n",
       "Centessa Pharmaceuticals                    Post-IPO Equity   \n",
       "Surround Care                                             —   \n",
       "Avenzo Therapeutics                                Series A   \n",
       "ACELYRIN                                           Series C   \n",
       "Taysha Gene Therapies                       Post-IPO Equity   \n",
       "Alumis                                             Series C   \n",
       "Biohaven                                    Post-IPO Equity   \n",
       "Odyssey Therapeutics                               Series C   \n",
       "Mirador Therapeutics                               Series A   \n",
       "Treeline Biosciences                               Series A   \n",
       "Invivyd                                            Series C   \n",
       "Cerebral                                           Series C   \n",
       "Areteia Therapeutics                               Series A   \n",
       "Transcarent                                        Series D   \n",
       "Scorpion Therapeutics                              Series C   \n",
       "Upstream Bio                                       Series B   \n",
       "CorroHealth                                  Private Equity   \n",
       "Sonoma BioTherapeutics                      Corporate Round   \n",
       "Tourmaline Bio                              Post-IPO Equity   \n",
       "Center for Breakthrough Medicines           Corporate Round   \n",
       "Main Street Health                 Venture - Series Unknown   \n",
       "Capstan Therapeutics                               Series B   \n",
       "METiS Pharmaceuticals                              Series C   \n",
       "Forge Biologics                                    Series C   \n",
       "Zenas BioPharma                                    Series C   \n",
       "2seventy bio                                Post-IPO Equity   \n",
       "Gen4 Dental Partners                         Private Equity   \n",
       "Hasten                             Venture - Series Unknown   \n",
       "Bicara Therapeutics                                Series C   \n",
       "CARGO Therapeutics                          Post-IPO Equity   \n",
       "ArriVent Biopharma                                 Series B   \n",
       "Normax Biomed                      Venture - Series Unknown   \n",
       "Uniquity Bio                                       Series A   \n",
       "KELIX bio                          Venture - Series Unknown   \n",
       "ReNAgade Therapeutics                              Series A   \n",
       "Beacon Therapeutics                                Series B   \n",
       "Metsera                                            Series A   \n",
       "AmplifyBio                         Venture - Series Unknown   \n",
       "Mineralys Therapeutics                      Post-IPO Equity   \n",
       "Orbital Therapeutics                               Series A   \n",
       "\n",
       "                                  Total Equity Funding Amount  \\\n",
       "Organization Name                                               \n",
       "Kenvue                                                      —   \n",
       "Cencora                                                     —   \n",
       "Altos Labs                                                  —   \n",
       "Resilience                                    $2,105,000,000    \n",
       "GoTo Group                                    $1,300,000,000    \n",
       "Xaira Therapeutics                                          —   \n",
       "Organon                                                     —   \n",
       "Nutrabolt                                                   —   \n",
       "NeoCannBio                                      $678,925,399    \n",
       "Apogee Therapeutics                             $652,000,000    \n",
       "Centessa Pharmaceuticals                        $350,000,000    \n",
       "Surround Care                                               —   \n",
       "Avenzo Therapeutics                             $569,350,002    \n",
       "ACELYRIN                                        $558,000,000    \n",
       "Taysha Gene Therapies                           $403,000,000    \n",
       "Alumis                                          $529,000,000    \n",
       "Biohaven                                        $523,200,000    \n",
       "Odyssey Therapeutics                            $487,000,000    \n",
       "Mirador Therapeutics                            $480,000,000    \n",
       "Treeline Biosciences                            $473,266,523    \n",
       "Invivyd                                         $466,000,000    \n",
       "Cerebral                                        $462,000,000    \n",
       "Areteia Therapeutics                            $425,000,000    \n",
       "Transcarent                                     $424,000,000    \n",
       "Scorpion Therapeutics                           $420,000,000    \n",
       "Upstream Bio                                    $408,000,000    \n",
       "CorroHealth                                     $376,268,825    \n",
       "Sonoma BioTherapeutics                          $365,000,000    \n",
       "Tourmaline Bio                                  $359,500,000    \n",
       "Center for Breakthrough Medicines               $350,000,000    \n",
       "Main Street Health                              $342,000,000    \n",
       "Capstan Therapeutics                            $340,000,000    \n",
       "METiS Pharmaceuticals                           $336,000,000    \n",
       "Forge Biologics                                 $250,000,000    \n",
       "Zenas BioPharma                                 $318,000,000    \n",
       "2seventy bio                                    $315,000,000    \n",
       "Gen4 Dental Partners                                        —   \n",
       "Hasten                                          $315,000,000    \n",
       "Bicara Therapeutics                             $313,000,000    \n",
       "CARGO Therapeutics                              $310,000,000    \n",
       "ArriVent Biopharma                              $305,000,000    \n",
       "Normax Biomed                                   € 300,000,000   \n",
       "Uniquity Bio                                    $300,000,000    \n",
       "KELIX bio                                       $300,000,000    \n",
       "ReNAgade Therapeutics                           $300,000,000    \n",
       "Beacon Therapeutics                             $290,139,662    \n",
       "Metsera                                         $290,000,000    \n",
       "AmplifyBio                                      $229,750,000    \n",
       "Mineralys Therapeutics                          $278,000,000    \n",
       "Orbital Therapeutics                            $270,000,000    \n",
       "\n",
       "                                                                     Top 5 Investors  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                                    Goldman Sachs, J.P. Morgan Securities Inc.   \n",
       "Cencora                                                                            —   \n",
       "Altos Labs                                                     ARCH Venture Partners   \n",
       "Resilience                         Google Ventures, 8VC, Mubadala, New Enterprise...   \n",
       "GoTo Group                         Google, Tencent, International Finance Corpora...   \n",
       "Xaira Therapeutics                 Menlo Ventures, Sequoia Capital, Lightspeed Ve...   \n",
       "Organon                                                                            —   \n",
       "Nutrabolt                                        Keurig Dr Pepper, MidOcean Partners   \n",
       "NeoCannBio                         QUAD Investment Management, HLB Group, Donghoo...   \n",
       "Apogee Therapeutics                Fidelity, OrbiMed, Wellington Management, RA C...   \n",
       "Centessa Pharmaceuticals           T. Rowe Price, IP Group, Franklin Templeton, W...   \n",
       "Surround Care                                                                      —   \n",
       "Avenzo Therapeutics                New Enterprise Associates, SR One, Lilly Asia ...   \n",
       "ACELYRIN                           OrbiMed, Decheng Capital, RTW Investments, Sur...   \n",
       "Taysha Gene Therapies              Fidelity, BlackRock, Trinity Capital, Google V...   \n",
       "Alumis                             Foresite Capital, Cormorant Asset Management, ...   \n",
       "Biohaven                                                                           —   \n",
       "Odyssey Therapeutics               Fidelity, T. Rowe Price, General Catalyst, Orb...   \n",
       "Mirador Therapeutics               Fidelity, Sanofi, Blue Owl, OrbiMed, Point72 V...   \n",
       "Treeline Biosciences               Kohlberg Kravis Roberts, OrbiMed, Google Ventu...   \n",
       "Invivyd                            Fidelity, OrbiMed, Google Ventures, RA Capital...   \n",
       "Cerebral                           Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...   \n",
       "Areteia Therapeutics               Sanofi, Google Ventures, Marshall Wace, Viking...   \n",
       "Transcarent                        General Catalyst, Kleiner Perkins, GreatPoint ...   \n",
       "Scorpion Therapeutics              Fidelity, OrbiMed, Lightspeed Venture Partners...   \n",
       "Upstream Bio                       OrbiMed, Wellington Management, Omega Funds, E...   \n",
       "CorroHealth                                                                        —   \n",
       "Sonoma BioTherapeutics             Fidelity, Mirae Asset, Regeneron, Google Ventu...   \n",
       "Tourmaline Bio                     RA Capital Management, Great Point Partners, L...   \n",
       "Center for Breakthrough Medicines                                        SK Holdings   \n",
       "Main Street Health                 Humana, Oak HC/FT, CVS Health, Optum Ventures,...   \n",
       "Capstan Therapeutics               Bristol-Myers Squibb, OrbiMed, RA Capital Mana...   \n",
       "METiS Pharmaceuticals              XtalPi, Sequoia Capital China, Source Code Cap...   \n",
       "Forge Biologics                    Drive Capital, MidCap Financial, RA Capital Ma...   \n",
       "Zenas BioPharma                    Wellington Management, Xencor, New Enterprise ...   \n",
       "2seventy bio                       Regeneron, Casdin Capital, Janus Henderson Inv...   \n",
       "Gen4 Dental Partners                     Saratoga Partners, Varagon Capital Partners   \n",
       "Hasten                                                    Mubadala, C-Bridge Capital   \n",
       "Bicara Therapeutics                TPG, F-Prime Capital, RA Capital Management, B...   \n",
       "CARGO Therapeutics                 T. Rowe Price, Wellington Management, Cormoran...   \n",
       "ArriVent Biopharma                 General Catalyst, OrbiMed, Sequoia Capital Chi...   \n",
       "Normax Biomed                                      The Global Emerging Markets Group   \n",
       "Uniquity Bio                                                Blackstone Life Sciences   \n",
       "KELIX bio                          British International Investment, Development ...   \n",
       "ReNAgade Therapeutics                                       MPM Capital, F2 Ventures   \n",
       "Beacon Therapeutics                Oxford Science Enterprises, Forbion Capital Pa...   \n",
       "Metsera                            Google Ventures, F-Prime Capital, Mubadala Cap...   \n",
       "AmplifyBio                         Hercules Capital, Battelle, Narya Capital, Vik...   \n",
       "Mineralys Therapeutics             Andera Partners, OrbiMed, RA Capital Managemen...   \n",
       "Orbital Therapeutics               Andreessen Horowitz, EXOR N.V., Invus, Alexand...   \n",
       "\n",
       "                                  IPO Status               Country  \n",
       "Organization Name                                                   \n",
       "Kenvue                                Public         United States  \n",
       "Cencora                               Public         United States  \n",
       "Altos Labs                           Private         United States  \n",
       "Resilience                           Private         United States  \n",
       "GoTo Group                            Public             Indonesia  \n",
       "Xaira Therapeutics                   Private         United States  \n",
       "Organon                               Public         United States  \n",
       "Nutrabolt                            Private         United States  \n",
       "NeoCannBio                           Private           South Korea  \n",
       "Apogee Therapeutics                   Public         United States  \n",
       "Centessa Pharmaceuticals              Public         United States  \n",
       "Surround Care                        Private         United States  \n",
       "Avenzo Therapeutics                  Private         United States  \n",
       "ACELYRIN                              Public         United States  \n",
       "Taysha Gene Therapies                 Public         United States  \n",
       "Alumis                                Public         United States  \n",
       "Biohaven                              Public         United States  \n",
       "Odyssey Therapeutics                 Private         United States  \n",
       "Mirador Therapeutics                 Private         United States  \n",
       "Treeline Biosciences                 Private         United States  \n",
       "Invivyd                               Public         United States  \n",
       "Cerebral                             Private         United States  \n",
       "Areteia Therapeutics                 Private         United States  \n",
       "Transcarent                          Private         United States  \n",
       "Scorpion Therapeutics                Private         United States  \n",
       "Upstream Bio                         Private         United States  \n",
       "CorroHealth                          Private         United States  \n",
       "Sonoma BioTherapeutics               Private         United States  \n",
       "Tourmaline Bio                        Public         United States  \n",
       "Center for Breakthrough Medicines    Private         United States  \n",
       "Main Street Health                   Private         United States  \n",
       "Capstan Therapeutics                 Private         United States  \n",
       "METiS Pharmaceuticals                Private                 China  \n",
       "Forge Biologics                      Private         United States  \n",
       "Zenas BioPharma                      Private         United States  \n",
       "2seventy bio                          Public         United States  \n",
       "Gen4 Dental Partners                 Private         United States  \n",
       "Hasten                               Private                 China  \n",
       "Bicara Therapeutics                  Private         United States  \n",
       "CARGO Therapeutics                    Public         United States  \n",
       "ArriVent Biopharma                    Public         United States  \n",
       "Normax Biomed                        Private               Ireland  \n",
       "Uniquity Bio                         Private         United States  \n",
       "KELIX bio                            Private  United Arab Emirates  \n",
       "ReNAgade Therapeutics                Private         United States  \n",
       "Beacon Therapeutics                  Private        United Kingdom  \n",
       "Metsera                              Private         United States  \n",
       "AmplifyBio                           Private         United States  \n",
       "Mineralys Therapeutics                Public         United States  \n",
       "Orbital Therapeutics                 Private         United States  \n",
       "\n",
       "[50 rows x 27 columns]"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_2['Country']= df_2 ['Headquarters Location'].str.extract(r',\\s*([^,]+)$')\n",
    "df_2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "4233ce5d-2481-4850-acf5-c9a06de9b5d8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'$', 'CHF', '£', '—', '₩', '€', '₹'}"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#convert currency into USD for funding amount comparsion\n",
    "#column contains currency information 'Last Funding Amount','Total Funding Amount','Last Equity Funding Amount','Total Equity Funding Amount'\n",
    "#identify unique currency used in the dataset \n",
    "\n",
    "import re\n",
    "def extract_currency_symbol(amount):\n",
    "    match = re.search(r'[^\\d,.]+', amount)\n",
    "    return match.group(0).strip() if match else 'USD'  # Default to USD if no symbol is found\n",
    "\n",
    "currency_columns = ['Last Funding Amount', 'Total Funding Amount', 'Last Equity Funding Amount', 'Total Equity Funding Amount']\n",
    "currency_symbols_1 = set()\n",
    "\n",
    "for columns in currency_columns:\n",
    "    currency_symbols_1.update(df_1[columns].dropna().apply(extract_currency_symbol))\n",
    "\n",
    "currency_symbols_1\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "8be247df-61f1-4ae1-af88-e195366a10a6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industries</th>\n",
       "      <th>Headquarters Location</th>\n",
       "      <th>Description</th>\n",
       "      <th>CB Rank (Company)</th>\n",
       "      <th>Estimated Revenue Range</th>\n",
       "      <th>Website</th>\n",
       "      <th>Company Type</th>\n",
       "      <th>Founded Date</th>\n",
       "      <th>Operating Status</th>\n",
       "      <th>Full Description</th>\n",
       "      <th>...</th>\n",
       "      <th>Total Funding Amount</th>\n",
       "      <th>Last Funding Type</th>\n",
       "      <th>Last Equity Funding Amount</th>\n",
       "      <th>Last Equity Funding Type</th>\n",
       "      <th>Total Equity Funding Amount</th>\n",
       "      <th>Top 5 Investors</th>\n",
       "      <th>IPO Status</th>\n",
       "      <th>Country</th>\n",
       "      <th>Total_Funding_Amount_Currency</th>\n",
       "      <th>Total Funding Amount (USD)</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Organization Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Cerebral</th>\n",
       "      <td>Health Care, Medical, Mental Health, mHealth, ...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Cerebral is a mental health telemedicine compa...</td>\n",
       "      <td>24,597</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>cerebral.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cerebral is a mental health telemedicine compa...</td>\n",
       "      <td>...</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>462000000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Harbor Health</th>\n",
       "      <td>Health Care, Medical, mHealth, Personal Health...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Harbor Health is a multi-specialty clinic grou...</td>\n",
       "      <td>5,140</td>\n",
       "      <td>—</td>\n",
       "      <td>harborhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Harbor Health is a multi-specialty clinic grou...</td>\n",
       "      <td>...</td>\n",
       "      <td>$125,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$95,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$125,500,000</td>\n",
       "      <td>General Catalyst, 8VC, Alta Partners, Martin V...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>125500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Avi Medical</th>\n",
       "      <td>Health Care, Medical, mHealth, Personal Health</td>\n",
       "      <td>Munich, Bayern, Germany</td>\n",
       "      <td>Avi Medical is a digital health care company t...</td>\n",
       "      <td>7,992</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>avimedical.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Avi Medical is a digital health care company t...</td>\n",
       "      <td>...</td>\n",
       "      <td>€ 88,500,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>€ 50,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>€ 88,500,000</td>\n",
       "      <td>Eurazeo, Picus Capital, 3VC, Operator Partners...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "      <td>€</td>\n",
       "      <td>97350000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>BetterVet</th>\n",
       "      <td>Health Care, mHealth, Veterinary</td>\n",
       "      <td>Boston, Massachusetts, United States</td>\n",
       "      <td>BetterVet is a veterinary startup that provide...</td>\n",
       "      <td>12,253</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>bettervet.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>01-Jul-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>BetterVet is a veterinary startup that provide...</td>\n",
       "      <td>...</td>\n",
       "      <td>$57,928,818</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$17,928,818</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$57,928,818</td>\n",
       "      <td>Alta Partners, Daniel J Adams, Bruce Herzfelder</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>57928818.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Antidote Health</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, mHe...</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Antidote Health offers an AI-based health plat...</td>\n",
       "      <td>8,740</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>antidotehealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>15-Mar-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Antidote Health offers an AI-based health plat...</td>\n",
       "      <td>...</td>\n",
       "      <td>$56,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$13,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$56,000,000</td>\n",
       "      <td>iAngels, Google for Startups, Flint Capital, G...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>56000000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Pace</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Social, W...</td>\n",
       "      <td>California City, California, United States</td>\n",
       "      <td>Pace provides online peer support groups to gi...</td>\n",
       "      <td>12,690</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>pace.group</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Inactive</td>\n",
       "      <td>Pace is a mental fitness and social wellness p...</td>\n",
       "      <td>...</td>\n",
       "      <td>$50,900,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$13,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$50,900,000</td>\n",
       "      <td>Sequoia Capital, BoxGroup, SV Angel, Pace Capi...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>50900000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>DeepCardio</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, mHe...</td>\n",
       "      <td>Seoul, Seoul-t'ukpyolsi, South Korea</td>\n",
       "      <td>DeepCardio develops artificial intelligence te...</td>\n",
       "      <td>78,967</td>\n",
       "      <td>—</td>\n",
       "      <td>deepcardio.net</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>—</td>\n",
       "      <td>...</td>\n",
       "      <td>₩40,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>₩40,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>₩40,000,000,000</td>\n",
       "      <td>SoftBank, Dayli Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>South Korea</td>\n",
       "      <td>₩</td>\n",
       "      <td>29200000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Brisk Health</th>\n",
       "      <td>Health Care, Home Health Care, Medical, mHealt...</td>\n",
       "      <td>Denver, Colorado, United States</td>\n",
       "      <td>All-Inclusive Healthcare</td>\n",
       "      <td>31,918</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>briskhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Oct</td>\n",
       "      <td>Active</td>\n",
       "      <td>Brisk Health developed the most advanced mobil...</td>\n",
       "      <td>...</td>\n",
       "      <td>$27,080,000</td>\n",
       "      <td>Series D</td>\n",
       "      <td>$1,000,000</td>\n",
       "      <td>Series D</td>\n",
       "      <td>$27,080,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>27080000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Courier Health</th>\n",
       "      <td>Health Care, Medical, mHealth</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Courier Health develops a patient engagement p...</td>\n",
       "      <td>720</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>courierhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Courier Health develops a patient engagement p...</td>\n",
       "      <td>...</td>\n",
       "      <td>$20,450,002</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$16,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$20,450,002</td>\n",
       "      <td>Norwest Venture Partners, Work-Bench</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>20450002.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cartwheel</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Therapeut...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Cartwheel offers mental health support to stud...</td>\n",
       "      <td>10,286</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.cartwheelcare.org</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cartwheel offers mental health support to stud...</td>\n",
       "      <td>...</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Reach Capital, Menlo Ventures, General Catalys...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>20000000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Clearing</th>\n",
       "      <td>Consumer, Health Care, mHealth, Wellness</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Clearing is a healthcare platform focused on p...</td>\n",
       "      <td>19,828</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.clearing.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Jul</td>\n",
       "      <td>Active</td>\n",
       "      <td>Clearing is a digital healthcare platform buil...</td>\n",
       "      <td>...</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$20,000,000</td>\n",
       "      <td>Hims &amp; Hers, Grubhub, Founders Fund, Bessemer ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>20000000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cardo Health</th>\n",
       "      <td>Health Care, mHealth</td>\n",
       "      <td>Stockholm, Stockholms Lan, Sweden</td>\n",
       "      <td>Cardo Health is a digital health company with ...</td>\n",
       "      <td>40,403</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>cardohealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cardo Health is a digital health company with ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$17,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$17,500,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$17,500,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>Sweden</td>\n",
       "      <td>$</td>\n",
       "      <td>17500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Anima</th>\n",
       "      <td>Health Care, Medical, mHealth, Mobile Apps</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>The next generation care enablement platform</td>\n",
       "      <td>8,353</td>\n",
       "      <td>—</td>\n",
       "      <td>www.animahealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Anima is a next generation clinical operating ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$14,625,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$12,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$14,625,000</td>\n",
       "      <td>Y Combinator, Molten Ventures, Hummingbird Ven...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>14625000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oliva Health</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Personal ...</td>\n",
       "      <td>Barcelona, Catalonia, Spain</td>\n",
       "      <td>Employee Mental Well-Being Platform</td>\n",
       "      <td>13,133</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.oliva.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Oliva Therapy is an online therapy for busy pe...</td>\n",
       "      <td>...</td>\n",
       "      <td>£10,720,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£4,260,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£10,720,000</td>\n",
       "      <td>Alumni Ventures, Molten Ventures, Moonfire Ven...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Spain</td>\n",
       "      <td>£</td>\n",
       "      <td>13721600.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Inflow</th>\n",
       "      <td>Health Care, mHealth, Wellness</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>Inflow develops a science-based digital progra...</td>\n",
       "      <td>88,841</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.getinflow.io</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Inflow develops a science-based digital progra...</td>\n",
       "      <td>...</td>\n",
       "      <td>$13,980,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$11,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$13,980,000</td>\n",
       "      <td>Y Combinator, Octopus Ventures, Route 66 Ventu...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>$</td>\n",
       "      <td>13980000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Likeminded</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Wellness</td>\n",
       "      <td>Berlin, Berlin, Germany</td>\n",
       "      <td>Likeminded operates a digital platform for men...</td>\n",
       "      <td>11,739</td>\n",
       "      <td>Less than $1M</td>\n",
       "      <td>www.likeminded.care</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Likeminded operates a digital platform for men...</td>\n",
       "      <td>...</td>\n",
       "      <td>€ 10,900,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 10,900,000</td>\n",
       "      <td>Heartcore Capital, IBB Ventures, Holtzbrinck D...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "      <td>€</td>\n",
       "      <td>11990000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Heading Health</th>\n",
       "      <td>Health Care, Medical, Mental Health, mHealth, ...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Heading Health is a technology-enabled mental ...</td>\n",
       "      <td>14,148</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>headinghealth.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Heading Health is a technology-enabled mental ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$9,978,120</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>—</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$9,878,120</td>\n",
       "      <td>Alumni Ventures, Global Brain Corporation, Gai...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>9978120.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Violet</th>\n",
       "      <td>Health Care, Medical, mHealth</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Violet is a platform that helps the healthcare...</td>\n",
       "      <td>26,457</td>\n",
       "      <td>—</td>\n",
       "      <td>www.joinviolet.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Feb</td>\n",
       "      <td>Active</td>\n",
       "      <td>Violet is a platform that helps the healthcare...</td>\n",
       "      <td>...</td>\n",
       "      <td>$6,800,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,300,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$6,800,000</td>\n",
       "      <td>The Venture Collective, SemperVirens Venture C...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>6800000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Anebulo Pharmaceuticals</th>\n",
       "      <td>Biotechnology, Life Science, mHealth</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Anebulo is a biotech company developing novel ...</td>\n",
       "      <td>11,250</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.anebulo.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Anebulo is a clinical-stage biotechnology comp...</td>\n",
       "      <td>...</td>\n",
       "      <td>$7,500,000</td>\n",
       "      <td>Grant</td>\n",
       "      <td>$6,600,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$6,600,000</td>\n",
       "      <td>National Institute on Drug Abuse (NIDA), Merid...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>7500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alyve Health</th>\n",
       "      <td>Health Care, mHealth, Wellness</td>\n",
       "      <td>Mumbai, Maharashtra, India</td>\n",
       "      <td>Alyve Health is a tech platform providing pers...</td>\n",
       "      <td>425</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.alyve.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>18-May-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Imagine a healthcare ecosystem where care meet...</td>\n",
       "      <td>...</td>\n",
       "      <td>$6,288,066</td>\n",
       "      <td>Series A</td>\n",
       "      <td>₹450,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$6,288,066</td>\n",
       "      <td>1Crowd, Axilor Ventures, Trifecta Capital Advi...</td>\n",
       "      <td>Private</td>\n",
       "      <td>India</td>\n",
       "      <td>$</td>\n",
       "      <td>6288066.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Radicle Science</th>\n",
       "      <td>Dietary Supplements, Health Care, mHealth, Wel...</td>\n",
       "      <td>San Diego, California, United States</td>\n",
       "      <td>Radicle Science is a health tech company that ...</td>\n",
       "      <td>26,451</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>radiclescience.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>AI-driven healthtech B-Corp providing history'...</td>\n",
       "      <td>...</td>\n",
       "      <td>$5,999,716</td>\n",
       "      <td>Seed</td>\n",
       "      <td>—</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,999,716</td>\n",
       "      <td>Everywhere Ventures (The Fund), Wayne Chang, S...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>5999716.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Behavidence</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Mobile Apps</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Behavidence develops tools to monitor and mana...</td>\n",
       "      <td>29,177</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.behavidence.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Jun</td>\n",
       "      <td>Active</td>\n",
       "      <td>Behavidence utilizes AI to detect and monitor ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$5,625,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,300,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,625,000</td>\n",
       "      <td>Fusion, GoAhead Ventures, Kicker Ventures, Lon...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>5625000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>MYNDUP</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Personal ...</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>Live 1-1 virtual mental health sessions to sto...</td>\n",
       "      <td>47,661</td>\n",
       "      <td>—</td>\n",
       "      <td>www.myndup.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Feb</td>\n",
       "      <td>Active</td>\n",
       "      <td>MYNDUP is stopping the “one size fits all” app...</td>\n",
       "      <td>...</td>\n",
       "      <td>£4,700,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>£4,400,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>£4,700,000</td>\n",
       "      <td>Arpit Gupta</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>£</td>\n",
       "      <td>6016000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Persimmon</th>\n",
       "      <td>Beauty, Cosmetic Surgery, Medical, mHealth, Te...</td>\n",
       "      <td>Larkspur, California, United States</td>\n",
       "      <td>Persimmon provides aesthetic treatments in the...</td>\n",
       "      <td>23,433</td>\n",
       "      <td>—</td>\n",
       "      <td>www.persimmon.life/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Persimmon is an in-home aesthetics teleHealth ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$5,323,629</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,323,629</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,323,629</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>5323629.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Elfie</th>\n",
       "      <td>Health Care, Home Health Care, Medical, mHealt...</td>\n",
       "      <td>Singapore, Central Region, Singapore</td>\n",
       "      <td>Elfie is a product that reduces the burden of ...</td>\n",
       "      <td>16,903</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.elfie.co</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>25-Oct-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Elfie is a product that reduces the burden of ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>Google for Startups, Hustle Fund, FEBE Venture...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Singapore</td>\n",
       "      <td>$</td>\n",
       "      <td>5000000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Comedi Health Technology Limited</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, Ima...</td>\n",
       "      <td>Hong Kong, Hong Kong Island, Hong Kong</td>\n",
       "      <td>Comedi Health is a platform that provides tele...</td>\n",
       "      <td>89,470</td>\n",
       "      <td>—</td>\n",
       "      <td>www.comedi.com.hk</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>31-May-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>COMEDI Health is a one-stop technology platfor...</td>\n",
       "      <td>...</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$5,000,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>Hong Kong</td>\n",
       "      <td>$</td>\n",
       "      <td>5000000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>tapouts</th>\n",
       "      <td>Apps, Health Care, Mental Health, mHealth, Mob...</td>\n",
       "      <td>Venice, California, United States</td>\n",
       "      <td>Mobile Mental Health Care</td>\n",
       "      <td>26,340</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.tapouts.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>12-Jan-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>tapouts is a mental health edutainment platfor...</td>\n",
       "      <td>...</td>\n",
       "      <td>$4,800,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$3,200,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,800,000</td>\n",
       "      <td>M Venture Partners (MVP), Sidespin Ventures, R...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>4800000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>TOM Medications</th>\n",
       "      <td>Health Care, mHealth, Mobile Apps, Personal He...</td>\n",
       "      <td>Uster, Zurich, Switzerland</td>\n",
       "      <td>TOM - Medications - Making therapies easier to...</td>\n",
       "      <td>72,709</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.tommedications.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Jan</td>\n",
       "      <td>Active</td>\n",
       "      <td>TOM Medications is a digital solution for pati...</td>\n",
       "      <td>...</td>\n",
       "      <td>$4,762,184</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>CHF1,300,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$4,762,184</td>\n",
       "      <td>Galenica, Sanitas Disruptive</td>\n",
       "      <td>Private</td>\n",
       "      <td>Switzerland</td>\n",
       "      <td>$</td>\n",
       "      <td>4762184.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Realize Me</th>\n",
       "      <td>Dietary Supplements, Fitness, Health Care, mHe...</td>\n",
       "      <td>Los Angeles, California, United States</td>\n",
       "      <td>The premium platform for health and performanc...</td>\n",
       "      <td>72,273</td>\n",
       "      <td>—</td>\n",
       "      <td>www.realize.me</td>\n",
       "      <td>—</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>—</td>\n",
       "      <td>...</td>\n",
       "      <td>$4,025,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,025,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$4,025,000</td>\n",
       "      <td>Moonshots Capital</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>4025000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Axenya</th>\n",
       "      <td>Health Care, Medical, mHealth</td>\n",
       "      <td>Montevideo, NA - Uruguay, Uruguay</td>\n",
       "      <td>Axenya is a digital health platform.</td>\n",
       "      <td>52,530</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.axenya.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Apr</td>\n",
       "      <td>Active</td>\n",
       "      <td>Axenya leverages the power of data to deliver ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$4,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>—</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$4,000,000</td>\n",
       "      <td>NXTP Ventures, Igah Ventures, big_bets, Alexia...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Uruguay</td>\n",
       "      <td>$</td>\n",
       "      <td>4000000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Phenomune</th>\n",
       "      <td>Health Care, mHealth, Wellness</td>\n",
       "      <td>Houston, Texas, United States</td>\n",
       "      <td>Phenomune engages in bringing general wellness...</td>\n",
       "      <td>98,808</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>phenomune.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Phenomune engages in bringing general wellness...</td>\n",
       "      <td>...</td>\n",
       "      <td>$3,300,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$3,300,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$3,300,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>3300000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Shen.AI @ MX Labs</th>\n",
       "      <td>Artificial Intelligence (AI), Health Diagnosti...</td>\n",
       "      <td>Tallinn, Harjumaa, Estonia</td>\n",
       "      <td>Shen.AI offers app &amp; tele-health integration f...</td>\n",
       "      <td>32,136</td>\n",
       "      <td>—</td>\n",
       "      <td>shen.ai</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Oct</td>\n",
       "      <td>Active</td>\n",
       "      <td>Shen.AI is clinically proven software technolo...</td>\n",
       "      <td>...</td>\n",
       "      <td>$3,107,521</td>\n",
       "      <td>Grant</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$3,000,000</td>\n",
       "      <td>SMOK Ventures, Superhero Capital, Verge Health...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Estonia</td>\n",
       "      <td>$</td>\n",
       "      <td>3107521.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Fleming</th>\n",
       "      <td>Apps, Health Care, Information Technology, mHe...</td>\n",
       "      <td>Vilnius, Vilniaus Apskritis, Lithuania</td>\n",
       "      <td>Fleming is a smart healthcare app that allows ...</td>\n",
       "      <td>68,562</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>fleming.app</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Fleming app is a smart way to take care of you...</td>\n",
       "      <td>...</td>\n",
       "      <td>€ 2,510,030</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,200,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 2,510,030</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>Lithuania</td>\n",
       "      <td>€</td>\n",
       "      <td>2761033.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oska Health</th>\n",
       "      <td>Health Care, mHealth</td>\n",
       "      <td>Frankfurt, Hessen, Germany</td>\n",
       "      <td>A German-UK health-tech company delivering dig...</td>\n",
       "      <td>56,935</td>\n",
       "      <td>—</td>\n",
       "      <td>oska-health.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>25-Jul-22</td>\n",
       "      <td>Active</td>\n",
       "      <td>Oska Health delivers digital-enabled care solu...</td>\n",
       "      <td>...</td>\n",
       "      <td>€ 2,500,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>€ 2,500,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>€ 2,500,000</td>\n",
       "      <td>Calm/Storm Ventures, LBBW VC, Hessen Kapital I...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "      <td>€</td>\n",
       "      <td>2750000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PERSOWN</th>\n",
       "      <td>Health Care, Health Diagnostics, mHealth</td>\n",
       "      <td>Jacksonville, Florida, United States</td>\n",
       "      <td>PERSOWN provides a family health diagnostic so...</td>\n",
       "      <td>39,782</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>persown.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>PERSOWN provides a family health diagnostic so...</td>\n",
       "      <td>...</td>\n",
       "      <td>$2,618,250</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$110,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,618,250</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>2618250.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Una Health</th>\n",
       "      <td>Artificial Intelligence (AI), Diabetes, Health...</td>\n",
       "      <td>Berlin, Berlin, Germany</td>\n",
       "      <td>The most effective Digital Therapy to reverse ...</td>\n",
       "      <td>57,957</td>\n",
       "      <td>—</td>\n",
       "      <td>unahealth.io</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Una Health uses mobile technology, biosensors,...</td>\n",
       "      <td>...</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,500,000</td>\n",
       "      <td>Plug and Play, PeakBridge, FoodLabs, Frank Wes...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "      <td>$</td>\n",
       "      <td>2500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Lifetime Health</th>\n",
       "      <td>Health Care, Health Diagnostics, Home Health C...</td>\n",
       "      <td>Bengaluru, Karnataka, India</td>\n",
       "      <td>Delivering healthcare to your doorstep with a ...</td>\n",
       "      <td>13,414</td>\n",
       "      <td>—</td>\n",
       "      <td>lifetimehealth.in/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>22-Mar-23</td>\n",
       "      <td>Active</td>\n",
       "      <td>We are a digital platform, transforming the he...</td>\n",
       "      <td>...</td>\n",
       "      <td>$2,392,919</td>\n",
       "      <td>Seed</td>\n",
       "      <td>₹124,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,392,919</td>\n",
       "      <td>SharesPro, The Garage Syndicate</td>\n",
       "      <td>Private</td>\n",
       "      <td>India</td>\n",
       "      <td>$</td>\n",
       "      <td>2392919.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Legion Health</th>\n",
       "      <td>Elder Care, Health Care, Home Health Care, Men...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Legion Health is reimagining mental health.</td>\n",
       "      <td>35,432</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>legion.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Legion Health is backed by Y Combinator and th...</td>\n",
       "      <td>...</td>\n",
       "      <td>$2,125,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,000,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$2,125,000</td>\n",
       "      <td>Y Combinator, Soma Capital, UpHonest Capital, ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>2125000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ONVY HealthTech</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, Mac...</td>\n",
       "      <td>Munich, Bayern, Germany</td>\n",
       "      <td>AI-as-a-Service for the Health and Wellness In...</td>\n",
       "      <td>33,467</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.onvy.health/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>16-Jan-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Predictive health - powered by AI. The world's...</td>\n",
       "      <td>...</td>\n",
       "      <td>€ 2,650,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>—</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,400,000</td>\n",
       "      <td>New Forge, Isartal Ventures, Wort &amp; Bild Verla...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Germany</td>\n",
       "      <td>€</td>\n",
       "      <td>2915000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Ailin</th>\n",
       "      <td>Health Care, Medical Device, mHealth, Telehealth</td>\n",
       "      <td>Madrid, Madrid, Spain</td>\n",
       "      <td>Ailin offers digital health monitoring solutio...</td>\n",
       "      <td>57,002</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>ailin.es</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Ailin specializes in providing health and well...</td>\n",
       "      <td>...</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>€ 1,500,000</td>\n",
       "      <td>Decelera, Centre for the Development of Indust...</td>\n",
       "      <td>Private</td>\n",
       "      <td>Spain</td>\n",
       "      <td>€</td>\n",
       "      <td>1650000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Malaica</th>\n",
       "      <td>Health Care, mHealth, Women's</td>\n",
       "      <td>Nairobi, Nairobi Area, Kenya</td>\n",
       "      <td>Malaica is a digital healthcare firm that offe...</td>\n",
       "      <td>52,863</td>\n",
       "      <td>—</td>\n",
       "      <td>malaica.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>22-Jan</td>\n",
       "      <td>Active</td>\n",
       "      <td>Malaica is on a mission to make the pregnancy ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,600,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>$1,000,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>$1,600,000</td>\n",
       "      <td>Markus Gemuend, Kapor Capital</td>\n",
       "      <td>Private</td>\n",
       "      <td>Kenya</td>\n",
       "      <td>$</td>\n",
       "      <td>1600000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Small Joys</th>\n",
       "      <td>Health Care, mHealth, Personal Health, Wellness</td>\n",
       "      <td>Fort Lee, New Jersey, United States</td>\n",
       "      <td>Small Joys is a pediatric behavioral health co...</td>\n",
       "      <td>83,107</td>\n",
       "      <td>—</td>\n",
       "      <td>www.smalljoys.life/home</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>20-Jul</td>\n",
       "      <td>Active</td>\n",
       "      <td>Small Joys is a pediatric behavioral health co...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,540,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,200,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,540,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>1540000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>SupportRoom</th>\n",
       "      <td>Employee Benefits, Health Care, Mental Health,...</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>SupportRoom is a digital behavioural technolog...</td>\n",
       "      <td>62,619</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>supportroom.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>01-Apr-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Workplace wellness people transformation platf...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,529,565</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£874,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,529,565</td>\n",
       "      <td>8X Ventures, Deepak Bhavsar</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>$</td>\n",
       "      <td>1529565.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Total Life</th>\n",
       "      <td>Elder Care, Electronic Health Record (EHR), He...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Total Life is rethinking aging making it easy ...</td>\n",
       "      <td>48,254</td>\n",
       "      <td>—</td>\n",
       "      <td>totallife.com/</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Total Life is a medicare platform that special...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Primetime Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>1500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Frankie Health</th>\n",
       "      <td>Health Care, Mental Health, mHealth, Wellness</td>\n",
       "      <td>Dublin, Dublin, Ireland</td>\n",
       "      <td>Frankie is a B2B mental health platform that d...</td>\n",
       "      <td>59,081</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.frankie.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>01-Aug-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Frankie gets high-quality support to employees...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,250,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>E15 VC</td>\n",
       "      <td>Private</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>$</td>\n",
       "      <td>1500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Docty Inc.</th>\n",
       "      <td>Health Care, Medical, mHealth, SaaS</td>\n",
       "      <td>Norwalk, Connecticut, United States</td>\n",
       "      <td>A SaaS Data-Driven, Human-Centric Digital heal...</td>\n",
       "      <td>75,552</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>docty.ai</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>17-Mar-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Our interactive ecosystem connects patients an...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>1500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>HECCO Technologies Inc (Prescribe)</th>\n",
       "      <td>Health Care, Hospital, Information Technology,...</td>\n",
       "      <td>Malappuram, Kerala, India</td>\n",
       "      <td>IIT-Madras based HealthTech Start-Up providing...</td>\n",
       "      <td>96,209</td>\n",
       "      <td>—</td>\n",
       "      <td>www.heyprescribe.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>26-Feb-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Prescribe is an IIT-M and IIM-C backed HealthT...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Y Combinator, Acequia Capital (AceCap), Vignes...</td>\n",
       "      <td>Private</td>\n",
       "      <td>India</td>\n",
       "      <td>$</td>\n",
       "      <td>1500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ApoWiser</th>\n",
       "      <td>B2B, Digital Marketing, E-Commerce, Health Car...</td>\n",
       "      <td>Ra'anana, HaMerkaz, Israel</td>\n",
       "      <td>ApoWiser: The Digital Bedrock of the OTC Self-...</td>\n",
       "      <td>122,028</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>www.apowiser.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>17-Jan-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Empowering the self-care revolution, ApoWiser ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Grant</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>$1,500,000</td>\n",
       "      <td>MATTER, Longliv Ventures</td>\n",
       "      <td>Private</td>\n",
       "      <td>Israel</td>\n",
       "      <td>$</td>\n",
       "      <td>1500000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Holly Health</th>\n",
       "      <td>Artificial Intelligence (AI), Health Care, mHe...</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>Digital coach, providing compassionate, popula...</td>\n",
       "      <td>44,308</td>\n",
       "      <td>—</td>\n",
       "      <td>www.hollyhealth.io</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>01-Apr-20</td>\n",
       "      <td>Active</td>\n",
       "      <td>Holly Health helps individuals to change their...</td>\n",
       "      <td>...</td>\n",
       "      <td>£2,060,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£327,000</td>\n",
       "      <td>Seed</td>\n",
       "      <td>£1,197,000</td>\n",
       "      <td>Innovate UK, Plug and Play, Kima Ventures, Mod...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>£</td>\n",
       "      <td>2636800.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Aide Health</th>\n",
       "      <td>Health Care, mHealth, Software</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>A new digital health service that helps patien...</td>\n",
       "      <td>57,266</td>\n",
       "      <td>—</td>\n",
       "      <td>www.aide.health</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>11-Jan-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Aide is a health technology company with a mis...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,320,000</td>\n",
       "      <td>Non-equity Assistance</td>\n",
       "      <td>$1,200,000</td>\n",
       "      <td>Pre-Seed</td>\n",
       "      <td>$1,320,000</td>\n",
       "      <td>Fuel Ventures, Salica, APX, 1818 Venture Capit...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>$</td>\n",
       "      <td>1320000.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>50 rows × 29 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                           Industries  \\\n",
       "Organization Name                                                                       \n",
       "Cerebral                            Health Care, Medical, Mental Health, mHealth, ...   \n",
       "Harbor Health                       Health Care, Medical, mHealth, Personal Health...   \n",
       "Avi Medical                            Health Care, Medical, mHealth, Personal Health   \n",
       "BetterVet                                            Health Care, mHealth, Veterinary   \n",
       "Antidote Health                     Artificial Intelligence (AI), Health Care, mHe...   \n",
       "Pace                                Health Care, Mental Health, mHealth, Social, W...   \n",
       "DeepCardio                          Artificial Intelligence (AI), Health Care, mHe...   \n",
       "Brisk Health                        Health Care, Home Health Care, Medical, mHealt...   \n",
       "Courier Health                                          Health Care, Medical, mHealth   \n",
       "Cartwheel                           Health Care, Mental Health, mHealth, Therapeut...   \n",
       "Clearing                                     Consumer, Health Care, mHealth, Wellness   \n",
       "Cardo Health                                                     Health Care, mHealth   \n",
       "Anima                                      Health Care, Medical, mHealth, Mobile Apps   \n",
       "Oliva Health                        Health Care, Mental Health, mHealth, Personal ...   \n",
       "Inflow                                                 Health Care, mHealth, Wellness   \n",
       "Likeminded                              Health Care, Mental Health, mHealth, Wellness   \n",
       "Heading Health                      Health Care, Medical, Mental Health, mHealth, ...   \n",
       "Violet                                                  Health Care, Medical, mHealth   \n",
       "Anebulo Pharmaceuticals                          Biotechnology, Life Science, mHealth   \n",
       "Alyve Health                                           Health Care, mHealth, Wellness   \n",
       "Radicle Science                     Dietary Supplements, Health Care, mHealth, Wel...   \n",
       "Behavidence                          Health Care, Mental Health, mHealth, Mobile Apps   \n",
       "MYNDUP                              Health Care, Mental Health, mHealth, Personal ...   \n",
       "Persimmon                           Beauty, Cosmetic Surgery, Medical, mHealth, Te...   \n",
       "Elfie                               Health Care, Home Health Care, Medical, mHealt...   \n",
       "Comedi Health Technology Limited    Artificial Intelligence (AI), Health Care, Ima...   \n",
       "tapouts                             Apps, Health Care, Mental Health, mHealth, Mob...   \n",
       "TOM Medications                     Health Care, mHealth, Mobile Apps, Personal He...   \n",
       "Realize Me                          Dietary Supplements, Fitness, Health Care, mHe...   \n",
       "Axenya                                                  Health Care, Medical, mHealth   \n",
       "Phenomune                                              Health Care, mHealth, Wellness   \n",
       "Shen.AI @ MX Labs                   Artificial Intelligence (AI), Health Diagnosti...   \n",
       "Fleming                             Apps, Health Care, Information Technology, mHe...   \n",
       "Oska Health                                                      Health Care, mHealth   \n",
       "PERSOWN                                      Health Care, Health Diagnostics, mHealth   \n",
       "Una Health                          Artificial Intelligence (AI), Diabetes, Health...   \n",
       "Lifetime Health                     Health Care, Health Diagnostics, Home Health C...   \n",
       "Legion Health                       Elder Care, Health Care, Home Health Care, Men...   \n",
       "ONVY HealthTech                     Artificial Intelligence (AI), Health Care, Mac...   \n",
       "Ailin                                Health Care, Medical Device, mHealth, Telehealth   \n",
       "Malaica                                                 Health Care, mHealth, Women's   \n",
       "Small Joys                            Health Care, mHealth, Personal Health, Wellness   \n",
       "SupportRoom                         Employee Benefits, Health Care, Mental Health,...   \n",
       "Total Life                          Elder Care, Electronic Health Record (EHR), He...   \n",
       "Frankie Health                          Health Care, Mental Health, mHealth, Wellness   \n",
       "Docty Inc.                                        Health Care, Medical, mHealth, SaaS   \n",
       "HECCO Technologies Inc (Prescribe)  Health Care, Hospital, Information Technology,...   \n",
       "ApoWiser                            B2B, Digital Marketing, E-Commerce, Health Car...   \n",
       "Holly Health                        Artificial Intelligence (AI), Health Care, mHe...   \n",
       "Aide Health                                            Health Care, mHealth, Software   \n",
       "\n",
       "                                                         Headquarters Location  \\\n",
       "Organization Name                                                                \n",
       "Cerebral                              San Francisco, California, United States   \n",
       "Harbor Health                                     Austin, Texas, United States   \n",
       "Avi Medical                                            Munich, Bayern, Germany   \n",
       "BetterVet                                 Boston, Massachusetts, United States   \n",
       "Antidote Health                              New York, New York, United States   \n",
       "Pace                                California City, California, United States   \n",
       "DeepCardio                                Seoul, Seoul-t'ukpyolsi, South Korea   \n",
       "Brisk Health                                   Denver, Colorado, United States   \n",
       "Courier Health                               New York, New York, United States   \n",
       "Cartwheel                              Cambridge, Massachusetts, United States   \n",
       "Clearing                                     New York, New York, United States   \n",
       "Cardo Health                                 Stockholm, Stockholms Lan, Sweden   \n",
       "Anima                                 San Francisco, California, United States   \n",
       "Oliva Health                                       Barcelona, Catalonia, Spain   \n",
       "Inflow                                         London, England, United Kingdom   \n",
       "Likeminded                                             Berlin, Berlin, Germany   \n",
       "Heading Health                                    Austin, Texas, United States   \n",
       "Violet                                       New York, New York, United States   \n",
       "Anebulo Pharmaceuticals                           Austin, Texas, United States   \n",
       "Alyve Health                                        Mumbai, Maharashtra, India   \n",
       "Radicle Science                           San Diego, California, United States   \n",
       "Behavidence                                  New York, New York, United States   \n",
       "MYNDUP                                         London, England, United Kingdom   \n",
       "Persimmon                                  Larkspur, California, United States   \n",
       "Elfie                                     Singapore, Central Region, Singapore   \n",
       "Comedi Health Technology Limited        Hong Kong, Hong Kong Island, Hong Kong   \n",
       "tapouts                                      Venice, California, United States   \n",
       "TOM Medications                                     Uster, Zurich, Switzerland   \n",
       "Realize Me                              Los Angeles, California, United States   \n",
       "Axenya                                       Montevideo, NA - Uruguay, Uruguay   \n",
       "Phenomune                                        Houston, Texas, United States   \n",
       "Shen.AI @ MX Labs                                   Tallinn, Harjumaa, Estonia   \n",
       "Fleming                                 Vilnius, Vilniaus Apskritis, Lithuania   \n",
       "Oska Health                                         Frankfurt, Hessen, Germany   \n",
       "PERSOWN                                   Jacksonville, Florida, United States   \n",
       "Una Health                                             Berlin, Berlin, Germany   \n",
       "Lifetime Health                                    Bengaluru, Karnataka, India   \n",
       "Legion Health                                     Austin, Texas, United States   \n",
       "ONVY HealthTech                                        Munich, Bayern, Germany   \n",
       "Ailin                                                    Madrid, Madrid, Spain   \n",
       "Malaica                                           Nairobi, Nairobi Area, Kenya   \n",
       "Small Joys                                 Fort Lee, New Jersey, United States   \n",
       "SupportRoom                                    London, England, United Kingdom   \n",
       "Total Life                            San Francisco, California, United States   \n",
       "Frankie Health                                         Dublin, Dublin, Ireland   \n",
       "Docty Inc.                                 Norwalk, Connecticut, United States   \n",
       "HECCO Technologies Inc (Prescribe)                   Malappuram, Kerala, India   \n",
       "ApoWiser                                            Ra'anana, HaMerkaz, Israel   \n",
       "Holly Health                                   London, England, United Kingdom   \n",
       "Aide Health                                    London, England, United Kingdom   \n",
       "\n",
       "                                                                          Description  \\\n",
       "Organization Name                                                                       \n",
       "Cerebral                            Cerebral is a mental health telemedicine compa...   \n",
       "Harbor Health                       Harbor Health is a multi-specialty clinic grou...   \n",
       "Avi Medical                         Avi Medical is a digital health care company t...   \n",
       "BetterVet                           BetterVet is a veterinary startup that provide...   \n",
       "Antidote Health                     Antidote Health offers an AI-based health plat...   \n",
       "Pace                                Pace provides online peer support groups to gi...   \n",
       "DeepCardio                          DeepCardio develops artificial intelligence te...   \n",
       "Brisk Health                                                 All-Inclusive Healthcare   \n",
       "Courier Health                      Courier Health develops a patient engagement p...   \n",
       "Cartwheel                           Cartwheel offers mental health support to stud...   \n",
       "Clearing                            Clearing is a healthcare platform focused on p...   \n",
       "Cardo Health                        Cardo Health is a digital health company with ...   \n",
       "Anima                                    The next generation care enablement platform   \n",
       "Oliva Health                                      Employee Mental Well-Being Platform   \n",
       "Inflow                              Inflow develops a science-based digital progra...   \n",
       "Likeminded                          Likeminded operates a digital platform for men...   \n",
       "Heading Health                      Heading Health is a technology-enabled mental ...   \n",
       "Violet                              Violet is a platform that helps the healthcare...   \n",
       "Anebulo Pharmaceuticals             Anebulo is a biotech company developing novel ...   \n",
       "Alyve Health                        Alyve Health is a tech platform providing pers...   \n",
       "Radicle Science                     Radicle Science is a health tech company that ...   \n",
       "Behavidence                         Behavidence develops tools to monitor and mana...   \n",
       "MYNDUP                              Live 1-1 virtual mental health sessions to sto...   \n",
       "Persimmon                           Persimmon provides aesthetic treatments in the...   \n",
       "Elfie                               Elfie is a product that reduces the burden of ...   \n",
       "Comedi Health Technology Limited    Comedi Health is a platform that provides tele...   \n",
       "tapouts                                                     Mobile Mental Health Care   \n",
       "TOM Medications                     TOM - Medications - Making therapies easier to...   \n",
       "Realize Me                          The premium platform for health and performanc...   \n",
       "Axenya                                           Axenya is a digital health platform.   \n",
       "Phenomune                           Phenomune engages in bringing general wellness...   \n",
       "Shen.AI @ MX Labs                   Shen.AI offers app & tele-health integration f...   \n",
       "Fleming                             Fleming is a smart healthcare app that allows ...   \n",
       "Oska Health                         A German-UK health-tech company delivering dig...   \n",
       "PERSOWN                             PERSOWN provides a family health diagnostic so...   \n",
       "Una Health                          The most effective Digital Therapy to reverse ...   \n",
       "Lifetime Health                     Delivering healthcare to your doorstep with a ...   \n",
       "Legion Health                             Legion Health is reimagining mental health.   \n",
       "ONVY HealthTech                     AI-as-a-Service for the Health and Wellness In...   \n",
       "Ailin                               Ailin offers digital health monitoring solutio...   \n",
       "Malaica                             Malaica is a digital healthcare firm that offe...   \n",
       "Small Joys                          Small Joys is a pediatric behavioral health co...   \n",
       "SupportRoom                         SupportRoom is a digital behavioural technolog...   \n",
       "Total Life                          Total Life is rethinking aging making it easy ...   \n",
       "Frankie Health                      Frankie is a B2B mental health platform that d...   \n",
       "Docty Inc.                          A SaaS Data-Driven, Human-Centric Digital heal...   \n",
       "HECCO Technologies Inc (Prescribe)  IIT-Madras based HealthTech Start-Up providing...   \n",
       "ApoWiser                            ApoWiser: The Digital Bedrock of the OTC Self-...   \n",
       "Holly Health                        Digital coach, providing compassionate, popula...   \n",
       "Aide Health                         A new digital health service that helps patien...   \n",
       "\n",
       "                                   CB Rank (Company) Estimated Revenue Range  \\\n",
       "Organization Name                                                              \n",
       "Cerebral                                      24,597          $100M to $500M   \n",
       "Harbor Health                                  5,140                       —   \n",
       "Avi Medical                                    7,992           Less than $1M   \n",
       "BetterVet                                     12,253            $10M to $50M   \n",
       "Antidote Health                                8,740           Less than $1M   \n",
       "Pace                                          12,690           Less than $1M   \n",
       "DeepCardio                                    78,967                       —   \n",
       "Brisk Health                                  31,918             $1M to $10M   \n",
       "Courier Health                                   720             $1M to $10M   \n",
       "Cartwheel                                     10,286             $1M to $10M   \n",
       "Clearing                                      19,828             $1M to $10M   \n",
       "Cardo Health                                  40,403             $1M to $10M   \n",
       "Anima                                          8,353                       —   \n",
       "Oliva Health                                  13,133             $1M to $10M   \n",
       "Inflow                                        88,841             $1M to $10M   \n",
       "Likeminded                                    11,739           Less than $1M   \n",
       "Heading Health                                14,148             $1M to $10M   \n",
       "Violet                                        26,457                       —   \n",
       "Anebulo Pharmaceuticals                       11,250             $1M to $10M   \n",
       "Alyve Health                                     425             $1M to $10M   \n",
       "Radicle Science                               26,451             $1M to $10M   \n",
       "Behavidence                                   29,177             $1M to $10M   \n",
       "MYNDUP                                        47,661                       —   \n",
       "Persimmon                                     23,433                       —   \n",
       "Elfie                                         16,903             $1M to $10M   \n",
       "Comedi Health Technology Limited              89,470                       —   \n",
       "tapouts                                       26,340             $1M to $10M   \n",
       "TOM Medications                               72,709             $1M to $10M   \n",
       "Realize Me                                    72,273                       —   \n",
       "Axenya                                        52,530             $1M to $10M   \n",
       "Phenomune                                     98,808             $1M to $10M   \n",
       "Shen.AI @ MX Labs                             32,136                       —   \n",
       "Fleming                                       68,562             $1M to $10M   \n",
       "Oska Health                                   56,935                       —   \n",
       "PERSOWN                                       39,782             $1M to $10M   \n",
       "Una Health                                    57,957                       —   \n",
       "Lifetime Health                               13,414                       —   \n",
       "Legion Health                                 35,432             $1M to $10M   \n",
       "ONVY HealthTech                               33,467             $1M to $10M   \n",
       "Ailin                                         57,002             $1M to $10M   \n",
       "Malaica                                       52,863                       —   \n",
       "Small Joys                                    83,107                       —   \n",
       "SupportRoom                                   62,619             $1M to $10M   \n",
       "Total Life                                    48,254                       —   \n",
       "Frankie Health                                59,081             $1M to $10M   \n",
       "Docty Inc.                                    75,552             $1M to $10M   \n",
       "HECCO Technologies Inc (Prescribe)            96,209                       —   \n",
       "ApoWiser                                     122,028             $1M to $10M   \n",
       "Holly Health                                  44,308                       —   \n",
       "Aide Health                                   57,266                       —   \n",
       "\n",
       "                                                    Website Company Type  \\\n",
       "Organization Name                                                          \n",
       "Cerebral                                       cerebral.com   For Profit   \n",
       "Harbor Health                              harborhealth.com   For Profit   \n",
       "Avi Medical                                  avimedical.com   For Profit   \n",
       "BetterVet                                     bettervet.com   For Profit   \n",
       "Antidote Health                          antidotehealth.com   For Profit   \n",
       "Pace                                             pace.group   For Profit   \n",
       "DeepCardio                                   deepcardio.net   For Profit   \n",
       "Brisk Health                                briskhealth.com   For Profit   \n",
       "Courier Health                            courierhealth.com   For Profit   \n",
       "Cartwheel                             www.cartwheelcare.org   For Profit   \n",
       "Clearing                                   www.clearing.com   For Profit   \n",
       "Cardo Health                                cardohealth.com   For Profit   \n",
       "Anima                                   www.animahealth.com   For Profit   \n",
       "Oliva Health                               www.oliva.health   For Profit   \n",
       "Inflow                                     www.getinflow.io   For Profit   \n",
       "Likeminded                              www.likeminded.care   For Profit   \n",
       "Heading Health                           headinghealth.com/   For Profit   \n",
       "Violet                                   www.joinviolet.com   For Profit   \n",
       "Anebulo Pharmaceuticals                     www.anebulo.com   For Profit   \n",
       "Alyve Health                               www.alyve.health   For Profit   \n",
       "Radicle Science                          radiclescience.com   For Profit   \n",
       "Behavidence                             www.behavidence.com   For Profit   \n",
       "MYNDUP                                       www.myndup.com   For Profit   \n",
       "Persimmon                               www.persimmon.life/   For Profit   \n",
       "Elfie                                          www.elfie.co   For Profit   \n",
       "Comedi Health Technology Limited          www.comedi.com.hk   For Profit   \n",
       "tapouts                                     www.tapouts.com   For Profit   \n",
       "TOM Medications                     www.tommedications.com/   For Profit   \n",
       "Realize Me                                   www.realize.me            —   \n",
       "Axenya                                      www.axenya.com/   For Profit   \n",
       "Phenomune                                    phenomune.com/   For Profit   \n",
       "Shen.AI @ MX Labs                                   shen.ai   For Profit   \n",
       "Fleming                                         fleming.app   For Profit   \n",
       "Oska Health                                oska-health.com/   For Profit   \n",
       "PERSOWN                                         persown.com   For Profit   \n",
       "Una Health                                     unahealth.io   For Profit   \n",
       "Lifetime Health                          lifetimehealth.in/   For Profit   \n",
       "Legion Health                                 legion.health   For Profit   \n",
       "ONVY HealthTech                            www.onvy.health/   For Profit   \n",
       "Ailin                                              ailin.es   For Profit   \n",
       "Malaica                                        malaica.com/   For Profit   \n",
       "Small Joys                          www.smalljoys.life/home   For Profit   \n",
       "SupportRoom                                supportroom.com/   For Profit   \n",
       "Total Life                                   totallife.com/   For Profit   \n",
       "Frankie Health                           www.frankie.health   For Profit   \n",
       "Docty Inc.                                         docty.ai   For Profit   \n",
       "HECCO Technologies Inc (Prescribe)     www.heyprescribe.com   For Profit   \n",
       "ApoWiser                                   www.apowiser.com   For Profit   \n",
       "Holly Health                             www.hollyhealth.io   For Profit   \n",
       "Aide Health                                 www.aide.health   For Profit   \n",
       "\n",
       "                                   Founded Date Operating Status  \\\n",
       "Organization Name                                                  \n",
       "Cerebral                                   2020           Active   \n",
       "Harbor Health                              2022           Active   \n",
       "Avi Medical                                2020           Active   \n",
       "BetterVet                             01-Jul-20           Active   \n",
       "Antidote Health                       15-Mar-20           Active   \n",
       "Pace                                       2020         Inactive   \n",
       "DeepCardio                                 2020           Active   \n",
       "Brisk Health                             20-Oct           Active   \n",
       "Courier Health                             2020           Active   \n",
       "Cartwheel                                  2022           Active   \n",
       "Clearing                                 20-Jul           Active   \n",
       "Cardo Health                               2021           Active   \n",
       "Anima                                      2021           Active   \n",
       "Oliva Health                               2020           Active   \n",
       "Inflow                                     2020           Active   \n",
       "Likeminded                                 2020           Active   \n",
       "Heading Health                             2020           Active   \n",
       "Violet                                   20-Feb           Active   \n",
       "Anebulo Pharmaceuticals                    2020           Active   \n",
       "Alyve Health                          18-May-20           Active   \n",
       "Radicle Science                            2020           Active   \n",
       "Behavidence                              20-Jun           Active   \n",
       "MYNDUP                                   20-Feb           Active   \n",
       "Persimmon                                  2021           Active   \n",
       "Elfie                                 25-Oct-20           Active   \n",
       "Comedi Health Technology Limited      31-May-21           Active   \n",
       "tapouts                               12-Jan-21           Active   \n",
       "TOM Medications                          20-Jan           Active   \n",
       "Realize Me                                 2021           Active   \n",
       "Axenya                                   20-Apr           Active   \n",
       "Phenomune                                  2021           Active   \n",
       "Shen.AI @ MX Labs                        20-Oct           Active   \n",
       "Fleming                                    2020           Active   \n",
       "Oska Health                           25-Jul-22           Active   \n",
       "PERSOWN                                    2020           Active   \n",
       "Una Health                                 2021           Active   \n",
       "Lifetime Health                       22-Mar-23           Active   \n",
       "Legion Health                              2021           Active   \n",
       "ONVY HealthTech                       16-Jan-20           Active   \n",
       "Ailin                                      2021           Active   \n",
       "Malaica                                  22-Jan           Active   \n",
       "Small Joys                               20-Jul           Active   \n",
       "SupportRoom                           01-Apr-20           Active   \n",
       "Total Life                                 2021           Active   \n",
       "Frankie Health                        01-Aug-20           Active   \n",
       "Docty Inc.                            17-Mar-20           Active   \n",
       "HECCO Technologies Inc (Prescribe)    26-Feb-21           Active   \n",
       "ApoWiser                              17-Jan-21           Active   \n",
       "Holly Health                          01-Apr-20           Active   \n",
       "Aide Health                           11-Jan-21           Active   \n",
       "\n",
       "                                                                     Full Description  \\\n",
       "Organization Name                                                                       \n",
       "Cerebral                            Cerebral is a mental health telemedicine compa...   \n",
       "Harbor Health                       Harbor Health is a multi-specialty clinic grou...   \n",
       "Avi Medical                         Avi Medical is a digital health care company t...   \n",
       "BetterVet                           BetterVet is a veterinary startup that provide...   \n",
       "Antidote Health                     Antidote Health offers an AI-based health plat...   \n",
       "Pace                                Pace is a mental fitness and social wellness p...   \n",
       "DeepCardio                                                                          —   \n",
       "Brisk Health                        Brisk Health developed the most advanced mobil...   \n",
       "Courier Health                      Courier Health develops a patient engagement p...   \n",
       "Cartwheel                           Cartwheel offers mental health support to stud...   \n",
       "Clearing                            Clearing is a digital healthcare platform buil...   \n",
       "Cardo Health                        Cardo Health is a digital health company with ...   \n",
       "Anima                               Anima is a next generation clinical operating ...   \n",
       "Oliva Health                        Oliva Therapy is an online therapy for busy pe...   \n",
       "Inflow                              Inflow develops a science-based digital progra...   \n",
       "Likeminded                          Likeminded operates a digital platform for men...   \n",
       "Heading Health                      Heading Health is a technology-enabled mental ...   \n",
       "Violet                              Violet is a platform that helps the healthcare...   \n",
       "Anebulo Pharmaceuticals             Anebulo is a clinical-stage biotechnology comp...   \n",
       "Alyve Health                        Imagine a healthcare ecosystem where care meet...   \n",
       "Radicle Science                     AI-driven healthtech B-Corp providing history'...   \n",
       "Behavidence                         Behavidence utilizes AI to detect and monitor ...   \n",
       "MYNDUP                              MYNDUP is stopping the “one size fits all” app...   \n",
       "Persimmon                           Persimmon is an in-home aesthetics teleHealth ...   \n",
       "Elfie                               Elfie is a product that reduces the burden of ...   \n",
       "Comedi Health Technology Limited    COMEDI Health is a one-stop technology platfor...   \n",
       "tapouts                             tapouts is a mental health edutainment platfor...   \n",
       "TOM Medications                     TOM Medications is a digital solution for pati...   \n",
       "Realize Me                                                                          —   \n",
       "Axenya                              Axenya leverages the power of data to deliver ...   \n",
       "Phenomune                           Phenomune engages in bringing general wellness...   \n",
       "Shen.AI @ MX Labs                   Shen.AI is clinically proven software technolo...   \n",
       "Fleming                             Fleming app is a smart way to take care of you...   \n",
       "Oska Health                         Oska Health delivers digital-enabled care solu...   \n",
       "PERSOWN                             PERSOWN provides a family health diagnostic so...   \n",
       "Una Health                          Una Health uses mobile technology, biosensors,...   \n",
       "Lifetime Health                     We are a digital platform, transforming the he...   \n",
       "Legion Health                       Legion Health is backed by Y Combinator and th...   \n",
       "ONVY HealthTech                     Predictive health - powered by AI. The world's...   \n",
       "Ailin                               Ailin specializes in providing health and well...   \n",
       "Malaica                             Malaica is on a mission to make the pregnancy ...   \n",
       "Small Joys                          Small Joys is a pediatric behavioral health co...   \n",
       "SupportRoom                         Workplace wellness people transformation platf...   \n",
       "Total Life                          Total Life is a medicare platform that special...   \n",
       "Frankie Health                      Frankie gets high-quality support to employees...   \n",
       "Docty Inc.                          Our interactive ecosystem connects patients an...   \n",
       "HECCO Technologies Inc (Prescribe)  Prescribe is an IIT-M and IIM-C backed HealthT...   \n",
       "ApoWiser                            Empowering the self-care revolution, ApoWiser ...   \n",
       "Holly Health                        Holly Health helps individuals to change their...   \n",
       "Aide Health                         Aide is a health technology company with a mis...   \n",
       "\n",
       "                                    ... Total Funding Amount  \\\n",
       "Organization Name                   ...                        \n",
       "Cerebral                            ...        $462,000,000    \n",
       "Harbor Health                       ...        $125,500,000    \n",
       "Avi Medical                         ...         € 88,500,000   \n",
       "BetterVet                           ...         $57,928,818    \n",
       "Antidote Health                     ...         $56,000,000    \n",
       "Pace                                ...         $50,900,000    \n",
       "DeepCardio                          ...      ₩40,000,000,000   \n",
       "Brisk Health                        ...         $27,080,000    \n",
       "Courier Health                      ...         $20,450,002    \n",
       "Cartwheel                           ...         $20,000,000    \n",
       "Clearing                            ...         $20,000,000    \n",
       "Cardo Health                        ...         $17,500,000    \n",
       "Anima                               ...         $14,625,000    \n",
       "Oliva Health                        ...          £10,720,000   \n",
       "Inflow                              ...         $13,980,000    \n",
       "Likeminded                          ...         € 10,900,000   \n",
       "Heading Health                      ...          $9,978,120    \n",
       "Violet                              ...          $6,800,000    \n",
       "Anebulo Pharmaceuticals             ...          $7,500,000    \n",
       "Alyve Health                        ...          $6,288,066    \n",
       "Radicle Science                     ...          $5,999,716    \n",
       "Behavidence                         ...          $5,625,000    \n",
       "MYNDUP                              ...           £4,700,000   \n",
       "Persimmon                           ...          $5,323,629    \n",
       "Elfie                               ...          $5,000,000    \n",
       "Comedi Health Technology Limited    ...          $5,000,000    \n",
       "tapouts                             ...          $4,800,000    \n",
       "TOM Medications                     ...          $4,762,184    \n",
       "Realize Me                          ...          $4,025,000    \n",
       "Axenya                              ...          $4,000,000    \n",
       "Phenomune                           ...          $3,300,000    \n",
       "Shen.AI @ MX Labs                   ...          $3,107,521    \n",
       "Fleming                             ...          € 2,510,030   \n",
       "Oska Health                         ...          € 2,500,000   \n",
       "PERSOWN                             ...          $2,618,250    \n",
       "Una Health                          ...          $2,500,000    \n",
       "Lifetime Health                     ...          $2,392,919    \n",
       "Legion Health                       ...          $2,125,000    \n",
       "ONVY HealthTech                     ...          € 2,650,000   \n",
       "Ailin                               ...          € 1,500,000   \n",
       "Malaica                             ...          $1,600,000    \n",
       "Small Joys                          ...          $1,540,000    \n",
       "SupportRoom                         ...          $1,529,565    \n",
       "Total Life                          ...          $1,500,000    \n",
       "Frankie Health                      ...          $1,500,000    \n",
       "Docty Inc.                          ...          $1,500,000    \n",
       "HECCO Technologies Inc (Prescribe)  ...          $1,500,000    \n",
       "ApoWiser                            ...          $1,500,000    \n",
       "Holly Health                        ...           £2,060,000   \n",
       "Aide Health                         ...          $1,320,000    \n",
       "\n",
       "                                           Last Funding Type  \\\n",
       "Organization Name                                              \n",
       "Cerebral                                            Series C   \n",
       "Harbor Health                                       Series A   \n",
       "Avi Medical                                         Series B   \n",
       "BetterVet                           Venture - Series Unknown   \n",
       "Antidote Health                                     Series A   \n",
       "Pace                                                Series A   \n",
       "DeepCardio                                          Series A   \n",
       "Brisk Health                                        Series D   \n",
       "Courier Health                                      Series A   \n",
       "Cartwheel                                           Series A   \n",
       "Clearing                                                Seed   \n",
       "Cardo Health                                        Series A   \n",
       "Anima                                               Series A   \n",
       "Oliva Health                                            Seed   \n",
       "Inflow                                              Series A   \n",
       "Likeminded                                              Seed   \n",
       "Heading Health                      Venture - Series Unknown   \n",
       "Violet                                                  Seed   \n",
       "Anebulo Pharmaceuticals                                Grant   \n",
       "Alyve Health                                        Series A   \n",
       "Radicle Science                                         Seed   \n",
       "Behavidence                                             Seed   \n",
       "MYNDUP                                              Series A   \n",
       "Persimmon                                               Seed   \n",
       "Elfie                                                   Seed   \n",
       "Comedi Health Technology Limited                        Seed   \n",
       "tapouts                                                 Seed   \n",
       "TOM Medications                              Corporate Round   \n",
       "Realize Me                                              Seed   \n",
       "Axenya                              Venture - Series Unknown   \n",
       "Phenomune                           Venture - Series Unknown   \n",
       "Shen.AI @ MX Labs                                      Grant   \n",
       "Fleming                                                 Seed   \n",
       "Oska Health                                         Pre-Seed   \n",
       "PERSOWN                                                 Seed   \n",
       "Una Health                                              Seed   \n",
       "Lifetime Health                                         Seed   \n",
       "Legion Health                                           Seed   \n",
       "ONVY HealthTech                                         Seed   \n",
       "Ailin                                                   Seed   \n",
       "Malaica                                             Pre-Seed   \n",
       "Small Joys                                              Seed   \n",
       "SupportRoom                                             Seed   \n",
       "Total Life                                              Seed   \n",
       "Frankie Health                                          Seed   \n",
       "Docty Inc.                                              Seed   \n",
       "HECCO Technologies Inc (Prescribe)                      Seed   \n",
       "ApoWiser                                               Grant   \n",
       "Holly Health                                            Seed   \n",
       "Aide Health                            Non-equity Assistance   \n",
       "\n",
       "                                   Last Equity Funding Amount  \\\n",
       "Organization Name                                               \n",
       "Cerebral                                        $300,000,000    \n",
       "Harbor Health                                    $95,500,000    \n",
       "Avi Medical                                      € 50,000,000   \n",
       "BetterVet                                        $17,928,818    \n",
       "Antidote Health                                  $13,000,000    \n",
       "Pace                                             $13,000,000    \n",
       "DeepCardio                                    ₩40,000,000,000   \n",
       "Brisk Health                                      $1,000,000    \n",
       "Courier Health                                   $16,500,000    \n",
       "Cartwheel                                        $20,000,000    \n",
       "Clearing                                         $20,000,000    \n",
       "Cardo Health                                     $17,500,000    \n",
       "Anima                                            $12,000,000    \n",
       "Oliva Health                                       £4,260,000   \n",
       "Inflow                                           $11,000,000    \n",
       "Likeminded                                        € 1,500,000   \n",
       "Heading Health                                              —   \n",
       "Violet                                            $5,300,000    \n",
       "Anebulo Pharmaceuticals                           $6,600,000    \n",
       "Alyve Health                                     ₹450,000,000   \n",
       "Radicle Science                                             —   \n",
       "Behavidence                                       $4,300,000    \n",
       "MYNDUP                                             £4,400,000   \n",
       "Persimmon                                         $5,323,629    \n",
       "Elfie                                             $4,000,000    \n",
       "Comedi Health Technology Limited                  $5,000,000    \n",
       "tapouts                                           $3,200,000    \n",
       "TOM Medications                                  CHF1,300,000   \n",
       "Realize Me                                        $4,025,000    \n",
       "Axenya                                                      —   \n",
       "Phenomune                                         $3,300,000    \n",
       "Shen.AI @ MX Labs                                 $2,500,000    \n",
       "Fleming                                           € 1,200,000   \n",
       "Oska Health                                       € 2,500,000   \n",
       "PERSOWN                                             $110,000    \n",
       "Una Health                                        $2,500,000    \n",
       "Lifetime Health                                  ₹124,000,000   \n",
       "Legion Health                                     $2,000,000    \n",
       "ONVY HealthTech                                             —   \n",
       "Ailin                                             € 1,500,000   \n",
       "Malaica                                           $1,000,000    \n",
       "Small Joys                                        $1,200,000    \n",
       "SupportRoom                                          £874,000   \n",
       "Total Life                                        $1,500,000    \n",
       "Frankie Health                                    $1,250,000    \n",
       "Docty Inc.                                          $500,000    \n",
       "HECCO Technologies Inc (Prescribe)                $1,500,000    \n",
       "ApoWiser                                          $1,500,000    \n",
       "Holly Health                                         £327,000   \n",
       "Aide Health                                       $1,200,000    \n",
       "\n",
       "                                    Last Equity Funding Type  \\\n",
       "Organization Name                                              \n",
       "Cerebral                                            Series C   \n",
       "Harbor Health                                       Series A   \n",
       "Avi Medical                                         Series B   \n",
       "BetterVet                           Venture - Series Unknown   \n",
       "Antidote Health                                     Series A   \n",
       "Pace                                                Series A   \n",
       "DeepCardio                                          Series A   \n",
       "Brisk Health                                        Series D   \n",
       "Courier Health                                      Series A   \n",
       "Cartwheel                                           Series A   \n",
       "Clearing                                                Seed   \n",
       "Cardo Health                                        Series A   \n",
       "Anima                                               Series A   \n",
       "Oliva Health                                            Seed   \n",
       "Inflow                                              Series A   \n",
       "Likeminded                                              Seed   \n",
       "Heading Health                      Venture - Series Unknown   \n",
       "Violet                                                  Seed   \n",
       "Anebulo Pharmaceuticals                      Post-IPO Equity   \n",
       "Alyve Health                                        Series A   \n",
       "Radicle Science                                         Seed   \n",
       "Behavidence                                             Seed   \n",
       "MYNDUP                                              Series A   \n",
       "Persimmon                                               Seed   \n",
       "Elfie                                                   Seed   \n",
       "Comedi Health Technology Limited                        Seed   \n",
       "tapouts                                                 Seed   \n",
       "TOM Medications                              Corporate Round   \n",
       "Realize Me                                              Seed   \n",
       "Axenya                              Venture - Series Unknown   \n",
       "Phenomune                           Venture - Series Unknown   \n",
       "Shen.AI @ MX Labs                                       Seed   \n",
       "Fleming                                                 Seed   \n",
       "Oska Health                                         Pre-Seed   \n",
       "PERSOWN                                                 Seed   \n",
       "Una Health                                              Seed   \n",
       "Lifetime Health                                         Seed   \n",
       "Legion Health                                           Seed   \n",
       "ONVY HealthTech                                         Seed   \n",
       "Ailin                                                   Seed   \n",
       "Malaica                                             Pre-Seed   \n",
       "Small Joys                                              Seed   \n",
       "SupportRoom                                             Seed   \n",
       "Total Life                                              Seed   \n",
       "Frankie Health                                          Seed   \n",
       "Docty Inc.                                              Seed   \n",
       "HECCO Technologies Inc (Prescribe)                      Seed   \n",
       "ApoWiser                                                Seed   \n",
       "Holly Health                                            Seed   \n",
       "Aide Health                                         Pre-Seed   \n",
       "\n",
       "                                   Total Equity Funding Amount  \\\n",
       "Organization Name                                                \n",
       "Cerebral                                         $462,000,000    \n",
       "Harbor Health                                    $125,500,000    \n",
       "Avi Medical                                       € 88,500,000   \n",
       "BetterVet                                         $57,928,818    \n",
       "Antidote Health                                   $56,000,000    \n",
       "Pace                                              $50,900,000    \n",
       "DeepCardio                                     ₩40,000,000,000   \n",
       "Brisk Health                                      $27,080,000    \n",
       "Courier Health                                    $20,450,002    \n",
       "Cartwheel                                         $20,000,000    \n",
       "Clearing                                          $20,000,000    \n",
       "Cardo Health                                      $17,500,000    \n",
       "Anima                                             $14,625,000    \n",
       "Oliva Health                                       £10,720,000   \n",
       "Inflow                                            $13,980,000    \n",
       "Likeminded                                        € 10,900,000   \n",
       "Heading Health                                     $9,878,120    \n",
       "Violet                                             $6,800,000    \n",
       "Anebulo Pharmaceuticals                            $6,600,000    \n",
       "Alyve Health                                       $6,288,066    \n",
       "Radicle Science                                    $5,999,716    \n",
       "Behavidence                                        $5,625,000    \n",
       "MYNDUP                                              £4,700,000   \n",
       "Persimmon                                          $5,323,629    \n",
       "Elfie                                              $5,000,000    \n",
       "Comedi Health Technology Limited                   $5,000,000    \n",
       "tapouts                                            $4,800,000    \n",
       "TOM Medications                                    $4,762,184    \n",
       "Realize Me                                         $4,025,000    \n",
       "Axenya                                             $4,000,000    \n",
       "Phenomune                                          $3,300,000    \n",
       "Shen.AI @ MX Labs                                  $3,000,000    \n",
       "Fleming                                            € 2,510,030   \n",
       "Oska Health                                        € 2,500,000   \n",
       "PERSOWN                                            $2,618,250    \n",
       "Una Health                                         $2,500,000    \n",
       "Lifetime Health                                    $2,392,919    \n",
       "Legion Health                                      $2,125,000    \n",
       "ONVY HealthTech                                    € 1,400,000   \n",
       "Ailin                                              € 1,500,000   \n",
       "Malaica                                            $1,600,000    \n",
       "Small Joys                                         $1,540,000    \n",
       "SupportRoom                                        $1,529,565    \n",
       "Total Life                                         $1,500,000    \n",
       "Frankie Health                                     $1,500,000    \n",
       "Docty Inc.                                         $1,500,000    \n",
       "HECCO Technologies Inc (Prescribe)                 $1,500,000    \n",
       "ApoWiser                                           $1,500,000    \n",
       "Holly Health                                        £1,197,000   \n",
       "Aide Health                                        $1,320,000    \n",
       "\n",
       "                                                                      Top 5 Investors  \\\n",
       "Organization Name                                                                       \n",
       "Cerebral                            Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...   \n",
       "Harbor Health                       General Catalyst, 8VC, Alta Partners, Martin V...   \n",
       "Avi Medical                         Eurazeo, Picus Capital, 3VC, Operator Partners...   \n",
       "BetterVet                             Alta Partners, Daniel J Adams, Bruce Herzfelder   \n",
       "Antidote Health                     iAngels, Google for Startups, Flint Capital, G...   \n",
       "Pace                                Sequoia Capital, BoxGroup, SV Angel, Pace Capi...   \n",
       "DeepCardio                                                   SoftBank, Dayli Partners   \n",
       "Brisk Health                                                                        —   \n",
       "Courier Health                                   Norwest Venture Partners, Work-Bench   \n",
       "Cartwheel                           Reach Capital, Menlo Ventures, General Catalys...   \n",
       "Clearing                            Hims & Hers, Grubhub, Founders Fund, Bessemer ...   \n",
       "Cardo Health                                                                        —   \n",
       "Anima                               Y Combinator, Molten Ventures, Hummingbird Ven...   \n",
       "Oliva Health                        Alumni Ventures, Molten Ventures, Moonfire Ven...   \n",
       "Inflow                              Y Combinator, Octopus Ventures, Route 66 Ventu...   \n",
       "Likeminded                          Heartcore Capital, IBB Ventures, Holtzbrinck D...   \n",
       "Heading Health                      Alumni Ventures, Global Brain Corporation, Gai...   \n",
       "Violet                              The Venture Collective, SemperVirens Venture C...   \n",
       "Anebulo Pharmaceuticals             National Institute on Drug Abuse (NIDA), Merid...   \n",
       "Alyve Health                        1Crowd, Axilor Ventures, Trifecta Capital Advi...   \n",
       "Radicle Science                     Everywhere Ventures (The Fund), Wayne Chang, S...   \n",
       "Behavidence                         Fusion, GoAhead Ventures, Kicker Ventures, Lon...   \n",
       "MYNDUP                                                                    Arpit Gupta   \n",
       "Persimmon                                                                           —   \n",
       "Elfie                               Google for Startups, Hustle Fund, FEBE Venture...   \n",
       "Comedi Health Technology Limited                                                    —   \n",
       "tapouts                             M Venture Partners (MVP), Sidespin Ventures, R...   \n",
       "TOM Medications                                          Galenica, Sanitas Disruptive   \n",
       "Realize Me                                                          Moonshots Capital   \n",
       "Axenya                              NXTP Ventures, Igah Ventures, big_bets, Alexia...   \n",
       "Phenomune                                                                           —   \n",
       "Shen.AI @ MX Labs                   SMOK Ventures, Superhero Capital, Verge Health...   \n",
       "Fleming                                                                             —   \n",
       "Oska Health                         Calm/Storm Ventures, LBBW VC, Hessen Kapital I...   \n",
       "PERSOWN                                                                             —   \n",
       "Una Health                          Plug and Play, PeakBridge, FoodLabs, Frank Wes...   \n",
       "Lifetime Health                                       SharesPro, The Garage Syndicate   \n",
       "Legion Health                       Y Combinator, Soma Capital, UpHonest Capital, ...   \n",
       "ONVY HealthTech                     New Forge, Isartal Ventures, Wort & Bild Verla...   \n",
       "Ailin                               Decelera, Centre for the Development of Indust...   \n",
       "Malaica                                                 Markus Gemuend, Kapor Capital   \n",
       "Small Joys                                                                          —   \n",
       "SupportRoom                                               8X Ventures, Deepak Bhavsar   \n",
       "Total Life                                                         Primetime Partners   \n",
       "Frankie Health                                                                 E15 VC   \n",
       "Docty Inc.                                                                          —   \n",
       "HECCO Technologies Inc (Prescribe)  Y Combinator, Acequia Capital (AceCap), Vignes...   \n",
       "ApoWiser                                                     MATTER, Longliv Ventures   \n",
       "Holly Health                        Innovate UK, Plug and Play, Kima Ventures, Mod...   \n",
       "Aide Health                         Fuel Ventures, Salica, APX, 1818 Venture Capit...   \n",
       "\n",
       "                                   IPO Status         Country  \\\n",
       "Organization Name                                               \n",
       "Cerebral                              Private   United States   \n",
       "Harbor Health                         Private   United States   \n",
       "Avi Medical                           Private         Germany   \n",
       "BetterVet                             Private   United States   \n",
       "Antidote Health                       Private   United States   \n",
       "Pace                                  Private   United States   \n",
       "DeepCardio                            Private     South Korea   \n",
       "Brisk Health                          Private   United States   \n",
       "Courier Health                        Private   United States   \n",
       "Cartwheel                             Private   United States   \n",
       "Clearing                              Private   United States   \n",
       "Cardo Health                          Private          Sweden   \n",
       "Anima                                 Private   United States   \n",
       "Oliva Health                          Private           Spain   \n",
       "Inflow                                Private  United Kingdom   \n",
       "Likeminded                            Private         Germany   \n",
       "Heading Health                        Private   United States   \n",
       "Violet                                Private   United States   \n",
       "Anebulo Pharmaceuticals                Public   United States   \n",
       "Alyve Health                          Private           India   \n",
       "Radicle Science                       Private   United States   \n",
       "Behavidence                           Private   United States   \n",
       "MYNDUP                                Private  United Kingdom   \n",
       "Persimmon                             Private   United States   \n",
       "Elfie                                 Private       Singapore   \n",
       "Comedi Health Technology Limited      Private       Hong Kong   \n",
       "tapouts                               Private   United States   \n",
       "TOM Medications                       Private     Switzerland   \n",
       "Realize Me                            Private   United States   \n",
       "Axenya                                Private         Uruguay   \n",
       "Phenomune                             Private   United States   \n",
       "Shen.AI @ MX Labs                     Private         Estonia   \n",
       "Fleming                               Private       Lithuania   \n",
       "Oska Health                           Private         Germany   \n",
       "PERSOWN                               Private   United States   \n",
       "Una Health                            Private         Germany   \n",
       "Lifetime Health                       Private           India   \n",
       "Legion Health                         Private   United States   \n",
       "ONVY HealthTech                       Private         Germany   \n",
       "Ailin                                 Private           Spain   \n",
       "Malaica                               Private           Kenya   \n",
       "Small Joys                            Private   United States   \n",
       "SupportRoom                           Private  United Kingdom   \n",
       "Total Life                            Private   United States   \n",
       "Frankie Health                        Private         Ireland   \n",
       "Docty Inc.                            Private   United States   \n",
       "HECCO Technologies Inc (Prescribe)    Private           India   \n",
       "ApoWiser                              Private          Israel   \n",
       "Holly Health                          Private  United Kingdom   \n",
       "Aide Health                               NaN  United Kingdom   \n",
       "\n",
       "                                   Total_Funding_Amount_Currency  \\\n",
       "Organization Name                                                  \n",
       "Cerebral                                                       $   \n",
       "Harbor Health                                                  $   \n",
       "Avi Medical                                                    €   \n",
       "BetterVet                                                      $   \n",
       "Antidote Health                                                $   \n",
       "Pace                                                           $   \n",
       "DeepCardio                                                     ₩   \n",
       "Brisk Health                                                   $   \n",
       "Courier Health                                                 $   \n",
       "Cartwheel                                                      $   \n",
       "Clearing                                                       $   \n",
       "Cardo Health                                                   $   \n",
       "Anima                                                          $   \n",
       "Oliva Health                                                   £   \n",
       "Inflow                                                         $   \n",
       "Likeminded                                                     €   \n",
       "Heading Health                                                 $   \n",
       "Violet                                                         $   \n",
       "Anebulo Pharmaceuticals                                        $   \n",
       "Alyve Health                                                   $   \n",
       "Radicle Science                                                $   \n",
       "Behavidence                                                    $   \n",
       "MYNDUP                                                         £   \n",
       "Persimmon                                                      $   \n",
       "Elfie                                                          $   \n",
       "Comedi Health Technology Limited                               $   \n",
       "tapouts                                                        $   \n",
       "TOM Medications                                                $   \n",
       "Realize Me                                                     $   \n",
       "Axenya                                                         $   \n",
       "Phenomune                                                      $   \n",
       "Shen.AI @ MX Labs                                              $   \n",
       "Fleming                                                        €   \n",
       "Oska Health                                                    €   \n",
       "PERSOWN                                                        $   \n",
       "Una Health                                                     $   \n",
       "Lifetime Health                                                $   \n",
       "Legion Health                                                  $   \n",
       "ONVY HealthTech                                                €   \n",
       "Ailin                                                          €   \n",
       "Malaica                                                        $   \n",
       "Small Joys                                                     $   \n",
       "SupportRoom                                                    $   \n",
       "Total Life                                                     $   \n",
       "Frankie Health                                                 $   \n",
       "Docty Inc.                                                     $   \n",
       "HECCO Technologies Inc (Prescribe)                             $   \n",
       "ApoWiser                                                       $   \n",
       "Holly Health                                                   £   \n",
       "Aide Health                                                    $   \n",
       "\n",
       "                                   Total Funding Amount (USD)  \n",
       "Organization Name                                              \n",
       "Cerebral                                          462000000.0  \n",
       "Harbor Health                                     125500000.0  \n",
       "Avi Medical                                        97350000.0  \n",
       "BetterVet                                          57928818.0  \n",
       "Antidote Health                                    56000000.0  \n",
       "Pace                                               50900000.0  \n",
       "DeepCardio                                         29200000.0  \n",
       "Brisk Health                                       27080000.0  \n",
       "Courier Health                                     20450002.0  \n",
       "Cartwheel                                          20000000.0  \n",
       "Clearing                                           20000000.0  \n",
       "Cardo Health                                       17500000.0  \n",
       "Anima                                              14625000.0  \n",
       "Oliva Health                                       13721600.0  \n",
       "Inflow                                             13980000.0  \n",
       "Likeminded                                         11990000.0  \n",
       "Heading Health                                      9978120.0  \n",
       "Violet                                              6800000.0  \n",
       "Anebulo Pharmaceuticals                             7500000.0  \n",
       "Alyve Health                                        6288066.0  \n",
       "Radicle Science                                     5999716.0  \n",
       "Behavidence                                         5625000.0  \n",
       "MYNDUP                                              6016000.0  \n",
       "Persimmon                                           5323629.0  \n",
       "Elfie                                               5000000.0  \n",
       "Comedi Health Technology Limited                    5000000.0  \n",
       "tapouts                                             4800000.0  \n",
       "TOM Medications                                     4762184.0  \n",
       "Realize Me                                          4025000.0  \n",
       "Axenya                                              4000000.0  \n",
       "Phenomune                                           3300000.0  \n",
       "Shen.AI @ MX Labs                                   3107521.0  \n",
       "Fleming                                             2761033.0  \n",
       "Oska Health                                         2750000.0  \n",
       "PERSOWN                                             2618250.0  \n",
       "Una Health                                          2500000.0  \n",
       "Lifetime Health                                     2392919.0  \n",
       "Legion Health                                       2125000.0  \n",
       "ONVY HealthTech                                     2915000.0  \n",
       "Ailin                                               1650000.0  \n",
       "Malaica                                             1600000.0  \n",
       "Small Joys                                          1540000.0  \n",
       "SupportRoom                                         1529565.0  \n",
       "Total Life                                          1500000.0  \n",
       "Frankie Health                                      1500000.0  \n",
       "Docty Inc.                                          1500000.0  \n",
       "HECCO Technologies Inc (Prescribe)                  1500000.0  \n",
       "ApoWiser                                            1500000.0  \n",
       "Holly Health                                        2636800.0  \n",
       "Aide Health                                         1320000.0  \n",
       "\n",
       "[50 rows x 29 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#identify exchange rate for identified currency code\n",
    "exchange_rates = {\n",
    "    'USD': 1.0,\n",
    "    '$': 1.0,\n",
    "    'CHF': 1.17,  # Swiss Franc to USD\n",
    "    '₣': 1.17,\n",
    "    'GBP': 1.28,  # British Pound to USD\n",
    "    '£': 1.28,\n",
    "    'KRW': 0.00073,  # South Korean Won to USD\n",
    "    '₩': 0.00073,\n",
    "    'EUR': 1.10,  # Euro to USD\n",
    "    '€': 1.10,\n",
    "    'INR': 0.012,  # Indian Rupee to USD\n",
    "    '₹': 0.012,\n",
    "    '—': 1.0  # Assume missing or unknown values are already in USD\n",
    "}\n",
    "\n",
    "#define function to convert other currency to USD \n",
    "#logic: \n",
    "#Step 1\n",
    "#add one additional column to the orignial dataset, stating the original currency.\n",
    "#for example, TOM Medications should have a column named currency, the value will be 'CHF'\n",
    "\n",
    "df_1['Total_Funding_Amount_Currency']= df_1 ['Total Funding Amount'].apply(extract_currency_symbol)\n",
    "\n",
    "#Step 2\n",
    "#Create a function to apply, logic is the following: \n",
    "#If the currency is listed in the exchange rate table, then use the exchange rate mapping and apply the original amount * the exchange rate, \n",
    "#if the currency is not found in the exchange rate table, then return the original amount \n",
    "\n",
    "# Define the conversion function\n",
    "def convert_to_usd(amount, currency, exchange_rates):\n",
    "    try:\n",
    "        # Remove non-numeric characters (except for decimal point) and convert to float\n",
    "        value = float(re.sub(r'[^\\d.]', '', str(amount)))\n",
    "    except ValueError:\n",
    "        return amount  # If conversion fails, return the original amount\n",
    "    if currency in exchange_rates:\n",
    "        return value * exchange_rates[currency] \n",
    "    else:\n",
    "        return amount  # Return the original amount if currency is not in exchange rates\n",
    "\n",
    "# Apply the conversion function\n",
    "df_1['Total Funding Amount (USD)'] = df_1.apply(\n",
    "    lambda row: convert_to_usd(row['Total Funding Amount'], row['Total_Funding_Amount_Currency'], exchange_rates),\n",
    "    axis=1\n",
    ")\n",
    "\n",
    "\n",
    "df_1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "d38f2497-452f-4540-ba87-bd97206e0074",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'$', '—', '₩', '€'}"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Apply the same currency conversion to dataset 2\n",
    "\n",
    "currency_symbols_2 = set()\n",
    "\n",
    "for columns in currency_columns:\n",
    "    currency_symbols_2.update(df_2[columns].dropna().apply(extract_currency_symbol))\n",
    "\n",
    "currency_symbols_2\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "e5a0cd51-507e-4640-a58d-68580b3213cb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industries</th>\n",
       "      <th>Headquarters Location</th>\n",
       "      <th>Description</th>\n",
       "      <th>CB Rank (Company)</th>\n",
       "      <th>Estimated Revenue Range</th>\n",
       "      <th>Website</th>\n",
       "      <th>Company Type</th>\n",
       "      <th>Founded Date</th>\n",
       "      <th>Operating Status</th>\n",
       "      <th>Full Description</th>\n",
       "      <th>...</th>\n",
       "      <th>Total Funding Amount</th>\n",
       "      <th>Last Funding Type</th>\n",
       "      <th>Last Equity Funding Amount</th>\n",
       "      <th>Last Equity Funding Type</th>\n",
       "      <th>Total Equity Funding Amount</th>\n",
       "      <th>Top 5 Investors</th>\n",
       "      <th>IPO Status</th>\n",
       "      <th>Country</th>\n",
       "      <th>Total_Funding_Amount_Currency</th>\n",
       "      <th>Total Funding Amount (USD)</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Organization Name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Kenvue</th>\n",
       "      <td>Lifestyle, Personal Health, Wellness</td>\n",
       "      <td>Skillman, New Jersey, United States</td>\n",
       "      <td>Kenvue is a consumer health company that deliv...</td>\n",
       "      <td>3,970</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>kenvue.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2023</td>\n",
       "      <td>Active</td>\n",
       "      <td>Kenvue is a consumer health company that deliv...</td>\n",
       "      <td>...</td>\n",
       "      <td>$3,646,591,000</td>\n",
       "      <td>Post-IPO Secondary</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Goldman Sachs, J.P. Morgan Securities Inc.</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>3646591000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cencora</th>\n",
       "      <td>Emergency Medicine, Enterprise Software, Healt...</td>\n",
       "      <td>Conshohocken, Pennsylvania, United States</td>\n",
       "      <td>Cencora is a global healthcare company that ad...</td>\n",
       "      <td>1,466</td>\n",
       "      <td>$10B+</td>\n",
       "      <td>cencora.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2023</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cencora, building on the legacy of Amerisource...</td>\n",
       "      <td>...</td>\n",
       "      <td>$3,025,000,000</td>\n",
       "      <td>Post-IPO Debt</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>3025000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Altos Labs</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care, Health ...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Altos Labs focuses on cellular rejuvenation pr...</td>\n",
       "      <td>2,590</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>altoslabs.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>Active</td>\n",
       "      <td>Altos Labs is a biotechnology company focused ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$3,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$3,000,000,000</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>ARCH Venture Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>3000000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Resilience</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care, Life Sc...</td>\n",
       "      <td>La Jolla, California, United States</td>\n",
       "      <td>Resilience provides end-to-end biopharmaceutic...</td>\n",
       "      <td>2,627</td>\n",
       "      <td>$500M to $1B</td>\n",
       "      <td>resilience.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Resilience provides end-to-end biopharmaceutic...</td>\n",
       "      <td>...</td>\n",
       "      <td>$2,515,000,000</td>\n",
       "      <td>Debt Financing</td>\n",
       "      <td>—</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>$2,105,000,000</td>\n",
       "      <td>Google Ventures, 8VC, Mubadala, New Enterprise...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>2515000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>GoTo Group</th>\n",
       "      <td>Delivery Service, Health Care, Information Tec...</td>\n",
       "      <td>Jakarta, Jakarta Raya, Indonesia</td>\n",
       "      <td>GoTo Group offers a digital ecosystem for on-d...</td>\n",
       "      <td>4,999</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>gotocompany.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>GoTo Group is an application used for ride-hai...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,450,000,000</td>\n",
       "      <td>Debt Financing</td>\n",
       "      <td>$1,300,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$1,300,000,000</td>\n",
       "      <td>Google, Tencent, International Finance Corpora...</td>\n",
       "      <td>Public</td>\n",
       "      <td>Indonesia</td>\n",
       "      <td>$</td>\n",
       "      <td>1450000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Xaira Therapeutics</th>\n",
       "      <td>Artificial Intelligence (AI), Biotechnology, H...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Xaira Therapeutics is an integrated biotechnol...</td>\n",
       "      <td>450</td>\n",
       "      <td>—</td>\n",
       "      <td>xaira.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2024</td>\n",
       "      <td>Active</td>\n",
       "      <td>Xaira Therapeutics is an integrated biotechnol...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,000,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$1,000,000,000</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Menlo Ventures, Sequoia Capital, Lightspeed Ve...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>1000000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Organon</th>\n",
       "      <td>Health Care, Medical Device, Pharmaceutical, W...</td>\n",
       "      <td>Jersey City, New Jersey, United States</td>\n",
       "      <td>Organon offers medicines and other products to...</td>\n",
       "      <td>9,345</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>organon.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Organon offers medicines and other products to...</td>\n",
       "      <td>...</td>\n",
       "      <td>$1,000,000,000</td>\n",
       "      <td>Post-IPO Debt</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>1000000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nutrabolt</th>\n",
       "      <td>Dietary Supplements, Fitness, Health Care, Mar...</td>\n",
       "      <td>Austin, Texas, United States</td>\n",
       "      <td>Nutrabolt is a dietary health supplement distr...</td>\n",
       "      <td>60,629</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>nutrabolt.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Nutrabolt produces and sells supplements for t...</td>\n",
       "      <td>...</td>\n",
       "      <td>$863,000,000</td>\n",
       "      <td>Secondary Market</td>\n",
       "      <td>—</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>—</td>\n",
       "      <td>Keurig Dr Pepper, MidOcean Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>863000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NeoCannBio</th>\n",
       "      <td>Biopharma, Cannabis, Health Care</td>\n",
       "      <td>Seoul, Seoul-t'ukpyolsi, South Korea</td>\n",
       "      <td>NeoCannBio offers natural product processing f...</td>\n",
       "      <td>59,673</td>\n",
       "      <td>—</td>\n",
       "      <td>neocannbio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>NeoCannBio provides natural product processing...</td>\n",
       "      <td>...</td>\n",
       "      <td>$678,925,399</td>\n",
       "      <td>Series B</td>\n",
       "      <td>₩10,000,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$678,925,399</td>\n",
       "      <td>QUAD Investment Management, HLB Group, Donghoo...</td>\n",
       "      <td>Private</td>\n",
       "      <td>South Korea</td>\n",
       "      <td>$</td>\n",
       "      <td>678925399</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Apogee Therapeutics</th>\n",
       "      <td>Biotechnology, Life Science, Medical, Therapeu...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Apogee Therapeutics is a biotechnology company...</td>\n",
       "      <td>37,763</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>apogeetherapeutics.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Apogee Therapeutics is a biotechnology company...</td>\n",
       "      <td>...</td>\n",
       "      <td>$652,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$483,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$652,000,000</td>\n",
       "      <td>Fidelity, OrbiMed, Wellington Management, RA C...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>652000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Centessa Pharmaceuticals</th>\n",
       "      <td>Biotechnology, Pharmaceutical</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Centessa Pharmaceuticals is a next-generation ...</td>\n",
       "      <td>9,162</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>centessa.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Centessa Pharmaceuticals is a next-generation ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$650,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$100,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>T. Rowe Price, IP Group, Franklin Templeton, W...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>650000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Surround Care</th>\n",
       "      <td>Health Care, Hospital, Medical</td>\n",
       "      <td>St Louis, Missouri, United States</td>\n",
       "      <td>Surround Care focuses on fixing healthcare aff...</td>\n",
       "      <td>28,699</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>surround-care.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Surround Care focuses on fixing healthcare aff...</td>\n",
       "      <td>...</td>\n",
       "      <td>$573,480,000</td>\n",
       "      <td>Undisclosed</td>\n",
       "      <td>$573,480,000</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>573480000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Avenzo Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Medical, Oncology,...</td>\n",
       "      <td>San Diego, California, United States</td>\n",
       "      <td>Avenzo Therapeutics specializes in the develop...</td>\n",
       "      <td>7,746</td>\n",
       "      <td>—</td>\n",
       "      <td>avenzotx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Avenzo Therapeutics specializes in the develop...</td>\n",
       "      <td>...</td>\n",
       "      <td>$569,350,002</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$150,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$569,350,002</td>\n",
       "      <td>New Enterprise Associates, SR One, Lilly Asia ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>569350002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ACELYRIN</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care</td>\n",
       "      <td>Los Angeles, California, United States</td>\n",
       "      <td>ACELYRIN is a biopharma company that identifie...</td>\n",
       "      <td>5,972</td>\n",
       "      <td>—</td>\n",
       "      <td>acelyrin.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>ACELYRIN is a biopharma company focused on pro...</td>\n",
       "      <td>...</td>\n",
       "      <td>$558,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$558,000,000</td>\n",
       "      <td>OrbiMed, Decheng Capital, RTW Investments, Sur...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>558000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Taysha Gene Therapies</th>\n",
       "      <td>Biotechnology, Genetics, Life Science</td>\n",
       "      <td>Dallas, Texas, United States</td>\n",
       "      <td>Taysha Gene Therapies develops treatments to e...</td>\n",
       "      <td>2,137</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>tayshagtx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Taysha Gene Therapies is on a mission to eradi...</td>\n",
       "      <td>...</td>\n",
       "      <td>$543,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$75,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$403,000,000</td>\n",
       "      <td>Fidelity, BlackRock, Trinity Capital, Google V...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>543000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Alumis</th>\n",
       "      <td>Biotechnology, Health Care, Life Science, Prec...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Alumis is a precision medicine company focused...</td>\n",
       "      <td>319</td>\n",
       "      <td>—</td>\n",
       "      <td>alumis.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Alumis develops precision medications to treat...</td>\n",
       "      <td>...</td>\n",
       "      <td>$529,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$259,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$529,000,000</td>\n",
       "      <td>Foresite Capital, Cormorant Asset Management, ...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>529000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Biohaven</th>\n",
       "      <td>Biopharma, Biotechnology, Health Care</td>\n",
       "      <td>New Haven, Connecticut, United States</td>\n",
       "      <td>Biohaven is a clinical-stage biopharmaceutical...</td>\n",
       "      <td>8,102</td>\n",
       "      <td>—</td>\n",
       "      <td>biohaven.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Biohaven is a clinical-stage biopharmaceutical...</td>\n",
       "      <td>...</td>\n",
       "      <td>$523,200,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$264,500,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$523,200,000</td>\n",
       "      <td>—</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>523200000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Odyssey Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Oncology, Therapeu...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Odyssey Therapeutics creates precision immunom...</td>\n",
       "      <td>44,888</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>odysseytx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Odyssey Therapeutics is pioneering the efficie...</td>\n",
       "      <td>...</td>\n",
       "      <td>$487,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$101,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$487,000,000</td>\n",
       "      <td>Fidelity, T. Rowe Price, General Catalyst, Orb...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>487000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Mirador Therapeutics</th>\n",
       "      <td>Health Care, Medical, Therapeutics</td>\n",
       "      <td>San Diego, California, United States</td>\n",
       "      <td>Mirador Therapeutics envisions precision medic...</td>\n",
       "      <td>6,447</td>\n",
       "      <td>—</td>\n",
       "      <td>miradortx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2024</td>\n",
       "      <td>Active</td>\n",
       "      <td>Mirador Therapeutics envisions precision medic...</td>\n",
       "      <td>...</td>\n",
       "      <td>$480,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$400,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$480,000,000</td>\n",
       "      <td>Fidelity, Sanofi, Blue Owl, OrbiMed, Point72 V...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>480000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Treeline Biosciences</th>\n",
       "      <td>Biotechnology, Health Care, Life Science, Medi...</td>\n",
       "      <td>Stamford, Connecticut, United States</td>\n",
       "      <td>Treeline Biosciences is a biotech company buil...</td>\n",
       "      <td>53,808</td>\n",
       "      <td>—</td>\n",
       "      <td>treeline.bio</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Treeline Biosciences is a biotech company buil...</td>\n",
       "      <td>...</td>\n",
       "      <td>$473,266,523</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$261,266,523</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$473,266,523</td>\n",
       "      <td>Kohlberg Kravis Roberts, OrbiMed, Google Ventu...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>473266523</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Invivyd</th>\n",
       "      <td>Biotechnology, Pharmaceutical, Therapeutics</td>\n",
       "      <td>Waltham, Massachusetts, United States</td>\n",
       "      <td>Invivyd develops antibodies to transcend the l...</td>\n",
       "      <td>7,599</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>invivyd.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Invivyd is on a mission to rapidly and perpetu...</td>\n",
       "      <td>...</td>\n",
       "      <td>$466,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$336,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$466,000,000</td>\n",
       "      <td>Fidelity, OrbiMed, Google Ventures, RA Capital...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>466000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cerebral</th>\n",
       "      <td>Health Care, Medical, Mental Health, mHealth, ...</td>\n",
       "      <td>San Francisco, California, United States</td>\n",
       "      <td>Cerebral is a mental health telemedicine compa...</td>\n",
       "      <td>24,999</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>cerebral.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Cerebral makes high-quality mental health care...</td>\n",
       "      <td>...</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$462,000,000</td>\n",
       "      <td>Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>462000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Areteia Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Life Science, Ther...</td>\n",
       "      <td>Bernardsville, New Jersey, United States</td>\n",
       "      <td>Areteia Therapeutics is a biotechnology compan...</td>\n",
       "      <td>10,909</td>\n",
       "      <td>—</td>\n",
       "      <td>areteiatx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Areteia Therapeutics is committed to putting a...</td>\n",
       "      <td>...</td>\n",
       "      <td>$425,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$75,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$425,000,000</td>\n",
       "      <td>Sanofi, Google Ventures, Marshall Wace, Viking...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>425000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Transcarent</th>\n",
       "      <td>Health Care, Personal Health, Software</td>\n",
       "      <td>Denver, Colorado, United States</td>\n",
       "      <td>Transcarent is a provider of a healthcare plat...</td>\n",
       "      <td>1,715</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>transcarent.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Transcarent is a consumer-directed health and ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$424,000,000</td>\n",
       "      <td>Series D</td>\n",
       "      <td>$126,000,000</td>\n",
       "      <td>Series D</td>\n",
       "      <td>$424,000,000</td>\n",
       "      <td>General Catalyst, Kleiner Perkins, GreatPoint ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>424000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Scorpion Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Life Science, Onco...</td>\n",
       "      <td>Boston, Massachusetts, United States</td>\n",
       "      <td>Scorpion Therapeutics is a clinical-stage onco...</td>\n",
       "      <td>317</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>scorpiontx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Scorpion Therapeutics develops targeted small-...</td>\n",
       "      <td>...</td>\n",
       "      <td>$420,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$150,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$420,000,000</td>\n",
       "      <td>Fidelity, OrbiMed, Lightspeed Venture Partners...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>420000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Upstream Bio</th>\n",
       "      <td>Biotechnology, Health Care, Pharmaceutical, Th...</td>\n",
       "      <td>Waltham, Massachusetts, United States</td>\n",
       "      <td>Upstream Bio focuses on developing an antibody...</td>\n",
       "      <td>8,112</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>upstreambio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Upstream Bio focuses on developing an antibody...</td>\n",
       "      <td>...</td>\n",
       "      <td>$408,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$408,000,000</td>\n",
       "      <td>OrbiMed, Wellington Management, Omega Funds, E...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>408000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CorroHealth</th>\n",
       "      <td>Document Management, Financial Services, Healt...</td>\n",
       "      <td>Plano, Texas, United States</td>\n",
       "      <td>CorroHealth helps individuals in the reimburse...</td>\n",
       "      <td>6,000</td>\n",
       "      <td>$100M to $500M</td>\n",
       "      <td>corrohealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>CorroHealth helps individuals in the reimburse...</td>\n",
       "      <td>...</td>\n",
       "      <td>$376,268,825</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>$50,000,000</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>$376,268,825</td>\n",
       "      <td>—</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>376268825</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sonoma BioTherapeutics</th>\n",
       "      <td>Biotechnology, Life Science, Therapeutics</td>\n",
       "      <td>South San Francisco, California, United States</td>\n",
       "      <td>Sonoma BioTherapeutics develops adoptive Treg ...</td>\n",
       "      <td>8,596</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>sonomabio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Sonoma Biotherapeutics is developing adoptive ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$365,000,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$30,000,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$365,000,000</td>\n",
       "      <td>Fidelity, Mirae Asset, Regeneron, Google Ventu...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>365000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tourmaline Bio</th>\n",
       "      <td>Biotechnology, Clinical Trials, Therapeutics</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Tourmaline Bio is a clinical biotechnology com...</td>\n",
       "      <td>3,834</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>tourmalinebio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Tourmaline Bio is a clinical biotechnology com...</td>\n",
       "      <td>...</td>\n",
       "      <td>$359,500,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$172,500,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$359,500,000</td>\n",
       "      <td>RA Capital Management, Great Point Partners, L...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>359500000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Center for Breakthrough Medicines</th>\n",
       "      <td>Biotechnology, Genetics, Manufacturing, Medical</td>\n",
       "      <td>King Of Prussia, Pennsylvania, United States</td>\n",
       "      <td>Center for Breakthrough Medicines is an innova...</td>\n",
       "      <td>23,276</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>breakthroughmedicines.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Center for Breakthrough Medicines is an innova...</td>\n",
       "      <td>...</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>Corporate Round</td>\n",
       "      <td>$350,000,000</td>\n",
       "      <td>SK Holdings</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>350000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Main Street Health</th>\n",
       "      <td>Health Care, Health Diagnostics, Medical</td>\n",
       "      <td>Nashville, Tennessee, United States</td>\n",
       "      <td>Main Street Health is a supplier of value-base...</td>\n",
       "      <td>6,051</td>\n",
       "      <td>—</td>\n",
       "      <td>mainstreetruralhealth.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Main Street Health is a provider of value-base...</td>\n",
       "      <td>...</td>\n",
       "      <td>$342,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$342,000,000</td>\n",
       "      <td>Humana, Oak HC/FT, CVS Health, Optum Ventures,...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>342000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Capstan Therapeutics</th>\n",
       "      <td>Biotechnology, Health Care, Therapeutics</td>\n",
       "      <td>San Diego, California, United States</td>\n",
       "      <td>Capstan Therapeutics is advancing cell enginee...</td>\n",
       "      <td>43,621</td>\n",
       "      <td>—</td>\n",
       "      <td>capstantx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Capstan Therapeutics is advancing precision in...</td>\n",
       "      <td>...</td>\n",
       "      <td>$340,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$175,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$340,000,000</td>\n",
       "      <td>Bristol-Myers Squibb, OrbiMed, RA Capital Mana...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>340000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>METiS Pharmaceuticals</th>\n",
       "      <td>Artificial Intelligence (AI), Biopharma, Biote...</td>\n",
       "      <td>Hangzhou, Zhejiang, China</td>\n",
       "      <td>METiS Pharmaceuticals is the world's first AI-...</td>\n",
       "      <td>8,268</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>metispharmaceuticals.cn</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Jitai Medicine (METiS) is a biotechnology comp...</td>\n",
       "      <td>...</td>\n",
       "      <td>$336,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$100,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$336,000,000</td>\n",
       "      <td>XtalPi, Sequoia Capital China, Source Code Cap...</td>\n",
       "      <td>Private</td>\n",
       "      <td>China</td>\n",
       "      <td>$</td>\n",
       "      <td>336000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Forge Biologics</th>\n",
       "      <td>Biotechnology, Health Care, Medical, Therapeutics</td>\n",
       "      <td>Grove City, Ohio, United States</td>\n",
       "      <td>Forge Biologics is a gene therapy development ...</td>\n",
       "      <td>68,370</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>forgebiologics.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Forge Biologics is a gene therapy development ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$330,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$90,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$250,000,000</td>\n",
       "      <td>Drive Capital, MidCap Financial, RA Capital Ma...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>330000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Zenas BioPharma</th>\n",
       "      <td>Biopharma, Health Care, Pharmaceutical</td>\n",
       "      <td>Waltham, Massachusetts, United States</td>\n",
       "      <td>Zenas BioPharma is a biopharmaceutical company...</td>\n",
       "      <td>3,020</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>zenasbio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Zenas BioPharma is a biopharmaceutical company...</td>\n",
       "      <td>...</td>\n",
       "      <td>$318,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$318,000,000</td>\n",
       "      <td>Wellington Management, Xencor, New Enterprise ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>318000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2seventy bio</th>\n",
       "      <td>Biotechnology, Genetics, Health Care, Oncology...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>2seventy bio is an immuno-oncology cell therap...</td>\n",
       "      <td>3,928</td>\n",
       "      <td>$50M to $100M</td>\n",
       "      <td>2seventybio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>2seventy bio is an immuno-oncology cell therap...</td>\n",
       "      <td>...</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$125,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Regeneron, Casdin Capital, Janus Henderson Inv...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>315000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gen4 Dental Partners</th>\n",
       "      <td>Dental, Health Care</td>\n",
       "      <td>Tempe, Arizona, United States</td>\n",
       "      <td>Gen4 Dental Partners is a doctor-centric, part...</td>\n",
       "      <td>22,565</td>\n",
       "      <td>$50M to $100M</td>\n",
       "      <td>gen4dental.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>Gen4 Dental Partners provides world-class supp...</td>\n",
       "      <td>...</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Debt Financing</td>\n",
       "      <td>—</td>\n",
       "      <td>Private Equity</td>\n",
       "      <td>—</td>\n",
       "      <td>Saratoga Partners, Varagon Capital Partners</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>315000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Hasten</th>\n",
       "      <td>Health Care, Hospital, Manufacturing, Pharmace...</td>\n",
       "      <td>Hefei, Anhui, China</td>\n",
       "      <td>Hasten is a pharmaceutical manufacturing compa...</td>\n",
       "      <td>36,870</td>\n",
       "      <td>—</td>\n",
       "      <td>hastenpharma.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Hasten is a pharmaceutical manufacturing compa...</td>\n",
       "      <td>...</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$315,000,000</td>\n",
       "      <td>Mubadala, C-Bridge Capital</td>\n",
       "      <td>Private</td>\n",
       "      <td>China</td>\n",
       "      <td>$</td>\n",
       "      <td>315000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Bicara Therapeutics</th>\n",
       "      <td>Biopharma, Biotechnology, Life Science, Oncolo...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Bicara Therapeutics develops dual-action cance...</td>\n",
       "      <td>58,367</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>bicara.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Bicara Therapeutics is a clinical-stage biotec...</td>\n",
       "      <td>...</td>\n",
       "      <td>$313,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$165,000,000</td>\n",
       "      <td>Series C</td>\n",
       "      <td>$313,000,000</td>\n",
       "      <td>TPG, F-Prime Capital, RA Capital Management, B...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>313000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>CARGO Therapeutics</th>\n",
       "      <td>Biotechnology, Medical, Therapeutics</td>\n",
       "      <td>San Mateo, California, United States</td>\n",
       "      <td>CARGO Therapeutics develops an adoptive cell t...</td>\n",
       "      <td>36,449</td>\n",
       "      <td>$1B to $10B</td>\n",
       "      <td>cargo-tx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>CARGO Therapeutics develops CAR T-cell therapy...</td>\n",
       "      <td>...</td>\n",
       "      <td>$310,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$110,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$310,000,000</td>\n",
       "      <td>T. Rowe Price, Wellington Management, Cormoran...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>310000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ArriVent Biopharma</th>\n",
       "      <td>Biotechnology, Life Science, Pharmaceutical</td>\n",
       "      <td>Pennsylvania Furnace, Pennsylvania, United States</td>\n",
       "      <td>ArriVent develops pharmaceutical products to c...</td>\n",
       "      <td>6,744</td>\n",
       "      <td>$10M to $50M</td>\n",
       "      <td>arrivent.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>ArriVent is a biopharmaceutical company develo...</td>\n",
       "      <td>...</td>\n",
       "      <td>$305,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$155,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$305,000,000</td>\n",
       "      <td>General Catalyst, OrbiMed, Sequoia Capital Chi...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>305000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Normax Biomed</th>\n",
       "      <td>Biotechnology, Manufacturing, Pharmaceutical</td>\n",
       "      <td>Cork, Cork, Ireland</td>\n",
       "      <td>Normax Biomed is an mRNA Vaccine research and ...</td>\n",
       "      <td>60,951</td>\n",
       "      <td>—</td>\n",
       "      <td>normaxbiomed.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Normax Biomed is an mRNA Vaccine research and ...</td>\n",
       "      <td>...</td>\n",
       "      <td>€ 300,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>€ 300,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>€ 300,000,000</td>\n",
       "      <td>The Global Emerging Markets Group</td>\n",
       "      <td>Private</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>€</td>\n",
       "      <td>330000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Uniquity Bio</th>\n",
       "      <td>Biotechnology, Medical</td>\n",
       "      <td>Malvern, Pennsylvania, United States</td>\n",
       "      <td>Uniquity Bio operates as a drug development co...</td>\n",
       "      <td>7,949</td>\n",
       "      <td>—</td>\n",
       "      <td>uniquity.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Uniquity Bio operates a drug development company.</td>\n",
       "      <td>...</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Blackstone Life Sciences</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>300000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>KELIX bio</th>\n",
       "      <td>Manufacturing, Pharmaceutical</td>\n",
       "      <td>Dubai, Dubai, United Arab Emirates</td>\n",
       "      <td>KELIX bio is a specialty generic business focu...</td>\n",
       "      <td>28,207</td>\n",
       "      <td>—</td>\n",
       "      <td>kelixbio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>KELIX bio is a specialty generic business focu...</td>\n",
       "      <td>...</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$200,000,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>British International Investment, Development ...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Arab Emirates</td>\n",
       "      <td>$</td>\n",
       "      <td>300000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ReNAgade Therapeutics</th>\n",
       "      <td>Biotechnology, Medical, Therapeutics</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>ReNAgade Therapeutics focuses on the boundless...</td>\n",
       "      <td>64,077</td>\n",
       "      <td>—</td>\n",
       "      <td>renagadetx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>ReNAgade Therapeutics focuses on the boundless...</td>\n",
       "      <td>...</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$300,000,000</td>\n",
       "      <td>MPM Capital, F2 Ventures</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>300000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Beacon Therapeutics</th>\n",
       "      <td>Health Care, Therapeutics</td>\n",
       "      <td>London, England, United Kingdom</td>\n",
       "      <td>Beacon Therapeutics is an ophthalmic gene ther...</td>\n",
       "      <td>1,196</td>\n",
       "      <td>—</td>\n",
       "      <td>beacontx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2023</td>\n",
       "      <td>Active</td>\n",
       "      <td>Beacon Therapeutics is an ophthalmic gene ther...</td>\n",
       "      <td>...</td>\n",
       "      <td>$290,139,662</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$170,000,000</td>\n",
       "      <td>Series B</td>\n",
       "      <td>$290,139,662</td>\n",
       "      <td>Oxford Science Enterprises, Forbion Capital Pa...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>$</td>\n",
       "      <td>290139662</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Metsera</th>\n",
       "      <td>Biopharma, Health Care, Medical</td>\n",
       "      <td>New York, New York, United States</td>\n",
       "      <td>Metsera operates as a clinical-stage biopharma...</td>\n",
       "      <td>8,384</td>\n",
       "      <td>—</td>\n",
       "      <td>metsera.com</td>\n",
       "      <td>—</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Metsera operates as a clinical-stage biopharma...</td>\n",
       "      <td>...</td>\n",
       "      <td>$290,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$290,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$290,000,000</td>\n",
       "      <td>Google Ventures, F-Prime Capital, Mubadala Cap...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>290000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>AmplifyBio</th>\n",
       "      <td>Biotechnology, Health Care, Life Science</td>\n",
       "      <td>West Jefferson, Ohio, United States</td>\n",
       "      <td>AmplifyBio is a biotechnology company that dev...</td>\n",
       "      <td>3,681</td>\n",
       "      <td>$50M to $100M</td>\n",
       "      <td>amplify-bio.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2021</td>\n",
       "      <td>Active</td>\n",
       "      <td>AmplifyBio is a biotechnology company that dev...</td>\n",
       "      <td>...</td>\n",
       "      <td>$279,750,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$49,750,000</td>\n",
       "      <td>Venture - Series Unknown</td>\n",
       "      <td>$229,750,000</td>\n",
       "      <td>Hercules Capital, Battelle, Narya Capital, Vik...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>279750000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Mineralys Therapeutics</th>\n",
       "      <td>Biopharma, Biotechnology, Medical, Pharmaceutical</td>\n",
       "      <td>Radnor, Pennsylvania, United States</td>\n",
       "      <td>Mineralys Therapeutics is a clinical-stage bio...</td>\n",
       "      <td>11,923</td>\n",
       "      <td>$1M to $10M</td>\n",
       "      <td>mineralystx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2020</td>\n",
       "      <td>Active</td>\n",
       "      <td>Mineralys Therapeutics is a biopharmaceutical ...</td>\n",
       "      <td>...</td>\n",
       "      <td>$278,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$120,000,000</td>\n",
       "      <td>Post-IPO Equity</td>\n",
       "      <td>$278,000,000</td>\n",
       "      <td>Andera Partners, OrbiMed, RA Capital Managemen...</td>\n",
       "      <td>Public</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>278000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Orbital Therapeutics</th>\n",
       "      <td>Alternative Medicine, Biotechnology, Life Scie...</td>\n",
       "      <td>Cambridge, Massachusetts, United States</td>\n",
       "      <td>Orbital Therapeutics is a biotechnology compan...</td>\n",
       "      <td>62,764</td>\n",
       "      <td>—</td>\n",
       "      <td>orbitaltx.com</td>\n",
       "      <td>For Profit</td>\n",
       "      <td>2022</td>\n",
       "      <td>Active</td>\n",
       "      <td>Orbital Therapeutics aims to enhance global he...</td>\n",
       "      <td>...</td>\n",
       "      <td>$270,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$270,000,000</td>\n",
       "      <td>Series A</td>\n",
       "      <td>$270,000,000</td>\n",
       "      <td>Andreessen Horowitz, EXOR N.V., Invus, Alexand...</td>\n",
       "      <td>Private</td>\n",
       "      <td>United States</td>\n",
       "      <td>$</td>\n",
       "      <td>270000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>50 rows × 29 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                          Industries  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                                          Lifestyle, Personal Health, Wellness   \n",
       "Cencora                            Emergency Medicine, Enterprise Software, Healt...   \n",
       "Altos Labs                         Biopharma, Biotechnology, Health Care, Health ...   \n",
       "Resilience                         Biopharma, Biotechnology, Health Care, Life Sc...   \n",
       "GoTo Group                         Delivery Service, Health Care, Information Tec...   \n",
       "Xaira Therapeutics                 Artificial Intelligence (AI), Biotechnology, H...   \n",
       "Organon                            Health Care, Medical Device, Pharmaceutical, W...   \n",
       "Nutrabolt                          Dietary Supplements, Fitness, Health Care, Mar...   \n",
       "NeoCannBio                                          Biopharma, Cannabis, Health Care   \n",
       "Apogee Therapeutics                Biotechnology, Life Science, Medical, Therapeu...   \n",
       "Centessa Pharmaceuticals                               Biotechnology, Pharmaceutical   \n",
       "Surround Care                                         Health Care, Hospital, Medical   \n",
       "Avenzo Therapeutics                Biotechnology, Health Care, Medical, Oncology,...   \n",
       "ACELYRIN                                       Biopharma, Biotechnology, Health Care   \n",
       "Taysha Gene Therapies                          Biotechnology, Genetics, Life Science   \n",
       "Alumis                             Biotechnology, Health Care, Life Science, Prec...   \n",
       "Biohaven                                       Biopharma, Biotechnology, Health Care   \n",
       "Odyssey Therapeutics               Biotechnology, Health Care, Oncology, Therapeu...   \n",
       "Mirador Therapeutics                              Health Care, Medical, Therapeutics   \n",
       "Treeline Biosciences               Biotechnology, Health Care, Life Science, Medi...   \n",
       "Invivyd                                  Biotechnology, Pharmaceutical, Therapeutics   \n",
       "Cerebral                           Health Care, Medical, Mental Health, mHealth, ...   \n",
       "Areteia Therapeutics               Biotechnology, Health Care, Life Science, Ther...   \n",
       "Transcarent                                   Health Care, Personal Health, Software   \n",
       "Scorpion Therapeutics              Biotechnology, Health Care, Life Science, Onco...   \n",
       "Upstream Bio                       Biotechnology, Health Care, Pharmaceutical, Th...   \n",
       "CorroHealth                        Document Management, Financial Services, Healt...   \n",
       "Sonoma BioTherapeutics                     Biotechnology, Life Science, Therapeutics   \n",
       "Tourmaline Bio                          Biotechnology, Clinical Trials, Therapeutics   \n",
       "Center for Breakthrough Medicines    Biotechnology, Genetics, Manufacturing, Medical   \n",
       "Main Street Health                          Health Care, Health Diagnostics, Medical   \n",
       "Capstan Therapeutics                        Biotechnology, Health Care, Therapeutics   \n",
       "METiS Pharmaceuticals              Artificial Intelligence (AI), Biopharma, Biote...   \n",
       "Forge Biologics                    Biotechnology, Health Care, Medical, Therapeutics   \n",
       "Zenas BioPharma                               Biopharma, Health Care, Pharmaceutical   \n",
       "2seventy bio                       Biotechnology, Genetics, Health Care, Oncology...   \n",
       "Gen4 Dental Partners                                             Dental, Health Care   \n",
       "Hasten                             Health Care, Hospital, Manufacturing, Pharmace...   \n",
       "Bicara Therapeutics                Biopharma, Biotechnology, Life Science, Oncolo...   \n",
       "CARGO Therapeutics                              Biotechnology, Medical, Therapeutics   \n",
       "ArriVent Biopharma                       Biotechnology, Life Science, Pharmaceutical   \n",
       "Normax Biomed                           Biotechnology, Manufacturing, Pharmaceutical   \n",
       "Uniquity Bio                                                  Biotechnology, Medical   \n",
       "KELIX bio                                              Manufacturing, Pharmaceutical   \n",
       "ReNAgade Therapeutics                           Biotechnology, Medical, Therapeutics   \n",
       "Beacon Therapeutics                                        Health Care, Therapeutics   \n",
       "Metsera                                              Biopharma, Health Care, Medical   \n",
       "AmplifyBio                                  Biotechnology, Health Care, Life Science   \n",
       "Mineralys Therapeutics             Biopharma, Biotechnology, Medical, Pharmaceutical   \n",
       "Orbital Therapeutics               Alternative Medicine, Biotechnology, Life Scie...   \n",
       "\n",
       "                                                               Headquarters Location  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                                           Skillman, New Jersey, United States   \n",
       "Cencora                                    Conshohocken, Pennsylvania, United States   \n",
       "Altos Labs                                  San Francisco, California, United States   \n",
       "Resilience                                       La Jolla, California, United States   \n",
       "GoTo Group                                          Jakarta, Jakarta Raya, Indonesia   \n",
       "Xaira Therapeutics                          San Francisco, California, United States   \n",
       "Organon                                       Jersey City, New Jersey, United States   \n",
       "Nutrabolt                                               Austin, Texas, United States   \n",
       "NeoCannBio                                      Seoul, Seoul-t'ukpyolsi, South Korea   \n",
       "Apogee Therapeutics                         San Francisco, California, United States   \n",
       "Centessa Pharmaceuticals                     Cambridge, Massachusetts, United States   \n",
       "Surround Care                                      St Louis, Missouri, United States   \n",
       "Avenzo Therapeutics                             San Diego, California, United States   \n",
       "ACELYRIN                                      Los Angeles, California, United States   \n",
       "Taysha Gene Therapies                                   Dallas, Texas, United States   \n",
       "Alumis                                      San Francisco, California, United States   \n",
       "Biohaven                                       New Haven, Connecticut, United States   \n",
       "Odyssey Therapeutics                         Cambridge, Massachusetts, United States   \n",
       "Mirador Therapeutics                            San Diego, California, United States   \n",
       "Treeline Biosciences                            Stamford, Connecticut, United States   \n",
       "Invivyd                                        Waltham, Massachusetts, United States   \n",
       "Cerebral                                    San Francisco, California, United States   \n",
       "Areteia Therapeutics                        Bernardsville, New Jersey, United States   \n",
       "Transcarent                                          Denver, Colorado, United States   \n",
       "Scorpion Therapeutics                           Boston, Massachusetts, United States   \n",
       "Upstream Bio                                   Waltham, Massachusetts, United States   \n",
       "CorroHealth                                              Plano, Texas, United States   \n",
       "Sonoma BioTherapeutics                South San Francisco, California, United States   \n",
       "Tourmaline Bio                                     New York, New York, United States   \n",
       "Center for Breakthrough Medicines       King Of Prussia, Pennsylvania, United States   \n",
       "Main Street Health                               Nashville, Tennessee, United States   \n",
       "Capstan Therapeutics                            San Diego, California, United States   \n",
       "METiS Pharmaceuticals                                      Hangzhou, Zhejiang, China   \n",
       "Forge Biologics                                      Grove City, Ohio, United States   \n",
       "Zenas BioPharma                                Waltham, Massachusetts, United States   \n",
       "2seventy bio                                 Cambridge, Massachusetts, United States   \n",
       "Gen4 Dental Partners                                   Tempe, Arizona, United States   \n",
       "Hasten                                                           Hefei, Anhui, China   \n",
       "Bicara Therapeutics                          Cambridge, Massachusetts, United States   \n",
       "CARGO Therapeutics                              San Mateo, California, United States   \n",
       "ArriVent Biopharma                 Pennsylvania Furnace, Pennsylvania, United States   \n",
       "Normax Biomed                                                    Cork, Cork, Ireland   \n",
       "Uniquity Bio                                    Malvern, Pennsylvania, United States   \n",
       "KELIX bio                                         Dubai, Dubai, United Arab Emirates   \n",
       "ReNAgade Therapeutics                        Cambridge, Massachusetts, United States   \n",
       "Beacon Therapeutics                                  London, England, United Kingdom   \n",
       "Metsera                                            New York, New York, United States   \n",
       "AmplifyBio                                       West Jefferson, Ohio, United States   \n",
       "Mineralys Therapeutics                           Radnor, Pennsylvania, United States   \n",
       "Orbital Therapeutics                         Cambridge, Massachusetts, United States   \n",
       "\n",
       "                                                                         Description  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                             Kenvue is a consumer health company that deliv...   \n",
       "Cencora                            Cencora is a global healthcare company that ad...   \n",
       "Altos Labs                         Altos Labs focuses on cellular rejuvenation pr...   \n",
       "Resilience                         Resilience provides end-to-end biopharmaceutic...   \n",
       "GoTo Group                         GoTo Group offers a digital ecosystem for on-d...   \n",
       "Xaira Therapeutics                 Xaira Therapeutics is an integrated biotechnol...   \n",
       "Organon                            Organon offers medicines and other products to...   \n",
       "Nutrabolt                          Nutrabolt is a dietary health supplement distr...   \n",
       "NeoCannBio                         NeoCannBio offers natural product processing f...   \n",
       "Apogee Therapeutics                Apogee Therapeutics is a biotechnology company...   \n",
       "Centessa Pharmaceuticals           Centessa Pharmaceuticals is a next-generation ...   \n",
       "Surround Care                      Surround Care focuses on fixing healthcare aff...   \n",
       "Avenzo Therapeutics                Avenzo Therapeutics specializes in the develop...   \n",
       "ACELYRIN                           ACELYRIN is a biopharma company that identifie...   \n",
       "Taysha Gene Therapies              Taysha Gene Therapies develops treatments to e...   \n",
       "Alumis                             Alumis is a precision medicine company focused...   \n",
       "Biohaven                           Biohaven is a clinical-stage biopharmaceutical...   \n",
       "Odyssey Therapeutics               Odyssey Therapeutics creates precision immunom...   \n",
       "Mirador Therapeutics               Mirador Therapeutics envisions precision medic...   \n",
       "Treeline Biosciences               Treeline Biosciences is a biotech company buil...   \n",
       "Invivyd                            Invivyd develops antibodies to transcend the l...   \n",
       "Cerebral                           Cerebral is a mental health telemedicine compa...   \n",
       "Areteia Therapeutics               Areteia Therapeutics is a biotechnology compan...   \n",
       "Transcarent                        Transcarent is a provider of a healthcare plat...   \n",
       "Scorpion Therapeutics              Scorpion Therapeutics is a clinical-stage onco...   \n",
       "Upstream Bio                       Upstream Bio focuses on developing an antibody...   \n",
       "CorroHealth                        CorroHealth helps individuals in the reimburse...   \n",
       "Sonoma BioTherapeutics             Sonoma BioTherapeutics develops adoptive Treg ...   \n",
       "Tourmaline Bio                     Tourmaline Bio is a clinical biotechnology com...   \n",
       "Center for Breakthrough Medicines  Center for Breakthrough Medicines is an innova...   \n",
       "Main Street Health                 Main Street Health is a supplier of value-base...   \n",
       "Capstan Therapeutics               Capstan Therapeutics is advancing cell enginee...   \n",
       "METiS Pharmaceuticals              METiS Pharmaceuticals is the world's first AI-...   \n",
       "Forge Biologics                    Forge Biologics is a gene therapy development ...   \n",
       "Zenas BioPharma                    Zenas BioPharma is a biopharmaceutical company...   \n",
       "2seventy bio                       2seventy bio is an immuno-oncology cell therap...   \n",
       "Gen4 Dental Partners               Gen4 Dental Partners is a doctor-centric, part...   \n",
       "Hasten                             Hasten is a pharmaceutical manufacturing compa...   \n",
       "Bicara Therapeutics                Bicara Therapeutics develops dual-action cance...   \n",
       "CARGO Therapeutics                 CARGO Therapeutics develops an adoptive cell t...   \n",
       "ArriVent Biopharma                 ArriVent develops pharmaceutical products to c...   \n",
       "Normax Biomed                      Normax Biomed is an mRNA Vaccine research and ...   \n",
       "Uniquity Bio                       Uniquity Bio operates as a drug development co...   \n",
       "KELIX bio                          KELIX bio is a specialty generic business focu...   \n",
       "ReNAgade Therapeutics              ReNAgade Therapeutics focuses on the boundless...   \n",
       "Beacon Therapeutics                Beacon Therapeutics is an ophthalmic gene ther...   \n",
       "Metsera                            Metsera operates as a clinical-stage biopharma...   \n",
       "AmplifyBio                         AmplifyBio is a biotechnology company that dev...   \n",
       "Mineralys Therapeutics             Mineralys Therapeutics is a clinical-stage bio...   \n",
       "Orbital Therapeutics               Orbital Therapeutics is a biotechnology compan...   \n",
       "\n",
       "                                  CB Rank (Company) Estimated Revenue Range  \\\n",
       "Organization Name                                                             \n",
       "Kenvue                                        3,970             $1B to $10B   \n",
       "Cencora                                       1,466                   $10B+   \n",
       "Altos Labs                                    2,590            $10M to $50M   \n",
       "Resilience                                    2,627            $500M to $1B   \n",
       "GoTo Group                                    4,999             $1M to $10M   \n",
       "Xaira Therapeutics                              450                       —   \n",
       "Organon                                       9,345             $1B to $10B   \n",
       "Nutrabolt                                    60,629          $100M to $500M   \n",
       "NeoCannBio                                   59,673                       —   \n",
       "Apogee Therapeutics                          37,763             $1B to $10B   \n",
       "Centessa Pharmaceuticals                      9,162            $10M to $50M   \n",
       "Surround Care                                28,699          $100M to $500M   \n",
       "Avenzo Therapeutics                           7,746                       —   \n",
       "ACELYRIN                                      5,972                       —   \n",
       "Taysha Gene Therapies                         2,137            $10M to $50M   \n",
       "Alumis                                          319                       —   \n",
       "Biohaven                                      8,102                       —   \n",
       "Odyssey Therapeutics                         44,888            $10M to $50M   \n",
       "Mirador Therapeutics                          6,447                       —   \n",
       "Treeline Biosciences                         53,808                       —   \n",
       "Invivyd                                       7,599             $1B to $10B   \n",
       "Cerebral                                     24,999          $100M to $500M   \n",
       "Areteia Therapeutics                         10,909                       —   \n",
       "Transcarent                                   1,715            $10M to $50M   \n",
       "Scorpion Therapeutics                           317             $1M to $10M   \n",
       "Upstream Bio                                  8,112             $1M to $10M   \n",
       "CorroHealth                                   6,000          $100M to $500M   \n",
       "Sonoma BioTherapeutics                        8,596             $1M to $10M   \n",
       "Tourmaline Bio                                3,834             $1M to $10M   \n",
       "Center for Breakthrough Medicines            23,276            $10M to $50M   \n",
       "Main Street Health                            6,051                       —   \n",
       "Capstan Therapeutics                         43,621                       —   \n",
       "METiS Pharmaceuticals                         8,268             $1M to $10M   \n",
       "Forge Biologics                              68,370             $1M to $10M   \n",
       "Zenas BioPharma                               3,020             $1M to $10M   \n",
       "2seventy bio                                  3,928           $50M to $100M   \n",
       "Gen4 Dental Partners                         22,565           $50M to $100M   \n",
       "Hasten                                       36,870                       —   \n",
       "Bicara Therapeutics                          58,367             $1M to $10M   \n",
       "CARGO Therapeutics                           36,449             $1B to $10B   \n",
       "ArriVent Biopharma                            6,744            $10M to $50M   \n",
       "Normax Biomed                                60,951                       —   \n",
       "Uniquity Bio                                  7,949                       —   \n",
       "KELIX bio                                    28,207                       —   \n",
       "ReNAgade Therapeutics                        64,077                       —   \n",
       "Beacon Therapeutics                           1,196                       —   \n",
       "Metsera                                       8,384                       —   \n",
       "AmplifyBio                                    3,681           $50M to $100M   \n",
       "Mineralys Therapeutics                       11,923             $1M to $10M   \n",
       "Orbital Therapeutics                         62,764                       —   \n",
       "\n",
       "                                                     Website Company Type  \\\n",
       "Organization Name                                                           \n",
       "Kenvue                                            kenvue.com   For Profit   \n",
       "Cencora                                          cencora.com   For Profit   \n",
       "Altos Labs                                     altoslabs.com   For Profit   \n",
       "Resilience                                    resilience.com   For Profit   \n",
       "GoTo Group                                   gotocompany.com   For Profit   \n",
       "Xaira Therapeutics                                 xaira.com   For Profit   \n",
       "Organon                                          organon.com   For Profit   \n",
       "Nutrabolt                                      nutrabolt.com   For Profit   \n",
       "NeoCannBio                                    neocannbio.com   For Profit   \n",
       "Apogee Therapeutics                   apogeetherapeutics.com   For Profit   \n",
       "Centessa Pharmaceuticals                        centessa.com   For Profit   \n",
       "Surround Care                              surround-care.com   For Profit   \n",
       "Avenzo Therapeutics                             avenzotx.com   For Profit   \n",
       "ACELYRIN                                        acelyrin.com   For Profit   \n",
       "Taysha Gene Therapies                          tayshagtx.com   For Profit   \n",
       "Alumis                                            alumis.com   For Profit   \n",
       "Biohaven                                        biohaven.com   For Profit   \n",
       "Odyssey Therapeutics                           odysseytx.com   For Profit   \n",
       "Mirador Therapeutics                           miradortx.com   For Profit   \n",
       "Treeline Biosciences                            treeline.bio   For Profit   \n",
       "Invivyd                                          invivyd.com   For Profit   \n",
       "Cerebral                                        cerebral.com   For Profit   \n",
       "Areteia Therapeutics                           areteiatx.com   For Profit   \n",
       "Transcarent                                  transcarent.com   For Profit   \n",
       "Scorpion Therapeutics                         scorpiontx.com   For Profit   \n",
       "Upstream Bio                                 upstreambio.com   For Profit   \n",
       "CorroHealth                                  corrohealth.com   For Profit   \n",
       "Sonoma BioTherapeutics                         sonomabio.com   For Profit   \n",
       "Tourmaline Bio                             tourmalinebio.com   For Profit   \n",
       "Center for Breakthrough Medicines  breakthroughmedicines.com   For Profit   \n",
       "Main Street Health                 mainstreetruralhealth.com   For Profit   \n",
       "Capstan Therapeutics                           capstantx.com   For Profit   \n",
       "METiS Pharmaceuticals                metispharmaceuticals.cn   For Profit   \n",
       "Forge Biologics                           forgebiologics.com   For Profit   \n",
       "Zenas BioPharma                                 zenasbio.com   For Profit   \n",
       "2seventy bio                                 2seventybio.com   For Profit   \n",
       "Gen4 Dental Partners                          gen4dental.com   For Profit   \n",
       "Hasten                                      hastenpharma.com   For Profit   \n",
       "Bicara Therapeutics                               bicara.com   For Profit   \n",
       "CARGO Therapeutics                              cargo-tx.com   For Profit   \n",
       "ArriVent Biopharma                              arrivent.com   For Profit   \n",
       "Normax Biomed                               normaxbiomed.com   For Profit   \n",
       "Uniquity Bio                                    uniquity.com   For Profit   \n",
       "KELIX bio                                       kelixbio.com   For Profit   \n",
       "ReNAgade Therapeutics                         renagadetx.com   For Profit   \n",
       "Beacon Therapeutics                             beacontx.com   For Profit   \n",
       "Metsera                                          metsera.com            —   \n",
       "AmplifyBio                                   amplify-bio.com   For Profit   \n",
       "Mineralys Therapeutics                       mineralystx.com   For Profit   \n",
       "Orbital Therapeutics                           orbitaltx.com   For Profit   \n",
       "\n",
       "                                  Founded Date Operating Status  \\\n",
       "Organization Name                                                 \n",
       "Kenvue                                    2023           Active   \n",
       "Cencora                                   2023           Active   \n",
       "Altos Labs                           15-Apr-21           Active   \n",
       "Resilience                                2020           Active   \n",
       "GoTo Group                                2021           Active   \n",
       "Xaira Therapeutics                        2024           Active   \n",
       "Organon                                   2020           Active   \n",
       "Nutrabolt                                 2020           Active   \n",
       "NeoCannBio                                2021           Active   \n",
       "Apogee Therapeutics                       2022           Active   \n",
       "Centessa Pharmaceuticals                  2021           Active   \n",
       "Surround Care                             2022           Active   \n",
       "Avenzo Therapeutics                       2022           Active   \n",
       "ACELYRIN                                  2020           Active   \n",
       "Taysha Gene Therapies                     2020           Active   \n",
       "Alumis                                    2021           Active   \n",
       "Biohaven                                  2022           Active   \n",
       "Odyssey Therapeutics                      2021           Active   \n",
       "Mirador Therapeutics                      2024           Active   \n",
       "Treeline Biosciences                      2021           Active   \n",
       "Invivyd                                   2020           Active   \n",
       "Cerebral                                  2020           Active   \n",
       "Areteia Therapeutics                      2022           Active   \n",
       "Transcarent                               2020           Active   \n",
       "Scorpion Therapeutics                     2020           Active   \n",
       "Upstream Bio                              2021           Active   \n",
       "CorroHealth                               2020           Active   \n",
       "Sonoma BioTherapeutics                    2020           Active   \n",
       "Tourmaline Bio                            2021           Active   \n",
       "Center for Breakthrough Medicines         2020           Active   \n",
       "Main Street Health                        2021           Active   \n",
       "Capstan Therapeutics                      2021           Active   \n",
       "METiS Pharmaceuticals                     2020           Active   \n",
       "Forge Biologics                           2020           Active   \n",
       "Zenas BioPharma                           2020           Active   \n",
       "2seventy bio                              2021           Active   \n",
       "Gen4 Dental Partners                      2021           Active   \n",
       "Hasten                                    2020           Active   \n",
       "Bicara Therapeutics                       2020           Active   \n",
       "CARGO Therapeutics                        2021           Active   \n",
       "ArriVent Biopharma                        2021           Active   \n",
       "Normax Biomed                             2020           Active   \n",
       "Uniquity Bio                              2022           Active   \n",
       "KELIX bio                                 2020           Active   \n",
       "ReNAgade Therapeutics                     2021           Active   \n",
       "Beacon Therapeutics                       2023           Active   \n",
       "Metsera                                   2022           Active   \n",
       "AmplifyBio                                2021           Active   \n",
       "Mineralys Therapeutics                    2020           Active   \n",
       "Orbital Therapeutics                      2022           Active   \n",
       "\n",
       "                                                                    Full Description  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                             Kenvue is a consumer health company that deliv...   \n",
       "Cencora                            Cencora, building on the legacy of Amerisource...   \n",
       "Altos Labs                         Altos Labs is a biotechnology company focused ...   \n",
       "Resilience                         Resilience provides end-to-end biopharmaceutic...   \n",
       "GoTo Group                         GoTo Group is an application used for ride-hai...   \n",
       "Xaira Therapeutics                 Xaira Therapeutics is an integrated biotechnol...   \n",
       "Organon                            Organon offers medicines and other products to...   \n",
       "Nutrabolt                          Nutrabolt produces and sells supplements for t...   \n",
       "NeoCannBio                         NeoCannBio provides natural product processing...   \n",
       "Apogee Therapeutics                Apogee Therapeutics is a biotechnology company...   \n",
       "Centessa Pharmaceuticals           Centessa Pharmaceuticals is a next-generation ...   \n",
       "Surround Care                      Surround Care focuses on fixing healthcare aff...   \n",
       "Avenzo Therapeutics                Avenzo Therapeutics specializes in the develop...   \n",
       "ACELYRIN                           ACELYRIN is a biopharma company focused on pro...   \n",
       "Taysha Gene Therapies              Taysha Gene Therapies is on a mission to eradi...   \n",
       "Alumis                             Alumis develops precision medications to treat...   \n",
       "Biohaven                           Biohaven is a clinical-stage biopharmaceutical...   \n",
       "Odyssey Therapeutics               Odyssey Therapeutics is pioneering the efficie...   \n",
       "Mirador Therapeutics               Mirador Therapeutics envisions precision medic...   \n",
       "Treeline Biosciences               Treeline Biosciences is a biotech company buil...   \n",
       "Invivyd                            Invivyd is on a mission to rapidly and perpetu...   \n",
       "Cerebral                           Cerebral makes high-quality mental health care...   \n",
       "Areteia Therapeutics               Areteia Therapeutics is committed to putting a...   \n",
       "Transcarent                        Transcarent is a consumer-directed health and ...   \n",
       "Scorpion Therapeutics              Scorpion Therapeutics develops targeted small-...   \n",
       "Upstream Bio                       Upstream Bio focuses on developing an antibody...   \n",
       "CorroHealth                        CorroHealth helps individuals in the reimburse...   \n",
       "Sonoma BioTherapeutics             Sonoma Biotherapeutics is developing adoptive ...   \n",
       "Tourmaline Bio                     Tourmaline Bio is a clinical biotechnology com...   \n",
       "Center for Breakthrough Medicines  Center for Breakthrough Medicines is an innova...   \n",
       "Main Street Health                 Main Street Health is a provider of value-base...   \n",
       "Capstan Therapeutics               Capstan Therapeutics is advancing precision in...   \n",
       "METiS Pharmaceuticals              Jitai Medicine (METiS) is a biotechnology comp...   \n",
       "Forge Biologics                    Forge Biologics is a gene therapy development ...   \n",
       "Zenas BioPharma                    Zenas BioPharma is a biopharmaceutical company...   \n",
       "2seventy bio                       2seventy bio is an immuno-oncology cell therap...   \n",
       "Gen4 Dental Partners               Gen4 Dental Partners provides world-class supp...   \n",
       "Hasten                             Hasten is a pharmaceutical manufacturing compa...   \n",
       "Bicara Therapeutics                Bicara Therapeutics is a clinical-stage biotec...   \n",
       "CARGO Therapeutics                 CARGO Therapeutics develops CAR T-cell therapy...   \n",
       "ArriVent Biopharma                 ArriVent is a biopharmaceutical company develo...   \n",
       "Normax Biomed                      Normax Biomed is an mRNA Vaccine research and ...   \n",
       "Uniquity Bio                       Uniquity Bio operates a drug development company.   \n",
       "KELIX bio                          KELIX bio is a specialty generic business focu...   \n",
       "ReNAgade Therapeutics              ReNAgade Therapeutics focuses on the boundless...   \n",
       "Beacon Therapeutics                Beacon Therapeutics is an ophthalmic gene ther...   \n",
       "Metsera                            Metsera operates as a clinical-stage biopharma...   \n",
       "AmplifyBio                         AmplifyBio is a biotechnology company that dev...   \n",
       "Mineralys Therapeutics             Mineralys Therapeutics is a biopharmaceutical ...   \n",
       "Orbital Therapeutics               Orbital Therapeutics aims to enhance global he...   \n",
       "\n",
       "                                   ... Total Funding Amount  \\\n",
       "Organization Name                  ...                        \n",
       "Kenvue                             ...      $3,646,591,000    \n",
       "Cencora                            ...      $3,025,000,000    \n",
       "Altos Labs                         ...      $3,000,000,000    \n",
       "Resilience                         ...      $2,515,000,000    \n",
       "GoTo Group                         ...      $1,450,000,000    \n",
       "Xaira Therapeutics                 ...      $1,000,000,000    \n",
       "Organon                            ...      $1,000,000,000    \n",
       "Nutrabolt                          ...        $863,000,000    \n",
       "NeoCannBio                         ...        $678,925,399    \n",
       "Apogee Therapeutics                ...        $652,000,000    \n",
       "Centessa Pharmaceuticals           ...        $650,000,000    \n",
       "Surround Care                      ...        $573,480,000    \n",
       "Avenzo Therapeutics                ...        $569,350,002    \n",
       "ACELYRIN                           ...        $558,000,000    \n",
       "Taysha Gene Therapies              ...        $543,000,000    \n",
       "Alumis                             ...        $529,000,000    \n",
       "Biohaven                           ...        $523,200,000    \n",
       "Odyssey Therapeutics               ...        $487,000,000    \n",
       "Mirador Therapeutics               ...        $480,000,000    \n",
       "Treeline Biosciences               ...        $473,266,523    \n",
       "Invivyd                            ...        $466,000,000    \n",
       "Cerebral                           ...        $462,000,000    \n",
       "Areteia Therapeutics               ...        $425,000,000    \n",
       "Transcarent                        ...        $424,000,000    \n",
       "Scorpion Therapeutics              ...        $420,000,000    \n",
       "Upstream Bio                       ...        $408,000,000    \n",
       "CorroHealth                        ...        $376,268,825    \n",
       "Sonoma BioTherapeutics             ...        $365,000,000    \n",
       "Tourmaline Bio                     ...        $359,500,000    \n",
       "Center for Breakthrough Medicines  ...        $350,000,000    \n",
       "Main Street Health                 ...        $342,000,000    \n",
       "Capstan Therapeutics               ...        $340,000,000    \n",
       "METiS Pharmaceuticals              ...        $336,000,000    \n",
       "Forge Biologics                    ...        $330,000,000    \n",
       "Zenas BioPharma                    ...        $318,000,000    \n",
       "2seventy bio                       ...        $315,000,000    \n",
       "Gen4 Dental Partners               ...        $315,000,000    \n",
       "Hasten                             ...        $315,000,000    \n",
       "Bicara Therapeutics                ...        $313,000,000    \n",
       "CARGO Therapeutics                 ...        $310,000,000    \n",
       "ArriVent Biopharma                 ...        $305,000,000    \n",
       "Normax Biomed                      ...        € 300,000,000   \n",
       "Uniquity Bio                       ...        $300,000,000    \n",
       "KELIX bio                          ...        $300,000,000    \n",
       "ReNAgade Therapeutics              ...        $300,000,000    \n",
       "Beacon Therapeutics                ...        $290,139,662    \n",
       "Metsera                            ...        $290,000,000    \n",
       "AmplifyBio                         ...        $279,750,000    \n",
       "Mineralys Therapeutics             ...        $278,000,000    \n",
       "Orbital Therapeutics               ...        $270,000,000    \n",
       "\n",
       "                                          Last Funding Type  \\\n",
       "Organization Name                                             \n",
       "Kenvue                                   Post-IPO Secondary   \n",
       "Cencora                                       Post-IPO Debt   \n",
       "Altos Labs                                         Series A   \n",
       "Resilience                                   Debt Financing   \n",
       "GoTo Group                                   Debt Financing   \n",
       "Xaira Therapeutics                                 Series A   \n",
       "Organon                                       Post-IPO Debt   \n",
       "Nutrabolt                                  Secondary Market   \n",
       "NeoCannBio                                         Series B   \n",
       "Apogee Therapeutics                         Post-IPO Equity   \n",
       "Centessa Pharmaceuticals                    Post-IPO Equity   \n",
       "Surround Care                                   Undisclosed   \n",
       "Avenzo Therapeutics                                Series A   \n",
       "ACELYRIN                                           Series C   \n",
       "Taysha Gene Therapies                       Post-IPO Equity   \n",
       "Alumis                                             Series C   \n",
       "Biohaven                                    Post-IPO Equity   \n",
       "Odyssey Therapeutics                               Series C   \n",
       "Mirador Therapeutics                               Series A   \n",
       "Treeline Biosciences                               Series A   \n",
       "Invivyd                                            Series C   \n",
       "Cerebral                                           Series C   \n",
       "Areteia Therapeutics                               Series A   \n",
       "Transcarent                                        Series D   \n",
       "Scorpion Therapeutics                              Series C   \n",
       "Upstream Bio                                       Series B   \n",
       "CorroHealth                                  Private Equity   \n",
       "Sonoma BioTherapeutics                      Corporate Round   \n",
       "Tourmaline Bio                              Post-IPO Equity   \n",
       "Center for Breakthrough Medicines           Corporate Round   \n",
       "Main Street Health                 Venture - Series Unknown   \n",
       "Capstan Therapeutics                               Series B   \n",
       "METiS Pharmaceuticals                              Series C   \n",
       "Forge Biologics                                    Series C   \n",
       "Zenas BioPharma                                    Series C   \n",
       "2seventy bio                                Post-IPO Equity   \n",
       "Gen4 Dental Partners                         Debt Financing   \n",
       "Hasten                             Venture - Series Unknown   \n",
       "Bicara Therapeutics                                Series C   \n",
       "CARGO Therapeutics                          Post-IPO Equity   \n",
       "ArriVent Biopharma                                 Series B   \n",
       "Normax Biomed                      Venture - Series Unknown   \n",
       "Uniquity Bio                                       Series A   \n",
       "KELIX bio                          Venture - Series Unknown   \n",
       "ReNAgade Therapeutics                              Series A   \n",
       "Beacon Therapeutics                                Series B   \n",
       "Metsera                                            Series A   \n",
       "AmplifyBio                         Venture - Series Unknown   \n",
       "Mineralys Therapeutics                      Post-IPO Equity   \n",
       "Orbital Therapeutics                               Series A   \n",
       "\n",
       "                                  Last Equity Funding Amount  \\\n",
       "Organization Name                                              \n",
       "Kenvue                                                     —   \n",
       "Cencora                                                    —   \n",
       "Altos Labs                                   $3,000,000,000    \n",
       "Resilience                                                 —   \n",
       "GoTo Group                                   $1,300,000,000    \n",
       "Xaira Therapeutics                           $1,000,000,000    \n",
       "Organon                                                    —   \n",
       "Nutrabolt                                                  —   \n",
       "NeoCannBio                                   ₩10,000,000,000   \n",
       "Apogee Therapeutics                            $483,000,000    \n",
       "Centessa Pharmaceuticals                       $100,000,000    \n",
       "Surround Care                                  $573,480,000    \n",
       "Avenzo Therapeutics                            $150,000,000    \n",
       "ACELYRIN                                       $300,000,000    \n",
       "Taysha Gene Therapies                           $75,000,000    \n",
       "Alumis                                         $259,000,000    \n",
       "Biohaven                                       $264,500,000    \n",
       "Odyssey Therapeutics                           $101,000,000    \n",
       "Mirador Therapeutics                           $400,000,000    \n",
       "Treeline Biosciences                           $261,266,523    \n",
       "Invivyd                                        $336,000,000    \n",
       "Cerebral                                       $300,000,000    \n",
       "Areteia Therapeutics                            $75,000,000    \n",
       "Transcarent                                    $126,000,000    \n",
       "Scorpion Therapeutics                          $150,000,000    \n",
       "Upstream Bio                                   $200,000,000    \n",
       "CorroHealth                                     $50,000,000    \n",
       "Sonoma BioTherapeutics                          $30,000,000    \n",
       "Tourmaline Bio                                 $172,500,000    \n",
       "Center for Breakthrough Medicines              $350,000,000    \n",
       "Main Street Health                             $315,000,000    \n",
       "Capstan Therapeutics                           $175,000,000    \n",
       "METiS Pharmaceuticals                          $100,000,000    \n",
       "Forge Biologics                                 $90,000,000    \n",
       "Zenas BioPharma                                $200,000,000    \n",
       "2seventy bio                                   $125,000,000    \n",
       "Gen4 Dental Partners                                       —   \n",
       "Hasten                                         $315,000,000    \n",
       "Bicara Therapeutics                            $165,000,000    \n",
       "CARGO Therapeutics                             $110,000,000    \n",
       "ArriVent Biopharma                             $155,000,000    \n",
       "Normax Biomed                                  € 300,000,000   \n",
       "Uniquity Bio                                   $300,000,000    \n",
       "KELIX bio                                      $200,000,000    \n",
       "ReNAgade Therapeutics                          $300,000,000    \n",
       "Beacon Therapeutics                            $170,000,000    \n",
       "Metsera                                        $290,000,000    \n",
       "AmplifyBio                                      $49,750,000    \n",
       "Mineralys Therapeutics                         $120,000,000    \n",
       "Orbital Therapeutics                           $270,000,000    \n",
       "\n",
       "                                   Last Equity Funding Type  \\\n",
       "Organization Name                                             \n",
       "Kenvue                                                    —   \n",
       "Cencora                                                   —   \n",
       "Altos Labs                                                —   \n",
       "Resilience                                   Private Equity   \n",
       "GoTo Group                         Venture - Series Unknown   \n",
       "Xaira Therapeutics                                        —   \n",
       "Organon                                                   —   \n",
       "Nutrabolt                                    Private Equity   \n",
       "NeoCannBio                                         Series B   \n",
       "Apogee Therapeutics                         Post-IPO Equity   \n",
       "Centessa Pharmaceuticals                    Post-IPO Equity   \n",
       "Surround Care                                             —   \n",
       "Avenzo Therapeutics                                Series A   \n",
       "ACELYRIN                                           Series C   \n",
       "Taysha Gene Therapies                       Post-IPO Equity   \n",
       "Alumis                                             Series C   \n",
       "Biohaven                                    Post-IPO Equity   \n",
       "Odyssey Therapeutics                               Series C   \n",
       "Mirador Therapeutics                               Series A   \n",
       "Treeline Biosciences                               Series A   \n",
       "Invivyd                                            Series C   \n",
       "Cerebral                                           Series C   \n",
       "Areteia Therapeutics                               Series A   \n",
       "Transcarent                                        Series D   \n",
       "Scorpion Therapeutics                              Series C   \n",
       "Upstream Bio                                       Series B   \n",
       "CorroHealth                                  Private Equity   \n",
       "Sonoma BioTherapeutics                      Corporate Round   \n",
       "Tourmaline Bio                              Post-IPO Equity   \n",
       "Center for Breakthrough Medicines           Corporate Round   \n",
       "Main Street Health                 Venture - Series Unknown   \n",
       "Capstan Therapeutics                               Series B   \n",
       "METiS Pharmaceuticals                              Series C   \n",
       "Forge Biologics                                    Series C   \n",
       "Zenas BioPharma                                    Series C   \n",
       "2seventy bio                                Post-IPO Equity   \n",
       "Gen4 Dental Partners                         Private Equity   \n",
       "Hasten                             Venture - Series Unknown   \n",
       "Bicara Therapeutics                                Series C   \n",
       "CARGO Therapeutics                          Post-IPO Equity   \n",
       "ArriVent Biopharma                                 Series B   \n",
       "Normax Biomed                      Venture - Series Unknown   \n",
       "Uniquity Bio                                       Series A   \n",
       "KELIX bio                          Venture - Series Unknown   \n",
       "ReNAgade Therapeutics                              Series A   \n",
       "Beacon Therapeutics                                Series B   \n",
       "Metsera                                            Series A   \n",
       "AmplifyBio                         Venture - Series Unknown   \n",
       "Mineralys Therapeutics                      Post-IPO Equity   \n",
       "Orbital Therapeutics                               Series A   \n",
       "\n",
       "                                  Total Equity Funding Amount  \\\n",
       "Organization Name                                               \n",
       "Kenvue                                                      —   \n",
       "Cencora                                                     —   \n",
       "Altos Labs                                                  —   \n",
       "Resilience                                    $2,105,000,000    \n",
       "GoTo Group                                    $1,300,000,000    \n",
       "Xaira Therapeutics                                          —   \n",
       "Organon                                                     —   \n",
       "Nutrabolt                                                   —   \n",
       "NeoCannBio                                      $678,925,399    \n",
       "Apogee Therapeutics                             $652,000,000    \n",
       "Centessa Pharmaceuticals                        $350,000,000    \n",
       "Surround Care                                               —   \n",
       "Avenzo Therapeutics                             $569,350,002    \n",
       "ACELYRIN                                        $558,000,000    \n",
       "Taysha Gene Therapies                           $403,000,000    \n",
       "Alumis                                          $529,000,000    \n",
       "Biohaven                                        $523,200,000    \n",
       "Odyssey Therapeutics                            $487,000,000    \n",
       "Mirador Therapeutics                            $480,000,000    \n",
       "Treeline Biosciences                            $473,266,523    \n",
       "Invivyd                                         $466,000,000    \n",
       "Cerebral                                        $462,000,000    \n",
       "Areteia Therapeutics                            $425,000,000    \n",
       "Transcarent                                     $424,000,000    \n",
       "Scorpion Therapeutics                           $420,000,000    \n",
       "Upstream Bio                                    $408,000,000    \n",
       "CorroHealth                                     $376,268,825    \n",
       "Sonoma BioTherapeutics                          $365,000,000    \n",
       "Tourmaline Bio                                  $359,500,000    \n",
       "Center for Breakthrough Medicines               $350,000,000    \n",
       "Main Street Health                              $342,000,000    \n",
       "Capstan Therapeutics                            $340,000,000    \n",
       "METiS Pharmaceuticals                           $336,000,000    \n",
       "Forge Biologics                                 $250,000,000    \n",
       "Zenas BioPharma                                 $318,000,000    \n",
       "2seventy bio                                    $315,000,000    \n",
       "Gen4 Dental Partners                                        —   \n",
       "Hasten                                          $315,000,000    \n",
       "Bicara Therapeutics                             $313,000,000    \n",
       "CARGO Therapeutics                              $310,000,000    \n",
       "ArriVent Biopharma                              $305,000,000    \n",
       "Normax Biomed                                   € 300,000,000   \n",
       "Uniquity Bio                                    $300,000,000    \n",
       "KELIX bio                                       $300,000,000    \n",
       "ReNAgade Therapeutics                           $300,000,000    \n",
       "Beacon Therapeutics                             $290,139,662    \n",
       "Metsera                                         $290,000,000    \n",
       "AmplifyBio                                      $229,750,000    \n",
       "Mineralys Therapeutics                          $278,000,000    \n",
       "Orbital Therapeutics                            $270,000,000    \n",
       "\n",
       "                                                                     Top 5 Investors  \\\n",
       "Organization Name                                                                      \n",
       "Kenvue                                    Goldman Sachs, J.P. Morgan Securities Inc.   \n",
       "Cencora                                                                            —   \n",
       "Altos Labs                                                     ARCH Venture Partners   \n",
       "Resilience                         Google Ventures, 8VC, Mubadala, New Enterprise...   \n",
       "GoTo Group                         Google, Tencent, International Finance Corpora...   \n",
       "Xaira Therapeutics                 Menlo Ventures, Sequoia Capital, Lightspeed Ve...   \n",
       "Organon                                                                            —   \n",
       "Nutrabolt                                        Keurig Dr Pepper, MidOcean Partners   \n",
       "NeoCannBio                         QUAD Investment Management, HLB Group, Donghoo...   \n",
       "Apogee Therapeutics                Fidelity, OrbiMed, Wellington Management, RA C...   \n",
       "Centessa Pharmaceuticals           T. Rowe Price, IP Group, Franklin Templeton, W...   \n",
       "Surround Care                                                                      —   \n",
       "Avenzo Therapeutics                New Enterprise Associates, SR One, Lilly Asia ...   \n",
       "ACELYRIN                           OrbiMed, Decheng Capital, RTW Investments, Sur...   \n",
       "Taysha Gene Therapies              Fidelity, BlackRock, Trinity Capital, Google V...   \n",
       "Alumis                             Foresite Capital, Cormorant Asset Management, ...   \n",
       "Biohaven                                                                           —   \n",
       "Odyssey Therapeutics               Fidelity, T. Rowe Price, General Catalyst, Orb...   \n",
       "Mirador Therapeutics               Fidelity, Sanofi, Blue Owl, OrbiMed, Point72 V...   \n",
       "Treeline Biosciences               Kohlberg Kravis Roberts, OrbiMed, Google Ventu...   \n",
       "Invivyd                            Fidelity, OrbiMed, Google Ventures, RA Capital...   \n",
       "Cerebral                           Oak HC/FT, Gaingels, WestCap, Liquid 2 Venture...   \n",
       "Areteia Therapeutics               Sanofi, Google Ventures, Marshall Wace, Viking...   \n",
       "Transcarent                        General Catalyst, Kleiner Perkins, GreatPoint ...   \n",
       "Scorpion Therapeutics              Fidelity, OrbiMed, Lightspeed Venture Partners...   \n",
       "Upstream Bio                       OrbiMed, Wellington Management, Omega Funds, E...   \n",
       "CorroHealth                                                                        —   \n",
       "Sonoma BioTherapeutics             Fidelity, Mirae Asset, Regeneron, Google Ventu...   \n",
       "Tourmaline Bio                     RA Capital Management, Great Point Partners, L...   \n",
       "Center for Breakthrough Medicines                                        SK Holdings   \n",
       "Main Street Health                 Humana, Oak HC/FT, CVS Health, Optum Ventures,...   \n",
       "Capstan Therapeutics               Bristol-Myers Squibb, OrbiMed, RA Capital Mana...   \n",
       "METiS Pharmaceuticals              XtalPi, Sequoia Capital China, Source Code Cap...   \n",
       "Forge Biologics                    Drive Capital, MidCap Financial, RA Capital Ma...   \n",
       "Zenas BioPharma                    Wellington Management, Xencor, New Enterprise ...   \n",
       "2seventy bio                       Regeneron, Casdin Capital, Janus Henderson Inv...   \n",
       "Gen4 Dental Partners                     Saratoga Partners, Varagon Capital Partners   \n",
       "Hasten                                                    Mubadala, C-Bridge Capital   \n",
       "Bicara Therapeutics                TPG, F-Prime Capital, RA Capital Management, B...   \n",
       "CARGO Therapeutics                 T. Rowe Price, Wellington Management, Cormoran...   \n",
       "ArriVent Biopharma                 General Catalyst, OrbiMed, Sequoia Capital Chi...   \n",
       "Normax Biomed                                      The Global Emerging Markets Group   \n",
       "Uniquity Bio                                                Blackstone Life Sciences   \n",
       "KELIX bio                          British International Investment, Development ...   \n",
       "ReNAgade Therapeutics                                       MPM Capital, F2 Ventures   \n",
       "Beacon Therapeutics                Oxford Science Enterprises, Forbion Capital Pa...   \n",
       "Metsera                            Google Ventures, F-Prime Capital, Mubadala Cap...   \n",
       "AmplifyBio                         Hercules Capital, Battelle, Narya Capital, Vik...   \n",
       "Mineralys Therapeutics             Andera Partners, OrbiMed, RA Capital Managemen...   \n",
       "Orbital Therapeutics               Andreessen Horowitz, EXOR N.V., Invus, Alexand...   \n",
       "\n",
       "                                  IPO Status               Country  \\\n",
       "Organization Name                                                    \n",
       "Kenvue                                Public         United States   \n",
       "Cencora                               Public         United States   \n",
       "Altos Labs                           Private         United States   \n",
       "Resilience                           Private         United States   \n",
       "GoTo Group                            Public             Indonesia   \n",
       "Xaira Therapeutics                   Private         United States   \n",
       "Organon                               Public         United States   \n",
       "Nutrabolt                            Private         United States   \n",
       "NeoCannBio                           Private           South Korea   \n",
       "Apogee Therapeutics                   Public         United States   \n",
       "Centessa Pharmaceuticals              Public         United States   \n",
       "Surround Care                        Private         United States   \n",
       "Avenzo Therapeutics                  Private         United States   \n",
       "ACELYRIN                              Public         United States   \n",
       "Taysha Gene Therapies                 Public         United States   \n",
       "Alumis                                Public         United States   \n",
       "Biohaven                              Public         United States   \n",
       "Odyssey Therapeutics                 Private         United States   \n",
       "Mirador Therapeutics                 Private         United States   \n",
       "Treeline Biosciences                 Private         United States   \n",
       "Invivyd                               Public         United States   \n",
       "Cerebral                             Private         United States   \n",
       "Areteia Therapeutics                 Private         United States   \n",
       "Transcarent                          Private         United States   \n",
       "Scorpion Therapeutics                Private         United States   \n",
       "Upstream Bio                         Private         United States   \n",
       "CorroHealth                          Private         United States   \n",
       "Sonoma BioTherapeutics               Private         United States   \n",
       "Tourmaline Bio                        Public         United States   \n",
       "Center for Breakthrough Medicines    Private         United States   \n",
       "Main Street Health                   Private         United States   \n",
       "Capstan Therapeutics                 Private         United States   \n",
       "METiS Pharmaceuticals                Private                 China   \n",
       "Forge Biologics                      Private         United States   \n",
       "Zenas BioPharma                      Private         United States   \n",
       "2seventy bio                          Public         United States   \n",
       "Gen4 Dental Partners                 Private         United States   \n",
       "Hasten                               Private                 China   \n",
       "Bicara Therapeutics                  Private         United States   \n",
       "CARGO Therapeutics                    Public         United States   \n",
       "ArriVent Biopharma                    Public         United States   \n",
       "Normax Biomed                        Private               Ireland   \n",
       "Uniquity Bio                         Private         United States   \n",
       "KELIX bio                            Private  United Arab Emirates   \n",
       "ReNAgade Therapeutics                Private         United States   \n",
       "Beacon Therapeutics                  Private        United Kingdom   \n",
       "Metsera                              Private         United States   \n",
       "AmplifyBio                           Private         United States   \n",
       "Mineralys Therapeutics                Public         United States   \n",
       "Orbital Therapeutics                 Private         United States   \n",
       "\n",
       "                                  Total_Funding_Amount_Currency  \\\n",
       "Organization Name                                                 \n",
       "Kenvue                                                        $   \n",
       "Cencora                                                       $   \n",
       "Altos Labs                                                    $   \n",
       "Resilience                                                    $   \n",
       "GoTo Group                                                    $   \n",
       "Xaira Therapeutics                                            $   \n",
       "Organon                                                       $   \n",
       "Nutrabolt                                                     $   \n",
       "NeoCannBio                                                    $   \n",
       "Apogee Therapeutics                                           $   \n",
       "Centessa Pharmaceuticals                                      $   \n",
       "Surround Care                                                 $   \n",
       "Avenzo Therapeutics                                           $   \n",
       "ACELYRIN                                                      $   \n",
       "Taysha Gene Therapies                                         $   \n",
       "Alumis                                                        $   \n",
       "Biohaven                                                      $   \n",
       "Odyssey Therapeutics                                          $   \n",
       "Mirador Therapeutics                                          $   \n",
       "Treeline Biosciences                                          $   \n",
       "Invivyd                                                       $   \n",
       "Cerebral                                                      $   \n",
       "Areteia Therapeutics                                          $   \n",
       "Transcarent                                                   $   \n",
       "Scorpion Therapeutics                                         $   \n",
       "Upstream Bio                                                  $   \n",
       "CorroHealth                                                   $   \n",
       "Sonoma BioTherapeutics                                        $   \n",
       "Tourmaline Bio                                                $   \n",
       "Center for Breakthrough Medicines                             $   \n",
       "Main Street Health                                            $   \n",
       "Capstan Therapeutics                                          $   \n",
       "METiS Pharmaceuticals                                         $   \n",
       "Forge Biologics                                               $   \n",
       "Zenas BioPharma                                               $   \n",
       "2seventy bio                                                  $   \n",
       "Gen4 Dental Partners                                          $   \n",
       "Hasten                                                        $   \n",
       "Bicara Therapeutics                                           $   \n",
       "CARGO Therapeutics                                            $   \n",
       "ArriVent Biopharma                                            $   \n",
       "Normax Biomed                                                 €   \n",
       "Uniquity Bio                                                  $   \n",
       "KELIX bio                                                     $   \n",
       "ReNAgade Therapeutics                                         $   \n",
       "Beacon Therapeutics                                           $   \n",
       "Metsera                                                       $   \n",
       "AmplifyBio                                                    $   \n",
       "Mineralys Therapeutics                                        $   \n",
       "Orbital Therapeutics                                          $   \n",
       "\n",
       "                                  Total Funding Amount (USD)  \n",
       "Organization Name                                             \n",
       "Kenvue                                            3646591000  \n",
       "Cencora                                           3025000000  \n",
       "Altos Labs                                        3000000000  \n",
       "Resilience                                        2515000000  \n",
       "GoTo Group                                        1450000000  \n",
       "Xaira Therapeutics                                1000000000  \n",
       "Organon                                           1000000000  \n",
       "Nutrabolt                                          863000000  \n",
       "NeoCannBio                                         678925399  \n",
       "Apogee Therapeutics                                652000000  \n",
       "Centessa Pharmaceuticals                           650000000  \n",
       "Surround Care                                      573480000  \n",
       "Avenzo Therapeutics                                569350002  \n",
       "ACELYRIN                                           558000000  \n",
       "Taysha Gene Therapies                              543000000  \n",
       "Alumis                                             529000000  \n",
       "Biohaven                                           523200000  \n",
       "Odyssey Therapeutics                               487000000  \n",
       "Mirador Therapeutics                               480000000  \n",
       "Treeline Biosciences                               473266523  \n",
       "Invivyd                                            466000000  \n",
       "Cerebral                                           462000000  \n",
       "Areteia Therapeutics                               425000000  \n",
       "Transcarent                                        424000000  \n",
       "Scorpion Therapeutics                              420000000  \n",
       "Upstream Bio                                       408000000  \n",
       "CorroHealth                                        376268825  \n",
       "Sonoma BioTherapeutics                             365000000  \n",
       "Tourmaline Bio                                     359500000  \n",
       "Center for Breakthrough Medicines                  350000000  \n",
       "Main Street Health                                 342000000  \n",
       "Capstan Therapeutics                               340000000  \n",
       "METiS Pharmaceuticals                              336000000  \n",
       "Forge Biologics                                    330000000  \n",
       "Zenas BioPharma                                    318000000  \n",
       "2seventy bio                                       315000000  \n",
       "Gen4 Dental Partners                               315000000  \n",
       "Hasten                                             315000000  \n",
       "Bicara Therapeutics                                313000000  \n",
       "CARGO Therapeutics                                 310000000  \n",
       "ArriVent Biopharma                                 305000000  \n",
       "Normax Biomed                                      330000000  \n",
       "Uniquity Bio                                       300000000  \n",
       "KELIX bio                                          300000000  \n",
       "ReNAgade Therapeutics                              300000000  \n",
       "Beacon Therapeutics                                290139662  \n",
       "Metsera                                            290000000  \n",
       "AmplifyBio                                         279750000  \n",
       "Mineralys Therapeutics                             278000000  \n",
       "Orbital Therapeutics                               270000000  \n",
       "\n",
       "[50 rows x 29 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_2['Total_Funding_Amount_Currency']= df_2 ['Total Funding Amount'].apply(extract_currency_symbol)\n",
    "\n",
    "# Apply the conversion function\n",
    "df_2['Total Funding Amount (USD)'] = df_2.apply(\n",
    "    lambda row: convert_to_usd(row['Total Funding Amount'], row['Total_Funding_Amount_Currency'], exchange_rates),\n",
    "    axis=1\n",
    ")\n",
    "df_2['Total Funding Amount (USD)'] = df_2['Total Funding Amount (USD)'].apply(lambda x:format(x, ' .0f'))\n",
    "df_2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "016c8ddc-121f-4264-80eb-2f3965858f48",
   "metadata": {},
   "outputs": [],
   "source": [
    "#Re-Rank Companies base on Total Funding Amount (USD) Desc and rename dataset\n",
    "\n",
    "df_1_sorted = df_1.sort_values(by = 'Total Funding Amount (USD)', ascending = False) \n",
    "df_1_sorted['Total Funding Amount (USD)'] = pd.to_numeric(df_1_sorted['Total Funding Amount (USD)'], errors='coerce')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "f57c318b-13db-48d2-b6f6-05bce83cc346",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_2_sorted = df_2.sort_values(by = 'Total Funding Amount (USD)', ascending = False) \n",
    "df_2_sorted['Total Funding Amount (USD)'] = pd.to_numeric(df_2_sorted['Total Funding Amount (USD)'], errors='coerce')\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f38f48c1-6b69-4c58-b376-d3edb0befcb9",
   "metadata": {},
   "source": [
    "# Data Analysis and Visualization\n",
    "\n",
    "In this section, we will be exploring the following research question\n",
    "\n",
    "Questions to Explore:\n",
    "\n",
    "1.Mhealth Dataset Deep Dive \n",
    "\n",
    "- General statics - distribution of total fundings \n",
    "- What are the key themes of MHealth companies that got most of the fundings since 2020\n",
    "- Who are the most active investor in this space\n",
    "- How many mHealth company made to top 50 of general healthcare company?\n",
    "  \n",
    "2. Mhealth vs General Healthcare company (use both dataset 1 and dataset 2)  \n",
    "\n",
    "- What is the distribution of Mhealth Funding (and IPO Status) and how does it compares to general healthcare company's funding (and IPO Status)\n",
    "- What are the key categories of healthcare companies that got most of the fundings since 2020\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d897d1da-146d-426c-858c-cf2f7e219e2e",
   "metadata": {},
   "source": [
    "## Generate General Statistics base on Total Fundings Information "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "74f9da8e-a498-486b-8247-86c24963f5bf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Statistic</th>\n",
       "      <th>mHealth</th>\n",
       "      <th>healthcare</th>\n",
       "      <th>Comparison</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Count</td>\n",
       "      <td>50</td>\n",
       "      <td>50</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Mean</td>\n",
       "      <td>23,231,784</td>\n",
       "      <td>668,989,428</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Standard Deviation</td>\n",
       "      <td>67,796,067</td>\n",
       "      <td>750,953,320</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Min</td>\n",
       "      <td>1,320,000</td>\n",
       "      <td>270,000,000</td>\n",
       "      <td>204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>25%</td>\n",
       "      <td>2,529,562</td>\n",
       "      <td>315,000,000</td>\n",
       "      <td>124</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>50% (Median)</td>\n",
       "      <td>5,000,000</td>\n",
       "      <td>414,000,000</td>\n",
       "      <td>82</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>75%</td>\n",
       "      <td>14,463,750</td>\n",
       "      <td>566,512,501</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Max</td>\n",
       "      <td>462,000,000</td>\n",
       "      <td>3,646,591,000</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            Statistic      mHealth     healthcare Comparison\n",
       "0               Count           50             50          1\n",
       "1                Mean   23,231,784    668,989,428         28\n",
       "2  Standard Deviation   67,796,067    750,953,320         11\n",
       "3                 Min    1,320,000    270,000,000        204\n",
       "4                 25%    2,529,562    315,000,000        124\n",
       "5        50% (Median)    5,000,000    414,000,000         82\n",
       "6                 75%   14,463,750    566,512,501         39\n",
       "7                 Max  462,000,000  3,646,591,000          7"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Generate General Statistics base on total fundings information \n",
    "\n",
    "statistics_mHealth = df_1_sorted ['Total Funding Amount (USD)'].describe()\n",
    "#statistics_mHealth_formatted = statistics_mHealth.apply(lambda x: f\"{x:,.2f}\")\n",
    "\n",
    "statistics_healthcare = df_2_sorted ['Total Funding Amount (USD)'].describe()\n",
    "#statistics_healthcare_formatted = statistics_healthcare.apply(lambda x: f\"{x:,.2f}\")\n",
    "\n",
    "combined_statistics = pd.DataFrame({\n",
    "    'Statistic': ['Count', 'Mean', 'Standard Deviation', 'Min', '25%', '50% (Median)', '75%', 'Max'],\n",
    "    'mHealth': statistics_mHealth.values,\n",
    "    'healthcare': statistics_healthcare.values\n",
    "})\n",
    "\n",
    "combined_statistics['Comparison'] = combined_statistics['healthcare'] / combined_statistics['mHealth']\n",
    "combined_statistics['mHealth'] = combined_statistics['mHealth'].apply(lambda x: f\"{int(x):,}\" if pd.notnull(x) else 'NaN')\n",
    "combined_statistics['healthcare'] = combined_statistics['healthcare'].apply(lambda x: f\"{int(x):,}\" if pd.notnull(x) else 'NaN')\n",
    "combined_statistics['Comparison'] = combined_statistics['Comparison'].apply(lambda x: f\"{int(x):,}\" if pd.notnull(x) else 'NaN')\n",
    "\n",
    "combined_statistics"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "4cc61e53-b275-4d15-affe-95b4f5eb5d27",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#Draw historgram to visualize the distribution of total funding value \n",
    "from matplotlib.ticker import FuncFormatter\n",
    "def millions(x, pos):\n",
    "    'The two args are the value and tick position'\n",
    "    if x >= 1e9:\n",
    "        return f'${x * 1e-9:.1f}B'\n",
    "    else:\n",
    "        return f'${x * 1e-6:.0f}M'\n",
    "\n",
    "formatter = FuncFormatter(millions)\n",
    "\n",
    "plt.figure(figsize = (10,5))\n",
    "df_1_sorted['Total Funding Amount (USD)'].hist(bins = 20, alpha = 0.5, color = 'blue', label = 'mHealth')\n",
    "plt.title('Histogram of Total Funding Distribution (USD) for mHealth Company')\n",
    "plt.xlabel('Total Funding Amount (USD)')\n",
    "plt.ylabel('Frequency')\n",
    "plt.legend()\n",
    "plt.gca().xaxis.set_major_formatter(formatter)\n",
    "plt.xticks(rotation=45)  # Rotate x-axis labels for better readability\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "95a0f58a-de6d-4175-b35e-6c59807db905",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize = (10,5))\n",
    "df_2_sorted['Total Funding Amount (USD)'].hist(bins = 20, alpha = 0.5, color = 'blue', label = 'healthcare')\n",
    "plt.title('Histogram of Total Funding Distribution (USD) for healthcare Company')\n",
    "plt.xlabel('Total Funding Amount (USD)')\n",
    "plt.ylabel('Frequency')\n",
    "plt.legend()\n",
    "plt.gca().xaxis.set_major_formatter(formatter)\n",
    "plt.xticks(rotation=45)  # Rotate x-axis labels for better readability\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "1fc9d669-d7df-4fde-b7e4-f191a96c6ee4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Cerebral'], dtype='object', name='Organization Name')"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Is there any mHealth companies made to top 50 of overall healthcare company?\n",
    "\n",
    "common_indices = df_1_sorted.index.intersection(df_2_sorted.index)\n",
    "common_indices\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f858f015-4aca-429c-b4bd-6a1ff4e021a4",
   "metadata": {},
   "source": [
    "### Interpretation of general statistics comparasion\n",
    "\n",
    "Insights #1 \n",
    "Healthcare companies receive significantly higher funding on average compared to mHealth companies.The distribution of funding is more varied in Healthcare, indicated by the higher standard deviation.The data suggests a higher barrier to entry in terms of minimum funding for Healthcare companies. Only Cerebral (mHealth) Company made to one of the Top 50 of overall healthcare company. \n",
    "\n",
    "Insights #2 \n",
    "Even the least funded companies in Healthcare receive substantially more funding than those in mHealth.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a694214a-9e0d-4ebf-a654-7dc1afb32fc8",
   "metadata": {},
   "source": [
    "## Understand Specific Industries Trend under Healthcare and mHealth"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "ef4c7802-a6a9-4bef-9869-11953bd42c74",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industry Groups</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Health Care</td>\n",
       "      <td>50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Mobile</td>\n",
       "      <td>50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Software</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Science and Engineering</td>\n",
       "      <td>8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Artificial Intelligence (AI)</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Data and Analytics</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Apps</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Information Technology</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Community and Lifestyle</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Other</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Food and Beverage</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Financial Services</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Commerce and Shopping</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Administrative Services</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Sports</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Consumer Goods</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Sales and Marketing</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 Industry Groups  Count\n",
       "0                    Health Care     50\n",
       "1                         Mobile     50\n",
       "2                       Software     18\n",
       "3        Science and Engineering      8\n",
       "4   Artificial Intelligence (AI)      7\n",
       "5             Data and Analytics      7\n",
       "6                           Apps      7\n",
       "7         Information Technology      3\n",
       "8        Community and Lifestyle      2\n",
       "9                          Other      2\n",
       "10             Food and Beverage      2\n",
       "11            Financial Services      2\n",
       "12         Commerce and Shopping      1\n",
       "13       Administrative Services      1\n",
       "14                 Biotechnology      1\n",
       "15                        Sports      1\n",
       "16                Consumer Goods      1\n",
       "17           Sales and Marketing      1"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from collections import Counter\n",
    "\n",
    "mHealth_industries_groups_list = df_1_sorted['Industry Groups'].dropna().str.split(', ')\n",
    "mHealth_all_industries_groups = [industry for sublist in mHealth_industries_groups_list for industry in sublist]\n",
    "mHealth_industry_groups_counts = Counter(mHealth_all_industries_groups)\n",
    "\n",
    "mHealth_industry_groups_counts_df = pd.DataFrame(list(mHealth_industry_groups_counts.items()), columns=['Industry Groups', 'Count'])\n",
    "mHealth_industry_groups_counts_df = mHealth_industry_groups_counts_df.sort_values(by='Count', ascending=False)\n",
    "mHealth_industry_groups_counts_df.reset_index(drop=True, inplace=True)\n",
    "mHealth_industry_groups_counts_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "494c46b6-93e4-47da-9942-261c21cc5b70",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industry</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Health Care</td>\n",
       "      <td>50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Science and Engineering</td>\n",
       "      <td>35</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Software</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Manufacturing</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Community and Lifestyle</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Food and Beverage</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Information Technology</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Artificial Intelligence (AI)</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Data and Analytics</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Sales and Marketing</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Sports</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Mobile</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Financial Services</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Transportation</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        Industry  Count\n",
       "0                    Health Care     50\n",
       "1                  Biotechnology     35\n",
       "2        Science and Engineering     35\n",
       "3                       Software      5\n",
       "4                  Manufacturing      4\n",
       "5        Community and Lifestyle      3\n",
       "6              Food and Beverage      2\n",
       "7         Information Technology      2\n",
       "8   Artificial Intelligence (AI)      2\n",
       "9             Data and Analytics      2\n",
       "10           Sales and Marketing      1\n",
       "11                        Sports      1\n",
       "12                        Mobile      1\n",
       "13            Financial Services      1\n",
       "14                Transportation      1"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "healthcare_industries_groups_list = df_2_sorted['Industry Groups'].dropna().str.split(', ')\n",
    "healthcare_all_industries_groups = [industry for sublist in healthcare_industries_groups_list for industry in sublist]\n",
    "healthcare_industry_groups_counts = Counter(healthcare_all_industries_groups)\n",
    "\n",
    "healthcare_industry_groups_counts_df = pd.DataFrame(list(healthcare_industry_groups_counts.items()), columns=['Industry', 'Count'])\n",
    "healthcare_industry_groups_counts_df = healthcare_industry_groups_counts_df.sort_values(by='Count', ascending=False)\n",
    "healthcare_industry_groups_counts_df.reset_index(drop=True, inplace=True)\n",
    "healthcare_industry_groups_counts_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "7245ec09-0718-4f0e-88b5-0684c8f0d22a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: wordcloud in /opt/anaconda3/lib/python3.11/site-packages (1.9.3)\n",
      "Requirement already satisfied: numpy>=1.6.1 in /opt/anaconda3/lib/python3.11/site-packages (from wordcloud) (1.26.4)\n",
      "Requirement already satisfied: pillow in /opt/anaconda3/lib/python3.11/site-packages (from wordcloud) (10.2.0)\n",
      "Requirement already satisfied: matplotlib in /opt/anaconda3/lib/python3.11/site-packages (from wordcloud) (3.8.0)\n",
      "Requirement already satisfied: contourpy>=1.0.1 in /opt/anaconda3/lib/python3.11/site-packages (from matplotlib->wordcloud) (1.2.0)\n",
      "Requirement already satisfied: cycler>=0.10 in /opt/anaconda3/lib/python3.11/site-packages (from matplotlib->wordcloud) (0.11.0)\n",
      "Requirement already satisfied: fonttools>=4.22.0 in /opt/anaconda3/lib/python3.11/site-packages (from matplotlib->wordcloud) (4.25.0)\n",
      "Requirement already satisfied: kiwisolver>=1.0.1 in /opt/anaconda3/lib/python3.11/site-packages (from matplotlib->wordcloud) (1.4.4)\n",
      "Requirement already satisfied: packaging>=20.0 in /opt/anaconda3/lib/python3.11/site-packages (from matplotlib->wordcloud) (23.1)\n",
      "Requirement already satisfied: pyparsing>=2.3.1 in /opt/anaconda3/lib/python3.11/site-packages (from matplotlib->wordcloud) (3.0.9)\n",
      "Requirement already satisfied: python-dateutil>=2.7 in /opt/anaconda3/lib/python3.11/site-packages (from matplotlib->wordcloud) (2.8.2)\n",
      "Requirement already satisfied: six>=1.5 in /opt/anaconda3/lib/python3.11/site-packages (from python-dateutil>=2.7->matplotlib->wordcloud) (1.16.0)\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "pip install wordcloud"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "872ae0d5-124b-4ad7-b5f2-40b7540ca754",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from wordcloud import WordCloud\n",
    "\n",
    "mHealth_industries_list = df_1_sorted['Industries'].dropna().str.split(', ')\n",
    "mHealth_all_industries = [industry for sublist in mHealth_industries_list for industry in sublist]\n",
    "mHealth_industry_counts = Counter(mHealth_all_industries)\n",
    "\n",
    "mHealth_industry_counts_df = pd.DataFrame(list(mHealth_industry_counts.items()), columns=['Industry', 'Count'])\n",
    "mHealth_industry_counts_df = mHealth_industry_counts_df.sort_values(by='Count', ascending=False)\n",
    "mHealth_industry_counts_df.reset_index(drop=True, inplace=True)\n",
    "mHealth_industry_counts_df\n",
    "\n",
    "#Convert dataframe to dictionary\n",
    "mHealth_industry_counts_dict = mHealth_industry_counts_df.set_index('Industry')['Count'].to_dict()\n",
    "wordcloud = WordCloud(width=600, height=200, background_color='white').generate_from_frequencies(mHealth_industry_counts_dict)\n",
    "\n",
    "# Display the word cloud\n",
    "plt.figure(figsize=(12, 8))\n",
    "plt.imshow(wordcloud, interpolation='bilinear')\n",
    "plt.axis('off')\n",
    "plt.title('mHealth Industry Mentions Word Cloud')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "6e37118c-5516-48b5-884f-effe9ba71fec",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industry</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>mHealth</td>\n",
       "      <td>50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Health Care</td>\n",
       "      <td>46</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Wellness</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Medical</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Mental Health</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Personal Health</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Artificial Intelligence (AI)</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Mobile Apps</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Telehealth</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Software</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Home Health Care</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Health Diagnostics</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Information Technology</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Therapeutics</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Elder Care</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Machine Learning</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Apps</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Medical Device</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Dietary Supplements</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Psychology</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Beauty</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Veterinary</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>E-Commerce</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Digital Marketing</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>B2B</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Hospital</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>SaaS</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Outpatient Care</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Health Insurance</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Electronic Health Record (EHR)</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Employee Benefits</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Women's</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Social</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Diabetes</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Cosmetic Surgery</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Consumer</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Predictive Analytics</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>InsurTech</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Nutrition</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Fitness</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Mobile</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Life Science</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>Image Recognition</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Pharmaceutical</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                          Industry  Count\n",
       "0                          mHealth     50\n",
       "1                      Health Care     46\n",
       "2                         Wellness     25\n",
       "3                          Medical     14\n",
       "4                    Mental Health     12\n",
       "5                  Personal Health     12\n",
       "6     Artificial Intelligence (AI)      7\n",
       "7                      Mobile Apps      6\n",
       "8                       Telehealth      5\n",
       "9                         Software      5\n",
       "10                Home Health Care      4\n",
       "11              Health Diagnostics      4\n",
       "12          Information Technology      3\n",
       "13                    Therapeutics      3\n",
       "14                      Elder Care      2\n",
       "15                Machine Learning      2\n",
       "16                            Apps      2\n",
       "17                  Medical Device      2\n",
       "18             Dietary Supplements      2\n",
       "19                      Psychology      2\n",
       "20                          Beauty      1\n",
       "21                      Veterinary      1\n",
       "22                      E-Commerce      1\n",
       "23               Digital Marketing      1\n",
       "24                             B2B      1\n",
       "25                        Hospital      1\n",
       "26                            SaaS      1\n",
       "27                 Outpatient Care      1\n",
       "28                Health Insurance      1\n",
       "29  Electronic Health Record (EHR)      1\n",
       "30               Employee Benefits      1\n",
       "31                         Women's      1\n",
       "32                          Social      1\n",
       "33                        Diabetes      1\n",
       "34                Cosmetic Surgery      1\n",
       "35                        Consumer      1\n",
       "36            Predictive Analytics      1\n",
       "37                       InsurTech      1\n",
       "38                   Biotechnology      1\n",
       "39                       Nutrition      1\n",
       "40                         Fitness      1\n",
       "41                          Mobile      1\n",
       "42                    Life Science      1\n",
       "43               Image Recognition      1\n",
       "44                  Pharmaceutical      1"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mHealth_industry_counts_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "5a3b1ccf-56b1-4898-8add-7288c3c3a0d8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "healthcare_industries_list = df_2_sorted['Industries'].dropna().str.split(', ')\n",
    "healthcare_all_industries = [industry for sublist in healthcare_industries_list for industry in sublist]\n",
    "healthcare_industry_counts = Counter(healthcare_all_industries)\n",
    "\n",
    "healthcare_industry_counts_df = pd.DataFrame(list(healthcare_industry_counts.items()), columns=['Industry', 'Count'])\n",
    "healthcare_industry_counts_df = healthcare_industry_counts_df.sort_values(by='Count', ascending=False)\n",
    "healthcare_industry_counts_df.reset_index(drop=True, inplace=True)\n",
    "healthcare_industry_counts_df\n",
    "\n",
    "\n",
    "#Convert dataframe to dictionary\n",
    "healthcare_industry_counts_dict = healthcare_industry_counts_df.set_index('Industry')['Count'].to_dict()\n",
    "wordcloud = WordCloud(width=600, height=200, background_color='white').generate_from_frequencies(healthcare_industry_counts_dict)\n",
    "\n",
    "# Display the word cloud\n",
    "plt.figure(figsize=(12, 8))\n",
    "plt.imshow(wordcloud, interpolation='bilinear')\n",
    "plt.axis('off')\n",
    "plt.title('healthcare Industry Mentions Word Cloud')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "ea2b0839-a046-4fd5-803d-41e391315ac7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Industry</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Health Care</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Biotechnology</td>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Therapeutics</td>\n",
       "      <td>18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Medical</td>\n",
       "      <td>16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Pharmaceutical</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Life Science</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Biopharma</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Oncology</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Manufacturing</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Precision Medicine</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Genetics</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Health Diagnostics</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Artificial Intelligence (AI)</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Medical Device</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Personal Health</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Wellness</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Hospital</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Alternative Medicine</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Enterprise Software</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Emergency Medicine</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Dental</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Clinical Trials</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Delivery Service</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Information Technology</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Same Day Delivery</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Dietary Supplements</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Lifestyle</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Financial Services</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Document Management</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Software</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Fitness</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Telehealth</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>mHealth</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Mental Health</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Cannabis</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Nutrition</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Marketing</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>Women's</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                        Industry  Count\n",
       "0                    Health Care     32\n",
       "1                  Biotechnology     32\n",
       "2                   Therapeutics     18\n",
       "3                        Medical     16\n",
       "4                 Pharmaceutical     13\n",
       "5                   Life Science     12\n",
       "6                      Biopharma     10\n",
       "7                       Oncology      5\n",
       "8                  Manufacturing      4\n",
       "9             Precision Medicine      3\n",
       "10                      Genetics      3\n",
       "11            Health Diagnostics      2\n",
       "12  Artificial Intelligence (AI)      2\n",
       "13                Medical Device      2\n",
       "14               Personal Health      2\n",
       "15                      Wellness      2\n",
       "16                      Hospital      2\n",
       "17          Alternative Medicine      1\n",
       "18           Enterprise Software      1\n",
       "19            Emergency Medicine      1\n",
       "20                        Dental      1\n",
       "21               Clinical Trials      1\n",
       "22              Delivery Service      1\n",
       "23        Information Technology      1\n",
       "24             Same Day Delivery      1\n",
       "25           Dietary Supplements      1\n",
       "26                     Lifestyle      1\n",
       "27            Financial Services      1\n",
       "28           Document Management      1\n",
       "29                      Software      1\n",
       "30                       Fitness      1\n",
       "31                    Telehealth      1\n",
       "32                       mHealth      1\n",
       "33                 Mental Health      1\n",
       "34                      Cannabis      1\n",
       "35                     Nutrition      1\n",
       "36                     Marketing      1\n",
       "37                       Women's      1"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "healthcare_industry_counts_df"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a1e80842-a8d1-49a0-beac-2feb6fb8bf09",
   "metadata": {},
   "source": [
    "### Interpretation of top trend and categories \n",
    "\n",
    "Within mHealth, mental health and personal wellness is receiving attention from VCs. In general healthcare categories, biotechnology, Therapeutics, Medical are some of the key words that attracts larger funding\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dc42b457-eb55-474f-aa50-f26f7a85712c",
   "metadata": {},
   "source": [
    "## Other Interesting Data and insights "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "98e7f80e-f0e5-4139-910d-5b91e2852279",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Investor</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Y Combinator</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Welltech Ventures</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Alta Partners</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>The Venture Collective</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Google for Startups</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>Rhythm VC</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>Route 66 Ventures</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>Octopus Ventures</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>Sidar Sahin</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>DigitalHealth.London Accelerator</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>143 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                             Investor  Count\n",
       "0                        Y Combinator      4\n",
       "1                   Welltech Ventures      2\n",
       "2                       Alta Partners      2\n",
       "3              The Venture Collective      2\n",
       "4                 Google for Startups      2\n",
       "..                                ...    ...\n",
       "138                         Rhythm VC      1\n",
       "139                 Route 66 Ventures      1\n",
       "140                  Octopus Ventures      1\n",
       "141                       Sidar Sahin      1\n",
       "142  DigitalHealth.London Accelerator      1\n",
       "\n",
       "[143 rows x 2 columns]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Lead Investor \n",
    "\n",
    "mHealth_investor_list = df_1_sorted['Top 5 Investors'].dropna().str.split(', ')\n",
    "mHealth_investor_list = mHealth_investor_list.apply(lambda x: [investor for investor in x if investor != '—'])\n",
    "mHealth_top_investor = [investor for sublist in mHealth_investor_list for investor in sublist]\n",
    "mHealth_investor_counts = Counter(mHealth_top_investor)\n",
    "\n",
    "mHealth_investor_counts_df = pd.DataFrame(list(mHealth_investor_counts.items()), columns=['Investor', 'Count'])\n",
    "mHealth_investor_counts_df = mHealth_investor_counts_df.sort_values(by='Count', ascending=False)\n",
    "mHealth_investor_counts_df.reset_index(drop=True, inplace=True)\n",
    "mHealth_investor_counts_df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "43b3bf62-30f2-43f5-874c-e06d2a8ebeca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Investor</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>OrbiMed</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>RA Capital Management</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Google Ventures</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Fidelity</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Wellington Management</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>Samsara BioCapital</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>Intermountain Healthcare</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>GreatPoint Ventures</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>Kleiner Perkins</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>Sequoia Capital</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>124 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                     Investor  Count\n",
       "0                     OrbiMed     11\n",
       "1       RA Capital Management      7\n",
       "2             Google Ventures      7\n",
       "3                    Fidelity      7\n",
       "4       Wellington Management      6\n",
       "..                        ...    ...\n",
       "119        Samsara BioCapital      1\n",
       "120  Intermountain Healthcare      1\n",
       "121       GreatPoint Ventures      1\n",
       "122           Kleiner Perkins      1\n",
       "123           Sequoia Capital      1\n",
       "\n",
       "[124 rows x 2 columns]"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "healthcare_investor_list = df_2_sorted['Top 5 Investors'].dropna().str.split(', ')\n",
    "healthcare_top_investor = [investor for sublist in healthcare_investor_list for investor in sublist]\n",
    "healthcare_investor_counts = Counter(healthcare_top_investor)\n",
    "\n",
    "healthcare_investor_counts_df = pd.DataFrame(list(healthcare_investor_counts.items()), columns=['Investor', 'Count'])\n",
    "healthcare_investor_counts_df = healthcare_investor_counts_df.sort_values(by='Count', ascending=False)\n",
    "healthcare_investor_counts_df.reset_index(drop=True, inplace=True)\n",
    "healthcare_investor_counts_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "f2c9c0be-da10-43f5-94aa-4d981a020206",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAccAAAHyCAYAAACeSwWsAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy81sbWrAAAACXBIWXMAAA9hAAAPYQGoP6dpAABGv0lEQVR4nO3de1yO9/8H8Nfd6e6gknScSlLOmZjjVLQcwoZtsowa5hCG9GX4EmYZJjEjzMjZbDFjIofYRmTktJxDpuRYOSXdn98ffvf9dV8d1F26U6/n43E9uK/j+7qv+7pfXdf1ua5bJoQQICIiIhUdbRdARERU0TAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJVIlwXLVqFWQyGY4dO1bg8O7du6N27dpq/WrXro2goKASLefQoUOYNm0aHjx4oFmhVdCmTZvQqFEjGBkZQSaTISkpqcDx4uPjIZPJ8PPPP6v6KberstPT00OtWrXw2Wef4d9//803j+TkZAQFBcHR0REGBgaoWbMm/Pz8sHPnzmLXe/fuXUycOBENGzaEiYkJzM3NUb9+ffTv3x+nTp1SjVcWn4Xff/8d06ZN03j60irutqkoZDIZRo4cWeCwn3/+GTKZDPHx8a+9hpe32T///INp06bh6tWr+cb19vZG48aNS7W8nJwcLFq0CO+++y4sLCxgYGCAt956C3369MGBAwdKNe+qrkqEoya2bNmCKVOmlGiaQ4cOYfr06QzHYrp9+zb69+8PFxcXxMbG4vDhw3BzcyvxfFauXInDhw8jLi4On3/+OTZs2ID27dvj0aNHqnFiYmLQrFkzHD16FFOmTMGePXuwZMkSAICfnx/Gjx//yuU8fPgQrVu3xqpVqzB48GBs27YN69atw5AhQ5CSkqIWHmXxWfj9998xffp0jacvjbLaNlXdP//8g+nTpxcYjqV1584dtGvXDiEhIWjcuDFWrVqFvXv3Yt68edDV1YWPjw9OnjxZ5sutKvS0XUBF1axZM22XUGK5ubmqI6g3wYULF5Cbm4tPP/0UXl5eGs+ncePGaNGiBQCgQ4cOyMvLw1dffYWtW7eiX79+uHz5Mvr3748mTZogPj4eJiYmqmk//vhjDB8+HHPnzoWHhwf69u1b6HI2b96MS5cuYd++fejQoYPasJCQECgUCo3XoaIpq23zssePH8PY2LhM5kXAgAEDcPLkSezatQsdO3ZUG9a3b1+EhITAwsJCS9W9+XjkWAjpaVWFQoGZM2eiXr16MDIyQvXq1eHu7o4FCxYAAKZNm4b//Oc/AABnZ2fVqT7laRyFQoE5c+agfv36kMvlsLa2xoABA3Djxg215QohEB4eDicnJxgaGqJFixaIi4uDt7c3vL29VeMpTzOuWbMG48aNw1tvvQW5XI5Lly7h9u3bCA4ORsOGDVGtWjVYW1ujY8eO+OOPP9SWdfXqVchkMsydOxezZ89G7dq1YWRkBG9vb9WX45dffgl7e3uYm5ujV69eyMjIKNb7t23bNrRp0wbGxsYwNTWFr68vDh8+rBoeFBSEd999FwDg7+8PmUymtn6l0bp1awDAtWvXAADz58/H48eP8d1336kFo9K8efNQvXp1fP3110XO9+7duwAAOzu7Aofr6LzYnV71Wdi0aRM6deoEOzs7GBkZoUGDBvjyyy/VjnSDgoLw/fffA4DaqeOrV6+qttuqVavy1SA9rXf79m0MGTIEDg4OkMvlsLKyQrt27bBnz55C1/NV2+ZV21b5HshkMhw/fhwfffQRLCws4OLiUugylafI9+3bh88//xyWlpYwMzPDgAED8OjRI6Snp6NPnz6oXr067OzsEBoaitzc3ELnV1zHjh3D+++/jxo1asDQ0BDNmjXDTz/9pDZOcfengtbp448/BvDijzblNpRut8TERLRv3x7GxsaoU6cOvvnmm1f+ofX3339j586dGDRoUL5gVHrnnXfg6Oioen3mzBl88MEHsLCwgKGhId5++21ER0erTaP8Xlm/fj0mTJgAOzs7VKtWDT169MCtW7eQnZ2NIUOGoGbNmqhZsyY+++wzPHz4UG0eytPbS5cuhZubG+RyORo2bIiNGzdq9L4qP+/ffvstIiIi4OzsjGrVqqFNmzZISEhQjbdmzRrIZLJ8n0UAmDFjBvT19XHz5s0i31c1ogpYuXKlACASEhJEbm5uvs7Pz084OTmpTePk5CQCAwNVr2fNmiV0dXVFWFiY2Lt3r4iNjRWRkZFi2rRpQgghUlNTxahRowQAERMTIw4fPiwOHz4sMjMzhRBCDBkyRAAQI0eOFLGxsSIqKkpYWVkJBwcHcfv2bdVyJk6cKACIIUOGiNjYWLF8+XLh6Ogo7OzshJeXl2q8/fv3CwDirbfeEh999JHYtm2b2L59u7h79644d+6cGD58uNi4caOIj48X27dvF4MGDRI6Ojpi//79qnmkpKQIAMLJyUn06NFDbN++Xaxdu1bY2NgINzc30b9/fzFw4ECxc+dOERUVJapVqyZ69Ojxyvd73bp1AoDo1KmT2Lp1q9i0aZNo3ry5MDAwEH/88YcQQohLly6J77//XgAQ4eHh4vDhw+Ls2bOFzlO5vps3b863XRMTE9XGXbBggQAgli1bJoQQws3NTdjY2BRZc58+fQQAkZaWVug4f/75pwAg3nnnHbFlyxZx586dAsd71Wfhq6++EvPnzxc7duwQ8fHxIioqSjg7O4sOHTqo5nHp0iXx0UcfCQCq6Q8fPiyePn2q2m4rV67Mt2wAIiwsTPW6c+fOwsrKSixbtkzEx8eLrVu3iqlTp4qNGzcWup5FbZvibFshhAgLC1N9tiZMmCDi4uLE1q1bC12mcls6OzuLcePGid27d4vZs2cLXV1d8cknnwgPDw8xc+ZMERcXJyZMmCAAiHnz5uVb9+Dg4AL38U2bNgkAap//ffv2CQMDA9G+fXuxadMmERsbK4KCgvK9t8Xdn6Tvf0ZGhggPDxcAxPfff6/ahhkZGUIIIby8vISlpaVwdXUVUVFRIi4uTgQHBwsAIjo6utD3Sgihmu/OnTuLHO/ldTA1NRUuLi5i9erVYseOHeKTTz4RAMTs2bNV4yn3MycnJxEUFKT6rqpWrZro0KGD8PX1FaGhoWrbZ9SoUfneAwcHB9GwYUOxYcMGsW3bNtGlS5d8+29Jv6dq164tunTpIrZu3Sq2bt0qmjRpIiwsLMSDBw+EEELk5OQIW1tb0a9fP7V6cnNzhb29vfj444+L9V6p1qNEY7+hlDteUd2rwrF79+7i7bffLnI5c+fOFQBESkqKWv/k5GTVjvuyI0eOCABi0qRJQggh7t27J+RyufD391cb7/DhwwJAgeHo6en5yvV//vy5yM3NFT4+PqJXr16q/soPXdOmTUVeXp6qf2RkpAAg3n//fbX5jBkzRgBQfckXJC8vT9jb24smTZqozTM7O1tYW1uLtm3b5luHl3eYwhQVjso/erKzs8X27duFlZWVMDU1Fenp6UIIIQwNDUXr1q2LnL/yC/fIkSNFjjdjxgxhYGCg+tw4OzuLYcOGiZMnT6qNV9hnQUqhUIjc3Fxx4MABAUBtPiNGjBAF/f1aknCsVq2aGDNmTJE1FKSg97sk21YZjlOnTi3W8pTbUvpF27NnTwFAREREqPV/++23hYeHh1q/V+3j0nCsX7++aNasmcjNzVWbT/fu3YWdnZ3aOr6ssP1JWcPL7//mzZvzLVfJy8urwM9cw4YNRefOnQtcttKwYcMEAHHu3Lkix1Pq27evkMvl4vr162r9u3btKoyNjVUBo9zu0j+Clfv+F198oda/Z8+eokaNGmr9AAgjIyPV/ifEi/esfv36om7duoXW+KrvqSZNmojnz5+r+h89elQAEBs2bFD1CwsLEwYGBuLWrVuqfso/jA4cOFDosgtSpU6rrl69GomJifk65SmkorRs2RInT55EcHAwdu3ahaysrGIvd//+/QCQr/Vry5Yt0aBBA+zduxcAkJCQgJycHPTp00dtvNatW+drTav04YcfFtg/KioKHh4eMDQ0hJ6eHvT19bF3714kJyfnG9fPz091ShAAGjRoAADo1q2b2njK/tevXy9kTYHz58/j5s2b6N+/v9o8q1Wrhg8//BAJCQl4/PhxodNronXr1tDX14epqSm6d+8OW1tb7Ny5EzY2NsWeh/j/nzWVyWRFjjdlyhRcv34dP/74I4YOHYpq1aohKioKzZs3x4YNG4q1rCtXriAgIAC2trbQ1dWFvr6+6rpeQdunNFq2bIlVq1Zh5syZSEhIKNWpSE22bWGfz8J0795d7XVRn0XlafOX9enTp8B9fPbs2WrjXbp0CefOnUO/fv0AAM+fP1d1fn5+SEtLw/nz51Xjl2R/KglbW1u0bNlSrZ+7u3uB61Ya+/btg4+PDxwcHNT6BwUF4fHjx/lORZZkO9y7dy/fqVUfHx+1/U9XVxf+/v64dOmS2qWkkryv3bp1g66uruq1u7s7AKi9V8OHDwcALF++XNVv0aJFaNKkCTw9PfPNsyhVKhwbNGiAFi1a5OvMzc1fOe3EiRPx7bffIiEhAV27doWlpSV8fHwKvT3kZUVdq7K3t1cNV/5b0Jd6YV/0Bc0zIiICw4cPR6tWrfDLL78gISEBiYmJ6NKlC548eZJv/Bo1aqi9NjAwKLL/06dPC6zl5XUobF0VCgXu379f6PSaUP7Rc+LECdy8eROnTp1Cu3btVMMdHR2RkpJS5DyUrQmlXx4FsbGxwWeffYaoqCicOnUKBw4cgIGBAUaPHv3KaR8+fIj27dvjyJEjmDlzJuLj45GYmIiYmBgAKHD7lMamTZsQGBiIH374AW3atEGNGjUwYMAApKenl3hemmzbwq7PFqYkn8WCPodWVlYF7uN16tRRG+/WrVsAgNDQUOjr66t1wcHBAF60BgVKvj+VhKWlZb5+crn8lfNVXkt81eda6e7du4VuN+Xwl5X2O8HW1jbfspT9lMsq6fsqfa/kcjkA9X3GxsYG/v7+WLp0KfLy8nDq1Cn88ccfhd7iU5Q3o1ljBaCnp4eQkBCEhITgwYMH2LNnDyZNmoTOnTsjNTW1yFZ4yo2alpaGWrVqqQ27efMmatasqTaecsd9WXp6eoFHjwUd6axduxbe3t6qWxWUsrOzi17JMvDyukrdvHkTOjo6Zd6CTvlHT2F8fX3x/fffIyEhQdVY52WPHz9GXFwcGjduXOBO/Sqenp7o1KkTtm7dioyMDFhbWxc67r59+3Dz5k3Ex8ertQItyS0fhoaGAF7c4/Yy6RccANSsWRORkZGIjIzE9evXsW3bNnz55ZfIyMhAbGxssZcJaLZtX3Ukri3KfW7ixIno3bt3gePUq1cPgHb3p8J07twZkyZNwtatW9GlS5dXjm9paVnodgP+936UlYL++FL2U36OXtf7Onr0aKxZswa//vorYmNjUb16ddUZgpKoUkeOZaV69er46KOPMGLECNy7d0911FHQXzIAVK3J1q5dq9Y/MTERycnJ8PHxAQC0atUKcrkcmzZtUhsvISGhRKdZZDKZqhalU6dOFdiKq6zVq1cPb731FtavX686VQkAjx49wi+//KJq5Viexo4dCyMjI4waNUqtRahSaGgo7t+/j//+979FzufWrVsFtiLMy8vDxYsXYWxsjOrVqwMo/LOgDAvp9lm6dGm++RY2DxsbGxgaGqo9dAAAfv311yLrd3R0xMiRI+Hr64vjx48XOW5BKuK21VS9evXg6uqKkydPFnik2aJFC5iamgIo3f5U2DYsLQ8PD3Tt2hUrVqzAvn37Chzn2LFjqksgPj4+qj/MXrZ69WoYGxsX+Edjaezdu1ftj/y8vDxs2rQJLi4uqgOE1/U91bx5c7Rt2xazZ8/GunXrEBQUVGAr9VfhkWMx9ejRQ3U/nZWVFa5du4bIyEg4OTnB1dUVANCkSRMAwIIFCxAYGAh9fX3Uq1cP9erVw5AhQ/Ddd99BR0cHXbt2xdWrVzFlyhQ4ODhg7NixAF6csggJCcGsWbNgYWGBXr164caNG5g+fTrs7OzUrvMUpXv37vjqq68QFhYGLy8vnD9/HjNmzICzszOeP3/+et6g/6ejo4M5c+agX79+6N69O4YOHYqcnBzMnTsXDx48wDfffPNal18QFxcXrFmzBv369cM777yDkJAQ1KtXD7du3cKPP/6InTt3IjQ0FP7+/kXOZ82aNVi6dCkCAgLwzjvvwNzcHDdu3MAPP/yAs2fPYurUqarTTIV9Ftq2bQsLCwsMGzYMYWFh0NfXx7p16wq8WVs5j9mzZ6Nr167Q1dWFu7s7DAwM8Omnn+LHH3+Ei4sLmjZtiqNHj2L9+vVq02dmZqJDhw4ICAhA/fr1YWpqisTERMTGxhZ6tFSUirhtS2Pp0qXo2rUrOnfujKCgILz11lu4d+8ekpOTcfz4cWzevBlA6fYn5RNwli1bBlNTUxgaGsLZ2bnA06kltXr1anTp0gVdu3bFwIED0bVrV1hYWCAtLQ2//fYbNmzYgL///huOjo4ICwvD9u3b0aFDB0ydOhU1atTAunXrsGPHDsyZM6dYl5ZKombNmujYsSOmTJkCExMTLF68GOfOnVO7neN1fk+NHj1adRuS8jR5iZWo+c4bqrAm/0rdunV7ZWvVefPmibZt24qaNWsKAwMD4ejoKAYNGiSuXr2qNt3EiROFvb290NHRUWullpeXJ2bPni3c3NyEvr6+qFmzpvj0009Famqq2vQKhULMnDlT1KpVSxgYGAh3d3exfft20bRpU7UWXEW19MzJyRGhoaHirbfeEoaGhsLDw0Ns3bpVBAYGqq2nshXY3Llz1aYvbN6veh9ftnXrVtGqVSthaGgoTExMhI+Pj/jrr7+KtZyClORWjsKcPXtWBAYGilq1agl9fX1Ro0YN0aVLF7Fjx45iTf/PP/+IcePGiRYtWggrKyuhp6cnLCwshJeXl1izZk2+8Qv7LBw6dEi0adNGGBsbCysrKzF48GBx/PjxfC1Qc3JyxODBg4WVlZWQyWRqrV8zMzPF4MGDhY2NjTAxMRE9evQQV69eVWst+fTpUzFs2DDh7u4uzMzMhJGRkahXr54ICwsTjx49KnJdi9o2xdm2ytaqL9+mVJTCtmVh8wkMDBQmJiZq/QCIESNGFDj/wlqNnjx5UvTp00dYW1sLfX19YWtrKzp27CiioqJU4xR3f1LW8HJrVSFetP52dnYWurq6atvYy8tLNGrUKF+tBc23ME+ePBELFy4Ubdq0EWZmZkJPT0/Y29uL3r175/tcnz59WvTo0UOYm5sLAwMD0bRp03wtnku67xe0fZTbYfHixcLFxUXo6+uL+vXri3Xr1qlNW9rvKeWypO+3ct5yuVx06dKlqLevSLL/XwBVYCkpKahfvz7CwsIwadIkbZdDRFQomUyGESNGYNGiRVqr4bfffsP777+PHTt2wM/PT6N58LRqBXPy5Els2LABbdu2hZmZGc6fP485c+bAzMwMgwYN0nZ5REQV1j///INr165h3LhxePvtt9G1a1eN58VwrGBMTExw7NgxrFixAg8ePIC5uTm8vb3x9ddfl+i+PSKiqiY4OBh//fUXPDw8EB0dXarW0jytSkREJMFbOYiIiCQYjkRERBKV/pqjQqHAzZs3YWpqWmGf1kFERK+fEALZ2dmwt7d/9X3jGt8EUgaU98i83L3800IKhUKEhYUJOzs7YWhoKLy8vMSZM2dKtIzU1NRiPa2fHTt27NhVjU56f3lBtH7k2KhRI7UfXn35qetz5sxBREQEVq1aBTc3N8ycORO+vr44f/686tFOr6IcLzU1FWZmZmVbPBERvTGysrLg4OBQrPzQejjq6ekV+LBnIQQiIyMxefJk1aOuoqOjYWNjg/Xr12Po0KEFzi8nJ0ftgczKh9iamZkxHImIqFiX2LTeIOfixYuwt7eHs7Mz+vbtiytXrgB48VSY9PR0dOrUSTWuXC6Hl5cXDh06VOj8Zs2aBXNzc1VXnJ8gIiIieplWw7FVq1ZYvXo1du3aheXLlyM9PR1t27bF3bt3VT9vIr3x3cbGpsjfops4cSIyMzNVXWpq6mtdByIiqny0elr15Uf7NGnSBG3atIGLiwuio6NVP6EiPfwVQhR5SCyXy/P9DAoREVFJaP2a48tMTEzQpEkTXLx4ET179gTw4gcyX/4F64yMDD5GjYjeaHl5ecjNzdV2GZWOvr6+WqPO0qhQ4ZiTk4Pk5GS0b98ezs7OsLW1RVxcHJo1awYAePbsGQ4cOIDZs2druVIiopITQiA9PR0PHjzQdimVVvXq1WFra1vq+9q1Go6hoaHo0aMHHB0dkZGRgZkzZyIrKwuBgYGQyWQYM2YMwsPD4erqCldXV4SHh8PY2BgBAQHaLJuISCPKYLS2toaxsTEfTFKGhBB4/PgxMjIyAEDtjKMmtBqON27cwCeffII7d+7AysoKrVu3RkJCApycnAAA48ePx5MnTxAcHIz79++jVatW2L17d7HvcSQiqijy8vJUwWhpaantciolIyMjAC8uv1lbW5fqFGul/1WOrKwsmJubIzMzk/c5EpHWPH36FCkpKahdu7bqS5zK3pMnT3D16lU4OzvD0NBQbVhJ8kDr9zkSEVUlPJX6epXV+8twJCIikmA4EhERSVSoWzmIiKqiadMq9/LeRDxyJCKiCu/q1auQyWRISkoql+UxHImIiCQYjkRE9EoKhQKzZ89G3bp1IZfL4ejoiK+//hoAcPr0aXTs2BFGRkawtLTEkCFD8PDhQ9W03t7eGDNmjNr8evbsiaCgINXr2rVrIzw8HAMHDoSpqSkcHR2xbNky1XBnZ2cAQLNmzSCTyeDt7f3a1hVgOBIRUTFMnDgRs2fPxpQpU/DPP/9g/fr1sLGxwePHj9GlSxdYWFggMTERmzdvxp49ezBy5MgSL2PevHlo0aIFTpw4geDgYAwfPhznzp0DABw9ehQAsGfPHqSlpSEmJqZM10+KDXLeALx4rn3cBlSVZWdnY8GCBVi0aBECAwMBAC4uLnj33XexfPlyPHnyBKtXr4aJiQkAYNGiRejRowdmz55doh+K8PPzQ3BwMABgwoQJmD9/PuLj41G/fn1YWVkBACwtLWFra1vGa5gfjxyJiKhIycnJyMnJgY+PT4HDmjZtqgpGAGjXrh0UCgXOnz9fouW4u7ur/i+TyWBra6t6Vmp5YzgSEVGRinrcXVG/savsr6OjA+mTSgv6yS59ff180ysUipKWWyYYjkREVCRXV1cYGRlh7969+YY1bNgQSUlJePTokarfX3/9BR0dHbi5uQEArKyskJaWphqel5eHM2fOlKgGAwMD1bTlgeFIRERFMjQ0xIQJEzB+/HisXr0aly9fRkJCAlasWIF+/frB0NAQgYGBOHPmDPbv349Ro0ahf//+quuNHTt2xI4dO7Bjxw6cO3cOwcHBJf5NS2traxgZGSE2Nha3bt1CZmbma1jT/2GDHCIiLXsTGnxNmTIFenp6mDp1Km7evAk7OzsMGzYMxsbG2LVrF0aPHo133nkHxsbG+PDDDxEREaGaduDAgTh58iQGDBgAPT09jB07Fh06dCjR8vX09LBw4ULMmDEDU6dORfv27REfH1/Ga/k//MmqN8CbsONUdtwGVFrKn6wq6KeUqOwU9T7zJ6uIiIhKgeFIREQkwXAkIiKSYDgSERFJMByJiMqRtm5qryrK6v3lrRxEROXAwMAAOjo6uHnzJqysrGBgYFDok2Wo5IQQePbsGW7fvg0dHR3VQwM0xXAkIioHOjo6cHZ2RlpaGm7evKntciotY2NjODo6QkendCdGGY5EROXEwMAAjo6OeP78ebk9Bq0q0dXVhZ6eXpkckTMciYjKkUwmg76+fr6HbFPFwgY5REREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJCIikmA4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIVJhxnzZoFmUyGMWPGqPoJITBt2jTY29vDyMgI3t7eOHv2rPaKJCKiKqFChGNiYiKWLVsGd3d3tf5z5sxBREQEFi1ahMTERNja2sLX1xfZ2dlaqpSIiKoCrYfjw4cP0a9fPyxfvhwWFhaq/kIIREZGYvLkyejduzcaN26M6OhoPH78GOvXr9dixUREVNlpPRxHjBiBbt264b333lPrn5KSgvT0dHTq1EnVTy6Xw8vLC4cOHSp0fjk5OcjKylLriIiISkJPmwvfuHEjjh8/jsTExHzD0tPTAQA2NjZq/W1sbHDt2rVC5zlr1ixMnz69bAslIqIqRWtHjqmpqRg9ejTWrl0LQ0PDQseTyWRqr4UQ+fq9bOLEicjMzFR1qampZVYzERFVDVo7cvz777+RkZGB5s2bq/rl5eXh4MGDWLRoEc6fPw/gxRGknZ2dapyMjIx8R5Mvk8vlkMvlr69wIiKq9LR25Ojj44PTp08jKSlJ1bVo0QL9+vVDUlIS6tSpA1tbW8TFxammefbsGQ4cOIC2bdtqq2wiIqoCtHbkaGpqisaNG6v1MzExgaWlpar/mDFjEB4eDldXV7i6uiI8PBzGxsYICAjQRslERFRFaLVBzquMHz8eT548QXBwMO7fv49WrVph9+7dMDU11XZpRERUicmEEELbRbxOWVlZMDc3R2ZmJszMzLRdjkamTdN2BcRtQPTmK0keaP0+RyIiooqG4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJCIikmA4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJCIikmA4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJCIikmA4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkodVwXLJkCdzd3WFmZgYzMzO0adMGO3fuVA0XQmDatGmwt7eHkZERvL29cfbsWS1WTEREVYFWw7FWrVr45ptvcOzYMRw7dgwdO3bEBx98oArAOXPmICIiAosWLUJiYiJsbW3h6+uL7OxsbZZNRESVnFbDsUePHvDz84Obmxvc3Nzw9ddfo1q1akhISIAQApGRkZg8eTJ69+6Nxo0bIzo6Go8fP8b69esLnWdOTg6ysrLUOiIiopKoMNcc8/LysHHjRjx69Aht2rRBSkoK0tPT0alTJ9U4crkcXl5eOHToUKHzmTVrFszNzVWdg4NDeZRPRESViNbD8fTp06hWrRrkcjmGDRuGLVu2oGHDhkhPTwcA2NjYqI1vY2OjGlaQiRMnIjMzU9Wlpqa+1vqJiKjy0dN2AfXq1UNSUhIePHiAX375BYGBgThw4IBquEwmUxtfCJGv38vkcjnkcvlrq5eIiCo/rR85GhgYoG7dumjRogVmzZqFpk2bYsGCBbC1tQWAfEeJGRkZ+Y4miYiIypLWw1FKCIGcnBw4OzvD1tYWcXFxqmHPnj3DgQMH0LZtWy1WSERElZ1Gp1VTUlLg7Oxc6oVPmjQJXbt2hYODA7Kzs7Fx40bEx8cjNjYWMpkMY8aMQXh4OFxdXeHq6orw8HAYGxsjICCg1MsmIiIqjEbhWLduXXh6emLQoEH46KOPYGhoqNHCb926hf79+yMtLQ3m5uZwd3dHbGwsfH19AQDjx4/HkydPEBwcjPv376NVq1bYvXs3TE1NNVoeERFRcciEEKKkE505cwY//vgj1q1bh5ycHPj7+2PQoEFo2bLl66ixVLKysmBubo7MzEyYmZlpuxyNTJum7QqI24DozVeSPNDommPjxo0RERGBf//9FytXrkR6ejreffddNGrUCBEREbh9+7ZGhRMREVUEpWqQo6enh169euGnn37C7NmzcfnyZYSGhqJWrVoYMGAA0tLSyqpOIiKiclOqcDx27BiCg4NhZ2eHiIgIhIaG4vLly9i3bx/+/fdffPDBB2VVJxERUbnRqEFOREQEVq5cifPnz8PPzw+rV6+Gn58fdHReZK2zszOWLl2K+vXrl2mxRERE5UGjcFyyZAkGDhyIzz77THWzvpSjoyNWrFhRquKIiIi0QaNwvHjx4ivHMTAwQGBgoCazJyIi0iqNrjmuXLkSmzdvztd/8+bNiI6OLnVRRERE2qRROH7zzTeoWbNmvv7W1tYIDw8vdVFERETapFE4Xrt2rcDHxzk5OeH69eulLoqIiEibNApHa2trnDp1Kl//kydPwtLSstRFERERaZNG4di3b1988cUX2L9/P/Ly8pCXl4d9+/Zh9OjR6Nu3b1nXSEREVK40aq06c+ZMXLt2DT4+PtDTezELhUKBAQMG8JojERG98TQKRwMDA2zatAlfffUVTp48CSMjIzRp0gROTk5lXR8REVG50ygcldzc3ODm5lZWtRAREVUIGoVjXl4eVq1ahb179yIjIwMKhUJt+L59+8qkOCIiIm3QKBxHjx6NVatWoVu3bmjcuDFkMllZ10VERKQ1GoXjxo0b8dNPP8HPz6+s6yEiItI6jW7lMDAwQN26dcu6FiIiogpBo3AcN24cFixYACFEWddDRESkdRqdVv3zzz+xf/9+7Ny5E40aNYK+vr7a8JiYmDIpjoiISBs0Csfq1aujV69eZV0LERFRhaBROK5cubKs6yAiIqowNLrmCADPnz/Hnj17sHTpUmRnZwMAbt68iYcPH5ZZcURERNqg0ZHjtWvX0KVLF1y/fh05OTnw9fWFqakp5syZg6dPnyIqKqqs6yQiIio3Gh05jh49Gi1atMD9+/dhZGSk6t+rVy/s3bu3zIojIiLSBo1bq/71118wMDBQ6+/k5IR///23TAojIiLSFo2OHBUKBfLy8vL1v3HjBkxNTUtdFBERkTZpFI6+vr6IjIxUvZbJZHj48CHCwsL4SDkiInrjaXRadf78+ejQoQMaNmyIp0+fIiAgABcvXkTNmjWxYcOGsq6RiIioXGkUjvb29khKSsKGDRtw/PhxKBQKDBo0CP369VNroENERPQm0vjHjo2MjDBw4EAMHDiwLOshIiLSOo3CcfXq1UUOHzBggEbFEBERVQQa/9jxy3Jzc/H48WMYGBjA2NiY4UhERG80jVqr3r9/X617+PAhzp8/j3fffZcNcoiI6I2n8bNVpVxdXfHNN9/kO6okIiJ605RZOAKArq4ubt68WZazJCIiKncaXXPctm2b2mshBNLS0rBo0SK0a9euTAojIiLSFo3CsWfPnmqvZTIZrKys0LFjR8ybN68s6iIiItIajcJRoVCUdR1EREQVRplecyQiIqoMNDpyDAkJKfa4ERERmiyCiIhIazQKxxMnTuD48eN4/vw56tWrBwC4cOECdHV14eHhoRpPJpOVTZVERETlSKNw7NGjB0xNTREdHQ0LCwsALx4M8Nlnn6F9+/YYN25cmRZJRERUnjS65jhv3jzMmjVLFYwAYGFhgZkzZ7K1KhERvfE0CsesrCzcunUrX/+MjAxkZ2eXuigiIiJt0igce/Xqhc8++ww///wzbty4gRs3buDnn3/GoEGD0Lt377KukYiIqFxpdM0xKioKoaGh+PTTT5Gbm/tiRnp6GDRoEObOnVumBRIREZU3jcLR2NgYixcvxty5c3H58mUIIVC3bl2YmJiUdX1ERETlrlQPAUhLS0NaWhrc3NxgYmICIURZ1UVERKQ1GoXj3bt34ePjAzc3N/j5+SEtLQ0AMHjwYN7GQUREbzyNwnHs2LHQ19fH9evXYWxsrOrv7++P2NjYMiuOiIhIGzS65rh7927s2rULtWrVUuvv6uqKa9eulUlhRERE2qLRkeOjR4/UjhiV7ty5A7lcXuqiiIiItEmjcPT09MTq1atVr2UyGRQKBebOnYsOHTqUWXFERETaoNFp1blz58Lb2xvHjh3Ds2fPMH78eJw9exb37t3DX3/9VdY1EhERlSuNjhwbNmyIU6dOoWXLlvD19cWjR4/Qu3dvnDhxAi4uLmVdIxERUbkq8ZFjbm4uOnXqhKVLl2L69OmvoyYiIiKtKvGRo76+Ps6cOcPfaiQiokpLo9OqAwYMwIoVK8q6FiIiogpBowY5z549ww8//IC4uDi0aNEi3zNVIyIiyqQ4IiIibShROF65cgW1a9fGmTNn4OHhAQC4cOGC2jg83UpERG+6EoWjq6sr0tLSsH//fgAvHhe3cOFC2NjYvJbiiIiItKFE1xylv7qxc+dOPHr0qEwLIiIi0rZS/WQVf6KKiIgqoxKFo0wmy3dNkdcYiYiosinRNUchBIKCglQPF3/69CmGDRuWr7VqTExMseY3a9YsxMTE4Ny5czAyMkLbtm0xe/Zs1KtXT22Z06dPx7Jly3D//n20atUK33//PRo1alSS0omIiIqtREeOgYGBsLa2hrm5OczNzfHpp5/C3t5e9VrZFdeBAwcwYsQIJCQkIC4uDs+fP0enTp3UrmPOmTMHERERWLRoERITE2FrawtfX19kZ2eXpHQiIqJik4kKdOHw9u3bsLa2xoEDB+Dp6QkhBOzt7TFmzBhMmDABAJCTkwMbGxvMnj0bQ4cOfeU8s7KyYG5ujszMTJiZmb3uVXgtpk3TdgXEbUD05itJHpSqQU5Zy8zMBADUqFEDAJCSkoL09HR06tRJNY5cLoeXlxcOHTpU4DxycnKQlZWl1hEREZVEhQlHIQRCQkLw7rvvonHjxgCA9PR0AMh3H6WNjY1qmNSsWbPUTvE6ODi83sKJiKjSqTDhOHLkSJw6dQobNmzIN0zaIlYIUWgr2YkTJyIzM1PVpaamvpZ6iYio8tLo2aplbdSoUdi2bRsOHjyIWrVqqfrb2toCeHEEaWdnp+qfkZFR6FN55HK5qjUtERGRJrR65CiEwMiRIxETE4N9+/bB2dlZbbizszNsbW0RFxen6vfs2TMcOHAAbdu2Le9yiYioitDqkeOIESOwfv16/PrrrzA1NVVdRzQ3N4eRkRFkMhnGjBmD8PBwuLq6wtXVFeHh4TA2NkZAQIA2SyciokpMq+G4ZMkSAIC3t7da/5UrVyIoKAgAMH78eDx58gTBwcGqhwDs3r0bpqam5VwtERFVFVoNx+LcYimTyTBt2jRM441mRERUTipMa1UiIqKKguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJCIikmA4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJCIikmA4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISEKr4Xjw4EH06NED9vb2kMlk2Lp1q9pwIQSmTZsGe3t7GBkZwdvbG2fPntVOsUREVGVoNRwfPXqEpk2bYtGiRQUOnzNnDiIiIrBo0SIkJibC1tYWvr6+yM7OLudKiYioKtHT5sK7du2Krl27FjhMCIHIyEhMnjwZvXv3BgBER0fDxsYG69evx9ChQ8uzVCIiqkIq7DXHlJQUpKeno1OnTqp+crkcXl5eOHToUKHT5eTkICsrS60jIiIqiQobjunp6QAAGxsbtf42NjaqYQWZNWsWzM3NVZ2Dg8NrrZOIiCqfChuOSjKZTO21ECJfv5dNnDgRmZmZqi41NfV1l0hERJWMVq85FsXW1hbAiyNIOzs7Vf+MjIx8R5Mvk8vlkMvlr70+IiKqvCrskaOzszNsbW0RFxen6vfs2TMcOHAAbdu21WJlRERU2Wn1yPHhw4e4dOmS6nVKSgqSkpJQo0YNODo6YsyYMQgPD4erqytcXV0RHh4OY2NjBAQEaLFqIiKq7LQajseOHUOHDh1Ur0NCQgAAgYGBWLVqFcaPH48nT54gODgY9+/fR6tWrbB7926Ymppqq2QiIqoCZEIIoe0iXqesrCyYm5sjMzMTZmZm2i5HI9OmabsC4jYgevOVJA8q7DVHIiIibWE4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJCIikmA4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJCIikmA4EhERSTAciYiIJBiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZGEnrYLICIqjmnTtF0BVaVtwCNHIiIiCYYjERGRBMORiIhI4o0Ix8WLF8PZ2RmGhoZo3rw5/vjjD22XRERElViFD8dNmzZhzJgxmDx5Mk6cOIH27duja9euuH79urZLIyKiSqrCt1aNiIjAoEGDMHjwYABAZGQkdu3ahSVLlmDWrFn5xs/JyUFOTo7qdWZmJgAgKyurfAp+DV5aHdKSN/jjU2lwP9C+N30/UOaAEOLVI4sKLCcnR+jq6oqYmBi1/l988YXw9PQscJqwsDABgB07duzYsSuwS01NfWX+VOgjxzt37iAvLw82NjZq/W1sbJCenl7gNBMnTkRISIjqtUKhwL1792BpaQmZTPZa66WCZWVlwcHBAampqTAzM9N2OURawf1A+4QQyM7Ohr29/SvHrdDhqCQNNSFEoUEnl8shl8vV+lWvXv11lUYlYGZmxi8FqvK4H2iXubl5scar0A1yatasCV1d3XxHiRkZGfmOJomIiMpKhQ5HAwMDNG/eHHFxcWr94+Li0LZtWy1VRURElV2FP60aEhKC/v37o0WLFmjTpg2WLVuG69evY9iwYdoujYpJLpcjLCws3+luoqqE+8GbRSZEcdq0atfixYsxZ84cpKWloXHjxpg/fz48PT21XRYREVVSb0Q4EhERlacKfc2RiIhIGxiOREREEgxHIiIiCYYjERGRBMORiIhIguFIREQkwXCkCol3GBGRNjEcqUJRhmJBD5snqsyUn/EbN27g3r17Wq6GGI5UYSh/beXw4cMIDw/H9OnTsXbtWgD5w5KoMlF+9n/99Ve8//772LFjBwNSyxiOVGHIZDLExMTAz88PSUlJuHTpEkaOHImhQ4dquzSi10omk+H333/HJ598gv79+8PT0xM1atTQdllVWoV/8DhVHZcvX8a4ceMwc+ZMjBgxAhcuXMC2bdugo8O/4ahyyc3Nhb6+PoAXR42PHz/G/PnzMXbsWIwdO1Y1XlG/XUuvF791SOsUCgUAID09HVZWVhgxYgSuXbsGHx8fBAQEYMmSJQCAo0eParNMojIxbtw4bNy4UfVaGX6pqamoV68egP/tE8phGRkZ5VwlMRypXCl3euW/AHD37l3V/3V1dXHw4EF4enrCz88P3333HQAgKSkJS5Yswfnz58u3YKIypq+vjyZNmgD4335gaGiIvLw8HD9+HACgo6ODvLw8AMC5c+ewY8cOZGZmaqfgKorhSOVKR0cHFy5cwPLlywEAmzdvRvPmzZGRkYGaNWsiOzsbnTt3ho+PD5YuXQo9vRdn/tesWYMbN26gZs2a2iyfSGM3btwAAHzzzTd4++23ERsbi5UrVyI7Oxu6urr4/PPPsXv3bixduhTAiz8UAWD58uX48ccf2WK7nPGaI5W7bdu2Yfz48Th69Ciio6OxYsUKWFtbw9raGpMnT0a/fv1gbm6OgwcPwtzcHNHR0Vi5ciUOHjwIS0tLbZdPVGJRUVH45Zdf8NVXX6F169YAgNjYWCxcuBC6uroICgqCv78/Ll26hMjISPz9999wc3PD2bNnERMTg4MHD6J69eraXYmqRhBpgb+/v9DV1RX9+vXLN2zFihXC3d1dVK9eXTRp0kR4eHiIEydOlH+RRGXk0KFDonbt2qJPnz4iISFB1X/cuHFCX19f/PDDD0IIIf7991+xdOlS0axZM9G6dWvRs2dPcfr0aW2VXaXxx46pXClb6fn7++PZs2fYtm0bIiIiMHDgQJiamqrGS01Nxb1792BkZAQrKytYWFhosWoizSkUCujo6ODYsWP45JNP0LRpU4wdOxbt2rUDAIwdOxaLFi1CVFQUPvvsM1Xr7Ly8POTl5cHAwECb5VdZPK1K5UrZfH3Tpk0AgOnTpyMkJAQAMGjQIFSrVg3AiybsTZs21U6RRGVIR0cHCoUCLVq0wPr16xEQEID58+dDJpOhbdu2mD9/PgBg+PDh0NXVRe/evWFmZgZdXV3VdUcqfwxHeu3E/9+rdfbsWdy9exdPnjyBj48P9PT0EBYWBplMhnHjxgEAPvroI6xatQorV67EyZMnYWxszPu86I2nPBp85513sGbNGvTv3x8REREAoApIXV1dDBw4EHp6evj000+1WS6B4UivmTIYt2zZghEjRsDKygrJycn46KOPMGLECLRr1w5Tp06Fjo4OJk2ahDVr1iAlJQW7du2CiYmJtssnKrG8vDzo6uri+fPn0NPTQ3JyMv79919YWVnBwcEBrVu3xurVqzFgwAC1gPz2228hl8vRvHlzLa8BAQCvOdJrt2fPHvj7++Obb77B559/jn379uG9997D+++/j7Fjx8LLywsAsGvXLmRnZ6N58+ZwdnbWctVEJbdq1SrcuHEDISEhMDY2xqZNmzBixAjo6+vDxMQEpqamWLduHRo2bIiEhAQMGDAAzZo1w/Dhw+Ht7a3t8uklDEd6rR4/fowJEybAzMwMX3/9Na5cuYLOnTvD3d0dx44dg7OzM6ZPn64KSKI3lUKhQL9+/XDhwgV8+umn6NSpE4KCgjB48GB07twZycnJWLx4Mf744w8cPnwYDRo0QGJiIrp27Ypu3bohKioKRkZG2l4N+n8MRypzylOpWVlZMDMzw549e+Dk5AQrKyv4+vqiadOm+OGHHxAXF4cePXrA09MTYWFhqtZ7RG+qnJwcjBkzBmfOnEGbNm1w8eJFrF69WtUS+/r16xg+fDju37+PHTt2wMLCAklJSTA1NYWLi4uWq6eX8Qk5VOZkMhkOHTqEkJAQKBQKtGnTBq6urti3bx9kMhmmTJkCAHjy5Ak8PDyQlZUFR0dHLVdNVDp5eXmQy+WIjIyEq6sr1q9fj+PHj6tuxRBCwNHREQMHDsStW7dw+/ZtAMDbb7/NYKyAGI70Wly5cgU//vgjkpOTVQ1r7ty5g0ePHuHp06cAgMTERPTo0QP79++Hg4ODNsslKjVdXV3cvn0bcrkcS5YsQe/evfHw4UPMmDEDmZmZqlbXDRo0wNOnT9WeKUwVD0+rUplRfpSUXwIff/wxACA6OhrGxsY4ffo0vL29UadOHRgYGODMmTM4ePAg72ekSiEpKQnDhw/HtGnT0LlzZ+Tk5GDUqFE4ceIEOnbsiMmTJ+PJkyeYP38+1q1bh8TERNja2mq7bCoEjxyp1JShqLzWqPw1AV9fX1y4cAFpaWkAgCZNmiA2Nhaenp5o164dDh8+zGCkSuPu3bswMzNDeHg49uzZA7lcjoULF8LDwwNLly5Fo0aNMGTIEPz555/49ddfGYwVHI8cSSOLFy+Gra0tevfuDQA4fPgw5syZg5kzZ6JOnTqqVncNGzaEh4cH1q5dq81yicqUKORHiOPj47Fw4ULcunUL06dPx3vvvYecnBx8+eWXiI6ORkhICIYOHQorKystVE0lwSNHKhEhBO7cuYM9e/aoHfWlpKTg3r17aN++Pb744gts3rwZAPD111/j2rVr+OOPP7RVMlGZePk3SJXBmJSUhBMnTqj6e3t7Y+TIkbC1tcXUqVNx4MAByOVyzJo1CwEBAQgMDGQwviF45EgaefbsGQwMDJCQkICMjAy8//77AF7cBB0fH4+ffvoJ/v7+cHFxwS+//IKgoCCMHj1ay1UTaUb58PDU1FTs2rULDx8+RI0aNRAbG4s7d+5gzpw5ePvtt1Xj7969G8HBwbCxsUFYWBg6deqkveJJIwxHKhEhBIQQ0NHRgRAC3bp1w+3btxEaGgp/f38AL27ROH36NGbMmAEhBHbu3IlatWrhwoULkMvlfFYqvVGUwXjq1Cl88MEHsLCwwJUrV2BkZITatWvD1dUVWVlZmDFjBtzd3VXT9erVC4cOHULz5s2xefNmPif4DcNwJI2sWrUKeXl58PX1xYgRI/DkyRMMHjwYffv2VY2TlZWFa9euYdWqVRgwYAAb39Ab5+VgbNOmDUaNGoUJEyYgOTkZK1aswN69e9GnTx8cP34cpqam+Oqrr9C4cWMoFAqMHj0aderUQUBAAGxsbLS9KlRCDEcqlpdv07h69So8PDwwbtw4TJ48GRcvXsQXX3yB3NxcfP7556ojSKLKIDU1FR4eHujQoQN++uknVf+YmBgMHjwYBw4cwKVLl7BkyRJkZWXhww8/RGpqKn777Tf89ddfsLe312L1pCk2yKFCSRsgyGQyHDlyBGvXrkVQUBAmT56MvLw8uLq6YuHChdDX18fy5cvx888/a7FqorKVl5cHZ2dn5OTk4M8//1T1t7W1xfPnz/H8+XP06tUL//nPf9CkSRMsWbIEx48fR0xMDIPxDcYjRyqQtAHCo0ePYGtri0OHDmHFihXo2LEjtm3bBoVCAYVCAT09PVy8eBEhISFIT0/HpEmT0KtXL22vBlGZUJ4dUSgUiIyMRK1atVC3bl0MGDAAc+fOVY0nhMD9+/ehp6cHMzMzLVZMpcVwpHwKaoBw+fJlyOVyeHp6wtraGqtWrVLd0K9QKCCEgK6uLs6dO4cpU6Zg3rx5fF4qVSoXL17E6NGj8fjxY5w6dQqBgYGYP38+gP/9hiNVHjytSmqkDRD8/f2xd+9exMbGonv37jhy5AgaNWqETp06YdSoUfjrr7+go6MDmUyG58+fo379+li/fj2DkSodV1dXLFiwALq6ujAzM1M7M6Kjw6/SyoZHjpRPYQ0QtmzZgoEDB2L//v149uwZ5s6di4sXL2Lx4sVo27at6qkhhT09hKgyuHTpEkaNGgUhBKZMmcKfWquk+OcO5VNYAwQbGxvk5eVBoVCgZcuW+OKLL1C/fn0EBATgyJEjqkBkMFJlVrduXVUDtNDQUCQkJGi7JHoNGI6UT+3atbFu3To8e/YMX331FZKTk5GdnY1evXph6NCh8PDwAAC0b98eQ4YMgbe3Nx+JRVWKq6sr5s6di1q1arFFaiXF06pUqKIaIDx//hx6enoAXjwRR/mgcaKqRPkYRap8eORIhSqqAYKurq7qwQAMRqqqGIyVF48c6ZXYAIGIqhoeOdIrsQECEVU1DEcqFjZAIKKqhKdVqUTYAIGIqgKGIxERkQRPqxIREUkwHImIiCQYjkRERBIMRyIiIgmGIxERkQTDkYiISILhSEREJMFwJHqNgoKC0LNnT7XXMpkMMpkM+vr6qFOnDkJDQ/Ho0SO16aKjo9GyZUuYmJjA1NQUnp6e2L59+yuXd+LECXTv3h3W1tYwNDRE7dq14e/vjzt37gAA4uPjIZPJ8ODBgxKtx9WrVyGTyZCUlFSi6YjeVAxHonLWpUsXpKWl4cqVK5g5cyYWL16M0NBQ1fDQ0FAMHToUffr0wcmTJ3H06FG0b98eH3zwARYtWlTofDMyMvDee++hZs2a2LVrF5KTk/Hjjz/Czs4Ojx8/Lo9VI6o8BBG9NoGBgeKDDz4o9LUQQgwePFjY2toKIYQ4fPiwACAWLlyYb14hISFCX19fXL9+vcBlbdmyRejp6Ync3NwCh6ekpAgAal1gYKAQQoidO3eKdu3aCXNzc1GjRg3RrVs3cenSJdW00um8vLyEEEJ4eXmJ0aNHqy3ngw8+UM1XCCG+//57UbduXSGXy4W1tbX48MMPC6yPqCLhkSORlhkZGSE3NxcAsGHDBlSrVg1Dhw7NN964ceOQm5uLX375pcD52Nra4vnz59iyZYvqtzZf5uDgoJr2/PnzSEtLw4IFCwAAjx49QkhICBITE7F3717o6OigV69eUCgUAICjR48CAPbs2YO0tDTExMQUa92OHTuGL774AjNmzMD58+cRGxsLT0/PYk1LpE162i6AqCo7evQo1q9fDx8fHwDAhQsX4OLiUuDD3e3t7WFubo4LFy4UOK/WrVtj0qRJCAgIwLBhw9CyZUt07NgRAwYMgI2NDXR1dVGjRg0AgLW1NapXr66a9sMPP1Sb14oVK2BtbY1//vkHjRs3hpWVFQDA0tIStra2xV6/69evw8TEBN27d4epqSmcnJzQrFmzYk9PpC08ciQqZ9u3b0e1atVgaGiINm3awNPTE999912xphVCQCaTFTr866+/Rnp6OqKiotCwYUNERUWhfv36OH36dJHzvXz5MgICAlCnTh2YmZnB2dkZwItwKw1fX184OTmhTp066N+/P9atW8frn/RGYDgSlbMOHTogKSkJ58+fx9OnTxETEwNra2sAgJubGy5fvoxnz57lm+7mzZvIysqCq6trkfO3tLTExx9/jHnz5iE5ORn29vb49ttvi5ymR48euHv3LpYvX44jR47gyJEjAFBgHS/T0dHJdwpXeYoYAExNTXH8+HFs2LABdnZ2mDp1Kpo2bVri1rJE5Y3hSFTOTExMULduXTg5OUFfX19tWN++ffHw4UMsXbo033Tffvst9PX1850CLYqBgQFcXFxUt4ooT9fm5eWpxrl79y6Sk5Px3//+Fz4+PmjQoAHu37+fbz7S6QDAysoKaWlpqtd5eXk4c+aM2jh6enp47733MGfOHJw6dQpXr17Fvn37ir0ORNrAa45EFUibNm0wevRo/Oc//8GzZ8/Qs2dP5ObmYu3atViwYAEiIyPh4OBQ4LTbt2/Hxo0b0bdvX7i5uUEIgd9++w2///47Vq5cCQBwcnKCTCbD9u3b4efnByMjI1hYWMDS0hLLli2DnZ0drl+/ji+//FJt3tbW1jAyMkJsbCxq1aoFQ0NDmJubo2PHjggJCcGOHTvg4uKC+fPnqx0Vbt++HVeuXIGnpycsLCzw+++/Q6FQoF69eq/tPSQqE9ptLEtUuRXnVo6CrFixQrRo0UIYGRkJY2Nj8e6774pt27YVOc3ly5fF559/Ltzc3ISRkZGoXr26eOedd8TKlSvVxpsxY4awtbUVMplMdctFXFycaNCggZDL5cLd3V3Ex8cLAGLLli2q6ZYvXy4cHByEjo6O6laOZ8+eieHDh4saNWoIa2trMWvWLLVbOf744w/h5eUlLCwshJGRkXB3dxebNm165foTaZtMiALafBMREVVhvOZIREQkwXAkIiKSYDgSERFJMByJiIgkGI5EREQSDEciIiIJhiMREZEEw5GIiEiC4UhERCTBcCQiIpJgOBIREUn8H33h+Kez9S57AAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#Distribution by IPO Stage \n",
    "\n",
    "ipo_status_counts = df_1_sorted['IPO Status'].value_counts()\n",
    "\n",
    "plt.figure(figsize = (5,5))\n",
    "ipo_status_counts.plot(kind='bar', color='blue', alpha=0.5)\n",
    "plt.title('Histogram of IPO Status for mHealth Company')\n",
    "plt.xlabel('IPO Status')\n",
    "plt.ylabel('Frequency')\n",
    "plt.xticks(rotation=45)\n",
    "plt.legend()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "cf5497a3-3e6f-4351-9d8b-36198d4fd701",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Organization Name</th>\n",
       "      <th>Founded Date</th>\n",
       "      <th>Industries</th>\n",
       "      <th>Total Funding Amount (USD)</th>\n",
       "      <th>IPO Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Anebulo Pharmaceuticals</td>\n",
       "      <td>2020</td>\n",
       "      <td>Biotechnology, Life Science, mHealth</td>\n",
       "      <td>7500000.0</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          Organization Name Founded Date  \\\n",
       "17  Anebulo Pharmaceuticals         2020   \n",
       "\n",
       "                              Industries  Total Funding Amount (USD)  \\\n",
       "17  Biotechnology, Life Science, mHealth                   7500000.0   \n",
       "\n",
       "   IPO Status  \n",
       "17     Public  "
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_1_reset_index = df_1_sorted.reset_index()\n",
    "df_1_public = df_1_reset_index[df_1_reset_index['IPO Status']=='Public'][['Organization Name','Founded Date','Industries','Total Funding Amount (USD)','IPO Status']]\n",
    "df_1_public"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "e53fb4f1-7d37-4e89-a3ee-d31505ef234c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ipo_status_counts = df_2_sorted['IPO Status'].value_counts()\n",
    "\n",
    "plt.figure(figsize = (5,5))\n",
    "ipo_status_counts.plot(kind='bar', color='blue', alpha=0.5)\n",
    "plt.title('Histogram of IPO Status for healthcare Company')\n",
    "plt.xlabel('IPO Status')\n",
    "plt.ylabel('Frequency')\n",
    "plt.xticks(rotation=45)\n",
    "plt.legend()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "76e1e099-4c5f-4afb-a573-ef01fc9d0a25",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Organization Name</th>\n",
       "      <th>Founded Date</th>\n",
       "      <th>Industries</th>\n",
       "      <th>Total Funding Amount (USD)</th>\n",
       "      <th>IPO Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Kenvue</td>\n",
       "      <td>2023</td>\n",
       "      <td>Lifestyle, Personal Health, Wellness</td>\n",
       "      <td>3646591000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Cencora</td>\n",
       "      <td>2023</td>\n",
       "      <td>Emergency Medicine, Enterprise Software, Healt...</td>\n",
       "      <td>3025000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>GoTo Group</td>\n",
       "      <td>2021</td>\n",
       "      <td>Delivery Service, Health Care, Information Tec...</td>\n",
       "      <td>1450000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>Organon</td>\n",
       "      <td>2020</td>\n",
       "      <td>Health Care, Medical Device, Pharmaceutical, W...</td>\n",
       "      <td>1000000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Apogee Therapeutics</td>\n",
       "      <td>2022</td>\n",
       "      <td>Biotechnology, Life Science, Medical, Therapeu...</td>\n",
       "      <td>652000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Centessa Pharmaceuticals</td>\n",
       "      <td>2021</td>\n",
       "      <td>Biotechnology, Pharmaceutical</td>\n",
       "      <td>650000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>ACELYRIN</td>\n",
       "      <td>2020</td>\n",
       "      <td>Biopharma, Biotechnology, Health Care</td>\n",
       "      <td>558000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Taysha Gene Therapies</td>\n",
       "      <td>2020</td>\n",
       "      <td>Biotechnology, Genetics, Life Science</td>\n",
       "      <td>543000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Alumis</td>\n",
       "      <td>2021</td>\n",
       "      <td>Biotechnology, Health Care, Life Science, Prec...</td>\n",
       "      <td>529000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Biohaven</td>\n",
       "      <td>2022</td>\n",
       "      <td>Biopharma, Biotechnology, Health Care</td>\n",
       "      <td>523200000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Invivyd</td>\n",
       "      <td>2020</td>\n",
       "      <td>Biotechnology, Pharmaceutical, Therapeutics</td>\n",
       "      <td>466000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Tourmaline Bio</td>\n",
       "      <td>2021</td>\n",
       "      <td>Biotechnology, Clinical Trials, Therapeutics</td>\n",
       "      <td>359500000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>2seventy bio</td>\n",
       "      <td>2021</td>\n",
       "      <td>Biotechnology, Genetics, Health Care, Oncology...</td>\n",
       "      <td>315000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>CARGO Therapeutics</td>\n",
       "      <td>2021</td>\n",
       "      <td>Biotechnology, Medical, Therapeutics</td>\n",
       "      <td>310000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>ArriVent Biopharma</td>\n",
       "      <td>2021</td>\n",
       "      <td>Biotechnology, Life Science, Pharmaceutical</td>\n",
       "      <td>305000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Mineralys Therapeutics</td>\n",
       "      <td>2020</td>\n",
       "      <td>Biopharma, Biotechnology, Medical, Pharmaceutical</td>\n",
       "      <td>278000000</td>\n",
       "      <td>Public</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           Organization Name Founded Date  \\\n",
       "21                    Kenvue         2023   \n",
       "36                   Cencora         2023   \n",
       "47                GoTo Group         2021   \n",
       "49                   Organon         2020   \n",
       "2        Apogee Therapeutics         2022   \n",
       "3   Centessa Pharmaceuticals         2021   \n",
       "6                   ACELYRIN         2020   \n",
       "7      Taysha Gene Therapies         2020   \n",
       "8                     Alumis         2021   \n",
       "9                   Biohaven         2022   \n",
       "13                   Invivyd         2020   \n",
       "22            Tourmaline Bio         2021   \n",
       "31              2seventy bio         2021   \n",
       "34        CARGO Therapeutics         2021   \n",
       "35        ArriVent Biopharma         2021   \n",
       "44    Mineralys Therapeutics         2020   \n",
       "\n",
       "                                           Industries  \\\n",
       "21               Lifestyle, Personal Health, Wellness   \n",
       "36  Emergency Medicine, Enterprise Software, Healt...   \n",
       "47  Delivery Service, Health Care, Information Tec...   \n",
       "49  Health Care, Medical Device, Pharmaceutical, W...   \n",
       "2   Biotechnology, Life Science, Medical, Therapeu...   \n",
       "3                       Biotechnology, Pharmaceutical   \n",
       "6               Biopharma, Biotechnology, Health Care   \n",
       "7               Biotechnology, Genetics, Life Science   \n",
       "8   Biotechnology, Health Care, Life Science, Prec...   \n",
       "9               Biopharma, Biotechnology, Health Care   \n",
       "13        Biotechnology, Pharmaceutical, Therapeutics   \n",
       "22       Biotechnology, Clinical Trials, Therapeutics   \n",
       "31  Biotechnology, Genetics, Health Care, Oncology...   \n",
       "34               Biotechnology, Medical, Therapeutics   \n",
       "35        Biotechnology, Life Science, Pharmaceutical   \n",
       "44  Biopharma, Biotechnology, Medical, Pharmaceutical   \n",
       "\n",
       "    Total Funding Amount (USD) IPO Status  \n",
       "21                  3646591000     Public  \n",
       "36                  3025000000     Public  \n",
       "47                  1450000000     Public  \n",
       "49                  1000000000     Public  \n",
       "2                    652000000     Public  \n",
       "3                    650000000     Public  \n",
       "6                    558000000     Public  \n",
       "7                    543000000     Public  \n",
       "8                    529000000     Public  \n",
       "9                    523200000     Public  \n",
       "13                   466000000     Public  \n",
       "22                   359500000     Public  \n",
       "31                   315000000     Public  \n",
       "34                   310000000     Public  \n",
       "35                   305000000     Public  \n",
       "44                   278000000     Public  "
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_2_reset_index = df_2_sorted.reset_index()\n",
    "df_2_public = df_2_reset_index[df_2_reset_index['IPO Status']=='Public'][['Organization Name','Founded Date','Industries','Total Funding Amount (USD)','IPO Status']]\n",
    "df_2_public = df_2_public.sort_values(by = 'Total Funding Amount (USD)', ascending = False)\n",
    "df_2_public"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "84df5dc6-7f81-49ea-b31c-c9dcbdece65d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#Distribution by Funding Stage \n",
    "mHealth_ipo_status_counts = df_1_sorted[df_1_sorted['IPO Status']=='Private']['Last Funding Type'].value_counts()\n",
    "\n",
    "# Calculate the percentage for each funding type\n",
    "mhealth_total_counts = mHealth_ipo_status_counts.sum()\n",
    "mhealth_percentages = (mHealth_ipo_status_counts / mhealth_total_counts) * 100\n",
    "\n",
    "plt.figure(figsize = (10,5))\n",
    "ax = mHealth_ipo_status_counts.plot(kind='bar', color='blue', alpha=0.5)\n",
    "plt.title('Histogram of Last Funding Type for mHealth Company')\n",
    "plt.xlabel('Last Funding Type')\n",
    "plt.ylabel('Frequency')\n",
    "plt.xticks(rotation=80)\n",
    "plt.legend()\n",
    "\n",
    "for i, (count, percentage) in enumerate(zip(mHealth_ipo_status_counts, mhealth_percentages)):\n",
    "    ax.text(i, count, f'{percentage:.1f}%', ha='center', va='bottom')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "39877459-2d64-4504-beb0-85ba4f66bfa4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA0oAAAJ5CAYAAACQQ8BaAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguMCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy81sbWrAAAACXBIWXMAAA9hAAAPYQGoP6dpAADH60lEQVR4nOzdd1QU198G8GfpRUB6k6YCFrBgi4qAvWJsib1EjQ2NscUWWyxYUSN2sXeN3cQSFWNXFHtFxQoiKkWQuvf9w3f35y6ggsCu8nzO2aM7OzP7ncvs7D5T7kiEEAJEREREREQkp6HqAoiIiIiIiNQNgxIREREREZESBiUiIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSUT5ZvXo1JBIJwsLCsn29RYsWcHZ2Vhjm7OyMHj165Op9Tp8+jYkTJyIuLi5vhRZBW7ZsQfny5aGvrw+JRILLly9nO15oaCgkEgm2b99eKHUlJydj4sSJCA0N/azxIyMjIZFIsn1UrVq1YIvNRo8ePbKs0xKJBBMnTiz0OnJqlw8fuf2sFbTPXS/zw6e2TwVJ9rn6cD3/+++/c1xPJBIJBg4cWDjFFZKEhARMnToVVatWhbGxMXR1deHs7IyePXvi0qVLqi6PiHKgpeoCiIqynTt3wtjYOFfTnD59GpMmTUKPHj1QvHjxginsG/Ly5Ut07doVTZo0waJFi6Crqws3NzdVlwXgfVCaNGkSAMDPz++zpxs0aBA6deqkMKxYsWL5WVqenTlzBiVKlCjU9xw3bhz69esnf37p0iUEBARg2rRpqFu3rny4paVlodb1Meq8XhaGv//+GwsXLiz0UK0K9+/fR6NGjRATE4N+/fph0qRJKFasGCIjI7F161ZUqVIFcXFxMDExUXWpRKSEQYlIhSpXrqzqEnItPT0dEokEWlpfx+bj7t27SE9PR5cuXeDr66vqcvKFo6MjvvvuO1WXkS1V1FWqVCmUKlVK/jwlJQUA4OrqqrbtVBDrZXJyMgwMDPJlXgRkZmYiIyMDurq6XzSP1q1bIzY2FmfOnIGHh4f8NV9fX3Tv3h3//PMPtLW186NkIspnPPWOSIWUT72TSqWYMmUK3N3doa+vj+LFi6NChQqYP38+AGDixIkYMWIEAMDFxUV+SpHslBapVIqZM2eiTJky0NXVhZWVFbp164anT58qvK8QAtOmTYOTkxP09PRQtWpVHD58GH5+fgpHNmSnzKxbtw7Dhg2Dvb09dHV1ERERgZcvX2LAgAEoV64cihUrBisrK9SrVw8nTpxQeC/Z6WKzZs3CjBkz4OzsDH19ffj5+cl/LI4aNQp2dnYwMTFB69atERMT81ntt2fPHtSsWRMGBgYwMjJCw4YNcebMGfnrPXr0gLe3NwCgffv2kEgkuTpyk5NJkyahRo0aMDMzg7GxMby8vBASEgIhhMJ4R48ehZ+fH8zNzaGvrw9HR0e0bdsWycnJiIyMlB/hmDRpUr6dHqb8N5RRPk1O9neZPXs2goKC4OLigmLFiqFmzZo4e/ZslulXr14Nd3d36OrqomzZsli7dm2276986p3slK9jx46hf//+sLCwgLm5Odq0aYPnz58rTJuamophw4bBxsYGBgYG8PHxwcWLF/N0iuqHTpw4AYlEgk2bNmV5be3atZBIJLhw4QKA9+1UrFgx3LhxA/Xr14ehoSEsLS0xcOBAJCcnK0wrhMCiRYtQqVIl6Ovrw9TUFO3atcODBw8+Ws+n1stPrdfA+22BRCLBpUuX0K5dO5iamiqExZwkJiZ+8u8AvD8tsGbNmjA0NESxYsXQuHFjhIeHK4wTFhaGDh06yD/Tzs7O6NixIx49evTJ5V+4cCEAKJwaGRkZqTDeunXrULZsWRgYGKBixYrYt29flnndvn0bHTt2hLW1NXR1deHo6Ihu3bohNTUVAHK9nZo5cyamTJkCFxcX6Orq4tixY/JlbdmyJczMzKCnp4fKlStj69atH29sALt27cK1a9cwevRohZD0oaZNmyoE3JMnT6J+/fowMjKCgYEBatWqhf379ytMI/tcHT16FD///DPMzc1hbGyMbt26ISkpCdHR0fjxxx9RvHhx2NraYvjw4UhPT892eadOnQpHR0f5d8GRI0cU3isiIgI//fQTXF1dYWBgAHt7e/j7++PatWsK48m+LzZt2oSxY8fCzs4OxsbGaNCgAe7cuSMfb/LkydDS0sKTJ0+ytEXPnj1hbm4u39lBpHKCiPLFqlWrBABx9uxZkZ6enuXRrFkz4eTkpDCNk5OT6N69u/x5YGCg0NTUFBMmTBBHjhwRBw4cEPPmzRMTJ04UQgjx5MkTMWjQIAFA7NixQ5w5c0acOXNGxMfHCyGE6NOnjwAgBg4cKA4cOCCWLFkiLC0thYODg3j58qX8fUaPHi0AiD59+ogDBw6I5cuXC0dHR2Frayt8fX3l4x07dkwAEPb29qJdu3Ziz549Yt++feLVq1fi9u3bon///mLz5s0iNDRU7Nu3T/Tq1UtoaGiIY8eOyefx8OFDAUA4OTkJf39/sW/fPrF+/XphbW0t3NzcRNeuXUXPnj3FP//8I5YsWSKKFSsm/P39P9neGzZsEABEo0aNxK5du8SWLVtElSpVhI6Ojjhx4oQQQoiIiAixcOFCAUBMmzZNnDlzRty4cSPHecqWd9u2bR997x49eoiQkBBx+PBhcfjwYTF58mShr68vJk2apLDcenp6omHDhmLXrl0iNDRUbNiwQXTt2lW8efNGpKSkiAMHDggAolevXvK/ZURERI7vK2vLGTNmZFm/pFKpEEIIX19fhb+hTPfu3RXWP9m8nJ2dRZMmTcSuXbvErl27hKenpzA1NRVxcXHycWXr9vfffy/27t0r1q9fL0qXLi0cHByyrNMAxIQJE7JMW7JkSTFo0CBx8OBBsWLFCmFqairq1q2rMG3Hjh2FhoaGGDVqlDh06JCYN2+ecHBwECYmJgqfk0/J7u9YuXJlUbt27SzjVqtWTVSrVk2hnXR0dISjo6OYOnWqOHTokJg4caLQ0tISLVq0UJj2559/Ftra2mLYsGHiwIEDYuPGjaJMmTLC2tpaREdH51jfx9bLz1mvhRBiwoQJ8s/VyJEjxeHDh8WuXbtyfM/c/B2mTp0qJBKJ6Nmzp9i3b5/YsWOHqFmzpjA0NFT4/Gzbtk2MHz9e7Ny5Uxw/flxs3rxZ+Pr6CktLS4XtjezvIdsuREREiHbt2gkA8vX+zJkzIiUlRQgh5Otl9erVxdatW8Xff/8t/Pz8hJaWlrh//758vpcvXxbFihUTzs7OYsmSJeLIkSNi/fr14scffxQJCQlCCJHr7ZS9vb2oW7eu2L59uzh06JB4+PChOHr0qNDR0RF16tQRW7ZsEQcOHBA9evQQAMSqVatybHMh/rdNvnXr1kfHkwkNDRXa2tqiSpUqYsuWLWLXrl2iUaNGQiKRiM2bN2f5e7q4uIhhw4aJQ4cOiRkzZghNTU3RsWNH4eXlJaZMmSIOHz4sRo4cKQCIOXPmZFleBwcH4e3tLf766y+xbds2Ua1aNaGtrS1Onz4tH/f48eNi2LBhYvv27eL48eNi586dolWrVkJfX1/cvn07y9/Z2dlZdO7cWezfv19s2rRJODo6CldXV5GRkSGEEOLFixdCV1dXjB07VmHZX716JfT19cWIESM+q62ICgODElE+kX1xfezxqaDUokULUalSpY++z6xZswQA8fDhQ4Xht27dEgDEgAEDFIafO3dOABBjxowRQgjx+vVroaurK9q3b68w3pkzZwSAbIOSj4/PJ5c/IyNDpKeni/r164vWrVvLh8u+kCtWrCgyMzPlw+fNmycAiJYtWyrM59dffxUA5OEvO5mZmcLOzk54enoqzDMxMVFYWVmJWrVqZVmGT4Wf3I77YS3p6enijz/+EObm5vLAsn37dgFAXL58OcdpX758mSVYfIysLbN7HD58WAiR+6Dk6ekp/wEjhBDnz58XAMSmTZvky2dnZye8vLzkyyaEEJGRkUJbW/uzg5Lyejlz5kwBQERFRQkhhLhx44YAIEaOHKkw3qZNmwSALw5KsjrCw8OzLOuaNWvkw7p37y4AiPnz5yvMc+rUqQKAOHnypBDif5+XD398CvF+Z4a+vr747bffcl1jbtZrWVAaP378Z7TI5/8dHj9+LLS0tMSgQYMUxktMTBQ2Njbixx9/zPE9MjIyxNu3b4WhoaFC+ykHJSGECAgIEDntqwUgrK2t5WFHCCGio6OFhoaGCAwMlA+rV6+eKF68uIiJifl0A3xQ48e2U6VKlRJpaWkK05QpU0ZUrlxZpKenKwxv0aKFsLW1VfhbKWvSpIkAIA+Bn/Ldd98JKysrkZiYqFCzh4eHKFGihPwzKPt7Kv+dWrVqJQCIoKAgheGVKlUSXl5eWZbXzs5OvHv3Tj48ISFBmJmZiQYNGuRYY0ZGhkhLSxOurq5iyJAh8uGyv3OzZs0Uxt+6das8FMt0795dWFlZidTUVPmwGTNmCA0NjSzfbUSqxFPviPLZ2rVrceHChSwP2ak2H1O9enVcuXIFAwYMwMGDB5GQkPDZ7ys7RUT5FKXq1aujbNmy8tMpzp49i9TUVPz4448K43333XdZejCTadu2bbbDlyxZAi8vL+jp6UFLSwva2to4cuQIbt26lWXcZs2aQUPjf5ucsmXLAgCaN2+uMJ5s+OPHj3NYUuDOnTt4/vw5unbtqjDPYsWKoW3btjh79myW06Ty09GjR9GgQQOYmJhAU1MT2traGD9+PF69eiU/bbBSpUrQ0dFBnz59sGbNmk+ejpUbgwcPzrJ+1ahRI0/zat68OTQ1NeXPK1SoAADy06dkbd2pUydIJBL5eE5OTqhVq9Znv0/Lli0Vniu/z/HjxwEgy3rZrl27fLkermPHjrCyspKf8gUACxYsgKWlJdq3b59l/M6dOys8l3WeIfuc7du3DxKJBF26dEFGRob8YWNjg4oVK352T4Yfyst6ndNnMyef+jscPHgQGRkZ6Natm8Jy6enpwdfXV2G53r59i5EjR6J06dLQ0tKClpYWihUrhqSkpGy3AblRt25dGBkZyZ9bW1vDyspKXmdycjKOHz+OH3/88ZOddORmO9WyZUuF64UiIiJw+/Zt+frwYZs0a9YMUVFRCqeVfYmkpCScO3cO7dq1U+icRVNTE127dsXTp0+zvFeLFi0Unn9su5rdKZFt2rSBnp6e/LmRkRH8/f3x33//ITMzE8D7ZZ42bRrKlSsHHR0daGlpQUdHB/fu3cuxDT+kvI4B77dhMTEx2LZtG4D3p40vXrwYzZs3z/F7iEgVGJSI8lnZsmVRtWrVLI/P6dFo9OjRmD17Ns6ePYumTZvC3Nwc9evX/6wufV+9egUAsLW1zfKanZ2d/HXZv9bW1lnGy25YTvMMCgpC//79UaNGDfz11184e/YsLly4gCZNmuDdu3dZxjczM1N4rqOj89HhHztH/VPLKpVK8ebNmxyn/xLnz59Ho0aNAADLly/HqVOncOHCBYwdOxYA5MteqlQp/Pvvv7CyskJAQIC8wwHZ9WZfokSJElnWrw9/VOaGubm5wnPZheuy5ZC1tY2NTZZpsxv2pe+jvA5qaWllmTYvdHV10bdvX2zcuBFxcXF4+fIltm7dit69e2e5WD+795Qtq6zOFy9eQAgBa2traGtrKzzOnj2L2NjYXNeYl/U6u3E/5lN/hxcvXgAAqlWrlmW5tmzZorBcnTp1QnBwMHr37o2DBw/i/PnzuHDhAiwtLbPdBnxJnbJaZfN98+YNMjMzP9nDYm63U8rtKWuP4cOHZ2mPAQMGAMBH/9aOjo4AgIcPH360TtkyCSFy/PsD/1tHZHKzXc1um5rT5zotLQ1v374FAAwdOhTjxo1Dq1atsHfvXpw7dw4XLlxAxYoVs23DT61jwPuOjOrUqSPfcbFv3z5ERkZ+c93C09fv6+i2iqiI0NLSwtChQzF06FDExcXh33//xZgxY9C4cWM8efLkoz1ayb6coqKisvx4eP78OSwsLBTGk/0A+FB0dHS2e/M+PJIgs379evj5+WHx4sUKwxMTEz++kPngw2VV9vz5c2hoaMDU1LRA3nvz5s3Q1tbGvn37FPbE7tq1K8u4derUQZ06dZCZmYmwsDAsWLAAv/76K6ytrdGhQ4cCqU9PTw/x8fFZhuflhzvwv7aOjo7O8lp2w/Lqw/XS3t5ePjwjIyPLj8O86t+/P6ZPn46VK1ciJSUFGRkZCt2KK7/nhz/4ZMsqG2ZhYQGJRIITJ05k2ytaXnpKy8t6nd1n80vIthPbt2+Hk5NTjuPFx8dj3759mDBhAkaNGiUfnpqaitevX+drTdkxMzODpqZmlo5qlOV2O6XcnrL2GD16NNq0aZPtNO7u7jm+f+PGjbFs2TLs2rVLoZ2yY2pqCg0NjRz//h/Wk19y+lzr6OjIj2qtX78e3bp1w7Rp0xTGi42N/aJbVPzyyy/44YcfcOnSJQQHB8PNzQ0NGzbM8/yICgKPKBGpqeLFi6Ndu3YICAjA69ev5T1CZbd3DgDq1asH4P2X2ocuXLiAW7duoX79+gCAGjVqQFdXF1u2bFEY7+zZs5/srepDEokky4/Bq1evZumdqyC4u7vD3t4eGzduVOhpLikpCX/99Ze8x7CCIOsa/cPT1d69e4d169blOI2mpiZq1Kgh33squ8FkTn/LL+Hs7Iy7d+/Ke/0C3u+FPn36dJ7m5+7uDltbW2zatEmhrR89epTneWbHx8cHALKsl9u3b0dGRka+vIetrS1++OEHLFq0CEuWLIG/v798j7+yDRs2KDzfuHEjgP/d76pFixYQQuDZs2fZHkH29PTMdX2qXK9lGjduDC0tLdy/fz/b5ZLd2FgikUAIkWUbsGLFCvkpWx/zpeu+vr4+fH19sW3bto/uBPjS7ZS7uztcXV1x5cqVHNvjY0dzv//+e3h6eiIwMBDXr1/PdpyDBw8iOTkZhoaGqFGjBnbs2KHQLlKpFOvXr0eJEiXy/V5bO3bsUDjSlJiYiL1796JOnTrybVx2bbh//348e/bsi967devWcHR0xLBhw/Dvv/9iwIAB+R78ib4UjygRqRF/f394eHigatWqsLS0xKNHjzBv3jw4OTnB1dUVAOQ/wObPn4/u3btDW1sb7u7ucHd3R58+fbBgwQJoaGigadOmiIyMxLhx4+Dg4IAhQ4YAeL8ndujQoQgMDISpqSlat26Np0+fYtKkSbC1tVW4NuJjWrRogcmTJ2PChAnw9fXFnTt38Mcff8DFxSXfftjmRENDAzNnzkTnzp3RokUL9O3bF6mpqZg1axbi4uIwffr0L5p/dt1jA+/ve9K8eXMEBQWhU6dO6NOnD169eoXZs2dn+SGxZMkSHD16FM2bN4ejoyNSUlKwcuVKAECDBg0AvL8ewMnJCbt370b9+vVhZmYGCwuLLzpHv2vXrli6dCm6dOmCn3/+Ga9evcLMmTNzfWNjGQ0NDUyePBm9e/dG69at8fPPPyMuLg4TJ07M1al3n1K+fHl07NgRc+bMgaamJurVq4cbN25gzpw5MDEx+ez18lMGDx4sv55r1apV2Y6jo6ODOXPm4O3bt6hWrRpOnz6NKVOmoGnTpvJrDWvXro0+ffrgp59+QlhYGHx8fGBoaIioqCicPHkSnp6e6N+/f65qK+j1+nM4Ozvjjz/+wNixY/HgwQM0adIEpqamePHiBc6fPw9DQ0NMmjQJxsbG8PHxwaxZs+Tr7PHjxxESEvJZRxlk27EZM2agadOm0NTURIUKFeSnjn2OoKAgeHt7o0aNGhg1ahRKly6NFy9eYM+ePVi6dCmMjIzyZTu1dOlSNG3aFI0bN0aPHj1gb2+P169f49atW7h06ZL8OpvsaGpqYufOnWjUqBFq1qyJ/v37o27dujA0NMSjR4+wfft27N27V35KZWBgIBo2bIi6deti+PDh0NHRwaJFi3D9+nVs2rQp34OEpqYmGjZsiKFDh0IqlWLGjBlISEiQ3wgbeL+tX716NcqUKYMKFSrg4sWLmDVr1hffWFpTUxMBAQEYOXIkDA0Nv/jWCEQFQoUdSRB9U2S9EF24cCHb15s3b/7JXu/mzJkjatWqJSwsLORdFPfq1UtERkYqTDd69GhhZ2cnNDQ0FHqTyszMFDNmzBBubm5CW1tbWFhYiC5duognT54oTC+VSsWUKVNEiRIlhI6OjqhQoYLYt2+fqFixokJPUB/rBS41NVUMHz5c2NvbCz09PeHl5SV27dqVY+9qs2bNUpg+p3l/qh0/tGvXLlGjRg2hp6cnDA0NRf369cWpU6c+632yIxs3p4esnVeuXCnc3d2Frq6uKFmypAgMDBQhISEKvRGeOXNGtG7dWjg5OQldXV1hbm4ufH19xZ49exTe899//xWVK1cWurq6n+zdLae2VLZmzRpRtmxZoaenJ8qVKye2bNny2X8XIbL2XCeEECtWrBCurq5CR0dHuLm5iZUrV2aZZ3bT5vT3zK4ntJSUFDF06FBhZWUl9PT0xHfffSfOnDkjTExMFHrX+pRP/c2dnZ1F2bJls32te/fuwtDQUFy9elX4+fkJfX19YWZmJvr37y/evn2bZfyVK1eKGjVqCENDQ6Gvry9KlSolunXrJsLCwvJc4+es17Je7z7shvtjcvN3kNVQt25dYWxsLHR1dYWTk5No166d+Pfff+XjPH36VLRt21aYmpoKIyMj0aRJE3H9+vUs27Xs3iM1NVX07t1bWFpaColEovDZASACAgKyLIPyfIUQ4ubNm+KHH34Q5ubm8m1mjx495L3Mfel2SubKlSvixx9/FFZWVkJbW1vY2NiIevXqiSVLluTQ4ori4uLE5MmThZeXlyhWrJjQ1tYWjo6OokuXLln+tidOnBD16tWTr1Pfffed2Lt3r8I4Of09c1ovZOu18vLOmDFDTJo0Sf5dULlyZXHw4EGFad+8eSN69eolrKyshIGBgfD29hYnTpzI0sNmTuu07L2y60o9MjJSABD9+vX7ZBsSqYJECKU7JBJRkfTw4UOUKVMGEyZMwJgxY1RdDhEA4PTp06hduzY2bNgg73nuS1y9ehUVK1bEwoUL5Rfjf6hHjx7Yvn27/EJ2om9RZGQkXFxcMGvWLAwfPlxldSxYsAC//PILrl+/jvLly6usDqKc8NQ7oiLoypUr2LRpE2rVqgVjY2PcuXNHfnpWr169VF0eFVGHDx/GmTNnUKVKFejr6+PKlSuYPn06XF1dc7yQ/nPdv38fjx49wpgxY2Bra8vTfIhUKDw8HA8fPsQff/yB77//niGJ1BaDElERZGhoiLCwMISEhCAuLg4mJibw8/PD1KlTc+winKigGRsb49ChQ5g3bx4SExNhYWGBpk2bIjAwUKGHwbyYPHky1q1bh7Jly2Lbtm0F3ikCEeWsdevWiI6ORp06dbBkyRJVl0OUI556R0REREREpITdgxMRERERESlhUCIiIiIiIlLCoERERERERKTkm+/MQSqV4vnz5zAyMuIdn4mIiIiIijAhBBITE2FnZ/fJm5l/80Hp+fPncHBwUHUZRERERESkJp48eYISJUp8dJxvPigZGRkBeN8YxsbGKq6GiIiIiIhUJSEhAQ4ODvKM8DHffFCSnW5nbGzMoERERERERJ91SQ47cyAiIiIiIlLCoERERERERKSEQYmIiIiIiEgJg1IuBAYGolq1ajAyMoKVlRVatWqFO3fuKIzz4sUL9OjRA3Z2djAwMECTJk1w7969z36PzZs3QyKRoFWrVgrDN2zYAAcHB5iZmWHEiBEKr0VGRsLNzQ0JCQl5XjYiIiIiKlyZmZlISUnhIx8fmZmZ+fb3+eY7c8hPx48fR0BAAKpVq4aMjAyMHTsWjRo1ws2bN2FoaAghBFq1agVtbW3s3r0bxsbGCAoKQoMGDeTjfMyjR48wfPhw1KlTR2F4bGwsevfujdWrV6NkyZJo3rw5/Pz80Lx5cwBA//79MX36dHZWQURERPQVEEIgOjoacXFxqi7lm1S8eHHY2Nh88T1UGZRy4cCBAwrPV61aBSsrK1y8eBE+Pj64d+8ezp49i+vXr6N8+fIAgEWLFsHKygqbNm1C7969c5x3ZmYmOnfujEmTJuHEiRMKH5wHDx7AxMQE7du3BwDUrVsXN2/eRPPmzbFx40bo6OigTZs2+b/ARERERJTvZCHJysoKBgYGX/yDnt4TQiA5ORkxMTEAAFtb2y+aH4PSF4iPjwcAmJmZAQBSU1MBAHp6evJxNDU1oaOjg5MnT340KP3xxx+wtLREr169cOLECYXXXF1dkZycjPDwcDg5OeHChQvo2bMnXr9+jfHjx+PYsWP5vWhEREREVAAyMzPlIcnc3FzV5Xxz9PX1AQAxMTGwsrKCpqZmnufFa5TySAiBoUOHwtvbGx4eHgCAMmXKwMnJCaNHj8abN2+QlpaG6dOnIzo6GlFRUTnO69SpUwgJCcHy5cuzfd3U1BRr1qxBt27dUL16dXTr1g2NGzfG8OHDMWjQIDx8+BCVK1eGh4cHtm/fXiDLS0RERERfLj09HQBgYGCg4kq+XbK2lbV1XvGIUh4NHDgQV69excmTJ+XDtLW18ddff6FXr14wMzODpqYmGjRogKZNm+Y4n8TERHTp0gXLly+HhYVFjuO1bt0arVu3lj8PDQ3FtWvXEBwcjNKlS2PTpk2wsbFB9erV4ePjAysrq/xZUCIiIiLKdzzdruDkV9syKOXBoEGDsGfPHvz3338oUaKEwmtVqlTB5cuXER8fj7S0NFhaWqJGjRqoWrVqtvO6f/8+IiMj4e/vLx8mlUoBAFpaWrhz5w5KlSqlME1qaioGDBiA9evXIyIiAhkZGfD19QUAuLm54dy5cwrzIyIiIiKi3GFQygUhBAYNGoSdO3ciNDQULi4uOY5rYmICALh37x7CwsIwefLkbMcrU6YMrl27pjDs999/R2JiIubPnw8HB4cs00yePBlNmzaFl5cXwsPDkZGRIX8tPT09X7tFJCIiIiIqilQalP777z/MmjULFy9eRFRUFHbu3Klw/yAhBCZNmoRly5bhzZs3qFGjBhYuXCjvUa6wBQQEYOPGjdi9ezeMjIwQHR0N4H0okl04tm3bNlhaWsLR0RHXrl3D4MGD0apVKzRq1Eg+n27dusHe3h6BgYHQ09OTX+MkU7x4cQDIMhwAbty4gS1btuDy5csA3gctDQ0NhISEwMbGBrdv30a1atUKYOmJiIiIqCBNnPhtvld+iYyMhIuLC8LDw1GpUqUCfz+VduaQlJSEihUrIjg4ONvXZ86ciaCgIAQHB+PChQuwsbFBw4YNkZiYWMiVvrd48WLEx8fDz88Ptra28seWLVvk40RFRaFr164oU6YMfvnlF3Tt2hWbNm1SmM/jx48/2rlDToQQ6NOnD+bOnSu/J5O+vj5Wr16NP/74A7169UJwcDDs7e2/bEGJiIiIiIo4iRBCqLoI4P1FVx8eURJCwM7ODr/++itGjhwJ4P21OdbW1pgxYwb69u37WfNNSEiAiYkJ4uPjeUNWIiIiIlKplJQUPHz4EC4uLgq3lAHU/4iSVCrFrFmzsHz5cjx58gTW1tbo27cvxo4dKz+T6syZMzAwMEDbtm0RFBSEYsWKAQD8/PxQqVIlzJs3Tz6/Vq1aoXjx4li9ejUAwNnZGX369EFERAS2bdsGU1NT/P777+jTpw+ArJ00+Pr6IjQ0NEudH2vj3GQDte0e/OHDh4iOjlY4ZU1XVxe+vr44ffp0jtOlpqYiISFB4UFERERERF9m9OjRmDFjBsaNG4ebN29i48aNsLa2RnJyMpo0aQJTU1NcuHAB27Ztw7///ouBAwfm+j3mzJmDqlWrIjw8HAMGDED//v1x+/ZtAMD58+cBAP/++y+ioqKwY8eOfF0+ZWrbmYPs+h9ra2uF4dbW1nj06FGO0wUGBmLSpEkFVpc6n8+pzrURERER0ddL1tFYcHAwunfvDgAoVaoUvL29sXz5crx79w5r166VXx4SHBwMf39/zJgxI8vv+Y9p1qwZBgwYAAAYOXIk5s6di9DQUJQpUwaWlpYAAHNzc9jY2OTzEmaltkeUZJQPsQkhPto3+ujRoxEfHy9/PHnypKBLJCIiIiL6pt26dQupqamoX79+tq9VrFhRHpIAoHbt2pBKpbhz506u3qdChQry/0skEtjY2CAmJibvhX8BtT2iJEuJ0dHRsLW1lQ+PiYn5aCrV1dWFrq5ugddHRERERFRUyHp4zs7HDmTIhmtoaEC5a4T09PQs42tra2eZXnaP0cKmtkeUXFxcYGNjg8OHD8uHpaWl4fjx46hVq5YKKyMiIiIiKlpcXV2hr6+PI0eOZHmtXLlyuHz5MpKSkuTDTp06BQ0NDbi5uQEALC0tFXp9zszMxPXr13NVg46OjnzawqDSI0pv375FRESE/PnDhw9x+fJlmJmZwdHREb/++iumTZsGV1dXuLq6Ytq0aTAwMECnTp1UWDURERERUdGip6eHkSNH4rfffoOOjg5q166Nly9f4saNG+jcuTMmTJiA7t27Y+LEiXj58iUGDRqErl27ys8Eq1evHoYOHYr9+/ejVKlSmDt3LuLi4nJVg5WVFfT19XHgwAGUKFECenp6MDExKYClfU+lQSksLAx169aVPx86dCgAoHv37li9ejV+++03vHv3DgMGDJDfcPbQoUMwMjJSVclEREREREXSuHHjoKWlhfHjx+P58+ewtbVFv379YGBggIMHD2Lw4MGoVq2aQvfgMj179sSVK1fQrVs3aGlpYciQIQo54HNoaWnhzz//xB9//IHx48ejTp062XYPnl/U5j5KBSW/76Okzj3LqXNtRERERPTxe/xQ/vjm76NERERERESkKgxKREREREREShiUiIiIiIiIlDAoERERERERKWFQIiIiIiIqZN94f2oqlV9ty6BERERERFRItLW1AQDJyckqruTbJWtbWVvnlUrvo0REREREVJRoamqiePHiiImJAQAYGBhAIpGouKpvgxACycnJiImJQfHixaGpqflF82NQIiIiIiIqRDY2NgAgD0uUv4oXLy5v4y/BoEREREREVIgkEglsbW1hZWWF9PR0VZfzTdHW1v7iI0kyDEpERERERCqgqamZbz/qKf+xMwciIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREREREREShiUiIiIiIiIlDAoERERERERKWFQIiIiIiIiUsKgREREREREpIRBiYiIiIiISAmDEhERERERkRIGJSIiIiIiIiUMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEgJgxIREREREZESBiUiIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREREREREShiUiIiIiIiIlDAoERERERERKWFQIiIiIiIiUsKgREREREREpIRBiYiIiIiISAmDEhERERERkRIGJSIiIiIiIiUMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEgJgxIREREREZESBiUiIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSotZBKSMjA7///jtcXFygr6+PkiVL4o8//oBUKlV1aURERERE9A3TUnUBHzNjxgwsWbIEa9asQfny5REWFoaffvoJJiYmGDx4sKrLIyIiIiKib5RaB6UzZ87g+++/R/PmzQEAzs7O2LRpE8LCwlRcGRERERERfcvU+tQ7b29vHDlyBHfv3gUAXLlyBSdPnkSzZs1ynCY1NRUJCQkKDyIiIiIiotxQ6yNKI0eORHx8PMqUKQNNTU1kZmZi6tSp6NixY47TBAYGYtKkSYVYJRERERERfWvU+ojSli1bsH79emzcuBGXLl3CmjVrMHv2bKxZsybHaUaPHo34+Hj548mTJ4VYMRERERERfQvU+ojSiBEjMGrUKHTo0AEA4OnpiUePHiEwMBDdu3fPdhpdXV3o6uoWZplERERERPSNUesjSsnJydDQUCxRU1OT3YMTEREREVGBUusjSv7+/pg6dSocHR1Rvnx5hIeHIygoCD179lR1aURERERE9A1T66C0YMECjBs3DgMGDEBMTAzs7OzQt29fjB8/XtWlERERERHRN0ytg5KRkRHmzZuHefPmqboUIiIiIiIqQtT6GiUiIiIiIiJVYFAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREREREREShiUiIiIiIiIlDAoERERERERKWFQIiIiIiIiUsKgREREREREpIRBiYiIiIiISAmDEhERERERkRIGJSIiIiIiIiUMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUKICFRgYiGrVqsHIyAhWVlZo1aoV7ty5ozCOEAITJ06EnZ0d9PX14efnhxs3bnxy3nFxcQgICICtrS309PRQtmxZ/P333/LXN2zYAAcHB5iZmWHEiBEK00ZGRsLNzQ0JCQn5s6BERERE9E1hUKICdfz4cQQEBODs2bM4fPgwMjIy0KhRIyQlJcnHmTlzJoKCghAcHIwLFy7AxsYGDRs2RGJiYo7zTUtLQ8OGDREZGYnt27fjzp07WL58Oezt7QEAsbGx6N27N2bPno2DBw9izZo12L9/v3z6/v37Y/r06TA2Ni64hSciIiKir5aWqgugb9uBAwcUnq9atQpWVla4ePEifHx8IITAvHnzMHbsWLRp0wYAsGbNGlhbW2Pjxo3o27dvtvNduXIlXr9+jdOnT0NbWxsA4OTkJH/9wYMHMDExQfv27QEAdevWxc2bN9G8eXNs3LgROjo68vcjIiIiIlLGI0pUqOLj4wEAZmZmAICHDx8iOjoajRo1ko+jq6sLX19fnD59Osf57NmzBzVr1kRAQACsra3h4eGBadOmITMzEwDg6uqK5ORkhIeH4/Xr17hw4QIqVKiA169fY/z48QgODi7ApSQiIiKirx2DEhUaIQSGDh0Kb29veHh4AACio6MBANbW1grjWltby1/LzoMHD7B9+3ZkZmbi77//xu+//445c+Zg6tSpAABTU1OsWbMG3bp1Q/Xq1dGtWzc0btwYw4cPx6BBg/Dw4UNUrlwZHh4e2L59ewEtMRERERF9rXjqHRWagQMH4urVqzh58mSW1yQSicJzIUSWYR+SSqWwsrLCsmXLoKmpiSpVquD58+eYNWsWxo8fDwBo3bo1WrduLZ8mNDQU165dQ3BwMEqXLo1NmzbBxsYG1atXh4+PD6ysrPJpSYmIiIjoa8cjSlQoBg0ahD179uDYsWMoUaKEfLiNjQ0AZDl6FBMTk+Uo04dsbW3h5uYGTU1N+bCyZcsiOjoaaWlpWcZPTU3FgAEDsHTpUkRERCAjIwO+vr5wd3eHm5sbzp0796WLSERERETfEAYlKlBCCAwcOBA7duzA0aNH4eLiovC6i4sLbGxscPjwYfmwtLQ0HD9+HLVq1cpxvrVr10ZERASkUql82N27d2FrawsdHZ0s40+ePBlNmzaFl5cXMjMzkZGRIX8tPT1dfm0TERERERHAU++ogAUEBGDjxo3YvXs3jIyM5EeOTExMoK+vD4lEgl9//RXTpk2Dq6srXF1dMW3aNBgYGKBTp07y+XTr1g329vYIDAwE8L577wULFmDw4MEYNGgQ7t27h2nTpuGXX37JUsONGzewZcsWXL58GQBQpkwZaGhoICQkBDY2Nrh9+zaqVatW8I1BRERERF8NBiUqUIsXLwYA+Pn5KQxftWoVevToAQD47bff8O7dOwwYMABv3rxBjRo1cOjQIRgZGcnHf/z4MTQ0/ncA1MHBAYcOHcKQIUNQoUIF2NvbY/DgwRg5cqTC+wgh0KdPH8ydOxeGhoYAAH19faxevRoBAQFITU1FcHCw/P5LREREREQAIBFCCFUXUZASEhJgYmKC+Pj4fLm56MSJX15TQVHn2oiIiIiIVC032YDXKBERERERESnhqXdUKNT5aJc610ZEREREqsEjSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEgJgxIREREREZESBiUiIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREREREREShiUiIiIiIiIlDAoERERERERKWFQIiIiIiIiUsKgREREREREpIRBiYiIiIiISAmDEhERERERkRIGJSIiIiIiIiUMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEgJgxIREREREZGSPAWlhw8f5ncdREREREREaiNPQal06dKoW7cu1q9fj5SUlPyuScGzZ8/QpUsXmJubw8DAAJUqVcLFixcL9D2JiIiIiKhoy1NQunLlCipXroxhw4bBxsYGffv2xfnz5/O7Nrx58wa1a9eGtrY2/vnnH9y8eRNz5sxB8eLF8/29iIiIiIiIZPIUlDw8PBAUFIRnz55h1apViI6Ohre3N8qXL4+goCC8fPkyX4qbMWMGHBwcsGrVKlSvXh3Ozs6oX78+SpUqlS/zJyIiIiIiys4XdeagpaWF1q1bY+vWrZgxYwbu37+P4cOHo0SJEujWrRuioqK+qLg9e/agatWq+OGHH2BlZYXKlStj+fLlH50mNTUVCQkJCg8iIiIiIqLc+KKgFBYWhgEDBsDW1hZBQUEYPnw47t+/j6NHj+LZs2f4/vvvv6i4Bw8eYPHixXB1dcXBgwfRr18//PLLL1i7dm2O0wQGBsLExET+cHBw+KIaiIiIiIio6JEIIURuJwoKCsKqVatw584dNGvWDL1790azZs2gofG/3BUREYEyZcogIyMjz8Xp6OigatWqOH36tHzYL7/8ggsXLuDMmTPZTpOamorU1FT584SEBDg4OCA+Ph7GxsZ5rkVm4sQvnkWBYW15o861EREREVH+SUhIgImJyWdlA628vMHixYvRs2dP/PTTT7Cxscl2HEdHR4SEhORl9nK2trYoV66cwrCyZcvir7/+ynEaXV1d6OrqftH7EhERERFR0ZanoHTv3r1PjqOjo4Pu3bvnZfZytWvXxp07dxSG3b17F05OTl80XyIiIiIioo/J0zVKq1atwrZt27IM37ZtG9asWfPFRckMGTIEZ8+exbRp0xAREYGNGzdi2bJlCAgIyLf3ICIiIiIiUpanoDR9+nRYWFhkGW5lZYVp06Z9cVEy1apVw86dO7Fp0yZ4eHhg8uTJmDdvHjp37pxv70FERERERKQsT6fePXr0CC4uLlmGOzk54fHjx19c1IdatGiBFi1a5Os8iYiIiIiIPiZPR5SsrKxw9erVLMOvXLkCc3PzLy6KiIiIiIhIlfIUlDp06IBffvkFx44dQ2ZmJjIzM3H06FEMHjwYHTp0yO8aiYiIiIiIClWeTr2bMmUKHj16hPr160NL6/0spFIpunXrlq/XKBEREREREalCnoKSjo4OtmzZgsmTJ+PKlSvQ19eHp6cnu+0mIiIiIqJvQp6Ckoybmxvc3NzyqxYiIiIiIiK1kKeglJmZidWrV+PIkSOIiYmBVCpVeP3o0aP5UhwREREREZEq5CkoDR48GKtXr0bz5s3h4eEBiUSS33URERERERGpTJ6C0ubNm7F161Y0a9Ysv+shIiIiIiJSuTx1D66jo4PSpUvndy1ERERERERqIU9BadiwYZg/fz6EEPldDxERERERkcrl6dS7kydP4tixY/jnn39Qvnx5aGtrK7y+Y8eOfCmOiIiIiIhIFfIUlIoXL47WrVvndy1ERERERERqIU9BadWqVfldBxERERERkdrI0zVKAJCRkYF///0XS5cuRWJiIgDg+fPnePv2bb4VR0REREREpAp5OqL06NEjNGnSBI8fP0ZqaioaNmwIIyMjzJw5EykpKViyZEl+10lERERERFRo8nREafDgwahatSrevHkDfX19+fDWrVvjyJEj+VYcERERERGRKuS517tTp05BR0dHYbiTkxOePXuWL4URERERERGpSp6OKEmlUmRmZmYZ/vTpUxgZGX1xUURF3X///Qd/f3/Y2dlBIpFg165dOY7bt29fSCQSzJs376Pz9PPzg0QiyfJo3ry5fJwNGzbAwcEBZmZmGDFihML0kZGRcHNzQ0JCwpcsGhEREdFXIU9BqWHDhgo/yiQSCd6+fYsJEyagWbNm+VUbUZGVlJSEihUrIjg4+KPj7dq1C+fOnYOdnd0n57ljxw5ERUXJH9evX4empiZ++OEHAEBsbCx69+6N2bNn4+DBg1izZg32798vn75///6YPn06jI2Nv2zhiIiIiL4CeTr1bu7cuahbty7KlSuHlJQUdOrUCffu3YOFhQU2bdqU3zUSFTlNmzZF06ZNPzrOs2fPMHDgQBw8eFDhqFBOzMzMFJ5v3rwZBgYG8qD04MEDmJiYoH379gCAunXr4ubNm2jevDk2btwIHR0dtGnTJo9LRERERPR1yVNQsrOzw+XLl7Fp0yZcunQJUqkUvXr1QufOnRU6dyCigiGVStG1a1eMGDEC5cuXz9M8QkJC0KFDBxgaGgIAXF1dkZycjPDwcDg5OeHChQvo2bMnXr9+jfHjx+PYsWP5uQhEREREai1PQQkA9PX10bNnT/Ts2TM/6yGizzBjxgxoaWnhl19+ydP058+fx/Xr1xESEiIfZmpqijVr1qBbt2549+4dunXrhsaNG6Nnz54YNGgQHj58iJYtWyI9PR0TJ05Eu3bt8mtxiIiIiNROnoLS2rVrP/p6t27d8lQMEX3axYsXMX/+fFy6dAkSiSRP8wgJCYGHhweqV6+uMLx169Zo3bq1/HloaCiuXbuG4OBglC5dGps2bYKNjQ2qV68OHx8fWFlZfdGyEBEREamrPAWlwYMHKzxPT09HcnIydHR0YGBgwKBEVIBOnDiBmJgYODo6yodlZmZi2LBhmDdvHiIjIz86fXJyMjZv3ow//vjjo+OlpqZiwIABWL9+PSIiIpCRkQFfX18AgJubG86dOwd/f/8vXh4iIiIidZSnoPTmzZssw+7du4f+/ftn6VKYiPJX165d0aBBA4VhjRs3RteuXfHTTz99cvqtW7ciNTUVXbp0+eh4kydPRtOmTeHl5YXw8HBkZGTIX0tPT8/2FgFERERE34o8X6OkzNXVFdOnT0eXLl1w+/bt/JotUZH09u1bREREyJ8/fPgQly9fhpmZGRwdHWFubq4wvra2NmxsbODu7i4f1q1bN9jb2yMwMFBh3JCQELRq1SrLPD5048YNbNmyBZcvXwYAlClTBhoaGggJCYGNjQ1u376NatWq5cOSEhEREamnfAtKAKCpqYnnz5/n5yyJiqSwsDDUrVtX/nzo0KEAgO7du2P16tWfNY/Hjx9DQ0PxVml3797FyZMncejQoRynE0KgT58+mDt3rrxHPH19faxevRoBAQFITU1FcHAw7O3tc7lURERERF+PPAWlPXv2KDwXQiAqKgrBwcGoXbt2vhRGVJT5+flBCPHZ42d3XVJoaGiWYW5ubp+cr0QiwalTp7IMb9GiBVq0aPHZNRERERF9zfIUlFq1aqXwXCKRwNLSEvXq1cOcOXPyoy4iIiIiIiKVyVNQkkql+V0HERERERGR2sjXa5SIKP9MnKjqCnKmzrURERER5Yc8BSXZheWfIygoKC9vQUREREREpDJ5Ckrh4eG4dOkSMjIy5N0R3717F5qamvDy8pKPJ5FI8qdKIiIiIiKiQpSnoOTv7w8jIyOsWbMGpqamAN7fhPann35CnTp1MGzYsHwtkoiIiIiIqDBpfHqUrObMmYPAwEB5SAIAU1NTTJkyhb3eERERERHRVy9PQSkhIQEvXrzIMjwmJgaJiYlfXBQREREREZEq5SkotW7dGj/99BO2b9+Op0+f4unTp9i+fTt69eqFNm3a5HeNREREREREhSpP1ygtWbIEw4cPR5cuXZCenv5+Rlpa6NWrF2bNmpWvBRIRERERERW2PAUlAwMDLFq0CLNmzcL9+/chhEDp0qVhaGiY3/UREREREREVujydeicTFRWFqKgouLm5wdDQEEKI/KqLiIiIiIhIZfIUlF69eoX69evDzc0NzZo1Q1RUFACgd+/e7BqciIiIiIi+enkKSkOGDIG2tjYeP34MAwMD+fD27dvjwIED+VYcERERERGRKuTpGqVDhw7h4MGDKFGihMJwV1dXPHr0KF8KIyIiIiIiUpU8HVFKSkpSOJIkExsbC11d3S8uioiIiIiISJXyFJR8fHywdu1a+XOJRAKpVIpZs2ahbt26+VYcERERERGRKuTp1LtZs2bBz88PYWFhSEtLw2+//YYbN27g9evXOHXqVH7XSEREREREVKjydESpXLlyuHr1KqpXr46GDRsiKSkJbdq0QXh4OEqVKpXfNRIRERERERWqXB9RSk9PR6NGjbB06VJMmjSpIGoiIiIiIiJSqVwfUdLW1sb169chkUgKoh4iIiIiIiKVy9Opd926dUNISEh+10JERERERKQW8tSZQ1paGlasWIHDhw+jatWqMDQ0VHg9KCgoX4ojIiIiIiJShVwFpQcPHsDZ2RnXr1+Hl5cXAODu3bsK4/CUPCIiIiIi+trlKii5uroiKioKx44dAwC0b98ef/75J6ytrQukOCIiIiIiIlXI1TVKQgiF5//88w+SkpLytSAiIiIiIiJVy1NnDjLKwYmISJX+++8/+Pv7w87ODhKJBLt27VJ4fceOHWjcuDEsLCwgkUhw+fLlz5rvvHnz4O7uDn19fTg4OGDIkCFISUmRv75hwwY4ODjAzMwMI0aMUJg2MjISbm5uSEhI+NLFIyIiokKUq6AkkUiyXIPEa5KISF0kJSWhYsWKCA4OzvH12rVrY/r06Z89zw0bNmDUqFGYMGECbt26hZCQEGzZsgWjR48GAMTGxqJ3796YPXs2Dh48iDVr1mD//v3y6fv374/p06fD2Nj4yxaOiIiIClWurlESQqBHjx7Q1dUFAKSkpKBfv35Zer3bsWNH/lVIRPSZmjZtiqZNm+b4eteuXQG8P8rzuc6cOYPatWujU6dOAABnZ2d07NgR58+fB/C+kxsTExO0b98eAFC3bl3cvHkTzZs3x8aNG6Gjo4M2bdrkcYmIiIhIVXIVlLp3767wvEuXLvlaDBGRuvH29sb69etx/vx5VK9eHQ8ePMDff/8t3x66uroiOTkZ4eHhcHJywoULF9CzZ0+8fv0a48ePl3d+Q0RERF+XXAWlVatWFVQdRERqqUOHDnj58iW8vb0hhEBGRgb69++PUaNGAQBMTU2xZs0adOvWDe/evUO3bt3QuHFj9OzZE4MGDcLDhw/RsmVLpKenY+LEiWjXrp2Kl4iIiIg+R55uOEtEVFSEhoZi6tSpWLRoEWrUqIGIiAgMHjwYtra2GDduHACgdevWaN26tcI0165dQ3BwMEqXLo1NmzbBxsYG1atXh4+PD6ysrFS1OERERPSZGJSIiD5i3Lhx6Nq1K3r37g0A8PT0RFJSEvr06YOxY8dCQ0OxT5zU1FQMGDAA69evR0REBDIyMuDr6wsAcHNzw7lz5+Dv71/oy0FERES580XdgxMRfeuSk5OzhCFNTU0IIbK9RcLkyZPRtGlTeHl5ITMzExkZGfLX0tPTkZmZWeA1ExER0Zf7qo4oBQYGYsyYMRg8eDDmzZun6nKISM28ffsWERER8ucPHz7E5cuXYWZmBkdHR7x+/RqPHz/G8+fPAQB37twBANjY2MDGxgYA0K1bN9jb2yMwMBAA4O/vj6CgIFSuXFl+6t24cePQsmVLaGpqKrz/jRs3sGXLFvn9mcqUKQMNDQ2EhITAxsYGt2/fRrVq1Qq6GYiIiCgffDVB6cKFC1i2bBkqVKig6lKISE2FhYWhbt268udDhw4F8L7HztWrV2PPnj346aef5K936NABADBhwgRMnDgRAPD48WOFI0i///47JBIJfv/9dzx79gyWlpbw9/fH1KlTFd5bCIE+ffpg7ty58lsm6OvrY/Xq1QgICEBqaiqCg4Nhb29fIMtORERE+Usisjt3RM28ffsWXl5eWLRoEaZMmYJKlSp99hGlhIQEmJiYID4+Pl9u+Pj/v6XUEmvLG3WtTV3rAtS7NiIiIqKc5CYbfBXXKAUEBKB58+Zo0KDBJ8dNTU1FQkKCwoOIiIiIiCg31P7Uu82bN+PSpUu4cOHCZ40fGBiISZMmFXBVRKSu1PlolzrXRkRERIrU+ojSkydPMHjwYKxfvx56enqfNc3o0aMRHx8vfzx58qSAqyQiIiIiom+NWh9RunjxImJiYlClShX5sMzMTPz3338IDg5Gampqll6ndHV1oaurW9ilEhERERHRN0Stg1L9+vVx7do1hWE//fQTypQpg5EjR2YJSURERERERPlBrYOSkZERPDw8FIYZGhrC3Nw8y3AiIiIiIqL8otbXKBEREREREamCWh9Ryk5oaKiqSyAiIiIiom8cjygREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREREREREShiUiIiIiIiIlDAoERERERERKWFQIiIiIiIiUsKgREREREREpIRBiYiIiIiISAmDEhERERERkRIGJSIiIiIiIiUMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEgJgxIREREREZESBiUiIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREREREREShiUiIiIiIiIlDAoERERERERKWFQIiIiIiIiUsKgREREREREpIRBiYiIiIiISAmDEhERERERkRIGJSIiIiIiIiUMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEgJgxIREREREZESBiUiIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREQkN3HiREgkEoWHjY3NR6dZuHAhypYtC319fbi7u2Pt2rUKrx8+fBhubm4wMTFB9+7dkZaWJn8tPj4ebm5uePz4cYEsT2FhuxERfXsYlIiISEH58uURFRUlf1y7di3HcRcvXozRo0dj4sSJuHHjBiZNmoSAgADs3bsXACCVStG5c2f069cPp0+fxvnz57F8+XL59CNHjkS/fv3g6OhY4MtV0NhuRETfFi1VF0BEROpFS0vrk0dDZNatW4e+ffuiffv2AICSJUvi7NmzmDFjBvz9/REbG4uXL19iwIAB0NPTQ8uWLXHz5k0AwKlTpxAWFoaFCxcW2LIUJrYbEdG3hUeUiIhIwb1792BnZwcXFxd06NABDx48yHHc1NRU6OnpKQzT19fH+fPnkZ6eDktLS9ja2uLQoUN49+4dTpw4gQoVKiAtLQ39+/fHkiVLoKmpWdCLVCjYbkRE3xYGJSIikqtRowbWrl2LgwcPYvny5YiOjkatWrXw6tWrbMdv3LgxVqxYgYsXL0IIgbCwMKxcuRLp6emIjY2FRCLB1q1bMXnyZJQrVw6VK1dGz549MX36dNSvXx/6+vqoXbs23N3dERwcXMhLm3/YbkRE3x6eekdERHJNmzaV/9/T0xM1a9ZEqVKlsGbNGgwdOjTL+OPGjUN0dDS+++47CCFgbW2NHj16YObMmfIjHt7e3rhw4YJ8mrt372LdunUIDw+Hj48Pfv31VzRp0gQeHh7w8fFBhQoVCn5B8xnbjYjo28MjSkRElCNDQ0N4enri3r172b6ur6+PlStXIjk5GZGRkXj8+DGcnZ1hZGQECwuLLOMLIdCnTx/MmTMHUqkU4eHhaNeuHaysrODr64vjx48X9CIVCrYbEdHXj0GJiIhylJqailu3bsHW1vaj42lra6NEiRLQ1NTE5s2b0aJFC2hoZP2KCQkJgbm5OVq2bInMzEwAQHp6uvxf2bCvHduNiOjrx6BERERyw4cPx/Hjx/Hw4UOcO3cO7dq1Q0JCArp37w4AGD16NLp16yYf/+7du1i/fj3u3buH8+fPo0OHDrh+/TqmTZuWZd4xMTGYMmUK/vzzTwCAqakpypYti3nz5uHMmTM4cuQIatWqVTgLms/YbkRE3x61DkqBgYGoVq0ajIyMYGVlhVatWuHOnTuqLouI6Jv19OlTdOzYEe7u7mjTpg10dHRw9uxZODk5AQCioqIUbnKamZmJOXPmoGLFimjYsCFSUlJw+vRpODs7Z5n34MGDMXz4cNjb28uHrV69Wn4kZcSIEahevXqBL2NBYLsREX17JEIIoeoictKkSRN06NAB1apVQ0ZGBsaOHYtr167h5s2bMDQ0/Kx5JCQkwMTEBPHx8TA2Nv7imiZO/OJZFBjWljfqWpu61gWwtrxS59qIiIiKgtxkA7Xu9e7AgQMKz1etWgUrKytcvHgRPj4+KqqKiIiIiIi+dWodlJTFx8cDAMzMzHIcJzU1FampqfLnCQkJBV4XERERERF9W76aoCSEwNChQ+Ht7Q0PD48cxwsMDMSkSZMKsTIioq+bOp8SyNryRp1rIyL6Wqh1Zw4fGjhwIK5evYpNmzZ9dLzRo0cjPj5e/njy5EkhVUhERERERN+Kr+KI0qBBg7Bnzx78999/KFGixEfH1dXVha6ubiFVRkRERERE3yK1DkpCCAwaNAg7d+5EaGgoXFxcVF0SEREREREVAWodlAICArBx40bs3r0bRkZGiI6OBgCYmJhAX19fxdUREREREdG3Sq2vUVq8eDHi4+Ph5+cHW1tb+WPLli2qLo2IiIiIiL5han1ESY3vhUtERERERN8wtT6iREREREREpAoMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEgJgxIREREREZESBiUiIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREREVOgCAwNRrVo1GBkZwcrKCq1atcKdO3c+Od3ChQtRtmxZ6Ovrw93dHWvXrlV4/fDhw3Bzc4OJiQm6d++OtLQ0+Wvx8fFwc3PD48eP8315CgvbLffYZnnDdmNQIiIiIhU4fvw4AgICcPbsWRw+fBgZGRlo1KgRkpKScpxm8eLFGD16NCZOnIgbN25g0qRJCAgIwN69ewEAUqkUnTt3Rr9+/XD69GmcP38ey5cvl08/cuRI9OvXD46OjgW+fAWF7ZZ7bLO8YbsBWqougIiIiIqeAwcOKDxftWoVrKyscPHiRfj4+GQ7zbp169C3b1+0b98eAFCyZEmcPXsWM2bMgL+/P2JjY/Hy5UsMGDAAenp6aNmyJW7evAkAOHXqFMLCwrBw4cKCXbACxnbLPbZZ3rDdeESJiIiI1EB8fDwAwMzMLMdxUlNToaenpzBMX18f58+fR3p6OiwtLWFra4tDhw7h3bt3OHHiBCpUqIC0tDT0798fS5YsgaamZoEuR2Fju+Ue2yxvimK7MSgRERGRSgkhMHToUHh7e8PDwyPH8Ro3bowVK1bg4sWLEEIgLCwMK1euRHp6OmJjYyGRSLB161ZMnjwZ5cqVQ+XKldGzZ09Mnz4d9evXh76+PmrXrg13d3cEBwcX4hIWDLZb7rHN8qaothtPvSMiIiKVGjhwIK5evYqTJ09+dLxx48YhOjoa3333HYQQsLa2Ro8ePTBz5kz5Xmhvb29cuHBBPs3du3exbt06hIeHw8fHB7/++iuaNGkCDw8P+Pj4oEKFCgW6bAWJ7ZZ7bLO8KartxiNKREREpDKDBg3Cnj17cOzYMZQoUeKj4+rr62PlypVITk5GZGQkHj9+DGdnZxgZGcHCwiLL+EII9OnTB3PmzIFUKkV4eDjatWsHKysr+Pr64vjx4wW1WAWO7ZZ7bLO8KcrtxqBEREREhU4IgYEDB2LHjh04evQoXFxcPntabW1tlChRApqamti8eTNatGgBDY2sP2lCQkJgbm6Oli1bIjMzEwCQnp4u/1c27GvCdss9tlnesN146h0RERGpQEBAADZu3Ijdu3fDyMgI0dHRAAATExPo6+sDAEaPHo1nz57J78Ny9+5dnD9/HjVq1MCbN28QFBSE69evY82aNVnmHxMTgylTpuDUqVMAAFNTU5QtWxbz5s1Do0aNcOTIEYwZM6aQljb/sN1yj22WN2w3HlEiIiIiFVi8eDHi4+Ph5+cHW1tb+WPLli3ycaKiohRuPJmZmYk5c+agYsWKaNiwIVJSUnD69Gk4Oztnmf/gwYMxfPhw2Nvby4etXr1avnd7xIgRqF69eoEuY0Fgu+Ue2yxv2G6ARAghVFpBAUtISICJiQni4+NhbGz8xfObOPHLayoorC1v1LU2da0LYG15pa61qWtdAGvLK3WujYhIlXKTDXhEiYiIiIiISAmvUSIiIqJCoc5Hulhb3qhrbepaF8Da8koVtfGIEhERERERkRIGJSIiIiIiIiUMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEgJgxIREREREZESBiUiIiIiIiIlDEpERERERERKGJSIiIiIiIiUMCgREREREREpYVAiIiIiIiJSwqBERERERESkhEGJiIiIiIhICYMSERERERGREgYlIiIiIiIiJQxKREREREREShiUiIiIiIiIlDAoERERERERKWFQIiIiIiIiUsKgREREREREpIRBiYiIiIiISAmDEhERERERkRIGJSIiIiIiIiUMSkREREREREoYlIiIiIiIiJQwKBERERERESlhUCIiIiIiIlLCoERERERERKSEQYmIiIiIiEjJVxGUFi1aBBcXF+jp6aFKlSo4ceKEqksiIiIiIqJvmNoHpS1btuDXX3/F2LFjER4ejjp16qBp06Z4/PixqksjIiIiIqJvlNoHpaCgIPTq1Qu9e/dG2bJlMW/ePDg4OGDx4sWqLo2IiIiIiL5RWqou4GPS0tJw8eJFjBo1SmF4o0aNcPr06WynSU1NRWpqqvx5fHw8ACAhISFfavpg1monnxaxQLDdco9tljdst9xjm+UN2y332GZ5w3bLPbZZ3hSFdpNlAiHEp0cWauzZs2cCgDh16pTC8KlTpwo3N7dsp5kwYYIAwAcffPDBBx988MEHH3zwke3jyZMnn8wian1ESUYikSg8F0JkGSYzevRoDB06VP5cKpXi9evXMDc3z3EaVUlISICDgwOePHkCY2NjVZfzVWCb5Q3bLffYZnnDdss9tlnesN1yj22WN2y33FPnNhNCIDExEXZ2dp8cV62DkoWFBTQ1NREdHa0wPCYmBtbW1tlOo6urC11dXYVhxYsXL6gS84WxsbHarUTqjm2WN2y33GOb5Q3bLffYZnnDdss9tlnesN1yT13bzMTE5LPGU+vOHHR0dFClShUcPnxYYfjhw4dRq1YtFVVFRERERETfOrU+ogQAQ4cORdeuXVG1alXUrFkTy5Ytw+PHj9GvXz9Vl0ZERERERN8otQ9K7du3x6tXr/DHH38gKioKHh4e+Pvvv+Hk5KTq0r6Yrq4uJkyYkOVUQcoZ2yxv2G65xzbLG7Zb7rHN8obtlntss7xhu+Xet9JmEiE+p288IiIiIiKiokOtr1EiIiIiIiJSBQYlIiIiIiIiJQxKREREREREShiU1BQvHSMiIiIiUh0GJRUTQkAqlSo8BwCJRKKqkqiIY0h/TyqVQiqVsj2o0HGd+3IpKSmqLoG+IfxM5o9z586puoRcY1BSMYlEAg0NDXlgkkgkOH/+PKZNm4bVq1erujy1IZVKsXv3bgwaNEjVpXzzJBIJbt68idDQUNy+fRvJycmqLkklNDQ0oKGhwZ0WebRu3Tr06NEDISEhOHHiBGJjY1Vd0ldDIpFgw4YNuHbtGt6+favqcr46SUlJ6Nq1K969e6fqUtQWf/jnjkQiwevXrxEeHo579+4prFtsy8/z9OlT9OrVC4sWLZJ/H3wNOyPV/j5K3yKpVAoNDQ0kJCTg+PHjePToEZKTk3HgwAHcvn0bxYsXBwD4+/urtlA1IISARCLBsWPHsHLlSjRt2lRhuMzFixdx+fJl9OrVS1WlfhPi4uIwbdo07Ny5ExYWFkhLS4Oenh6srKzg4OCAChUqoHfv3qous0AJIbB//34EBwfDwcEBw4cPR+nSpXHz5k1cuXIFnp6eqFixoqrLVHuxsbG4f/8+bt68ifT0dCQmJsLa2hqOjo4oXbo0KlasCE9PT9jb26NYsWJZPtNFWWJiIqZNm4aoqChYWlrC2toaLi4u8jZzcXFByZIloaHBfZ3ZuX79Oo4dOwZ9fX1kZmbK1ysNDQ08evQIq1atwsSJE1VbpIpl91njGS3Zk30v7tu3D8nJyShWrBisra3RoEED/Pzzz7CwsFB1iV+FYsWKoWnTpggKCsKBAwcwevRo1KxZU/66un4H8D5KhUgWkGbPno3Vq1dDS0sLdnZ2iImJQfny5bFz5050794dHTp0gJWVFRwdHb/6G3V9KVmb/fLLL0hPT8fcuXOhp6cnf132wTpw4AAWLlyIoKAguLq6qrDir1NmZiY0NTWxYcMGTJgwAT169IC7uztevHiBp0+f4sWLF3jw4AHc3NywfPlyVZdbIGTrWkhICObOnQtHR0dER0fDx8cHhoaGCAwMBACYmZlh9uzZ6NGjh2oLVnOJiYmIjo5GXFwczp07h7lz5yIjIwOurq5ISUnB3bt3IZVKoampif3796Nq1aqqLlnlZNuzp0+fYty4cTh37hwqVaoEY2Nj3L59G+fOnYOuri5cXV3h5eWF0aNHw9nZWdVlq5ys3fbt24fr16/jwYMHuHr1Ks6ePZtl3GXLlmHp0qW4ePGifLtX1Dg5OcHNzQ3VqlVD1apVUaVKFTg4ODB4Z+P169cYPXo0tm3bhvbt28PU1BSvX7/GlStXcO7cOdSsWRMrVqxA2bJlVV3qV+Pq1auYOHEi9u/fjyZNmmDs2LGoXr26qsvKEYOSClhYWKBJkyYYOnQobG1tYWtrCwCwt7fH/Pnz0a5dOxVXqD5kP14rVKiAAQMGoF+/ftmO9/r1a3Tr1g09evRg++WB7AdDv379kJGRgRUrVii8/vbtW0RFRUFDQwOlSpVSUZUFS7aueXt7o0GDBhg0aBBiYmLQpEkTWFtbY8qUKfD09ESfPn2QkJCA9evXw8HBQdVlfxW+//571KhRAwMHDkRSUhKio6Px33//Ye7cuWjatClmz54NQ0NDVZepcrLPYXBwME6ePImpU6eiVKlSSExMREJCAlasWIFjx46hUaNGWL58OUqUKIH9+/fD2NhY1aWrhXnz5iEoKAjPnj2DEAImJiZwcXFB5cqVUbNmTVhaWmLBggUoV64c/vzzT2RkZEBLq2idWPPu3TvMnj0bERERuHnzJu7evYvExEQUK1YMJUqUQMWKFVGzZk1Uq1YNpUqVgpWVlapLVgnZ90FwcDB27dqFPn364Mcff1QY59y5c+jUqRMaNWqExYsXq+0REXWRnp4OTU1NeSA/ffo0li1bhlevXqFZs2b4/vvvYWdnp+IqsyGoUEmlUrFhwwZRp04d0bBhQ7Fr1y6RlJQkhBBCW1tbXLp0ScUVqid3d3exbds2kZmZKaRSaZbXpVKpcHFxEadOnVJBdV8/WZtu2bJFDB8+XGRkZKi4ItXR09NT+BxaWFiIrVu3yp9fvXpVODo6ivDwcBVU9/XIzMwUQrxvL0NDQ5GQkJBlnLlz54revXsXdmlqKz09XQghRP369cWIESOyvP7u3Tvx448/iiNHjog7d+6ISpUqib/++quwy1RbqampQgghatWqJSZOnCjWrVsnAgICRL169YSzs7PQ1NQUzZo1Ezdu3BBC/G8dLWpky/3w4UMxduxYUbZsWTFq1CgxfPhw4evrKyQSiZBIJMLNzU3FlaqOrI18fX1FYGCg/HlaWprIzMyUP58yZYqoV6+eePDggcpq/do8ffpUxMTEiDNnzoiffvpJvr61atVKXLlyRdXlZVG0dqWoAYlEgk6dOsHb2xsrV67E4sWLceXKFVSvXh06OjpwdHREZmYmLyL/QFpaGry8vLBt27ZsjxYJIXD79m3ExMTA09NTBRV+/WTr2okTJ7Br1y5oaWmhdevWcHR0hI2NjYqrKzwvX75Eenq6wnqUnp6O7777DsD7vYz29vZ4+fLlN3tkLb/I1qk3b97A2toaly9fRp06dRTGKV68OE6fPg3gf3twizLZaWClS5dGWFgYHjx4gJIlS8pf19XVxblz59CuXTvUq1cPaWlp7N3tAzo6OgCAY8eOQUNDA1paWujSpQsyMzMRHx8PAwMDaGpqQltbGwCK/Pq2ZcsW3Lp1CwcOHICjoyPS0tKQlJSEJUuW4Pjx45gxY4aqS1QZ2bpx6dIlzJw5ExoaGpBKpdDS0lL4bdamTRts27aNna58QlpaGkaMGIHXr1/j9evXOH36NHR0dNCoUSP8/vvvMDY2xn///YeqVati3bp1aN++vapLlmNQUhFHR0eMHTsWO3bswKJFizB16lSUKVMG2traRfKc6Y/R0dFBu3bt0K5dO/j6+qJz584wMTGRvy6VSjFp0iTUqFEDRkZGKqz065aSkoKIiAhYW1tj/fr1+Pfff1GsWDGYmZnB3t4ejo6OGDZs2DcZ4MX/nzJx8+ZNSKVSzJ8/H87Oznj16hW0tLQUflhFRUVBIpFwXfsE2Xri6ekJT09P9OrVC3/88QcqVKgAXV1dXLhwAcuXL0ft2rUBMCgB/2uzgIAAtG/fHkOGDEHbtm3h7OyMN2/eyK9t9fHxwbt37xAbG4tKlSqptmg1lJaWhrNnz2Lfvn2wsbHB0KFDYWZmhtTUVPlnuSiTfdaOHDkCDw8PODo6AgC0tbVhamqK3377DefPn0d4eHiR7rjm5cuXSE5ORpUqVQBkDdZSqRTGxsaIjIyEi4uLKkr8ajx79gzXr1+HpaUlatasicmTJ8PFxQWpqanynbHDhw/H5MmTMX36dLUKSrxGSU2EhIRg6tSpyMjIwIABA9CjR48itSf/U9LS0jBs2DAsWbIETZo0QZ06dVCqVCk8fPgQq1evxrt377Bu3TrUqlVL1aV+1RISEvDs2TM8ePAADx48wNOnTxEVFYXnz5/DyMgIO3fuVHWJBerIkSMYOnQoDAwMkJ6ejrdv3+L169do2rQprKys4OrqitOnT+PKlSsIDw9XdblfjefPn2PMmDHYv38/9PT0YG1tjZcvX8q/MF1dXRmUlJw6dQqTJk3C+fPnoaGhATs7O1hZWeG3335DkyZNMGvWLKxduxbXrl1TdalqQbazIzo6GuPGjcOePXvg5uaG2NhYXLt2DfHx8di0aRPq1auHcuXKqbpctTB8+HCcPn0au3btUrgWKSEhAZ6enliwYAFatmypwgpVQ7YuHT9+HHXr1sWcOXNgaWkJBwcH2Nvbw8rKSn5d4I0bN1CrVi3Ex8eruGr1JGvLS5cu4cWLF/Kei3OydetW9OnTB3FxcYVT4GdgUFKxD3vdiYuLw6JFixAUFITNmzejQYMGKq5Ovbx9+xarV6/Gli1bcOfOHcTFxUEIgRYtWmDEiBEMSXkk+4F69epVpKSkZOl9JjMzE9HR0UhKSoKbm5uKqixcz549w7179/Dw4UPcuXMHd+/excuXL5GWloabN28iICAA06dPV3WZXwXxwQXO9+/fR3h4OB4/fowqVarAx8fnmzxC+SWE0gXhGRkZuH37NuLj4+Hh4QETExMIIRAXF4fY2Fj28vn/ZN+l06dPx6FDh7Bt2zYsW7YM//77L44cOYKXL19i5MiRKF26NMaMGcML7wE8ePAADRo0gK6uLtq2bQsXFxdIJBJs2bIFT548wfHjx2FpaanqMlVGtuPM0NAQKSkp0NXVhYmJCSwtLWFjYyPfcXb58mVcvnxZ1eWqJdnnrHfv3nBzc8Nvv/0m70RF9lpkZCSMjY1hZmYGAIiOjlarAwUMSmomJSUFO3fuRIMGDYr0BupjYmNj8fz5c2hoaMDKygpGRkbQ19dXdVlfLVlQGj9+PKZMmYKGDRuiU6dO8PPzK3Jdxn7sx1NqaioePXqE27dvo3z58rxG6TNJpVJER0fD0tKSpz19phs3buDRo0ewsbFBiRIlimzPY7khC0qNGjVCtWrVMHXqVHTs2BFWVlaYP38+AKBVq1aoUqUKxo0bV2S7Blf25s0bTJgwAeHh4UhPT0dycjJMTU0RFBQkP+WsqJPtOJPtNIuMjERMTAzS09Nx48YN7jj7iMTERBgZGcHZ2Rnz58/H999/L38tPT0d2tra6Nq1Kzp16vTJo02qwqBERADe/6ANDQ3FmjVrcPfuXZQuXRo//vhjkb3xsVQqlf+/KIXF/CALnHFxcVi6dCmCgoLw8uVLmJqawsXFBZUqVYKXlxdq1KjBH2P/T7bDYsOGDZg7dy7u3LmDd+/eQSKRwMLCAuXLl4eTkxNGjRrFo0jZkK1zbdq0QeXKlTFu3DiUL18ew4cPx08//QSpVApXV1fMnj0brVu35qme/08WGOPi4nDr1i2YmZnB3d1d1WWpBe44+3KWlpYwMDBATEwMOnXqhCZNmqBixYpwdXWVt62enh5Onz4NLy8vtTzSy6CkhrgBJ1U7c+YMZs+ejV27dsHZ2RmdOnXCmDFjivyROyEEhBD8fH6C7MfX8uXLMWHCBAwcOBC+vr64d+8eLl++jOvXr8tv1njo0CHu3cf/fpQ5OTmhRYsW6Nu3L0xMTPDo0SNcu3YN165dw5EjR7BlyxZ4eXnxeyIHO3fuxMiRI7F79274+vri+PHjKFWqFIKDg7Fs2TIcO3ZMfu/Cou7w4cM4evQojh8/joEDB6JTp05ISkpCSkoKzM3NVV2eWuGOs9yTnSF1+fJlzJo1C9WrV8fz588RHx8PTU1NWFhYQFNTEwYGBrhw4YLatiuDkhqR/SnULU3Tty8lJQXHjx/H/fv38fz5c5iYmMDc3BwnTpzAmjVrACh+URB9jCz4dOzYEba2tggKCsoyTmJiIjIyMmBqaqqWexFVISkpCQ4ODrh//z5MTU2zvM5w9Hl+/fVXLFy4EJmZmahfvz60tLRw+fJlTJ8+Hd27d1d1eSolW4dWrVqFyZMno3bt2jhw4ACGDRuGUaNG4eDBg7h27Rq6du0Ka2trVZer1rjj7PNERkZi27Zt6Ny5M168eIGYmBg8ffoUT548QWZmJlq0aIEaNWqouswcMSgVItmPgTt37uDt27dwd3dHsWLF5D9A+WHLPYbLLyP70jxw4ACaNWuGGjVqwNvbG7GxsdDQ0EDp0qVRqlQpWFhYoF69eqouV6W4ruXe5s2bERERIe9JUCqVytuP7ZhVamoqFi5cCAsLC3Tr1k0+nOvex8m+W588eQJNTU3Y2dnhypUrOHToEMLDw6Gjo4MePXrAz89P1aWq3IdHLqdOnYouXbrA2dkZf/75J1q2bIlz584hICAA69atQ9myZVVdLn2lQkNDYWtr+9HTONPS0uT3PlNnvI9SIZJtoIYPH45GjRrJN0JLly7Fxo0bYWNjgwULFqhVbx+qxnBZsGTt5+TkhI4dO+L8+fN4+PAhfv31V1StWhV6enoqrrDwcF3Lf+Hh4Vi9ejVsbW3RpUsX6OrqqroktSQ7Ard//35MmzYNenp60NHRQZ06dWBvb8+A9AlSqVR+qmdKSgpmzpyJihUrwtPTU/65ffPmDeLj4xXuwVcUSSQSJCYm4tWrV2jSpAkyMjLw+vVr+e+REiVK4MGDB3BwcFBxpeqNOy8+bvbs2fDz84O7uzv69OmDc+fOoV69eqhSpQoqV64MNze3ryIkAQC/+QuRbIMdGhqKWrVqwcDAAMePH8fQoUNRo0YN3L17F8uWLUNmZqaKK1Ufso2R7H4PsjZcunQpfH198cMPPyA6OlqVJX4TypYti6VLl2L9+vVwdnbGzJkzMXr0aBw8eFDVpRUarmv5KyEhAfv27YOpqSn69u2L4sWLo2zZsvjxxx8xa9YsHD16VNUlqg3Z9Vk6Ojrw9vaGi4sLfv75Zzg4OMDExATVq1dH27ZtcebMGRVXqp5k7VeuXDns378fV65cAfC+a3UAePjwIdq3b4+tW7cC+N9nvah69eoVypUrhxs3buDu3bvQ1dVFiRIlAABXr16FhoYGihUrpuIqVUu2jty5cwcXL17E27dvAbwP5bIj4wxJOVu7di0CAgIAAN7e3vD09MS5c+cwZMgQVKhQAcWKFYObmxu8vb3x4MEDFVf7cTz1rpDI9lbfvn0bPj4+iImJQWpqKnr16gULCwvMmzcPmzdvxtSpU3kDwWwYGRkhNDQUVapUwfHjx9GkSRMEBATg8OHDaNu2LcaOHVvkLwb/ErJuOgHg6dOn+Oeff3D48GEcO3YMurq6OHr0aJG5hxLXtfyTmJiIuLg4xMTEICIiAlevXsX169dx6dIlmJiY4Pr167zuRklKSgpSUlIQFxeH58+f4/bt27h58yYOHz6MKVOmwN/fn51ffEAIIf/xqq2tjQ4dOiAjIwNbtmyBpqYmNm7ciEmTJsHJyQlLly6Fi4tLkb8mTiqVYsKECbh+/TqqVKmCffv24ezZs9i7dy/mz5+PUqVKYenSpaouU6Vk2yV/f380atQIvXr1goGBARYvXswzgPIoJSUF8fHxiI6Oxv3793Hz5k2cOnUKa9euVe/b4QgqFFKpVAghxNmzZ0W5cuXEmjVrxJ9//inKlSsnzp8/L4QQYv369cLV1VWVZaoVWZvdunVLWFpaCiGESElJEZ07dxaDBw8WQgixadMm4eHhoaoSvwlSqVQ0bdpUODs7C0dHR+Hn5yeaNGkiXFxchIaGhtDV1RWxsbGqLrNAcV3LfxkZGTkOf/PmjXjx4oUQ4n9tX1StWLFCpKamCiGE/F9lUqlUvHv3TmRmZhZmaV+ljIwM4ejoKGbNmiU6d+4srKysxMSJE1Vdltp58uSJ8Pf3FxKJRGhoaAhHR0fh4OAgevToIZ48eaLq8tRGsWLFRFhYmBBCiNDQUKGnpyeGDRsmKlSoICZNmpTjdq6ok23XU1NTxePHj0VSUlK22/qvYZvGa5QKiWzvVY0aNfDDDz9g7NixMDExQatWrVCtWjUkJSXhxIkTqFmzpoorVT/x8fGwtLTE2rVrER8fL7/uAXh/bn9qaqpqC/zKyc5P//HHHyGEQFJSEiwsLFCmTBmULFkSb9++LTJdxXJd+3Kyu66PHz8e9+7dg7e3N8qWLQtHR0f5PTWKFy8uH78o79l//PgxJk6ciF69eiEmJgaenp6oVq0aKlasiIoVK6Js2bKws7ODqalpkbpe8HOdPHkSzZs3h5+fHzw8PODl5YXvvvsOS5cuRY8ePdCgQQOcPHmS953KRokSJbBnzx7cu3cPZ8+eRWJiImxtbdG4cWMYGBioujyVEh+cAaSvr48qVaogNTUVy5cvR9++fTF79mz5GUDjx49XdblqSdaG+/fvR9u2beHl5QV3d3dUqFABHh4ecHZ2hpmZGczNzdX+WiUGJRX45ZdfUKtWLZibm8PDwwMAsHfvXty6dQvDhg1TcXXqg+GycJibm2POnDk5vm5sbFyI1agG17X8o6X1/mvFyMgIjx8/xowZMxAdHQ0tLS3Y29ujZs2aMDY2xrhx42BnZ6fialXL0dERjx49AgBoa2ujX79+ePDgAfbu3YsFCxbg7du3MDExgZWVFZo1a4a5c+equGL1Ym5uLg+Zx44dw/r16/HmzRt5hwXPnj3D6dOnERERAW9vbxgZGam6ZLWwc+dOuLq6omzZsnB1dYWrqys7usgGd5zlnex0aj8/P2zcuBE3b97EuXPnsHDhQjx//hzGxsbQ1NTE0KFDMXr0aLU+HZbXKKnI9evXER8fDy8vL+jr6yMzMxNRUVEwNzcv8jf1zM7r168RFhYmD5e6urrYvHkzFi9ejGHDhqFly5aqLvGr9vLlS+zfvx9hYWFwdnZGzZo1UaVKFejp6an1BqwgcF3Lf/Hx8bh+/Tp27tyJoKAg2NjYIDw8nPdp+Yjk5GQ8ffoUN2/exLFjx2BpaYnff/9dfsSO3ktNTUVaWhru3r2LpKQkvH37Fk+ePMHTp09x7do13L9/Hzdu3MCYMWMwZcqUIn9914sXL1CrVi1MmTIFHTt2xKtXr9CmTRtERESgadOmCAoKKhI7xz7XxIkTERISAhMTE3z//feYOnUqkpKSMGzYMLx7905+n0H6fE+ePEH37t0hkUgwZcoU1KxZU60/lwxKhezo0aPo2bMnrKysEBsbi+PHj8PBwQEnTpyAh4dHtjcZpPcYLvOX7GLVI0eOoF+/fgCAkiVL4s2bN0hISEDHjh0xatSoItmlM9e1L/fhV4ssaL99+xZTp06Fr68vmjRpoqrS1Irsc/jff//h5cuXqFu3LszMzFRd1ldn0KBB6NixI2rVqgXg/c17k5OTkZCQgKdPn6J06dKwt7cvcjt+ZGTr2e7duzFq1CjcunULCQkJCAwMxP79+xEQEID58+dj1KhRCvfwKuq44yx/yL4PxP/foDcsLAwrVqzA5MmT1bsjB7B78EIhW0GuXr2KESNG4Oeff0bfvn2RkJAAc3NzvHv3Dvv378f8+fNVXKl6Onr0KJydndGzZ0907doVsbGxAIDTp0/D0NCQP1zzSHZofNCgQWjZsiX27duHlStXIiQkBL/88gumTZuGuXPnyu8jVBRwXcsfsh+jyl3oFitWDF5eXhgzZgwAFKl161P++OMPREREyHdMyNrm1KlTOHDgAN69e6fK8tReSEiIwrpmaGgIS0tLlCpVCr6+vrC3twdQdK+Jk/0OuXz5MpycnAAAZ8+exdWrVzF69Gj07dsXDRs2xD///KPKMtWOmZkZ7OzskJKSIv9M/vDDD9iwYQMaNmyo4urUmxACz58/R0pKivy7QPa7w8XFBWvXrlX765MABqVCIftwHT58GHp6ehg7diyKFy8OJycnGBgYQF9fH/r6+rh8+bJqC1UjDJeFIy4uDg8ePMCQIUPg7u4Oe3t7eHp6YsCAAfIbIcvuRfKt4rqWf2Tryvz589GwYUNMnz4d+/btw507dxAXF4czZ85g2bJl8ptbMij9b4fFqVOn0LJlSxgaGioMl0gkmD59OoPSR6Snp2PEiBG4evWqqktRW7L1qWTJknj16hX27t2LRYsWwdTUFI0bNwbw/pQoWYgi7jjLK9l36pUrV1CiRAlUrlwZ33//PcaPH4+//voLf/31F7p06QInJyeYmJio/X3NGJQK0cOHD1GmTBkAwD///INy5crJX3vw4IHaH34sTAyXheP58+cKF5R/yM7ODs+fP/8q9vh8Ca5r+Ud27YylpSWEEFi1ahV++OEHeS9HLVq0gBACAwYMAADeP+n/PXjwAKamptne5LNYsWK4ePEiT8fLhuyze+vWLezduxfDhw9HSEgI7t+/z2CpRHYkrWXLlihXrhy6d++OW7duYciQITAzM8PFixdx48YN+Pn5qbZQFeOOsy8nW9fc3Nywa9cu9OzZE7q6uvjrr7/QrVs3dOzYERKJBCEhIQDU/wbQvCK0EMguUKtVqxZmzpwJqVSKyMhIdOrUCQBw+/ZtXLt2DUOGDFFlmWqJ4bJgOTg4oHLlyujSpQuCg4Ph6ekJQ0NDREREYNWqVfLz/YsCrmv5p3PnzujcuTOA950S3L17F48ePUJ8fDzq1auHEiVKAGBQktHS0kKpUqUQGBiIRYsWyYdLpVIcPnxYvpdfnS94VgXZ+hMTEwNNTU04OzujX79+0NDQgJ2dHcqXL4+SJUvixx9/hLe3t4qrVQ8mJiZYs2YNHj9+DEdHR/mP1OvXr6NBgwb47rvvVFyhakmlUmhqairsOPvrr7/kO84AQF9fH+Hh4SquVP0ZGBhkew1XcnIyUlJSYGZm9lXccJxBqYB9uBJ06tQJe/fuhYeHB27fvo0qVapgx44dmDRpEkqVKoVGjRqpuFr1wXBZOIyMjBAUFIQRI0agb9++sLa2hqWlJa5fv47SpUsXie6Iua4VjOTkZDx+/Bh2dnaoVKkSKlWqpOqS1JIQAo6Ojvjpp58wbtw4ZGZmwt/fH+bm5li9ejWOHj3Kde8TGjRogAYNGiA9PR2xsbG4c+cOwsPDcfXqVWzfvh3Ozs7w9vZm0Px/T548QVxcHIoVKyY/UtmkSRM0btxY4R5nRRl3nOWd7BrV7du3IzMzEyVLloS5uTmKFy+OYsWKwcDAQB461T0kAez1rtDFxsZixYoVOHXqFC5duoTk5GS0bNkSc+fO5akV/095D0PHjh1x5coV3L59GyNGjECNGjXk4XLx4sXsYvgLyDZo8fHxuHDhAs6dO4enT5/Cz88PTZs2/ea7ieW6lv8yMzNx8OBBLF26FPfv30d8fDysra3Rtm1bDBkyhDdOzcHbt2+xZs0aLFu2DJGRkUhMTETVqlUxbNgwtG7d+ps/BfZLfKonu6La052MbPkTExOxatUqrFu3DpGRkXjz5g0sLS3x008/Yfz48fxsfmDjxo2YOXMmLl26hEaNGqFTp07o2bMnbt++jU6dOmHIkCHo2rWrqstUa56ennj16pV8Z1Dp0qVRsmRJODs7w9bWFra2trC0tISxsbFa/9ZgUCpAERERiImJQa1atbLc+yI+Ph5paWmwsLAo0hvwz8FwWbC4l/V/uK7lnWw9+ueffzB27FiYmZmhY8eO0NHRwaVLl7Bv3z74+/tj5syZvA/QJ7x9+xaampp49+4dTE1N+R3xCZmZmQgNDUVcXJy8tzsLCwsYGhryonv877M5f/58rFixAn5+fujQoQMyMjJw5swZrFy5Ev7+/pgxY0aR/mxyx1n+ycjIwNKlSzF37lx06dIFsbGxuHLlCsLCwqCvrw8LCwsYGBjA3t4ednZ2WLx4sdquewxKBWjy5MlITk5GYGAgdu3ahT179qB8+fIoUaIESpYsCWtra5iamvJu4R9guCw86enp2LNnDyZMmICnT5/C3t4e5cuXh5eXF6pWrYqyZcvKu9T9FnFdy1+yNuzQoQP09PTkd7CX7c1esmQJgoODsXDhQvj6+qq2WDWTkZGBHTt2IDo6GqVKlUK5cuXg4uKi6rK+CgkJCZg1axaWLl2K1NRUJCUlQVNTE05OTvD09ISTkxOCgoJUXaZKyYJS9erV0bZtW4wcORLA/z6by5Ytw4IFC7BixQrUqFFDxdWqD+44yz1Z2Dx06BAmTJiApUuXokKFCvLXT506hUGDBiEgIABpaWm4cOEC3rx5g507d6qw6o9Tz/j2jWjdurV870RUVBTCw8Nx48YNpKWlQVdXF6amprCzs4Oenh569eoFLy8vFVeseps2bUJycjJq1aqFffv2ZRsu3759y3D5BWQbstDQUAwYMADNmzfHb7/9hnv37uHy5ctYuXIlxowZgzJlyuDmzZuqLrfAcF3LX7Jt3cOHD/Hjjz/Kh8uCZr9+/RAcHIwnT54AyLr3tqiR/Uh9+vQpBg4ciLCwMDg6OiImJgbv3r2T73WtWbNmkbhWMLdk68+///6LTZs2Yffu3UhLS8PPP/+MlStXYubMmdi5c6d8XSzKR85ly/3mzRvY2trKh8s+mz179sSECRO++VtBfEx2O84sLCwwatQo7jjLBdmxl3PnzkFfXx8VKlRAZmYmUlNToauri9q1a6Np06Z48eIFxowZg/79+6u44k9jUCpAHh4e8v936tQJ/fr1w5MnT3Dv3j3cuXMHd+7cwbNnz3Dy5Eme6/r/GC4LnmxDdujQIXh7e2PlypUKr6ekpODly5dISUlRRXmFhuta/pK1ZaNGjbBmzRr4+PigcuXK0NTUhEQiQWRkJKKiouDp6Qmg6N74U0bWu9bu3btx//59LFmyBM7Oznj16hWioqLw7NkzXL9+XX7dSFH+oZ8d2Xbs6NGjqFWrFmrWrInff/8dZcqUgbe3NwwNDVGqVCl5RxhFve2EEGjfvj2mTp0Kd3d3lC9fXt4dfWhoKBITE1GxYkUVV6k63HGWP2TfA7a2trh37x7279+P5s2byztvSE1NRXh4OFxdXQFAvlNInfHUuwIk2+OVkZEBHR0dhIeHZ7shSkpKgp6eXpHfkCuLj4+HsbFxtuHy2rVrWLNmTZHvyvRLrFy5Eg8ePMCECROgra0NqVQqv3t2UcN1Lf88fvwYPXr0QGZmJurXr4+SJUvi/v37WL16Nby8vLB9+/YiuY4pk30/BAQEQEdHJ8tRIyEEEhMTIYSAiYmJiqpUX7L2a926NTw8PDB58mT06NED5ubmmDNnDoD3veG1aNECv/76a5E/ggm8P9rbr18/vHnzBt999x3Mzc1x9epVHD9+HL169cKMGTNUXaLKXL9+HRoaGihXrhwWL16MZcuWQUdHhzvOcunD3xGdO3fG4cOH0bx5c/j5+cHKygrLli3DpUuXsH79etSpU+er+FwyKBWC58+fo02bNti9ezcsLCyQkZEBiUQCDQ0N+d5Weo/hsuDJTvnZsGEDZsyYgVGjRsm7wi5KuK7lP9m6dfPmTcyZMwfHjx9HfHw8SpUqBV9fXwwePBh2dnaqLlMtyNrqxIkTWLt2LWbPns1AlAcLFy5ERkYGBg8ejClTpuDQoUNYuXIlXrx4AX9/f+zatQs+Pj5Fvuc7mUePHmHx4sU4d+4ckpKS4Obmhnr16qFDhw7yvf5FHXec5Q9ZL4u7d+9GREQE3rx5g4oVKyIwMBC1atVS+4Akw6BUgGQb5mfPnmHKlCkwNzfHlClTchyP/ofhsmBJpVLY29vj3bt3SExMhJ2dHTw8PFClShXUqFFDfqPGooDrWsFKTU1Fenq6/DQfUuTn54ewsDDUq1cPbdq0gaenJ0qXLs3Q9BmkUilevXqFZ8+eoVKlSnj+/Dnq1KmDhIQEpKeno3Hjxli9erXan9pTUP79918YGBjA09Mz21PG0tLSkJKSotZdMxcW7jj7ci9evMDVq1fRsGFDheFxcXF4+/YtzMzMvsowzqBUgGQfvAULFmDMmDHIzMxErVq14O3tjYoVK8p7NtLR0WFY+n8Ml4VH9gPj8ePHuHHjBq5cuYJbt27h3r170NTURHx8vKpLLFBc1/JPQkICpk6dil27dqFEiRL46aef0KlTJwghIJVKERoaipkzZ6Jv375o166dqstVGykpKRg7dixiY2Nx48YNpKenIzU1FZqamjAzM4OTkxPWr1+v6jLVzsc+kzExMTh8+DCSk5PRqlWrIn1j0Hr16iE0NBRaWlowNzdHmTJlUKlSJVStWhVeXl5wd3f/avbqFxbuOMs92edxwYIFWL9+Pc6dOwcAuHbtGm7fvo0ffvghx2m+BgxKheDYsWM4ffo0Xr58iYiICMTHxyM+Ph5SqVTe/WSLFi1UXaZaYLgsWLI2e/ToEbS0tBS6/87IyEBycjLi4uKQlJSEsmXLqrDSgsd17cvJ2uXnn39GaGgovL29sW/fPmhrayMkJATnzp1DUFAQbGxs4OTkhGnTpqFatWpfxXnphSUjIwNxcXGIjY3Fs2fPEB0djaioKDx48AAaGhoIDg7m+vf/ZO3w999/Y8uWLShfvjxsbW1RqlQpODk5wcrKCtra2qouU23ExsYiNjYWjx8/xvXr1+U7wx4+fIjXr19DW1sbzs7OsLe3x7Zt24p0l9fccZZ3su15ly5doK+vj+XLlwMAxo4diydPnmDt2rXyzmh+//13vH37FvPmzftq2pJBqRBJpVK8e/cOjx49wtOnT/HixQvcuHED/fr1g7Ozs6rLUysMlwVDtrEaNWoUMjIyMHv2bPkw2UYrJiYG2traMDU1VXW5hYLr2pdJT0+Hvb09tm7diurVq+P48eNo3rw53N3d4ePjg65du8LCwgIlS5aEjo6Oqsv9arx9+xYpKSmwsLBQdSlqQ/aDrHv37li3bh2aNm0K4P0RTQMDA1haWsLW1haOjo6wsrKCj4+PQnfY9P7UsYSEBLx48QL379/HtWvXcPXqVezYsUPVpakUd5zlnaztypcvj19++QV9+/YFANSvXx916tTBxIkT5W3m5+cHHx8f/PHHH1nuX6iuGJQKQXp6Ol6+fIkLFy4AAL7//nsVV/T1YLgsGNu2bcPEiROxYcMGVKpUCSkpKdDT08Pdu3fRq1cv9OjRA7169VJ1mYWK61rehIWFoVGjRoiNjYWGhgYiIyPh7u6OXbt2yX/IUs7Onj2L3bt3Q1NTE2XLloWHhwfKlSsnPzLCo29ZLVmyBCNGjICxsTHatm2LMmXK4PHjx7h//z5evXqF9PR0PH/+HCtWrEDdunWL7A9b2boTExOD8+fPw93dXd4tM2WPO87yztDQEJcvX5avY46OjliwYAG+//57+Q5ZW1tbbNiwAfXq1ftqtm3qH+W+cklJSVixYgXGjBmDYsWKwcHBAQ0bNoQQAidOnICXlxesrKxUXabayS5clitXTsVVfd1k14tIpVL88MMP2L17NyZNmoRt27ZBT08PK1asQGBgIDw8PNCoUSNVl1touK7ljezH5/nz51GiRAn5F979+/dRtmxZeUjKzMyUfyHyAuj3ZG23aNEieQ9QO3fuhIGBAVJTU2FgYIDMzEz8+++/qFq1qqrLVTv9+vVDy5YtsXz5cty7dw+6uroYM2YMjI2NERUVhadPn+LmzZuoUKECgKJ7zy7ZfvDNmzfj5MmTmDp1KoD/nVkQFRWFq1evonLlyvwd8v/q1q2LunXr5rjj7MP7Y9L/vHnzBu/evcPDhw9hZmYGc3NzJCQkwNfXF8D7+5glJyfj5cuXqFy5MgB8FSEJYFAqMLIN0fbt27Fy5UqEhoYiLCwMy5Ytg4GBAZ4/f441a9bgypUrGDlypKrLVSsMlwVDIpFAU1NT/mN1/fr1KFWqFGbNmoWwsDCcPn0aQ4YMwW+//abiSgsP17Uv9/z5c1y/fh3169dHqVKlcOXKFWhpaeHBgwcoUaIEdHR0GJCUyH64z549G+PGjcMPP/yAw4cPIzg4GC9fvsSUKVPQtm1buLu7q7hS9WVnZ4f+/ftj69at+PPPP7F3714MGjQI9evXh62tLapVq6bqElVOFpT27t2L6tWry/f0y36gamlpYe3atUhMTGQnK/+PO87yJjo6Gvb29hg+fDgyMzOhoaGBhIQEBAYGonLlyqhYsSJiY2Pl96T6mo7yMigVENkG6p9//oGPjw+qVauGdevWye9Kb2dnBx0dHbx+/VqVZaoVhsuCExoaiiZNmsDHxwceHh7w8vJCzZo18eeff6JHjx7w9/dHWFiYQucO3zKua19O9iVXr1496Ovr4/Xr13j8+DF0dHTw6tUrNG/eHDo6OrCzs4OJiQl+//137o39wJ07dxAXF4c+ffrIT1v09/eHkZERUlJS8PLly2y7dKb3hBCwsrLCwIED8fPPP2PYsGFo3749WrZsiZUrV8o/40WZbPljYmLkoVsIIf+RamlpifPnz6N9+/aqLFNtcMdZ3tnb22PdunV4/fo1njx5gqdPn8LT0xPnz5/HwYMHkZGRIR8GvP8O/hquTwIYlAqMbI9NYmKivPews2fPKmyQrl27Bm9vb5XUp44YLguOjY0Nhg0bhhcvXuD/2rvv6CbL9oHj33TRkQ66B11QRimjpVCGMgReQBRBQAVkuxgKCIqCCAIyHKCiDAVBZIiDoS+gBQQEGQJldtHSlu5dunfS3x/8ktciDrCQJr0+5/QcSJ6mV57z5Ml93eO6z549y65du7Tnsbi4mJiYGL7//nucnZ3p3bu3wVc/kmut7vTu3ZvevXtTUVHBjRs3yM7OJj09ndTUVFJTU0lPT+fSpUvaxEqfehLvBc3710xRhJvfBa6urpSUlGBtba2tQgayRulWlZWVmJmZkZ+fT2hoKFeuXMHY2JicnBzy8vIoLCwEGu50u9/TnINu3bqxYcMGHnvsMezs7LSPR0RE1JoK1VBJx9m/Z2NjQ69evbT/r6qqIj8/n+zsbDIyMsjIyCAqKooOHToA+vX5lETpHtF8sT355JOsXbuWBQsWkJGRoV37sWfPHvLy8iRR+h1JLu+dVq1asXDhQsrKyigsLCQnJ4esrCxSUlK0+yht2LCBixcvsmDBAhYsWKDrkO8pudbqjqbh36hRI1xdXXF1ddUmnHAzEc/JycHLywvQry/Ie0Hz/h0cHPD39+fChQt4eXlhaWnJ5s2bGT58ODt37qRZs2aAJEoamvPwySefsGbNGiwtLQkKCtKez4EDB7JkyZIGU63zTkyfPp3+/fvz9NNPM2bMGNq0aUNcXBxz5syhT58+eHp66jpEnZKOs7qhOY8KhQJTU1OcnJxwcnKqNXVRrVYD6NVoryRK99iIESPYsmUL9vb25Ofn8/7779O4cWN27tzJ2LFjDX6vmjshyeW9ZWJigrW1tbbHWqOyslKbQKWmpjaICm9yrdWdWxOf339ZAiiVSpRK5X2Pq77r3LkznTt3pqKigkaNGtG/f38++ugjFi1aRKtWrfjggw8A/VnwfK9prqePP/6YnJwcOnbsiIWFBcOHDycoKAgrKyvMzc21x8t5+5+WLVuyfv16Vq5cybRp08jLy8PKyorRo0czf/58XYenc9JxVjdu1wn2+8Lamo179Y2UB79PtmzZws8//0x8fDzV1dUMGjSIOXPm6DqseqmiooJHHnmE8+fPk5+fz5gxY2oll5rKPeLulJSUEBYWRnV1Nba2tri6uuLg4FCrkdFQyLUm6pOTJ09SUFBAx44dcXJy0nU49U5NTQ1z5swhJSVF27mTn5+PsbExtra2ODs74+3tjYeHB88++6xsPnuL4uJi0tPTMTMzQ6lUapPLhj4dVmPz5s2sXbuW06dP4+Xlxb59+2jbti179uxhxowZ/Pjjj9K53QBJonQPaDZzc3FxwcbGBrh5g6+qqqq14aLcnP6aJJd1r6ioiHnz5rFhwwbUajUVFRVYW1vj5eWFv78/gYGBzJ07V9dh3ndyrdUNlUoF6Ne0Cl2pqKggLS2NuLg4jIyMcHNzw9PTE0tLS73sdb2fqqurtWXAExMTSUxMJDk5mczMTHJycoCb++E0ZJqpimvWrKGiooKnn34aZ2dncnNziY6Opnnz5lKY4BbScVZ3NFPsDOFeJolSHdIkPh9++CGJiYlMmzYNX19fABISEti+fTtZWVn069ePvn370qhRIx1HXH9Icnlvab40f/jhB5555hnWrl3Lo48+SmZmJpcvXyYsLIzjx48D8PPPP+s42ntLrrX7S87j/2jORXZ2NvPmzWP9+vW4u7vj5OSkHd11d3enVatWPP/887oOV++UlJSQkpJCYWEhnTp1atDXnua9+/v789prrzFmzBgqKip46KGHuHTpEpWVlezdu5eBAwfqOtR6RzrO7pwhf9YkUapDmgslKCiIkSNH8tJLL2FhYUF2djZ9+vShpKQEBwcH0tPT2bx5M71799Z1yDonyeX9oUmUFi1aRHR0NNu3b9d1SPedXGv31u7duzl48CAeHh5MnToVOzs7XYdU72iqa61du5aVK1eycuVKmjdvzoULF4iIiODatWuEh4cTHBzM5s2bpZDD3/h9qWtDbaT9G0VFRTg5OZGUlIS9vT0ff/wx69ev59ChQ6xcuZL4+Hi+/vrrBj1FUTrO6k55eTnbt2/nyy+/5OLFi6xZs4ZRo0aRnZ2NpaUlVlZWug7xrkgxhzqkUCiorKzk6tWrPPXUU1hYWAA3F5+qVCp2796Ng4MDkyZN4tNPP6Vr167aYxq6zZs3M3LkSFxdXQHIzs5m8ODB2uRy165dklz+C5rGVr9+/cjJySEmJoYWLVpon9c0OBpCo0yutbpVVlbGwoUL2blzJ61bt2bdunWMGTMGW1tblixZQpcuXejbt6+uw6xXLl++zMMPP8ygQYOAm1Upf6+kpASQCoF/53YJkjRo/3cOrl27hpubG05OThQVFbFz506mT5+Ou7s7AwYMYPz48Q02SdKco40bN2o7zjSJ0vXr16Xj7A5ozuWiRYv45ptveOWVVzh79iylpaUA/PDDD0RHRzN79my9XHtp+K2i++zq1as4OjpqL4bs7Gz27t3LxIkTadeuHR4eHsyaNYvz589LksQ/Sy53795NYGAgn376KWVlZTqOWD9p5guvXr2aTz75hHnz5nHkyBFSU1MpKyvT22o0d0KutbqluaZOnjzJ3r172bJlCzNmzMDHxwd3d3eqqqqoqalhx44dOo60/tB8xjp06ICpqam2IXErTc9rQ2/w/xXN9XcrOWf/Y2dnh5eXFw888ADDhg2joqJCW8nt8uXLDWaD8b+yefNm3Nzc/tBxtnHjRk6dOsWkSZM4ceKEjqOs3zSfufXr17N582YmTZqEhYWFdn+u9u3bc+DAAfR1Aptht4x0oKysDEdHR/bv3w/At99+S05ODoMHD9Yek5qaKoudf0eSy3vPyMgItVqNtbU1jz76KCdPnuQ///kPfn5+tGnThkGDBvHKK69QWVmp61DvKbnW6o7mS++XX37B3d2dLl26cOnSJTw9PTExMcHMzIzKykqys7OB/xV6aMg0DYpr166xadMmZs6cSWhoKBEREWRkZEhyfgc0SeefJUwNmUKhQK1W4+vry7Jly/Dy8sLDw4MlS5ZgZ2dHTEwMv/zyC//5z390HarOSMdZ3YqJiUGlUtG5c2dSU1Oprq7W7s9lampKUlKS3hYPkal3dSwkJITOnTvzxhtvsGvXLk6cOMGoUaPw8/MDblbrOXXqFB07dtRxpPXH75PL4cOHS3J5j2gqIMHNRm56ejpRUVFcunSJs2fPcuLEiVpzsg2RXGt1R9Por6ys1PZMnz9/nvbt22uPuXTp0h+mlTVUmvVGxcXFHD58GFdXV3bu3EloaChOTk40adIEHx8ffHx8mDZtmq7DrXc003vOnz9Pv379WLduHcOHDzf4kfA7deXKFfz8/LCwsECtVtOtWzcCAwOxtLTUHpOWlka3bt0YMmSI7gKtB/6u4wxg1qxZPPfcc9Jx9jeqq6tp06YNly5dIj8/HycnJ21idOzYMe2InWadpj6RROkemD17NpaWlpw8eZKZM2cyYcIE7XPffPMN58+fZ/r06TqMsH6R5PLe0DQsrl69SmRkJD4+Ptjb22NjY4OlpSXu7u64u7vTp08fXYd638i1Vnc0DdSxY8fSt29ftm3bxoULF5gyZQoAO3bsICEhgZdeegmQKVGaUV2lUsnZs2cBSElJ4fLly1y6dImIiAgOHTqEnZ0d06ZNk7U2t9CcC09PT0aOHMmiRYv473//y7Rp02jfvj0mJiZyzoDRo0dz8OBBLCws+OCDD3B1dcXHxwc7Ozvs7e2xtbWlV69e9OrVS9eh6px0nNUdzfYimnVI3t7exMXFsWvXLvbs2cPYsWN1HeJdk6p399m6devIyclh0qRJODo66jqceiMhIYFPPvmEkydPMmLECCZMmKBdWLl9+3Y++eQTpk+fXmunbPHXNI2G1157jffeew9PT0+cnZ1p1qwZLVq0wN/fn06dOmmThIbSyJBrre5t376d1atXc+rUKXr06IGjoyN79uzh3XffZerUqQ1+IfSPP/6Iubk5Dz30EDk5OahUKlxcXG57rFS6+3vFxcWEhoayZs0aioqKePHFF2s1xBrqOSwvL2fz5s288MIL5OXlERAQgImJCSYmJn8YtfTy8mrwI0oAkydP5vDhwwQHB3PixAlGjhzJ8uXLgZsdZzNmzCA/P5+tW7fqONL6S/N5q6ysZPbs2WzYsIHS0lL8/f0pLy9n1KhRzJ07FwsLC71sZ0iiJOo9SS7vnuamFB8fT3h4OGfOnOHChQvExsaSkpKCWq1mzJgxLF++HAcHB12Hq3Nyrd2ZyspKbW/ryZMnOXnyJMePH8fBwYEJEybQrVs3g5/O+U+MGzeOnj17MnHiRJYsWcKpU6do1aqVdt+kJk2a4O7ujrOzMzY2NnrZmNCFvLw8PvvsM9555x2aNm3KggULeOyxx3QdVr2SlJREeHg4Fy9e5MqVK8THx3P9+nX8/PykSAHScfZvaZKkXbt2MXDgQMzNzcnNzeXixYvEx8fTpUsX2rZtq+sw/xVJlIRooCoqKti3bx8zZsxg/vz5PPvss7oOSegJTUN+y5YtbN68mUOHDv3tsQ1ZTk4OJiYm2NnZsXLlSn755RcKCwspKChAoVBgbm6Oo6MjRkZGvPvuuzRv3lzXIeuFjIwMampqOHz4MC+//DKlpaU8+uijzJw5k5CQEF2Hd9+dP3+etLQ0WrZsiYODA/b29rc9rqqqioyMDO1ie3F70nH2z1RWVmoTpMaNG//h+aSkJLy8vHQQWd2QREmIBkKtVmsrlRkZGWkbr8uXL+fQoUP8+OOPDXZPDXFnCgsLsbGx4bnnnqOsrKzWtBTNYt3333+foqIiFi5cKMkSN/cw27VrF0qlUvtYUlIS0dHRREdHExcXR3h4OF9//bU0yv5EZWUlP/zwAwcOHODatWvU1NSQkJBAYWEh3bt3p1OnTpw6dYrS0lJWrVql9z3Zd+rFF1/k8OHDeHp64uTkhIuLC56ennh4eODq6kqTJk1wdnbWlp+Xz6X4NwoKCiguLubSpUuMGzeO7OzsP1xTkZGR9OjRg5ycHB1G+u9IMQchGgC1Wo1ardbul/T7G1mXLl1Yt26dJEnib2mmWcyePZuqqioOHTpE//79iY2NxdzcHBsbGywsLDA2NiY0NJQHH3xQ+3sNeUH0mTNnOHTokDZJSktL48033+Tzzz/Hy8uLfv366TjC+k3T+Dp58iSjRo1izJgxBAUF4enpSc+ePQkKCqK8vBxzc3MSExOZPHlyg9z/ZsKECQQGBhIfH09MTAzbtm0jKysLb29vnJycMDc3x8/PDysrK1599VW97uUXuqP5PG7dupWXXnoJb29vjIyMWLFihXb9m6urKxYWFuzevZsmTZoA+lnxDiRREsKglZSUYGVlhZGR0Z8ubr5w4YL2RibEX9FcQw4ODvzyyy8kJyezYcMGvvjiC9zc3PDz8yMwMJCqqirCw8NZvHhxrd9raDQNinPnzhEcHKx9/NSpU5w6dYqamhrtT0PY9PnfMjU1ZfPmzfTv3/8P08rMzc0B8Pb2Zty4caxatUoXIepUcHCw9jp79913KS4uZvbs2ZSUlBAZGcm+ffv45ptvaNasGQsXLtRxtEJfaTpan3zySQICAnjhhReoqKhg5cqVZGRkoFAocHd3x9HREZVKxbhx43Qc8b8jiZIQBkjT8z9t2jQ2b95Mx44dad26NR06dCA4OJg2bdpgbW3Npk2b+Pbbbxk5cqSuQxZ6ZMmSJQB07dqV3bt3k5SUxG+//caZM2f4+eefqampYenSpXTq1AlouKXBfz8S0rVrV+3jYWFhtGzZUrsxqCRJf02lUmFiYsKCBQvo1asX9vb22g2Mb9dD3bp1a23lsoakuroaExMTLl++zMqVKwkLC9PucTZo0CBee+01nnzySXr06PGn65eE+KecnJzo1asXCxcuJCgoiJYtW6JSqYiIiODs2bNERkYSEhLCoEGDgNt/VvWBJEpCGCBNo2v06NEEBASQmJjI1atXOXnyJDk5ORQXF1NTU4O1tTUzZsxg9OjROo5Y6JPKykrMzMw4deoUAK6urn9YPN9QSzTfjmYfs6NHj2rX0fTv3x/Q38bD/WRicrOp4uXlha2tLfDX562hrU3S0Hze4uLisLKy0k711FSnNDY25pFHHuHLL7/kxRdf1GWowkCoVCpGjBgB/C9Rb9eunXbDXkMgiZIQBuyhhx6iZ8+elJeXU1xcTH5+PllZWeTn5wPg6OhISEiINGjFHdGU/C4vL6eoqIi4uDiMjY1xdHSkcePGWFtbSwLA/xquTZo0ITExkTlz5tCoUSPOnTun3XfE19cXPz8/PD09ZQrs3+jfvz/vvfceAQEBPPjgg39aer6hFinQXG8+Pj6Ympoye/ZsPvroI+20xMTERPbv33/bymRC3A1jY2Oys7M5fvw4mZmZNGrUCEdHR9zc3LCzs/vL6ov6QqreCSGE+Mc0jdDExERee+01vv/+exwcHHBzc8PKyoqAgAAcHR0ZPHgwHTp00HW49UJiYiJJSUkkJCSQlJRESkoKmZmZFBQUUFZWpj3u8OHDWFhY6DDS+isxMRFfX18A7OzsCAkJoVOnTrRv356WLVvi4eGh9w2yuqD5fO7YsYNp06bRqFEjQkJCcHNz4+TJk1RVVfHhhx/Sp08fXYcq9JjmOktOTmbBggXs2bMHU1NTiouLadSoEUqlUjvdf+nSpboO91+RESUhGpBbe1obas+ruHuaCnYvv/wyhYWFREdH88gjj+Dm5oaFhQUbN26kqqqKjh070qFDB5mCx80CA97e3nTv3l37WEFBAWlpaSQlJREXF8eNGzckSfoL3t7eJCQkkJyczJkzZzh79iy7d+/m448/prCwkAceeIDjx483+HuaZt3biBEj6Nq1K19//TVnzpzh/PnzdOvWjVmzZmkTTiHuluZ7YMeOHZw/f56EhAT27t3Lxx9/zNq1a5k/fz7Hjh2jc+fOgP5WvAMZURJCCHEXHBwc2Lt3L127dsXT05M9e/YQHBzMlClTaNGiBZMmTdJO+WnoNF+zmkZ8Q27I17Xy8nLi4+MpKysjODhYEvP/J+dB3EuaxGfQoEEEBQWxaNEiRo8ejY2NDWvWrCEsLIyNGzfyyiuv6H1iLiNKQjQA8qUp6lJ2djZmZmb4+PhoC4NoRkOmT5/O4MGDmTZtmo6jrD80idGtCZKmNDg03BLqd6qmpobs7GxMTEywsrLCzMyM1q1ba59v6OexqqqK3377jS+++ILExEScnZ1p06aN9kffG62iftB8zoqKinBwcAAgPz9fW8QhODiYsWPH8p///AdfX1+9HumVREmIBqChNx5E3SooKKBHjx6kpaXh4eGBm5sbP//8M76+vvz6668UFRVhZGQkCfrfkNGlfy4uLo6XXnqJ06dP06pVKxo3bkyLFi1o3749Li4uPPTQQw16BFPTw793716mT5+Oh4cHISEhpKSksHv3bjZt2kR6ejqDBw9m69atug5X6DnNfWvYsGFYW1sD0K5dO77//nv69OlDZGQk169fJygoqNbx+kim3glhwGpqapg1axY9evRgyJAhANpS4SEhIdjZ2ek0PqGfVCoVV65cwdLSkhYtWrBo0SI2b95Mu3btuHLlCo899hgrV67U63npdU2z+bO4cxUVFTz00EM4OjoyadIkHn30UQYMGEB4eDgpKSnAzeRd02BriDSlmZ944gns7e1ZvXo1KpWKGzdukJeXR05ODteuXaNp06b06tVL1+EKA6FWq0lISKBZs2YkJSUxaNAgMjMzMTExYfjw4Xz44Ye6DvFfkxElIQyQZpg7KiqKnTt38tRTTwFw7tw5evfuTXFxMa1atWL//v34+PjoNlihNzQjRPv376d169Y0a9YMgGeeeQaVSsWZM2d49dVXGTNmDCAjmRpZWVnMmTOHtWvX3raktYy83Z7mPnbhwgWSk5M5ePAgubm5uLi4sH//fq5cucKMGTN4++23G3SSBP/bV8rLy4tmzZphYmKCiYkJrq6uuLq6AtCjRw9dhigMhOZzmZSURElJCf7+/sDNay80NJTTp0+jUCh45JFHdBxp3ZA7sxAGSK1WA3Dq1CkcHR3p3LkziYmJrFq1iiFDhpCTk4Ovry/btm3TcaRCHw0bNoyTJ09q/+/h4cHChQv58ccfeeGFF7C0tAT0e7pFXdBM2Lh8+TI7d+6slSSpVCoAYmNj2bBhg07iq+805+/ixYt4e3tjZWXFiRMn8PT0pKqqirZt29K3b1+2bNlS6/iGSPNZ8/Pz4+uvvyY7O1vHEQlDpWlf7NmzhyFDhvDll1+Sl5cH3Nx8fMiQIQwePFi7UbS+M4x3IYS4rfj4eLy9vQE4fvw42dnZzJ49G3t7ezw9Pbl69aqOIxT6RDPq8cwzz2j3rFGpVFRXV1NTU4OxsTGmpqa6DLFe0IwQ7dy5k+PHj3Pt2jX8/f1JTU3Fxsam1oa8u3fvZsuWLTz//PMyVfEWv0+0W7ZsCUBZWRmmpqZcv36d5s2bExkZqW2QqVQqg2mc3Y3s7GzeffddCgoK8Pf358EHH6R169a0adOG1q1b4+fnh1Kp1HWYQs9p7lH9+/fnypUrLF26lP379zNnzhzat28PGNYoecO9owhhwDQ3sp49e7J9+3ZGjhzJqVOnGD16ND179gQgKipKu25JiH+qoKAApVLJ/Pnz6dSpE87OztK4v4WmgZ+YmEhERASnT59GqVQyatQozM3NcXZ2pmnTplhZWfHdd98xdOhQoGGPiNyqpqZGu1dL//79sbe3Jzc3l4cffpg1a9Ywd+5cbG1tOXr0qHYdREMfwXRycmL16tWkp6cTFRVFcnIyv/76K/v27SM/Px9/f39++uknXYcpDETLli1Zv349hw4dYvny5XTo0IHHHnuMmTNn1tozTt9JMQchDNznn3/Ot99+i6+vL4sWLcLJyYm9e/fyyiuvsH37djp06KDrEIUe0MxLP3LkCAMHDsTc3Jzy8nJat25NUFAQHTt2JDAwkPbt28vGqf+vsrKSkpISxo0bR2BgIEqlksTERDIyMigqKiI3N5eAgADmzZtHixYt9LqE7v2gOT87duzgk08+ISMjg/nz5/PUU0/RqFEjXYd332l67T/66CO++eYbHn/8cR588EH8/f2xtbUFbpZvjo2N5dKlSzRu3Fg6x0SdqaysrDWd+JdffuHzzz8nIyODAQMGMGPGDIMYVZJESYgG6LvvviM7O5vnnnuuQU9VEXfuxo0bXL58mcLCQq5du8bVq1e5du0aaWlpREdHM2nSJNasWWNQUy/+rcjIyFp7/ZSWlpKSkkJxcTHt27eXEblb5ObmsnTpUtq2bUvTpk3x9vamSZMmcp7+xLZt27TlvxMSEigvL8fKyop27drRr18/JkyYgJeXl67DFAYqISEBU1NTMjMz2bx5M5988gnwv7VM+k4SJSEMWHp6OqtWrSI+Pp4ePXowefJkabyKOldYWEh6ejpJSUn4+vri5+cnidItDh8+TEFBAebm5rRu3Vq7dlBGkf7o3LlzPPPMM9pKdqampiiVSry9vfHw8KBp06a0bNkSd3d3nJ2ddRyt7qlUKsrLyykuLiYvL4+0tDSuXbvGhQsXCAsLw8bGhk8//RQ/Pz9dhyr0nGYd5alTp/jwww9Rq9Xk5uZy4cIFVCoVPXv2xMvLixYtWjB9+nSDWHcpiZIQBkbTQD179ixz587F1NSU6Oho7O3tOXfuHOHh4XzxxReMGTNGu/BSiDsRGxvL5cuXycvLw9nZmU6dOuHu7q7rsOoVTQKUnJzMe++9x86dOyksLKSiooKamhp69uzJ8uXL6dixo65DrXcqKyuJiYkhLy9PWzHw9OnTuLu74+rqSmZmJjU1Ndja2jJixAhmz54tCedtFBcXExMTw+jRoxk2bBhvvfWW3jdaRf2wbt06vv32W7y9vWnevDn9+vXD09OTiooK3N3dMTY2NpjPpMy5EcLAaBKlzz77DEdHR7Zt28bLL79MSUkJAM7OzsTFxfHbb79JoiTuiFqtZsuWLcyYMQO1Wo27uzsKhQKlUsnrr7/O448/bhBfjHVBU4Hts88+48CBAyxZsoQxY8agUqk4efIkb775JosWLWLTpk04ODjoOtx6xczMjDZt2gAQERGBm5sbBw4coF27dsTExBAeHs4HH3xAdXU1gYGBQMMemdOUmoeblSk150GpVNKhQweWLl3KggULWLx4sa5CFAYgNTUVNzc3jIyMGD9+PJMmTbrtcSqVyqA+jzIvQggDo7k5/frrr/Tv3x8jIyNOnDhBu3btgJuJUnJyspSJFf/Y7/cDmjdvHrNnz6agoIAjR46wbt06AgICmDZtGtHR0TqOtP7Q9NwfOHCA559/nvHjx2NsbIyZmRm9evVi+fLlXLx4kZ9//hkwnPn8daW6uhqARYsWMXz4cLp3746trS2dOnViwoQJvPfee9qS19CwNzc2NjbW/mju/2q1mqqqKgDKy8trJVNC3I3JkyeTm5sL3FznvG/fPs6dO0d6err28wrUug4NgYwoCWFgNA00zTA4QEpKCp06dQIgKyuL+Ph4bU+sEH9HU6b5yJEj+Pj4MGfOHODm5oKurq6EhIQwZMgQVq1axdq1aw2qN/FuJCYmaosPjB8/noyMjFrP19TU8MADD1BZWUnjxo11FGX9pikyY2trS3Jy8h+e7969O0899RTvvffe/Q6tXtB8xg4ePEhcXJx2zZaLiwt2dnYYGRlhZGREVVUVBw4cICQkRNchCz2Wn5+Pr68vTk5O5Ofn8+abb+Lo6IhSqcTe3h5XV1fc3d3x9PSkSZMm9O7dW9ch1xlJlIQwUJMnT+a5557DyMiI4uJiLC0tyc3NZdmyZfj6+taqwiXEX9EkPUVFRZiYmJCTk4OjoyOVlZUYGRlhbm5OkyZNtIl5Q974s7CwkO7du+Pk5ISzszOWlpYcPXoUb29vBg4ciKurKwqFgmXLltGnTx+6du0KNOwRkT+jUqmYMGECixcvxs7Ojn79+mFtbU1ycjKbN2/GwsICT09PXYepU99++y1HjhzByckJpVKJo6Mj7u7uODk5YWJiQmhoKBUVFSxYsEDXoQo9Zmdnx0cffaT997Fjxzhz5gyRkZHExcURExPDuXPnKCoqomXLlvTu3dtgOswa5jeZEAbq9zemRx55hDfeeIN169ZRXV3N3LlziY2Npby8nO+++07HkQp9omnEP/bYY3z11VesWLGCxYsXa/fQ2L17NydOnGDu3LlAw974U6VSMWvWLAoKCkhKSiInJwcPDw+mTJmCs7Mz5ubmVFVVkZuby+uvvy5TYP+CsbExL7/8MpmZmUyaNAlLS0s8PDwwMjKirKyMZcuWATTICouaz9jatWu5ceMGycnJREREcPbsWc6ePUt1dTVqtRo7Ozvefvttg9oAVNx/NTU1VFVVYWZmxrJlyygrK2PRokUMGzZMe0xmZiZRUVHaaXiGkihJ1TshDFhxcTHHjx/nt99+IyEhga5du/Loo4/SpEkTXYcm9NSaNWt44403KC0txcvLCzs7O1JTU3n88cdZtGiRFCb4nYKCAjIzM8nPzyc3N5e4uDiuX79OYmIiqampBAYGyp5Tf+H35yUjI4Pjx48THh6OpaUlQ4cOpXnz5jqOsP6qrKyktLQUOzs7XYciDITm8zh48GC8vLz4+OOPtbMKbp1BYChJEkiiJITBeOaZZxg7diw9e/YkJSUFFxcXTE1NdR2WMCCaL7/i4mL++9//EhkZSXl5OW3atGHcuHG6Dq9eKy4uRqlUUl1dTXFxMSkpKZiZmdGiRQuDalTUtdzcXMzMzLR7KgkhdGvfvn38+OOPrFy5UjurAG6OpldXV2NmZmZQ9zOZeieEgWjUqJG297BPnz7ExsbStGlTWrVqRXBwMCEhIQQGBuLh4aHbQIXeUigUpKSkYG5uzsiRI2s9ZwgbC9Y1lUrF8uXLiYiIICsri/nz59OjRw8UCoW2/DU07KmKf+Xw4cN88MEHnD9/ntLSUnx8fAgKCqJbt24EBwcTFBSk6xCFaHBWrlzJmTNnUCgUDB06lNatW+Pi4qKtvGhoZERJCAPx+4bqmTNnSE1NJTw8nEuXLhEVFUVSUhJlZWWo1WpycnKwt7fXccRCH2hGO/Ly8ti2bRvfffcdFy9epLq6moCAAO1IpoWFha5DrXdmzJjBoUOH6Nu3L6tWreLw4cP06tWLTz/9lJKSEu26G/FH5eXltGzZkoCAAJ544glKSkqIjIwkPDyc+Ph40tLSyM/Px8bGRtehCtFgFBQU8MILL3Djxg3Cw8MxNzfHzMwMGxsbPDw8aNOmDYsWLdJ1mHVKRpSEMBCaJCkhIYE9e/bw6quv8vjjj1NVVUVpaSk3btwgLS2NhIQESZLEP6YpDf7ee+/x9ddf079/f+0+SkePHuX9999HrVYzefJkXYdar2RlZbF161YOHjxIUFAQmzZtolmzZgDY29vz6aefMn36dB1HWf9oEvMLFy5QXl7O/v37gZvXYXV1NWVlZeTn50uSJMR9VlNTg62tLTt27KCyspLY2Fiio6NJS0sjLS2NmJgY0tPTAcMqsCKJkhAGQjOidPToUX766SeWLl1KTU0Npqam2NraYmtri4+PD926ddN1qEKPaKaFffHFFyxfvly7FkmtVjN48GAWLlzIqlWr6N27Ny1bttRlqPWCpqF/6dIl7OzsCAoK4vDhw1hbW+Ps7AyAUqkkNzcXY2NjWZ90C825sLe3Z/jw4SQlJeHl5QWAmZkZZmZm2Nra4u3trcswhWhQKioq2LZtGxs3bqS6upqHH36Y6dOnExAQANzcIDovL0+7sbGhJEkAhvNOhGjgNDcmBwcH2rVrR3Z2tjTAxL+mua6CgoJwcXGp9biVlRVz584lPj6eRo0a6SrEekmtVmNra6sdyW3WrBmNGjWipqaG06dP07RpUwBtw0LcpDkfkZGR/Pbbb9oNZQ2p4SWEvlCr1QCsWLGC119/HYVCgaurK++88w5LliyhvLwcuLlBtLOzM25ubroM956QO48QBkJzQ6usrOTMmTO88cYbXLlyhby8PCoqKpDliOJuFRUV4e3tzUcffURqaqp2nwyAH3/8kYCAAHx8fAAa/HWmUCioqamhf//++Pv7M2nSJNavX6/dGHXt2rXs2bOHp59+Wnu8+B9NQhQaGkp2djaff/45lpaWBAQE8OSTT/Luu++yb98+7ebGQoh7R3N/Wr9+PUuXLuWnn37iiy++YNmyZWzevJnMzEzAsO/7UsxBCAPTvn17rly5AkDjxo1p1aoVbdq0oW3btnh6etK/f3/Mzc11HKXQB5ppYceOHeOpp54iOzsbX19f+vTpg6WlJUlJSSQnJzN69GimTp0qvf63iIyMZP78+Zw7d47KykoKCwsxNjZmyZIlTJw4UQo5/IWUlBTS09MpKCggISGBmJgYYmJiSE5O5vLly0RERMhUTyHug/z8fFxcXMjOztauC6yoqMDCwoK8vDyD36tLEiUhDFRkZCSnT5/m7NmzhIWFERsbS0FBASUlJVKhTNyRkpISDh06RGxsLOHh4SQlJZGTk0NKSgqNGzcmODgYc3NzbGxsePjhh3nkkUd0HXK9EhYWRlRUFJaWlrRu3ZpWrVrpOiS9VFRUREZGBnl5eXTu3FnX4Qhh0DQdZUeOHGHIkCHcuHFD2xmWmZlJu3btSEtL0661rKmpMcjOMinmIISB0dzcWrduTevWrZk4caL2OUmSxJ3QFAhZvHgxTz31FIMHD9Y+l5aWRlJSEpcvXyYqKorU1FTOnDlDcHCwDiOuH4qLiwkNDSU6Ohp3d3eCg4N54oknZB3XHcjIyOD48ePExMRgampKy5Yt6du3L82bN9d1aEI0KImJiZSWljJ8+HCsra0JCAggNjYWpVJJdnY2Li4uKBQKg51GLCNKQhiYX3/9lTVr1nDs2DEmTZrEvHnztFN+rKyspMqW+Mc014qJiQnffPMNQ4cO/cuyr2VlZdTU1DToKWWhoaFMmjSJlJQUXFxcUKvVqFQqgoODmTdvHt26dTOo0rl1SXNewsPDmT9/PqGhoTRp0gRra2uysrLw8fFhxYoVdOrUSdehCtFgnDlzhu+//578/HzS0tIoLCwkKyuLkpISfHx8sLe3x8LCgokTJ/LQQw/pOtw6JyNKQhgATc//1q1bWbp0KQMHDkSpVBIbGwvAuXPn2L17N1OmTMHf31/H0Qp9oSlM8Pbbb5OTkwP8b7F9dXW1toCIiYkJRkZGDXa0UpNQnjp1ijfeeIOgoCC++uor1Go1GRkZXLhwga1btzJ48GC+/fZbevXqJR0Wt6FJlJYvX05hYSHnzp3D39+fgoICYmNjmT59OsuXL+eLL77A2tpa1+EK0SCEhIQQEhIC3NxwNi0tjZSUFBISEkhISCArK4uIiAhtkR9D6wiSESUhDIAmUQoODubpp59m5syZdOvWjaeffpqpU6eSlJTEmDFjePPNN+nbt6+uwxV6QNOQv379Ok8//TSpqamsW7eO4OBgnJycdB1evaJpGIwdOxYLCwvmzZunrXKnUVlZyQMPPED79u3ZsGGDjiKt3zTn0cvLi9WrVzNo0KBaz585c4YnnniC7du388ADD0iyKUQ9UFNTQ0ZGBvb29gY5vdhwUj4hGjBjY2MA4uLi6NmzJwDXrl3Tbgbn4OBAdHQ0Hh4eOotR6BdNAzQtLY2amhqUSiXDhw+nW7dudOvWjVGjRvH6669z9OhR3QZaD2jO1aFDhxg6dKg2SVKr1ajVaqqqqjAzM+P5558nMTGR5ORkXYZbb2l6oV1cXAgLC9OWHNbsrRQYGEhubi7u7u6AlFYXoj5QKBS4ubkZZJIEMvVOCINRXFxMSEgIsbGxtG7dmrKyMtq2bQtAREQEJSUlMu1O3LGgoCDWr1+vrTiWmJhIUlISGRkZ7N+/H0dHR3r16qUd1WyIFAoF+fn55Obm0rVrV20FKM1zpqamAHTt2pUlS5ZoS+yK25syZQrz5s3Dz89PWwQjLS2NRYsW4eHhga+vr65DFEI0EJIoCWEglEolQ4cO5c033yQmJgYHBwfy8vI4ffo0a9as4dFHH9V1iEIPWVhYaEcmNaqrq8nOziY9PV07SmlIc9LvhGb614ULFzA3N0epVP5pBaji4mIKCgqwtbXVQaT6Y+jQoVy6dIkXXniBZ599FqVSiZmZGe7u7rz//vsAMu1OCHFfSKIkhAHQ9OY/99xzFBQUsGLFCnJychg6dChlZWW0bNmSDz74QNdhCj21ceNGwsLCMDc3p2nTpvTr14/mzZvj5uamPaahN1p/X0LXxsYGb29v/Pz8aNasGd7e3nh4eBAXF6c9Zw15BO7v2Nra8uGHHzJz5kzOnTtHbm4u5ubmdOjQgYCAAEmShBD3jRRzEMIApaSkcOXKFWJjY2nVqhU9e/Y02PnD4t4pLS1l7ty57NixgxYtWlBaWkpiYiJFRUW8/PLLLFu2TNch1hu3ltAtKCjQlks3NzfHzc2NY8eO0a9fPzZt2kR1dTUmJtJXqaEp5PDdd99RXV3NwIEDZYqiEELnJFESQs/t3LmT8vJynnjiCczMzLSPl5SUUF1dLdN8xB3TNFp//vlnJkyYwEcffcTjjz+ufX79+vUsWbKEDRs2SBXF29CU0E1MTOT69eskJSWRmZnJpUuXWLRoEQMHDpQRpVtoRonatWvH8OHDeeWVV7C0tNQ+fuTIEYqKiujfv790+ggh7htJlITQY1VVVXTv3p2HH36YBQsWADcbuU899RQnTpzA0dGRCRMm8OKLL2oXlAvxdzSN+LfeeouzZ8+yb98+7b5JZmZmVFRUMHbsWKytrdmwYYPB7ZtxL9TU1JCVlYWdnZ009P9EWVkZ9vb2XL9+HWdn51rT63788UemT5/O+fPnUSqVOoxSCNGQyDebEHrs8uXLpKen88ILLwA3GxrLli3jwIEDvPnmm3Tv3p0333yTU6dO6ThSoU80DVQzMzMyMzNJTk7GxMREO2LZqFEjampqtJt+Sn/b31MoFLi4uEiSdBua6+fatWs4ODhQUlLyhzVIjo6O5OXlSZIkhLivJFESQg9pGhZnzpzBy8sLV1dX4GYZ8J9//plXX32VyZMns3r1ah5//HG2bt2qy3CFntGMDj3zzDNUV1fz/PPPs3//flJSUqipqeHdd9/lzJkzPPzww4AUchD/jub6cXJywt/fn/nz51NcXExlZSVwc5T8q6++omXLlsD/9lUSQoh7TVaSCqHHUlJSalUe27t3L9XV1QwZMkT7mJOTE3l5eTqITug7FxcXVq9ezVtvvcVLL71EdXU1WVlZWFpasnz5cu3mxjLtTtQFV1dXxo8fz/z585k4cSK9e/dGoVCwZcsW8vPzWbRoka5DFEI0MLJGSQg9dvjwYZ599llefPFFunTpwqhRo3j22WeZN2+e9piePXvy6KOP8uqrr+owUqFPysrKsLCw0P7/xo0bXLx4kaysLGxtbWnWrBnNmzfXYYTCUFVXV7N7925Wr15NZGQkSqWSHj16MGrUKPr166fr8IQQDYwkSkLoMZVKxZw5czh69CjJycm0a9eOL7/8EhcXFwB++eUXpkyZwubNm+nYsaOOoxX6IDMzkwULFlBYWMj27dulUIPQqRs3bqBUKqUYjRBCJ2TqnRB6zNjYmIULF3L48GEUCgUPP/xwrfUiO3fupGvXrrRr106HUQp9oEmINm3aREFBAa+99pr2uZqaGtRqNcbGxqxZs4aYmBg++OADWZsk6lR8fDwLFy4kOzsbpVLJp59+SuPGjUlPT8fZ2VnKqQsh7jvpJhRCz1lYWPDII48wcODAWg3XyspKevfuzeuvv15rfyUh/sq+fft48MEHCQwMBG6uP1IoFNpGasuWLYmPj+fKlSs6jFIYCs2klsjISKZOnUpmZiYWFhacPn0aa2trcnNz+eSTT9i7d6+OIxVCNESSKAlhANRq9R8eMzMzY8iQIfj5+ekgIqFvNNProqKi8Pf3/9PjQkJCSE1NpaysDJDS4OLf0dy7du3aRWlpKT/99BMjRozA09MTExMTLC0tyc7O5sCBA7WOF0KI+0ESJSEMwJ+tIZFGrLgTpaWluLm5kZubC9z++iktLeXq1avaYg4y/U7UhfPnz/PAAw8A8M033xAUFATcHDHPy8uTPbuEEDohiZIQBkwaseJOGBkZ0alTJ9atWwf88fpRq9UcPHiQxo0bY29vr4sQhYHRTOn09fXl6tWrACQlJdGpUycACgoKiIyMJDg4GJB7mhDi/pJESQghBDU1NZibmzN8+HCOHj3K008/TVhYGLm5uRQVFVFRUcGBAwd4++23GTt2LCDToETdmTlzJpGRkcyZM4dLly7h5OREaWkpkyZNwsbGRvbsEkLohJQHF8JAlJWVsWrVKqZNm1ZrDxwh/qmamhoUCgVr165l5syZmJub065dO1xdXYmPjycsLIxx48bxySefYGVlpT1eiLqwb98+3nvvPa5fv05ZWRn5+fk0b96cL7/8kg4dOug6PCFEAySJkhB6TlPW+ejRo0yYMIHY2FhMTKTyv7g7muQnJiaGXbt28dtvv5GSkoKNjQ0vvfQS/fr1w9LSUpIk8a/V1NSgUqlq3a/S09O5fPkyhYWFuLi40KJFC1xdXeV6E0LohLSmhNBzmr6O06dP06xZM0mSxL+iaYy2aNGC119/HZVKddv9a6TRKu6WJum5ePEiV65c4cEHH6Rp06YAuLm5YWJiQqNGjbCxsQGgurpa7mtCCJ2Qyb5C6DlNgzU2NpbWrVvrOBphaGSTT1HXNJ07K1eu5Oeff661z9uKFSvo3r07jo6O9OvXj7i4OEmShBA6I1PvhDAQRUVF1NTUaHthhRCiPtKMKDVp0oT169czYMAAFAoFBw8e5Mknn+Tpp5+mW7duvPHGG4wcOZKFCxdiamqq67CFEA2QJEpCCCGEuK8KCgpwd3fn+vXrODk5oVareeqppzA1NWX79u0AbNmyhVWrVnH06FGsrKx0HLEQoiGSqXdCCCGEuK+uX7+Ot7c3WVlZAMTHx3Py5ElGjhypPaZp06akpKRIkiSE0BlJlITQc7KXjRBC3zg7O+Pj48NHH31EVFQUr7zyCi4uLgwcOFB7zLlz5/Dw8ABApVLpKlQhRAMmiZIQekoza/Z2GzBK8iSEqM/c3NwYO3YsO3fuJCAggMzMTN577z1t8ZCUlBTOnDlDnz59dBypEKIhkzVKQughzWLoK1eucPnyZSwtLXnwwQdxcnLSdWhCCPG3NPewiooKEhISUCqVNGnSRPv4/PnzOXz4MO+//z5dunTR7hcnhBD3kyRKQuipb7/9lnfeeYfy8nIiIyPZv38/AwYM4KuvvsLNzY0HH3xQyuoKIfRSbm4uhYWFeHp6yn1MCKEz0j0jhB4qLS1l4cKFDB48mF9//RVbW1v8/PwAyMnJ4cMPP5Tpd0IIveXg4ICvr68kSUIInZJESQg9ohkADgsLIy8vjzfffJPExERMTU1xc3MDoHnz5kRERNTaxFEIIYQQQtwZSZSE0COaRCkpKQkvLy8AIiIi8PLy0pbQjYmJwdbWVmcxCiGEEEIYAkmUhNAjmsXMPXr0QK1Ws3btWg4dOkSLFi0AiIuL4/vvv6dv3766DFMIIYQQQu9JoiSEHvL09OTll1/mhx9+4PvvvycrK4uXXnqJkJAQnJ2def7553UdohBCCCGEXpNVkkLooeXLlzNu3DjMzc1p0qQJFy9e5OrVq8ydO5eRI0fi7u6u6xCFEEIIIfSalAcXQs+kpqbSvn17rl27hp2dnfbx8vJyzM3NdReYEEIIIYQBkal3QuiZvLw8OnXqRH5+fq3Hzc3NqampQfo+hBBCCCH+PUmUhNATmn2RTExMaNSoEYsXLyYuLo6CggJtcqRQKFAoFLoMUwghhBDCIMgaJSH0zMcff8wPP/yAQqEgIiKCDh064Ovri7e3N40bNyY4OBh7e3tdhymEEEIIoddkjZIQeiY3N5fIyEiioqI4e/YsUVFRpKeno1KpyMvL49ChQ4SEhOg6TCGEEEIIvSaJkhAGIj4+nvPnzzNgwACUSqWuwxFCCCGE0GuSKAmhR7Kysli4cCGtWrXC09MTb29vmjRpgpOTk65DE0IIIYQwKLJGSQg9Eh8fz7Fjx7h8+TJVVVVYWFigVCrx8PDA3t6e4OBghg0bpuswhRBCCCH0niRKQuiRLl26cODAAVJSUrh27RpxcXGEhYWxY8cOzM3NcXFx0XWIQgghhBAGQabeCWEAVq9eza+//sqbb75J69atdR2OEEIIIYTek32UhDAAY8aMITk5WfZQEkIIIYSoIzL1Tgg9UVlZydy5c/Hx8aFJkyZ4enri6uqKg4MDV69eJSwsDA8PD12HKYQQQghhECRREkJPpKSksHfvXmxsbFCr1VhZWWFnZ0dxcTFhYWEMGzYMGxsbXYcphBBCCGEQZI2SEHqipqaG6upqrl27RmxsLFFRUSQlJWFqakpISAgDBgzA3t5e12EKIYQQQhgESZSEqOdUKhXGxsbMmjWLdu3aMW7cuD89Vq1WY2QkSw+FEEIIIf4taVEJUc9pEp9du3ZhYnJztqxKpUKlUlFdXQ3AG2+8wblz5yRJEkIIIYSoI9KqEqKemz59Ops2bSI1NRUPDw+qqqowNjbG2NhYmzitW7cOMzMzHUcqhBBCCGE4ZOqdEPXYjRs36N27N6mpqeTk5NCoUSPc3d3x9/enffv2tGnThvj4eFauXElOTo6UBxdCCCGEqCOSKAmhB0JDQ5k0aRJbt27l5MmTnD9/nvDwcBISEmjcuDELFy5k4sSJug5TCCGEEMJgSKIkRD1XXV2tnWL3Z8/X1NRgamp6H6MSQgghhDBskigJoQfUajUFBQXExcVRUFCAg4MDzs7O2NnZYWlpqevwhBBCCCEMjmw4K0Q9VlNTg0KhYPv27cyePZuSkhKaNGmCvb09Li4ueHl5YWNjw6RJk3B1ddV1uEIIIYQQBkNGlITQA05OTkyePJmhQ4eSmJhIeHg4UVFRJCcnk5CQQFhYGE5OTroOUwghhBDCYEiiJEQ9Fxsby0MPPUR0dDRKpfIPzxcVFWFtba2DyIQQQgghDJfsoyREPadWq+nTpw8RERG3fV6SJCGEEEKIuieJkhD1lEqlAiAxMZHLly8zbdo0vv32Wy5evEhKSgrFxcXIgLAQQgghxL0hxRyEqKeMjY0BOHz4MHl5eVRUVDBjxgycnZ1xd3enWbNmNG7cmLFjx9KsWTMdRyuEEEIIYVhkjZIQeiInJ4fIyEguXbrEpUuXuHbtGufPn+fYsWMEBgbqOjwhhBBCCIMiiZIQeuDvNp0VQgghhBB1S9YoCVGPqdVqTp48ycMPP4ypqSlDhw6lrKyMsrIyMjIydB2eEEIIIYTBkkRJiHpIrVYDcPDgQaZOnUrHjh157rnnSEhIwMLCguTkZF566SV27dql40iFEEIIIQyTJEpC1EOaRGnLli107tyZZcuWYWJiQvv27QHw8fHBzMyM6OhoXYYphBBCCGGwJFESoh5SKBQAREVF0aZNGwB+++03baJkZmbG1atXcXV11VmMQgghhBCGTBIlIeohTWnw7t27ExUVBUBycjJdunQB4OrVqyQlJRESEqKzGIUQQgghDJmU0RKintFsNGtsbMykSZPo0aMHRkZGFBQUkJycTGZmJqtWreKBBx4gICBAx9EKIYQQQhgmGVESop7QVOo/cOAA7dq148CBA7Rq1YrQ0FAiIyMxMTHhrbfeYu7cuZiYmLBu3TrtFD0hhBBCCFG3ZB8lIeqZ8PBwZsyYQXp6OiNGjGD69OlYWFgQGRlJREQE3t7ePPDAA7oOUwghhBDCoEmiJEQ9lJSUxOeff86aNWtwdnbmrbfe4oknntA+r1arMTKSAWEhhBBCiHtFEiUh6rFr166xePFivv76azp16sSrr77Ko48+KkmSEEIIIcQ9JomSEPWQWq1GrVZjYnKz3sqpU6dYsmQJycnJjB8/nhEjRuDm5qbjKIUQQgghDJckSkLUMyqVSlse/Pfy8vKYMWMGW7duJTg4mLNnz+ogOiGEEEKIhkHKgwtRzxgbG1NRUcHVq1cpKysjOjqa0NBQkpOTMTU1xdXVFTs7O12HKYQQQghh0GRESYh6QFOc4ZtvvmHjxo0UFhaSl5dHcnIylpaWdOnShVatWuHq6kqnTp0ICgrC2tpa12ELIYQQQhgsGVESoh7Q7Id04MAB1Go1nTt3pmnTpvTt25emTZtSWVkpiZEQQgghxH0kI0pC1CMqlQq1Wo2pqeltn5ey4EIIIYQQ94ckSkIIIYQQQghxC+maFkIIIYQQQohbSKIkhBBCCCGEELeQREkIIYQQQgghbiGJkhBCCCGEEELcQhIlIYQQQgghhLiFJEpCCCEalPHjxzNkyBDt/3v16sWMGTN0Fo8QQoj6SRIlIYRogG5NFurS0aNHUSgU5Ofn/6Pjbv2ZN2/ePYnrz+zatYvFixffs9e/fv36bd/n73/eeuute/b3hRBC3B0TXQcghBCiYbt69So2Njba/yuVyvv69+3t7e/p63t6epKenq79//vvv89PP/3EoUOHtI/d7/cshBDi78mIkhBCiD9YuXIlbdu2xcrKCk9PT6ZMmUJxcbH2+cTERAYNGkTjxo2xsrIiICCA/fv3c/36dR566CEAGjdujEKhYPz48X/5t5ydnXF1ddX+KJXK245KXbx4EYVCwfXr1wH44osvsLOzIzQ0FH9/f5RKJQMGDKiVlKhUKmbOnImdnR0ODg7Mnj2bW/dZv3XqnY+PD0uXLmXixIlYW1vj5eXFZ599Vut3Tp48SWBgIObm5nTs2JE9e/agUCi4ePHiH96fsbHxH96fiYkJrq6uWFtb06JFC3766adav/Pf//4XKysrioqKtCNSO3bsoFu3bpibmxMQEMDRo0dr/U5kZCQDBw5EqVTi4uLCmDFjyMnJ+ctzL4QQ4s9JoiSEEOIPjIyMWLVqFeHh4WzevJnDhw8ze/Zs7fNTp06loqKCY8eOceXKFd555x2USiWenp7s3LkTuDlSlJ6ezkcffXTP4iwtLeX9999ny5YtHDt2jKSkJF555RXt8ytWrGDjxo18/vnn/Prrr+Tl5bF79+6/fd0VK1bQsWNHLly4wJQpU5g8eTLR0dEAFBUVMWjQINq2bcv58+dZvHgxr7322l3Fb2VlxYgRI9i0aVOtxzdt2sTw4cOxtrbWPvbqq68ya9YsLly4QLdu3XjsscfIzc0FID09nZ49exIYGMi5c+f46aefyMzM5Mknn7yruIQQQsjUOyGEELfx+xEWX19fFi9ezOTJk1mzZg0ASUlJDBs2jLZt2wLQtGlT7fGaqWzOzs7Y2dn97d9q0qRJrf8nJib+4zirqqpYt24dzZo1A+DFF19k0aJF2uc//PBD5syZw7BhwwBYt24doaGhf/u6AwcOZMqUKQC89tprfPDBBxw9epRWrVqxbds2FAoF69evx9zcnNatW5Oamspzzz33j+P+vWeffZZu3bqRlpaGu7s7OTk57N27l4MHD9Y67sUXX9S+j7Vr1/LTTz/x+eefM3v2bNauXUuHDh1YunSp9viNGzfi6elJTEwMLVq0uKvYhBCiIZNESQghxB8cOXKEpUuXEhkZSWFhIdXV1ZSXl1NSUoKVlRXTpk1j8uTJHDhwgL59+zJs2DDatWt3V3/r+PHjtUZOGjdu/I9/19LSUpskAbi5uZGVlQVAQUEB6enpdO3aVfu8iYkJHTt2/MP0u1v9/r0oFApcXV21r3v16lXatWuHubm59piQkJB/HPOtQkJCCAgI4Msvv+T1119ny5YteHl50aNHj1rH3e59REVFARAWFsaRI0duu9YpLi5OEiUhhLgLMvVOCCFELYmJiQwcOJA2bdqwc+dOwsLCWL16NXBzBAdujoLEx8czZswYrly5QseOHfn444/v6u/5+vri5+en/TEyMsLI6ObX0+8TGs3f/j1TU9Na/1coFH+bBP0Tt3tdtVqtjUmhUNR6/t/+zWeffVY7/W7Tpk1MmDDhD3/jdjTHqNVqBg0axMWLF2v9xMbG/iHhEkII8c9IoiSEEKKWc+fOUV1dzYoVK+jSpQstWrQgLS3tD8d5enoyadIkdu3axaxZs1i/fj0AZmZmwM1CCnfLyckJoFZhhtsVSvgrtra2uLm5cfr0ae1j1dXVhIWF3XVcAK1ateLy5ctUVFRoHzt37ty/es3Ro0eTlJTEqlWriIiIYNy4cX845nbvo1WrVgB06NCBiIgIfHx8aiWdfn5+WFlZ/avYhBCioZJESQghGqiCgoI/jEAkJSXRrFkzqqur+fjjj4mPj2fLli2sW7eu1u/OmDGD0NBQEhISOH/+PIcPH8bf3x8Ab29vFAoFe/fuJTs7u1a1vH/Kz88PT09P3nrrLWJiYti3bx8rVqy449eZPn06y5cvZ/fu3URHRzNlypS/3d/p74waNQq1Ws3zzz9PVFQUoaGhvP/++wD/aBTodho3bszQoUN59dVX6dev3x/WbQGsXr1a+z6mTp3KjRs3mDhxInCzuEZeXh4jR47kzJkzxMfHc+DAASZOnPivElYhhGjIJFESQogG6ujRowQFBdX6mT9/PoGBgaxcuZJ33nmHNm3asG3bNpYtW1brd1UqFVOnTsXf358BAwbQsmVLbaEHDw8PFi5cyOuvv46LiwsvvvjiHcdmamrKV199RXR0NO3bt+edd97h7bffvuPXmTVrFmPHjmX8+PF07doVa2trHn/88Tt+nd+zsbHhv//9LxcvXiQwMJA33niD+fPnA9Rat3SnnnnmGSorK7XJz62WL1/OO++8Q/v27Tl+/Djff/89jo6OALi7u3PixAlUKhX9+/enTZs2TJ8+HVtbW+00RiGEEHdGUVMXk7mFEEKIBmzbtm1MmDCBgoICLCws7vo1pk+fTlpamnb6IsD169fx9fXlwoULBAYG1lHEQggh/o5UvRNCCCHu0JdffknTpk3x8PDg0qVLvPbaazz55JN3lSSVlpaSkJDAsmXLeOGFF2olSUIIIXRHxuOFEEKIO5SRkcHo0aPx9/fn5Zdf5oknnuCzzz67q9d69913CQwMxMXFhTlz5tRxpEIIIe6WTL0TQgghhBBCiFvIiJIQQgghhBBC3EISJSGEEEIIIYS4hSRKQgghhBBCCHELSZSEEEIIIYQQ4haSKAkhhBBCCCHELSRREkIIIYQQQohbSKIkhBBCCCGEELeQREkIIYQQQgghbiGJkhBCCCGEEELc4v8AfBhimaXnyRwAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "healthcare_ipo_status_counts = df_2_sorted[df_2_sorted['IPO Status']=='Private']['Last Funding Type'].value_counts()\n",
    "\n",
    "# Calculate the percentage for each funding type\n",
    "healthcare_total_counts = healthcare_ipo_status_counts.sum()\n",
    "healthcare_percentages = (healthcare_ipo_status_counts /healthcare_total_counts) * 100\n",
    "\n",
    "plt.figure(figsize = (10,5))\n",
    "ax = healthcare_ipo_status_counts.plot(kind='bar', color='blue', alpha=0.5)\n",
    "plt.title('Histogram of Last Funding Type for healthcare Company')\n",
    "plt.xlabel('Last Funding Type')\n",
    "plt.ylabel('Frequency')\n",
    "plt.xticks(rotation=80)\n",
    "plt.legend()\n",
    "\n",
    "for i, (count, percentage) in enumerate(zip(healthcare_ipo_status_counts, healthcare_percentages)):\n",
    "    ax.text(i, count, f'{percentage:.1f}%', ha='center', va='bottom')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e26ff32e-87e7-4958-a3b1-9d529dafd22e",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
